data_1gjz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gjz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.55 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.5 tpt . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.23 0.538 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 17.4 pt20 -61.58 110.56 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.405 0.621 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 15' ' ' LEU . 37.0 pt -72.49 146.21 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.098 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -87.84 130.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.625 ' O ' HG21 ' A' ' 13' ' ' ILE . 64.8 t -144.55 151.05 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.96 117.95 29.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.325 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.594 HG22 ' HZ3' ' A' ' 11' ' ' LYS . 74.1 p -68.68 152.74 44.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.4 mt -50.29 -37.67 37.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.735 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -66.63 -44.99 80.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.499 ' H ' ' HG1' ' A' ' 7' ' ' THR . . . 144.02 -40.12 1.21 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.444 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.594 ' HZ3' HG22 ' A' ' 7' ' ' THR . 21.8 pttp -52.13 139.66 22.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 111.668 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 13' ' ' ILE . 58.4 m -73.34 148.1 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.62 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.625 HG21 ' O ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -134.83 133.33 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.274 0.559 . . . . 0.0 112.024 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.464 HG23 ' NE2' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -106.17 145.25 31.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.299 178.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.851 HD13 ' HG3' ' A' ' 33' ' ' LYS . 3.9 tt -155.31 113.76 3.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.339 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 25.4 pt-20 -80.43 136.69 36.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.422 . . . . 0.0 111.906 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 1' ' ' MET . 2.4 m -158.21 143.5 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.491 ' HB2' ' CG ' ' A' ' 21' ' ' ASP . 41.4 mt-10 -62.75 133.76 95.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.18 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.716 2.277 . . . . 0.0 111.851 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.5 t -64.72 -31.64 72.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.947 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.491 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 63.6 m-20 -52.44 135.33 33.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -56.71 143.79 35.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.769 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.691 HG12 HG12 ' B' ' 23' ' ' ILE . 60.7 mt -57.27 -44.45 83.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.98 -41.92 79.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.705 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -65.73 -43.01 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.648 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG12 HG23 ' A' ' 17' ' ' VAL . 59.9 t -59.55 -49.77 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 54.0 mttp -62.51 -39.79 94.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.827 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -35.72 67.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.328 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.626 ' HD2' HD23 ' A' ' 15' ' ' LEU . 24.4 ttmm -65.39 -36.48 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.031 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.712 HD11 ' HG2' ' A' ' 41' ' ' GLN . 51.1 mt -55.81 -31.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.561 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 68.9 mt-30 -61.09 -52.52 64.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.39 -34.67 72.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.25 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.851 ' HG3' HD13 ' A' ' 15' ' ' LEU . 43.9 mmtm -65.89 -33.43 75.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.298 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -141.66 -70.69 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.289 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.48 54.27 0.03 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.776 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.57 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -138.35 128.12 14.88 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 111.728 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.718 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 78.0 Cg_exo -44.03 141.21 4.68 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.961 2.44 . . . . 0.0 112.703 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 11.9 Cg_endo -57.85 -35.01 99.01 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.765 2.31 . . . . 0.0 112.711 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.99 -37.87 80.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.718 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 19.9 mt-30 -60.7 -44.91 95.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.579 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.712 ' HG2' HD11 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -54.33 125.48 19.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.343 . . . . 0.0 110.771 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.589 ' H ' ' H ' ' B' ' 46' ' ' ALA . 70.0 mtt-85 -85.84 122.02 29.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.908 HD13 HD13 ' B' ' 43' ' ' LEU . 13.8 tp -84.31 132.98 34.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.7 mt -143.16 145.53 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 111.672 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 17.2 m-85 -133.9 140.07 46.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.23 119.21 5.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.094 0.473 . . . . 0.0 111.648 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.72 179.722 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.536 ' O ' ' HG3' ' B' ' 1' ' ' MET . 15.4 tpt . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.317 0.58 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.713 ' HB2' HG23 ' B' ' 14' ' ' THR . 16.9 pt20 -61.46 110.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.129 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.577 HG12 ' O ' ' B' ' 15' ' ' LEU . 35.1 pt -72.96 147.48 9.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -87.87 130.15 34.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.617 ' O ' HG21 ' B' ' 13' ' ' ILE . 61.9 t -141.95 152.74 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -123.1 117.44 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.927 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.597 HG21 HG23 ' B' ' 13' ' ' ILE . 77.1 p -69.9 150.7 46.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.723 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -48.38 -37.81 17.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.979 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -66.81 -45.23 79.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.48 ' H ' ' HG1' ' B' ' 7' ' ' THR . . . 143.75 -41.92 1.1 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.517 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' B' ' 11' ' ' LYS . 0.0 OUTLIER -54.07 140.1 32.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.126 0.489 . . . . 0.0 111.67 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.525 HG21 ' N ' ' B' ' 13' ' ' ILE . 50.7 m -72.4 147.35 46.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.543 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.617 HG21 ' O ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -130.56 141.6 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.195 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.713 HG23 ' HB2' ' B' ' 2' ' ' GLN . 0.2 OUTLIER -119.21 143.97 46.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.019 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.577 ' O ' HG12 ' B' ' 3' ' ' ILE . 3.5 tp -155.67 114.01 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 15.1 pt-20 -77.91 134.42 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' B' ' 1' ' ' MET . 13.9 m -155.54 141.52 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.214 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.516 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 41.8 mt-10 -61.26 135.09 93.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.352 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.1 -39.55 90.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.777 2.318 . . . . 0.0 111.894 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.7 t -64.38 -30.55 71.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.912 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.516 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 63.0 m-20 -53.95 134.74 43.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 74.1 p -55.91 142.95 33.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.695 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.691 HG12 HG12 ' A' ' 23' ' ' ILE . 60.1 mt -57.16 -43.61 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.032 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.33 -42.47 81.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.552 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -65.81 -42.01 91.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.615 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.418 HG12 HG23 ' B' ' 17' ' ' VAL . 94.1 t -59.89 -48.78 86.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.535 ' HE2' HG21 ' B' ' 23' ' ' ILE . 64.5 mttm -64.26 -40.09 95.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.923 0.392 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.86 65.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.398 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.442 ' HD3' ' HZ2' ' B' ' 33' ' ' LYS . 24.6 ttmm -65.87 -35.32 80.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.66 HD11 ' HG2' ' B' ' 41' ' ' GLN . 50.2 mt -56.46 -30.69 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.689 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 66.6 mt-30 -61.12 -52.4 65.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -34.43 72.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.134 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.442 ' HZ2' ' HD3' ' B' ' 29' ' ' LYS . 43.5 mmtm -65.79 -33.04 74.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.258 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -143.31 -68.43 0.34 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.746 0.307 . . . . 0.0 111.252 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.83 53.2 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.311 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.756 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -133.23 132.23 22.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.688 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 72.1 Cg_exo -50.87 142.39 33.3 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.729 2.286 . . . . 0.0 111.998 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.689 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 32.4 Cg_exo -56.66 -35.73 97.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.675 2.25 . . . . 0.0 112.482 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.36 -37.52 86.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.756 ' NE2' HG23 ' B' ' 36' ' ' ILE . 27.6 mt-30 -63.08 -42.52 99.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.692 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.66 ' HG2' HD11 ' B' ' 30' ' ' ILE . 0.6 OUTLIER -56.52 127.28 30.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.745 0.307 . . . . 0.0 110.489 179.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 70.9 mtt-85 -86.84 123.44 31.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.433 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.908 HD13 HD13 ' A' ' 43' ' ' LEU . 14.3 tp -85.5 132.7 34.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 66.4 mt -143.22 145.64 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.894 0.378 . . . . 0.0 111.823 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 16.0 m-85 -134.53 139.98 45.82 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.993 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.589 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 117.34 5.03 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.084 0.469 . . . . 0.0 111.645 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.501 179.69 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 ptm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.018 0.437 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.739 ' HB2' HG23 ' A' ' 14' ' ' THR . 3.3 pt20 -61.91 130.19 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.236 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.615 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.2 pt -103.72 140.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.39 124.77 34.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.784 ' HB ' HG12 ' A' ' 13' ' ' ILE . 35.2 t -141.89 143.7 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 111.43 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.663 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 67.5 mttm -111.45 128.3 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.291 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 ' HB3' ' A' ' 11' ' ' LYS . 81.3 p -63.81 -156.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.008 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.574 HD22 HG22 ' A' ' 36' ' ' ILE . 34.0 mt -61.06 -53.6 55.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.849 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -72.99 -44.89 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.663 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 142.2 35.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.61 ' HB3' HG22 ' A' ' 7' ' ' THR . 60.9 tttp -80.61 126.02 30.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.311 . . . . 0.0 110.861 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.488 ' C ' HG21 ' A' ' 13' ' ' ILE . 84.9 m -72.88 134.49 44.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.611 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.784 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.6 pt -136.18 138.05 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -95.81 144.01 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.729 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 29' ' ' LYS . 5.3 tt -161.55 114.34 1.85 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.5 pt-20 -87.99 136.28 33.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 16' ' ' GLU . 3.3 m -156.92 151.9 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.766 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.562 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 50.9 mt-10 -72.71 136.9 80.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.43 -32.32 72.45 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.734 2.289 . . . . 0.0 111.959 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.487 ' O ' HG21 ' B' ' 22' ' ' THR . 69.1 m -63.97 -31.78 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -57.22 128.81 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.788 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.495 HG21 ' O ' ' B' ' 20' ' ' SER . 76.2 p -57.18 150.71 17.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.992 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HA ' HG23 ' A' ' 26' ' ' VAL . 67.4 mt -57.28 -31.11 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.541 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 19.0 tt0 -64.72 -36.89 85.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.877 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.46 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.3 m120 -73.71 -47.6 38.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.374 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 23' ' ' ILE . 33.2 m -57.82 -43.55 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.131 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HE3' ' HB3' ' A' ' 38' ' ' PRO . 53.4 mtmt -72.02 -34.9 69.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.678 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 24' ' ' GLU . . . -55.52 -38.9 69.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.7 ' HB2' HD12 ' A' ' 15' ' ' LEU . 41.2 mtpt -65.6 -38.48 89.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.617 ' HB ' HE22 ' A' ' 41' ' ' GLN . 48.3 mm -54.68 -31.96 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.628 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.685 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 64.9 mt-30 -61.13 -51.82 67.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.05 -34.62 75.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.254 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -65.26 -32.1 73.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.399 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -145.46 -68.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.61 61.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.205 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.574 HG22 HD22 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -146.43 124.42 6.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.933 0.396 . . . . 0.0 112.003 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 39.7 Cg_exo -39.8 143.14 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.461 2.774 . . . . 0.0 112.979 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.685 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 38.3 Cg_exo -60.64 -37.79 76.85 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.805 2.336 . . . . 0.0 112.743 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.4 -35.54 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.008 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.637 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 19.7 mt-30 -62.03 -42.95 99.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.208 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.617 HE22 ' HB ' ' A' ' 30' ' ' ILE . 73.5 mt-30 -58.06 126.04 25.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 18.7 ttm105 -87.7 126.78 35.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.566 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.503 ' N ' HD21 ' A' ' 43' ' ' LEU . 3.2 mm? -75.78 131.16 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.468 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.933 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 71.3 mt -143.24 136.03 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.777 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.5 m-85 -131.62 141.07 49.55 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.635 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -155.14 122.24 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.019 0.438 . . . . 0.0 111.951 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' B' ' 40' ' ' GLN . . . . . . . . 0 C--N 1.331 0.267 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.611 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.7 ptm . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.95 0.405 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.538 ' NE2' HG23 ' B' ' 14' ' ' THR . 3.1 pt20 -62.39 128.92 38.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.807 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.57 HD13 HD13 ' B' ' 30' ' ' ILE . 32.7 pt -101.44 137.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.011 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.77 124.25 33.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.707 ' O ' HG21 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.79 140.11 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 0.0 111.419 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.651 ' HB3' ' HA3' ' B' ' 10' ' ' GLY . 66.6 mttm -100.78 136.09 41.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.137 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.599 HG22 ' HB3' ' B' ' 11' ' ' LYS . 82.2 p -68.86 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.336 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 mt -59.26 -53.2 60.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.6 p -75.95 -45.45 34.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 110.812 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.651 ' HA3' ' HB3' ' B' ' 6' ' ' LYS . . . 144.32 32.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.418 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.599 ' HB3' HG22 ' B' ' 7' ' ' THR . 61.4 tttp -79.63 127.25 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -73.51 136.52 44.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.707 HG21 ' O ' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -142.72 124.35 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.538 HG23 ' NE2' ' B' ' 2' ' ' GLN . 1.9 p -85.07 147.55 26.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.962 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' B' ' 29' ' ' LYS . 7.1 tp -160.66 113.22 1.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.6 pt-20 -80.14 140.27 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 p -169.13 133.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.7 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 52.9 mt-10 -56.35 139.17 74.19 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.612 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.11 -32.29 91.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.976 2.45 . . . . 0.0 112.226 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.495 ' O ' HG21 ' A' ' 22' ' ' THR . 33.8 t -63.37 -21.82 66.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.165 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 65.8 m-20 -66.18 133.02 49.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.734 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.487 HG21 ' O ' ' A' ' 20' ' ' SER . 66.9 p -59.12 148.5 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.607 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.483 ' HA ' HG23 ' B' ' 26' ' ' VAL . 65.5 mt -55.41 -30.86 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.433 0.635 . . . . 0.0 109.698 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 82.9 tt0 -63.57 -37.83 88.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.91 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.474 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 3.2 m120 -72.94 -48.64 35.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.607 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.486 HG21 ' N ' ' B' ' 27' ' ' LYS . 34.7 m -56.52 -44.59 80.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.223 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' B' ' 38' ' ' PRO . 53.6 mtmt -70.91 -34.26 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 24' ' ' GLU . . . -57.1 -38.05 72.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.989 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HB2' HD23 ' B' ' 15' ' ' LEU . 32.4 mtpt -64.66 -40.1 94.84 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.608 ' HB ' HE22 ' B' ' 41' ' ' GLN . 50.6 mm -54.47 -32.05 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.902 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.674 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 66.5 mt-30 -60.79 -53.32 58.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.53 -32.03 72.06 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.309 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.477 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 72.7 mmtt -66.41 -31.62 72.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.448 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -147.48 -61.93 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.578 0.228 . . . . 0.0 111.428 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.483 ' H ' HD13 ' B' ' 36' ' ' ILE . . . 135.77 58.11 0.06 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.79 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.659 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -137.99 129.87 16.14 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.633 0.254 . . . . 0.0 111.309 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.635 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -50.27 142.18 29.61 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.619 2.213 . . . . 0.0 112.128 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.674 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 35.6 Cg_exo -58.31 -38.87 88.8 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.744 2.296 . . . . 0.0 112.608 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.53 -35.45 76.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.659 ' NE2' HG23 ' B' ' 36' ' ' ILE . 27.2 mt-30 -64.96 -39.7 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.315 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.777 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 73.2 mt-30 -60.09 128.11 35.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.661 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.642 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 18.5 ttm105 -88.97 126.26 35.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.186 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.57 ' N ' HD21 ' B' ' 43' ' ' LEU . 3.0 mm? -75.77 131.53 39.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.531 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.933 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.3 mt -144.04 138.3 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.632 ' HB2' HG12 ' A' ' 5' ' ' VAL . 13.5 m-85 -133.9 143.55 48.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.433 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.439 ' C ' ' HA ' ' A' ' 41' ' ' GLN . . . -156.25 120.27 4.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.649 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.2 ptt? . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.88 0.372 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.739 ' HB2' HG21 ' A' ' 14' ' ' THR . 16.7 pt20 -74.95 111.79 10.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.871 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 15' ' ' LEU . 33.5 pt -72.25 135.91 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.479 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.41 129.03 35.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.788 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.7 t -146.51 135.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.809 0.338 . . . . 0.0 111.593 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.45 123.05 36.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -70.41 -157.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.351 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 36' ' ' ILE . 2.2 mm? -86.05 -48.97 8.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.125 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -71.08 -45.11 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.86 -36.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.787 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -49.22 131.16 19.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.897 0.38 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -84.76 132.3 34.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.788 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -96.65 130.04 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.696 179.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.739 HG21 ' HB2' ' A' ' 2' ' ' GLN . 1.4 m -107.5 129.13 54.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.715 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -159.56 114.56 2.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.106 0.479 . . . . 0.0 111.283 -178.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -76.39 144.32 40.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.389 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' CG2' HG13 ' A' ' 26' ' ' VAL . 30.9 m -149.7 145.99 17.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -68.55 143.52 95.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.154 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.78 -39.47 81.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.67 2.247 . . . . 0.0 112.189 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.436 ' O ' HG21 ' B' ' 22' ' ' THR . 47.0 t -64.42 -29.59 70.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.001 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -55.91 130.02 42.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.412 HG21 ' O ' ' B' ' 20' ' ' SER . 70.5 p -62.35 148.48 45.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.724 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.545 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 66.6 mt -54.91 -42.2 62.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -62.89 -29.59 70.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.25 -49.29 51.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.626 HG21 ' N ' ' A' ' 27' ' ' LYS . 35.3 m -62.54 -42.04 94.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.15 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.626 ' N ' HG21 ' A' ' 26' ' ' VAL . 57.8 mtpt -60.88 -37.18 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.404 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.66 79.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.488 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' NZ ' ' HA ' ' A' ' 26' ' ' VAL . 49.3 mttp -62.21 -41.5 98.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.622 HD12 HG23 ' A' ' 5' ' ' VAL . 60.3 mt -54.96 -31.79 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.893 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 60.9 mt-30 -63.09 -51.35 66.93 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.31 -32.96 70.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.794 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 31.3 mmmt -69.79 -31.88 70.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.916 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -140.52 -68.31 0.41 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.166 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.14 -32.57 1.05 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.452 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.631 HG23 ' NE2' ' A' ' 40' ' ' GLN . 1.0 OUTLIER -47.79 132.62 11.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.727 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 87.7 Cg_exo -49.88 155.72 3.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.418 2.746 . . . . 0.0 112.743 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 16.9 Cg_exo -66.79 -39.44 14.97 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.899 2.399 . . . . 0.0 112.944 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.1 -40.07 76.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.727 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 23.2 mt-30 -61.03 -42.22 98.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.411 . . . . 0.0 110.665 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 67.2 mt-30 -57.51 143.28 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.182 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.65 ' H ' ' H ' ' B' ' 46' ' ' ALA . 64.6 mtt85 -135.98 110.83 8.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.427 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.563 ' H ' HD21 ' A' ' 43' ' ' LEU . 1.4 pt? -77.46 138.71 39.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.575 ' H ' ' H ' ' B' ' 44' ' ' ILE . 62.9 mt -136.42 112.36 12.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.293 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 4.3 m-85 -84.65 146.69 27.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.601 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.85 126.42 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.401 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.039 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.2 ptt? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.861 0.362 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 16.4 pt20 -71.87 112.47 7.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 110.393 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.562 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.6 pt -72.64 133.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.825 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.48 125.07 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.114 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.722 ' HB ' ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -150.86 131.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.662 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.7 130.97 34.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.46 HG23 ' HG3' ' B' ' 34' ' ' GLU . 74.5 p -74.53 -157.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.491 HD13 HG22 ' B' ' 36' ' ' ILE . 2.0 mm? -86.05 -48.66 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -70.67 -45.23 65.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.575 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.94 -35.9 0.62 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -49.86 130.54 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 0.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -82.26 140.87 33.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.397 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.501 HG13 HG11 ' B' ' 5' ' ' VAL . 15.4 pt -116.98 130.17 72.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.291 0.567 . . . . 0.0 111.779 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -112.35 137.51 50.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.153 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.562 ' O ' HG12 ' B' ' 3' ' ' ILE . 2.6 pp -162.8 118.62 1.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -70.73 146.03 50.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.761 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.726 HG22 HG13 ' B' ' 26' ' ' VAL . 8.4 m -150.88 141.8 16.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.523 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 46.5 mm-40 -67.45 143.05 96.91 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.01 -36.72 99.44 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.752 2.302 . . . . 0.0 112.099 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.412 ' O ' HG21 ' A' ' 22' ' ' THR . 44.1 t -64.49 -31.49 72.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.159 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 47.2 m-20 -54.67 130.78 41.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 20' ' ' SER . 72.9 p -63.21 148.36 48.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.502 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.544 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 68.1 mt -54.27 -42.11 55.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -63.1 -29.83 71.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.22 -49.48 49.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.726 HG13 HG22 ' B' ' 17' ' ' VAL . 35.5 m -62.52 -41.32 91.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.61 ' N ' HG21 ' B' ' 26' ' ' VAL . 58.3 mtpt -61.52 -38.23 86.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.56 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.77 75.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.554 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.548 ' NZ ' ' HA ' ' B' ' 26' ' ' VAL . 50.1 mttp -62.57 -41.09 98.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.426 HD11 HG22 ' B' ' 30' ' ' ILE . 59.3 mt -54.78 -32.13 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.903 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.524 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 61.9 mt-30 -62.93 -51.27 67.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.9 -32.07 70.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.956 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 31.1 mmmt -69.75 -31.97 70.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.463 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.636 ' HB2' HD13 ' B' ' 36' ' ' ILE . 5.5 mm-40 -141.27 -61.32 0.48 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.714 0.292 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 126.79 40.93 0.32 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.453 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.679 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -110.46 135.94 20.63 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.558 0.218 . . . . 0.0 111.063 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.609 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 65.8 Cg_exo -51.55 143.71 35.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.451 2.1 . . . . 0.0 111.896 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.524 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -60.89 -37.61 76.06 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.727 2.285 . . . . 0.0 112.697 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -60.47 -39.11 86.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.155 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.679 ' NE2' HG23 ' B' ' 36' ' ' ILE . 26.8 mt-30 -63.56 -39.04 93.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -60.9 144.82 52.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.735 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.601 ' H ' ' H ' ' A' ' 46' ' ' ALA . 64.1 mtt85 -137.87 114.56 10.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -78.27 145.4 35.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.973 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.575 ' H ' ' H ' ' A' ' 44' ' ' ILE . 69.3 mt -142.46 108.51 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.01 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.686 ' HB2' HG12 ' A' ' 5' ' ' VAL . 4.0 m-85 -82.91 145.24 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.75 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.65 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -157.51 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.224 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.016 -179.754 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.118 0.485 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 18.7 pt20 -68.99 135.53 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.958 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.629 HG12 HD21 ' A' ' 15' ' ' LEU . 35.5 pt -108.31 144.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -89.11 129.28 35.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.986 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 13' ' ' ILE . 87.1 t -149.13 129.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.46 126.69 34.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 11' ' ' LYS . 74.8 p -73.13 -157.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.94 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 36' ' ' ILE . 54.2 mt -74.25 -50.39 19.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.998 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -73.35 -45.43 55.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.575 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.94 -31.81 0.55 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.807 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 7' ' ' THR . 58.6 tttp -46.35 129.98 10.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.908 0.385 . . . . 0.0 111.578 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -85.43 134.87 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.895 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.536 HD12 HG13 ' A' ' 5' ' ' VAL . 8.7 pt -101.3 128.23 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 112.014 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.456 HG21 ' HB2' ' A' ' 2' ' ' GLN . 1.9 m -93.05 116.91 29.49 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 3' ' ' ILE . 2.4 tt -143.67 115.21 8.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.263 0.554 . . . . 0.0 111.993 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' A' ' 1' ' ' MET . 16.8 pt-20 -76.66 143.76 39.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.951 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.414 HG12 HG13 ' A' ' 26' ' ' VAL . 10.8 p -168.45 138.15 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -51.72 140.17 28.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.007 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.91 -42.58 11.12 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.83 2.353 . . . . 0.0 111.954 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.45 ' O ' HG21 ' B' ' 22' ' ' THR . 50.6 m -63.67 -23.05 67.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.402 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 7.7 t70 -54.16 131.86 42.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.362 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.448 HG21 ' O ' ' B' ' 20' ' ' SER . 72.7 p -56.82 142.37 41.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.867 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.476 HD11 HD22 ' A' ' 43' ' ' LEU . 65.9 mt -54.63 -35.73 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.913 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 16.9 pt-20 -63.43 -37.05 85.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.386 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.593 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 3.5 m120 -74.54 -49.17 22.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.775 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG13 HG12 ' A' ' 17' ' ' VAL . 30.4 m -54.06 -42.67 56.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.687 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 50.9 mtmt -70.43 -38.92 74.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -56.66 -35.13 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HE2' HD13 ' A' ' 15' ' ' LEU . 88.3 tttt -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.871 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.733 HG23 HD12 ' A' ' 36' ' ' ILE . 59.4 mt -58.32 -36.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 41.4 tt0 -60.76 -50.97 71.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.922 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.88 -33.09 71.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.901 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG3' HD11 ' A' ' 15' ' ' LEU . 30.6 mmmt -69.41 -35.73 76.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.267 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -135.08 -66.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.959 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.59 -39.53 0.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.347 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.736 HG22 HD22 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -45.04 121.45 4.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.714 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 82.8 Cg_exo -46.41 147.46 4.08 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.097 2.531 . . . . 0.0 112.251 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 18.0 Cg_endo -59.41 -36.51 93.72 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.475 2.117 . . . . 0.0 112.298 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.08 -36.79 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.413 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.714 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 27.8 mt-30 -61.58 -36.24 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.421 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.765 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 99.6 mm-40 -51.3 122.03 7.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.697 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 87.2 mtm180 -85.11 121.27 27.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.648 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 43' ' ' LEU . 8.9 mp -69.13 122.6 19.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.404 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.826 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 61.4 mt -143.64 132.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.744 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 39.1 m-85 -136.63 148.76 47.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.562 ' HB2' ' HE ' ' B' ' 42' ' ' ARG . . . -153.06 131.34 12.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.984 0.421 . . . . 0.0 111.55 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.241 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.74 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.4 ptm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.016 0.436 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.525 ' NE2' HG23 ' B' ' 14' ' ' THR . 18.2 pt20 -67.84 130.97 44.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.596 HG12 ' HG ' ' B' ' 15' ' ' LEU . 39.5 pt -102.31 143.13 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.32 129.37 35.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.44 HG21 ' O ' ' B' ' 4' ' ' PHE . 97.4 t -148.92 127.7 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 111.34 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -83.23 126.45 32.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.554 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.456 HG22 ' O ' ' B' ' 11' ' ' LYS . 70.8 p -73.29 -157.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 54.1 mt -74.34 -49.83 21.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -74.28 -45.35 48.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.95 -31.33 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.773 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.456 ' O ' HG22 ' B' ' 7' ' ' THR . 55.9 tttp -47.05 129.88 12.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.691 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 40.7 m -82.63 143.97 30.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.427 HG12 ' O ' ' B' ' 5' ' ' VAL . 28.7 pt -119.24 129.31 75.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.14 0.495 . . . . 0.0 112.079 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.525 HG23 ' NE2' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -100.63 128.0 46.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.07 178.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.596 ' HG ' HG12 ' B' ' 3' ' ' ILE . 2.5 pp -152.9 120.16 5.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.2 pt-20 -73.06 138.18 45.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.029 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' B' ' 15' ' ' LEU . 2.2 m -157.65 137.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.416 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' B' ' 21' ' ' ASP . 92.6 mt-10 -53.99 139.34 53.8 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.19 -41.73 26.29 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.621 2.214 . . . . 0.0 111.799 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 22' ' ' THR . 60.9 m -64.14 -21.87 66.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.494 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.577 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.0 t70 -55.06 132.34 47.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 20' ' ' SER . 77.1 p -57.98 142.43 46.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.807 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.517 HD11 HD22 ' B' ' 43' ' ' LEU . 65.7 mt -54.74 -36.09 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.88 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.452 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 11.4 pt-20 -63.43 -36.86 85.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.577 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 3.5 m120 -73.74 -50.05 22.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 19.6 m -53.75 -42.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.591 ' HD2' ' HB2' ' B' ' 41' ' ' GLN . 50.7 mtmt -70.58 -38.73 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.376 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -58.03 -28.67 64.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' B' ' 33' ' ' LYS . 87.4 tttt -74.66 -32.91 62.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 109.906 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.618 HG23 HD12 ' B' ' 36' ' ' ILE . 53.0 mt -61.9 -41.0 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.155 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.698 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.3 pt20 -63.91 -42.83 97.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -58.47 -34.29 70.71 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.4 mmmt -72.35 -33.09 67.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.924 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -136.96 -65.86 0.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 161.42 -34.77 0.38 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.37 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.651 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -48.78 122.75 11.26 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.664 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 84.2 Cg_exo -50.13 146.57 17.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.804 2.336 . . . . 0.0 111.897 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.463 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 18.4 Cg_endo -57.98 -38.28 92.67 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.529 2.153 . . . . 0.0 112.693 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.41 -37.26 86.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.468 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.664 ' NE2' ' HD2' ' B' ' 37' ' ' PRO . 27.3 mt-30 -61.38 -35.41 77.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.629 0.252 . . . . 0.0 111.482 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.744 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 6.1 mm-40 -54.6 124.55 16.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 110.876 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 87.0 mtm180 -85.93 123.24 31.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.832 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.517 HD22 HD11 ' B' ' 23' ' ' ILE . 8.9 mp -70.57 123.14 21.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.199 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.826 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 61.5 mt -143.35 132.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.765 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 41.1 m-85 -136.9 148.38 47.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.591 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.639 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.15 134.75 15.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.024 0.44 . . . . 0.0 111.789 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.567 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.553 ' HE3' ' HG ' ' B' ' 43' ' ' LEU . 18.1 ptm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.017 0.437 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -63.31 139.05 58.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.79 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.602 HG12 ' O ' ' A' ' 15' ' ' LEU . 32.0 pt -114.47 153.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -87.45 131.13 34.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.697 ' HB ' HG22 ' A' ' 13' ' ' ILE . 50.1 t -142.28 155.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 89.3 mttt -141.22 122.24 14.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 51.4 p -69.16 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp -68.79 -46.51 68.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.785 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -83.44 26.8 0.63 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.107 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.88 37.1 83.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.594 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 22.0 ttmm -76.05 128.28 34.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.597 0.237 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -72.83 134.72 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.53 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.697 HG22 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -151.3 133.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.234 0.54 . . . . 0.0 112.233 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -97.64 149.63 22.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.509 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 3' ' ' ILE . 12.4 tp -155.83 113.19 3.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.0 pt-20 -81.53 130.22 34.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.268 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.582 HG13 ' NZ ' ' A' ' 29' ' ' LYS . 5.6 m -156.72 131.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.495 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 25.4 pt-20 -55.55 141.59 63.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.84 -37.82 91.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.813 2.342 . . . . 0.0 112.313 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.8 m -63.67 -21.8 66.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.623 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' OD2' HG11 ' A' ' 26' ' ' VAL . 38.7 t70 -61.47 134.29 56.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 p -64.67 146.33 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.473 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.698 HG21 ' HZ1' ' A' ' 27' ' ' LYS . 60.4 mt -55.43 -37.17 43.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.241 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.705 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 16.3 pt-20 -58.13 -35.62 71.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.209 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.499 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 m120 -75.12 -48.36 24.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.748 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 23' ' ' ILE . 34.5 m -56.02 -42.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.561 0.219 . . . . 0.0 111.146 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.705 ' HZ2' ' HA ' ' A' ' 24' ' ' GLU . 35.4 mtmm -69.8 -38.44 76.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.408 . . . . 0.0 110.569 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.21 77.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.638 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.582 ' NZ ' HG13 ' A' ' 17' ' ' VAL . 83.3 mttt -63.66 -38.29 90.55 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.53 HG22 HG13 ' A' ' 5' ' ' VAL . 72.8 mt -56.06 -34.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.731 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.42 ' OE1' ' HG3' ' A' ' 38' ' ' PRO . 20.7 mt-30 -61.52 -43.14 99.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -63.89 -39.82 95.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.26 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HD3' HD13 ' A' ' 13' ' ' ILE . 67.4 mttm -78.08 3.4 15.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.124 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -169.05 -109.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.197 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.46 51.28 0.03 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.354 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -123.09 129.26 25.02 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.451 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.721 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 91.8 Cg_exo -45.84 150.09 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.997 2.465 . . . . 0.0 112.509 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 32.1 Cg_exo -57.15 -34.33 97.56 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.518 2.146 . . . . 0.0 112.07 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.96 -39.49 93.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.03 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.721 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 27.3 mt-30 -60.89 -36.64 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.257 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.666 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 4.1 mm-40 -53.07 122.73 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.807 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 79.5 mtp180 -91.38 121.31 33.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.656 HD13 ' HE3' ' B' ' 1' ' ' MET . 8.0 mt -82.28 129.91 34.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 1.002 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 63.3 mt -143.14 140.77 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.948 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 42.0 m-85 -135.14 138.87 44.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.676 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.86 138.47 21.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 111.512 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.337 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.908 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 43' ' ' LEU . 18.5 ptm . . . . . 0 C--O 1.23 0.038 0 CA-C-O 121.09 0.472 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.742 ' HB2' HG23 ' B' ' 14' ' ' THR . 19.1 pt20 -62.28 142.75 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.656 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.4 pt -118.28 152.23 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.757 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -87.37 132.41 33.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.621 ' HB ' HG22 ' B' ' 13' ' ' ILE . 48.8 t -143.82 154.62 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.003 0.43 . . . . 0.0 111.349 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 57.9 mttp -139.04 123.22 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.186 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' B' ' 11' ' ' LYS . 56.2 p -72.72 -156.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.173 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.575 HD11 ' N ' ' B' ' 8' ' ' LEU . 6.5 mp -64.07 -50.91 66.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -82.8 28.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.335 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.02 36.66 68.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.485 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.65 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 21.6 ttmm -73.95 128.67 36.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 111.001 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -72.88 131.76 42.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.376 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.621 HG22 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -145.02 136.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.342 0.591 . . . . 0.0 111.85 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.742 HG23 ' HB2' ' B' ' 2' ' ' GLN . 0.3 OUTLIER -101.18 147.16 26.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.912 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.656 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.8 tt -157.62 114.13 2.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.153 0.502 . . . . 0.0 111.15 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.518 ' O ' HG11 ' B' ' 17' ' ' VAL . 24.5 pt-20 -83.39 134.23 34.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.778 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.604 HG13 ' NZ ' ' B' ' 29' ' ' LYS . 1.8 m -159.47 133.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' B' ' 21' ' ' ASP . 14.4 pt-20 -56.25 141.06 70.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.411 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.75 -37.86 95.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.921 2.414 . . . . 0.0 112.169 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 51.0 m -63.66 -24.45 67.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.715 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.521 ' HB2' ' HG3' ' B' ' 18' ' ' GLU . 63.2 t0 -58.95 133.46 56.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 76.8 p -64.12 146.86 53.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.637 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.698 HG21 ' HZ1' ' B' ' 27' ' ' LYS . 60.4 mt -56.07 -37.0 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.292 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.7 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 16.3 pt-20 -58.23 -36.54 73.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.363 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.1 m120 -74.88 -48.9 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.701 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' B' ' 23' ' ' ILE . 34.4 m -55.12 -41.73 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.634 0.254 . . . . 0.0 111.017 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.7 ' HZ2' ' HA ' ' B' ' 24' ' ' GLU . 35.4 mtmm -70.21 -38.4 75.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.403 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.89 73.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.471 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.604 ' NZ ' HG13 ' B' ' 17' ' ' VAL . 84.5 mttt -66.16 -37.22 85.12 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.56 HG22 HG13 ' B' ' 5' ' ' VAL . 67.8 mt -57.68 -32.12 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.643 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 21.8 mt-30 -61.58 -46.81 88.28 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.44 -33.89 77.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.57 ' HG3' HD13 ' B' ' 15' ' ' LEU . 71.9 mmtt -68.78 -18.08 64.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.435 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -157.72 -90.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.742 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.07 48.53 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.607 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.811 HG23 HE21 ' B' ' 40' ' ' GLN . 0.4 OUTLIER -118.35 134.51 23.42 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.614 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 71.0 Cg_exo -51.57 147.64 22.82 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.771 2.314 . . . . 0.0 111.851 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HG3' ' OE1' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -56.95 -34.44 97.37 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.448 2.098 . . . . 0.0 112.075 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.33 -35.03 78.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.561 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.811 HE21 HG23 ' B' ' 36' ' ' ILE . 26.5 mt-30 -66.96 -37.48 84.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.676 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -52.26 126.93 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.788 0.327 . . . . 0.0 110.675 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.676 ' H ' ' H ' ' A' ' 46' ' ' ALA . 80.0 mtp180 -90.17 125.98 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.164 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.553 ' HG ' ' HE3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -80.87 125.4 30.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 1.002 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 63.2 mt -143.25 138.82 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.408 . . . . 0.0 111.307 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 35.3 m-85 -136.93 140.26 42.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.543 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.02 136.4 17.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.605 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.216 179.747 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.63 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.6 ptt? . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.993 0.425 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.594 ' HB3' HG21 ' A' ' 14' ' ' THR . 15.2 mt-30 -66.49 111.23 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.58 HG23 HD21 ' B' ' 43' ' ' LEU . 44.7 pt -84.14 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.203 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -88.0 133.01 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.72 ' HB ' HG13 ' A' ' 13' ' ' ILE . 88.6 t -149.07 126.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -82.28 116.04 21.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.54 ' HG1' HG21 ' A' ' 9' ' ' THR . 72.7 p -67.7 -159.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.432 . . . . 0.0 110.911 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 36' ' ' ILE . 1.3 mp -82.45 -44.63 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.72 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.54 HG21 ' HG1' ' A' ' 7' ' ' THR . 5.9 t -73.15 -44.84 59.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.312 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.75 -39.96 0.64 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.998 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -51.86 135.12 30.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 111.565 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 p -81.18 138.65 35.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.6 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.72 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -96.4 129.33 46.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.594 HG21 ' HB3' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -96.76 137.0 36.51 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.853 HD12 ' HD2' ' A' ' 29' ' ' LYS . 2.0 tp -162.32 115.1 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 111.975 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 1' ' ' MET . 25.4 pt-20 -85.06 132.68 34.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.359 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.562 HG22 HG13 ' A' ' 26' ' ' VAL . 6.9 m -157.27 139.76 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.747 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.64 144.03 89.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.431 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.94 -37.7 52.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.769 2.313 . . . . 0.0 112.159 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -63.13 -23.23 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.374 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -60.96 134.84 57.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 p -61.69 141.57 57.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.71 HG12 HG12 ' B' ' 23' ' ' ILE . 57.6 mt -53.83 -41.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.124 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 22.3 pt-20 -55.29 -39.99 70.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.334 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.472 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.5 m120 -66.34 -51.02 61.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.822 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 17' ' ' VAL . 11.5 m -60.08 -40.05 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.022 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.687 ' NZ ' ' HB2' ' A' ' 41' ' ' GLN . 29.5 mtpp -64.02 -43.7 94.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.733 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -58.37 -42.37 86.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.11 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.853 ' HD2' HD12 ' A' ' 15' ' ' LEU . 39.5 ttmt -62.71 -36.5 83.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 26' ' ' VAL . 62.8 mt -55.51 -37.05 43.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.733 HE21 ' HA ' ' A' ' 28' ' ' ALA . 68.1 mt-30 -58.83 -40.43 84.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.77 -39.83 95.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.649 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 4.8 mmmp? -61.22 -40.0 92.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.71 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.35 -89.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.442 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 45.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.578 HG23 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -122.68 126.43 26.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.641 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 65.8 Cg_exo -43.13 141.7 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.089 2.526 . . . . 0.0 112.706 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.589 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 28.0 Cg_endo -62.14 -33.84 80.87 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.641 2.227 . . . . 0.0 112.125 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.641 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 15.6 mt-30 -63.33 -39.92 95.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.581 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.687 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 6.6 mm100 -53.06 132.26 37.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.705 ' H ' ' H ' ' B' ' 46' ' ' ALA . 22.1 tpp180 -107.53 119.67 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.34 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.497 HD21 HG23 ' B' ' 3' ' ' ILE . 11.0 mp -66.88 126.79 30.19 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.158 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.827 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.9 mt -144.21 123.25 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 4.0 m-85 -121.84 148.6 44.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.425 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.652 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.64 130.28 14.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 0.0 111.916 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.394 179.313 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.1 ptt? . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.533 ' NE2' HG23 ' B' ' 14' ' ' THR . 17.2 pt20 -65.4 110.72 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.302 0.572 . . . . 0.0 110.868 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.519 HG12 ' HB3' ' B' ' 15' ' ' LEU . 37.4 pt -76.99 141.04 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.08 131.29 34.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.657 ' HB ' HG13 ' B' ' 13' ' ' ILE . 98.4 t -149.04 124.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 111.353 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -82.49 120.53 25.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.253 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.625 ' HG1' HG21 ' B' ' 9' ' ' THR . 73.5 p -69.96 -160.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.65 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.858 HD13 HG22 ' B' ' 36' ' ' ILE . 6.3 mp -82.14 -42.87 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.625 HG21 ' HG1' ' B' ' 7' ' ' THR . 5.8 t -71.58 -44.79 63.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.91 -39.66 0.72 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.036 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -52.04 134.95 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 111.961 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -82.12 142.71 32.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.021 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.657 HG13 ' HB ' ' B' ' 5' ' ' VAL . 11.4 pt -114.15 122.86 69.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.308 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.533 HG23 ' NE2' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -87.51 148.67 24.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.67 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.527 ' C ' ' HA ' ' B' ' 2' ' ' GLN . 5.3 tt -162.94 112.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.429 . . . . 0.0 110.659 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' B' ' 1' ' ' MET . 14.5 pt-20 -82.78 132.16 35.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.821 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.55 HG22 HG23 ' B' ' 26' ' ' VAL . 2.4 m -159.44 139.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.617 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.86 142.75 88.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.452 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 26.3 Cg_endo -60.22 -37.24 84.49 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.878 2.385 . . . . 0.0 112.141 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.8 m -63.63 -26.48 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.659 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -56.64 135.26 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.343 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -61.87 142.27 57.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.71 HG12 HG12 ' A' ' 23' ' ' ILE . 58.8 mt -54.61 -40.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.533 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 12.0 pt-20 -55.16 -44.46 75.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.533 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.2 m120 -64.13 -47.95 77.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.55 HG23 HG22 ' B' ' 17' ' ' VAL . 24.6 t -56.34 -45.17 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.224 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.657 ' NZ ' ' HB2' ' B' ' 41' ' ' GLN . 28.2 mtpp -66.25 -41.16 90.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.203 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.703 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -58.28 -40.97 83.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.58 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -63.41 -34.89 78.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.397 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 26' ' ' VAL . 59.2 mt -58.19 -35.69 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.274 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.703 HE21 ' HA ' ' B' ' 28' ' ' ALA . 68.7 mt-30 -60.48 -47.74 84.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.66 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.687 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' B' ' 33' ' ' LYS . 22.8 tptp -65.65 -32.57 74.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.931 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.418 ' HB3' HD13 ' B' ' 36' ' ' ILE . 5.3 tp10 -144.89 -68.25 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.684 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.89 47.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.737 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.858 HG22 HD13 ' B' ' 8' ' ' LEU . 0.1 OUTLIER -124.94 128.88 24.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.5 0.19 . . . . 0.0 111.394 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.641 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 54.2 Cg_exo -51.77 138.35 50.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.341 2.028 . . . . 0.0 111.554 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.562 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 19.0 Cg_endo -58.88 -34.0 98.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.577 2.185 . . . . 0.0 112.202 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.84 -39.15 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.643 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.699 ' NE2' HG23 ' B' ' 36' ' ' ILE . 22.9 mt-30 -65.79 -38.21 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.657 ' HB2' ' NZ ' ' B' ' 27' ' ' LYS . 7.0 mm100 -54.31 133.78 45.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.652 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.1 tpp180 -108.49 121.79 45.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.58 HD21 HG23 ' A' ' 3' ' ' ILE . 10.8 mp -68.94 127.41 33.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.189 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.827 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -144.14 122.44 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.034 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.638 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.1 m-85 -120.97 146.03 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.705 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -148.25 128.9 14.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 111.696 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.302 179.526 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' HG3' ' A' ' 1' ' ' MET . 15.1 tpt . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.209 0.528 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.417 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 3.2 pt20 -61.72 127.34 30.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 15' ' ' LEU . 28.8 pt -95.47 132.44 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.576 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -88.83 128.77 35.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.76 HG12 ' HB2' ' B' ' 45' ' ' PHE . 63.4 t -148.49 138.49 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.151 0.501 . . . . 0.0 112.242 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' N ' HG11 ' A' ' 5' ' ' VAL . 35.8 mtmm -99.44 127.71 45.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.725 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.6 HG22 ' HB3' ' A' ' 11' ' ' LYS . 73.1 p -68.49 -156.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 111.302 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.649 ' H ' HD13 ' A' ' 8' ' ' LEU . 2.7 mp -64.36 -51.15 64.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -78.61 -45.73 20.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.866 0.365 . . . . 0.0 111.067 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 28.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.315 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HB3' HG22 ' A' ' 7' ' ' THR . 15.8 tppt? -77.37 122.65 25.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 m -75.38 138.71 41.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.548 HG13 ' HB ' ' A' ' 5' ' ' VAL . 12.4 pt -140.07 128.69 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.215 0.531 . . . . 0.0 112.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -97.37 145.99 25.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.67 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 3' ' ' ILE . 5.8 tt -163.94 114.05 1.27 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.04 0.448 . . . . 0.0 110.656 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' HG11 ' A' ' 17' ' ' VAL . 11.9 pt-20 -79.4 138.1 37.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -159.46 137.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.84 135.45 89.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -35.93 76.77 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 111.749 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -63.77 -29.18 70.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.11 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.52 135.27 50.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.249 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.631 HG23 ' HG2' ' A' ' 24' ' ' GLU . 21.4 m -59.68 148.84 32.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 111.482 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 64.3 mt -60.34 -43.44 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.226 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.631 ' HG2' HG23 ' A' ' 22' ' ' THR . 12.6 pt-20 -59.25 -30.46 68.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 2.0 m120 -71.26 -52.25 20.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' ' 27' ' ' LYS . 34.4 m -59.97 -40.98 84.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.43 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 58.4 mtpt -62.39 -42.79 99.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -57.93 -34.8 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.349 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.3 mttm -66.6 -45.56 78.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.053 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.726 HD11 HG23 ' A' ' 5' ' ' VAL . 79.0 mt -55.15 -36.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 45.8 tt0 -61.92 -49.5 75.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.085 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -62.09 -32.27 72.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.058 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HG3' HD13 ' A' ' 15' ' ' LEU . 30.7 mmmt -68.49 -36.46 78.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.215 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.37 -67.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.789 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.33 -35.22 0.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.427 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.676 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.73 122.55 4.63 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.72 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 89.2 Cg_exo -47.22 147.07 5.95 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.161 2.574 . . . . 0.0 112.469 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.98 -35.62 98.27 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.463 2.109 . . . . 0.0 111.993 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -61.69 -38.34 87.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.72 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 26.2 mt-30 -65.72 -44.03 87.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.566 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.0 mt-30 -54.69 125.67 20.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.951 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.655 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 70.6 mtt-85 -97.36 127.99 43.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.524 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.555 ' HG ' ' HE1' ' A' ' 45' ' ' PHE . 10.8 tp -75.07 128.91 36.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 66.2 mt -143.5 139.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.935 0.397 . . . . 0.0 111.885 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.696 ' HB2' HG12 ' B' ' 5' ' ' VAL . 4.2 m-85 -128.19 147.72 50.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.612 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.4 124.66 5.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 111.596 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' HA3' ' C ' ' B' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.243 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.549 ' O ' ' HG3' ' B' ' 1' ' ' MET . 14.2 tpt . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.247 0.546 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 3.3 pt20 -61.81 126.62 27.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.549 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.633 HD13 HD22 ' B' ' 15' ' ' LEU . 29.8 pt -95.62 133.39 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.92 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.36 129.63 35.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.714 ' HB ' HG13 ' B' ' 13' ' ' ILE . 61.0 t -147.8 143.97 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.053 0.454 . . . . 0.0 112.086 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.473 ' N ' HG11 ' B' ' 5' ' ' VAL . 36.4 mtmm -104.97 126.6 52.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.825 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -69.53 -156.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.868 0.366 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.4 ' H ' HD11 ' B' ' 8' ' ' LEU . 5.6 mp -59.96 -57.17 14.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -74.86 -45.49 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.64 30.59 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.003 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -82.43 130.99 35.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.408 . . . . 0.0 111.011 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -75.72 131.16 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.234 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.714 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -118.54 130.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.854 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -104.25 135.15 46.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.573 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.633 HD22 HD13 ' B' ' 3' ' ' ILE . 3.9 tp -161.35 113.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.169 0.509 . . . . 0.0 111.705 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.469 ' O ' HD13 ' B' ' 15' ' ' LEU . 12.4 pt-20 -77.78 142.4 38.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.703 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' B' ' 1' ' ' MET . 12.3 p -165.42 135.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -54.64 133.27 64.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.868 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 11.1 Cg_endo -55.94 -36.63 96.05 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.871 2.381 . . . . 0.0 111.843 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.424 ' O ' HG21 ' A' ' 22' ' ' THR . 46.1 t -63.74 -27.81 69.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -56.15 135.42 53.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.73 ' HB ' HD21 ' B' ' 25' ' ' ASN . 23.4 m -58.24 150.27 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.492 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 64.2 mt -62.3 -43.92 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.546 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.623 ' HG2' HG23 ' B' ' 22' ' ' THR . 12.5 pt-20 -57.4 -33.19 67.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.649 0.261 . . . . 0.0 111.195 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.73 HD21 ' HB ' ' B' ' 22' ' ' THR . 70.4 m-80 -73.05 -50.21 24.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.409 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.486 HG21 ' N ' ' B' ' 27' ' ' LYS . 33.0 m -58.66 -38.06 69.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 59.0 mtpt -65.96 -43.64 87.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.044 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -59.31 -25.69 64.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.628 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 53.9 mttm -74.12 -39.79 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 109.918 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.665 HD11 HG23 ' B' ' 5' ' ' VAL . 69.4 mt -59.59 -41.74 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.283 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.9 pt20 -65.43 -40.18 92.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.33 -32.48 72.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.6 mmmt -73.92 -31.44 63.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.769 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.505 ' HB3' HD13 ' B' ' 36' ' ' ILE . 48.3 tp10 -135.55 -67.19 0.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 151.85 -25.88 0.92 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.163 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.707 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -51.13 123.58 20.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.688 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -52.39 144.93 38.31 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.804 2.336 . . . . 0.0 111.85 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.48 -35.49 96.69 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.501 2.134 . . . . 0.0 112.246 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.15 -38.6 89.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.189 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.707 ' NE2' HG23 ' B' ' 36' ' ' ILE . 26.9 mt-30 -66.55 -41.63 88.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.417 ' HA ' ' C ' ' A' ' 46' ' ' ALA . 71.3 mt-30 -56.77 130.93 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.612 ' H ' ' H ' ' A' ' 46' ' ' ALA . 71.6 mtt-85 -106.48 133.08 51.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.973 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.566 HD11 HG23 ' A' ' 3' ' ' ILE . 23.3 mt -76.61 131.83 39.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.896 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 65.4 mt -143.75 128.93 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.76 ' HB2' HG12 ' A' ' 5' ' ' VAL . 2.7 m-85 -121.45 142.41 50.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.648 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.44 125.66 9.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.048 0.452 . . . . 0.0 111.593 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.503 ' HA3' ' C ' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.012 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.105 0.479 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.873 ' HB2' HG21 ' A' ' 14' ' ' THR . 3.1 pt20 -66.58 110.59 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.295 0.569 . . . . 0.0 111.083 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 15' ' ' LEU . 18.8 pt -77.44 140.99 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.774 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -89.5 131.97 35.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.949 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 13' ' ' ILE . 2.3 p -149.86 135.04 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.804 0.335 . . . . 0.0 111.383 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -100.11 131.19 46.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.698 HG23 ' HG3' ' A' ' 34' ' ' GLU . 74.6 p -67.21 -158.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.735 0.302 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.427 ' CD1' HG22 ' A' ' 36' ' ' ILE . 4.8 mp -89.28 -46.85 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.475 HG21 ' N ' ' A' ' 10' ' ' GLY . 6.0 t -72.05 -45.15 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' N ' HG21 ' A' ' 9' ' ' THR . . . 158.58 -31.37 0.47 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.927 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 12' ' ' THR . 7.0 tmtm? -45.48 126.95 7.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.905 0.384 . . . . 0.0 110.748 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.505 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 66.9 m -83.24 138.02 33.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.787 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -118.8 139.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.873 HG21 ' HB2' ' A' ' 2' ' ' GLN . 6.8 m -127.37 137.99 52.9 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.656 HD22 HG11 ' A' ' 17' ' ' VAL . 4.0 tt -159.82 121.97 3.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.048 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 22.8 pt-20 -72.13 143.42 48.98 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.75 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.656 HG11 HD22 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -158.36 140.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.414 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.34 143.24 90.44 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.086 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.85 -37.63 95.59 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.811 2.341 . . . . 0.0 112.14 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -64.17 -31.84 73.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.852 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -56.2 130.69 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.569 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.411 HG23 ' O ' ' B' ' 20' ' ' SER . 70.3 p -63.5 147.7 50.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.74 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.594 HG12 HG12 ' B' ' 23' ' ' ILE . 65.5 mt -54.58 -37.9 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.253 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 12.6 pt-20 -62.06 -31.7 72.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.95 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.48 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.4 m120 -74.62 -49.33 21.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.669 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.538 HG21 ' N ' ' A' ' 27' ' ' LYS . 26.8 m -57.15 -42.63 80.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.162 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' N ' HG21 ' A' ' 26' ' ' VAL . 51.1 mtmt -67.15 -37.71 84.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.464 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.485 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . . . -53.7 -36.86 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.262 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.556 ' HZ3' HG13 ' A' ' 17' ' ' VAL . 80.5 mttt -69.13 -42.55 75.86 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 HD13 ' A' ' 36' ' ' ILE . 61.4 mt -57.93 -30.35 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.578 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 15.6 mt-30 -60.83 -44.53 96.82 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.722 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 72.5 mmtt -61.52 -29.17 69.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.621 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG3' HG23 ' A' ' 7' ' ' THR . 58.6 mm-40 -146.78 -84.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.88 43.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.079 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.656 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -113.28 124.04 32.22 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.784 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 56.8 Cg_exo -41.78 143.78 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.994 2.463 . . . . 0.0 112.334 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 11.8 Cg_endo -57.21 -35.53 98.91 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.494 2.129 . . . . 0.0 112.066 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -64.51 -39.65 94.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.683 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.784 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 27.8 mt-30 -60.22 -39.87 88.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.464 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 70.7 mt-30 -61.15 119.81 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.93 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 22.5 tpp180 -90.44 128.49 36.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.569 HD12 HG23 ' A' ' 23' ' ' ILE . 21.7 mt -80.82 136.24 36.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 111.01 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.959 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.1 mt -143.27 126.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.959 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.645 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 1.9 m-85 -116.48 142.08 47.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -145.13 123.23 12.12 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.992 0.425 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.311 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.819 179.748 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.536 ' HG2' ' O ' ' B' ' 1' ' ' MET . 28.2 ttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.13 0.49 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.694 ' HB2' HG21 ' B' ' 14' ' ' THR . 3.0 pt20 -62.27 110.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 43' ' ' LEU . 13.7 pt -80.09 140.74 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.105 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -89.12 130.13 35.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.012 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.83 HG11 HG13 ' B' ' 13' ' ' ILE . 1.6 p -150.07 131.52 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.335 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -93.38 131.58 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.732 HG23 ' HG3' ' B' ' 34' ' ' GLU . 74.1 p -68.44 -157.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 111.263 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -85.96 -48.89 8.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.055 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.459 HG21 ' N ' ' B' ' 10' ' ' GLY . 5.7 t -74.69 -45.2 46.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.827 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.459 ' N ' HG21 ' B' ' 9' ' ' THR . . . 159.49 -30.73 0.42 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.732 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.503 ' HD3' ' N ' ' B' ' 12' ' ' THR . 7.3 tmtm? -45.65 127.87 8.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.97 0.414 . . . . 0.0 110.767 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.503 ' N ' ' HD3' ' B' ' 11' ' ' LYS . 34.0 m -84.46 140.55 31.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.687 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.83 HG13 HG11 ' B' ' 5' ' ' VAL . 7.1 pt -134.67 140.62 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.022 0.439 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.694 HG21 ' HB2' ' B' ' 2' ' ' GLN . 4.1 m -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.727 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.477 ' C ' ' HA ' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -153.94 134.92 13.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 12.5 pt-20 -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.174 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' B' ' 1' ' ' MET . 7.5 m -154.81 137.47 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.064 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.527 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 4.5 mm-40 -69.74 143.66 92.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.29 -35.82 98.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.778 2.319 . . . . 0.0 112.232 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 22' ' ' THR . 43.5 t -63.88 -31.5 72.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.986 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 49.7 m-20 -57.49 130.33 45.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.652 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -62.9 147.39 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.594 HG12 HG12 ' A' ' 23' ' ' ILE . 65.9 mt -53.28 -37.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.468 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 22.2 pt-20 -62.42 -32.61 73.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.468 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.4 m120 -73.39 -49.22 28.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.687 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.521 HG21 ' N ' ' B' ' 27' ' ' LYS . 28.2 m -57.86 -42.85 83.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.64 0.257 . . . . 0.0 111.158 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.521 ' N ' HG21 ' B' ' 26' ' ' VAL . 51.8 mtmt -66.42 -37.25 84.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.508 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HA ' ' CD ' ' B' ' 31' ' ' GLN . . . -54.9 -37.48 66.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -67.63 -42.22 82.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 62.8 mt -58.45 -30.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.594 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.582 ' OE1' ' HD3' ' B' ' 38' ' ' PRO . 16.3 mt-30 -61.2 -45.57 94.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.61 -35.87 82.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.772 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 72.5 mmtt -61.01 -29.32 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.523 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.732 ' HG3' HG23 ' B' ' 7' ' ' THR . 57.4 mm-40 -147.41 -81.15 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.2 44.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.751 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.706 HG23 HE21 ' B' ' 40' ' ' GLN . 0.4 OUTLIER -112.96 124.44 31.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.616 0.246 . . . . 0.0 111.479 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.785 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 97.1 Cg_exo -44.78 143.66 4.09 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.818 2.346 . . . . 0.0 112.043 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.582 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 11.6 Cg_endo -56.65 -35.74 97.62 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.194 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -64.99 -39.24 93.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.785 ' NE2' ' HD2' ' B' ' 37' ' ' PRO . 27.9 mt-30 -61.56 -39.76 92.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.468 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 70.5 mt-30 -59.72 124.41 20.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.532 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 22.4 tpp180 -95.43 123.47 38.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.73 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.533 HD12 HG23 ' B' ' 23' ' ' ILE . 27.1 mt -75.49 135.31 40.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.088 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.959 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 71.7 mt -143.39 124.99 11.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.2 m-85 -115.64 146.52 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.584 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.5 129.59 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.529 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.524 179.754 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.552 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.8 tpt . . . . . 0 CA--C 1.532 0.275 0 CA-C-O 121.062 0.458 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 pt20 -61.18 111.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.183 0.516 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 15' ' ' LEU . 24.6 pt -75.56 132.86 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.98 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -89.08 131.56 35.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.798 ' HB ' HG13 ' A' ' 13' ' ' ILE . 64.9 t -143.79 131.39 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 111.665 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.72 123.46 35.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.184 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 11' ' ' LYS . 71.5 p -70.48 -157.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.103 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.763 HD22 HG22 ' A' ' 36' ' ' ILE . 2.3 mm? -82.37 -48.13 11.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.778 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -73.18 -45.28 57.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.02 -31.64 0.5 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.881 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 7' ' ' THR . 40.2 ttmt -46.66 130.08 11.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.985 0.421 . . . . 0.0 111.757 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.491 HG21 ' N ' ' A' ' 13' ' ' ILE . 43.3 m -90.76 145.01 25.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.753 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.798 HG13 ' HB ' ' A' ' 5' ' ' VAL . 2.3 pt -119.44 126.64 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.516 HG23 ' OE1' ' A' ' 2' ' ' GLN . 0.8 OUTLIER -97.68 132.04 43.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 29' ' ' LYS . 9.0 tp -153.59 113.18 3.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.157 0.503 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 39.3 tt0 -70.3 133.9 47.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.501 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 1' ' ' MET . 16.2 m -154.26 137.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.33 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.485 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 4.5 mm-40 -72.05 139.72 82.62 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.229 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.31 -38.0 61.37 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.817 2.345 . . . . 0.0 111.751 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 t -64.06 -33.68 76.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.017 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 36.3 m-20 -55.23 130.89 43.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.98 0.419 . . . . 0.0 110.627 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.4 p -59.49 146.79 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.905 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.646 ' HA ' HG23 ' A' ' 26' ' ' VAL . 63.3 mt -57.91 -29.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.022 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.02 -37.32 85.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.4 m120 -72.1 -46.83 55.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 23' ' ' ILE . 32.7 m -58.35 -41.69 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.961 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.616 ' N ' HG21 ' A' ' 26' ' ' VAL . 68.1 mttm -66.7 -40.79 88.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 0.0 110.606 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.621 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -53.55 -40.29 65.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.406 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.62 ' HB2' HD23 ' A' ' 15' ' ' LEU . 50.0 mttm -64.74 -41.36 96.0 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.991 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 30' ' ' ILE . 67.4 mt -57.46 -35.93 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.621 HE21 ' HA ' ' A' ' 28' ' ' ALA . 70.1 mt-30 -61.45 -45.63 93.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.011 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -64.65 -31.69 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.725 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -144.89 -67.2 0.32 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 48.97 0.06 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.972 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.763 HG22 HD22 ' A' ' 8' ' ' LEU . 2.3 pt -125.05 129.03 24.68 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.611 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 95.2 Cg_exo -45.88 140.67 9.69 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.793 2.329 . . . . 0.0 112.242 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 17.3 Cg_endo -58.57 -32.62 96.99 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.429 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.37 -36.51 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.611 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 21.9 mt-30 -60.02 -45.64 92.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.549 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.741 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -58.8 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 111.144 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.646 ' H ' ' H ' ' B' ' 46' ' ' ALA . 72.2 mtt-85 -97.44 128.89 44.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 43' ' ' LEU . 27.1 mt -78.62 131.4 36.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 0.0 111.448 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 66.4 mt -143.97 127.5 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.626 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.736 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 0.5 OUTLIER -115.35 145.09 42.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.389 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -152.22 122.88 7.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.921 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.603 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.6 tpt . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 121.25 0.547 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 16.3 pt20 -61.32 110.44 1.42 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.617 HG12 ' O ' ' B' ' 15' ' ' LEU . 21.2 pt -76.74 131.43 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.069 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.26 132.91 34.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 45' ' ' PHE . 66.3 t -145.08 131.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.757 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.26 123.5 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.196 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -71.05 -157.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.286 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.51 ' H ' HD21 ' B' ' 8' ' ' LEU . 2.6 mm? -81.15 -49.83 10.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -72.19 -45.35 60.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.575 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.61 -31.42 0.52 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.769 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.58 128.58 10.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.997 0.427 . . . . 0.0 111.627 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 42.9 m -89.46 139.3 30.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.602 HG13 ' HB ' ' B' ' 5' ' ' VAL . 13.4 pt -113.75 127.25 71.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 112.022 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -96.37 137.15 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' B' ' 29' ' ' LYS . 5.0 tt -158.3 114.65 2.78 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.614 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 40.7 tt0 -71.91 138.6 48.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' B' ' 1' ' ' MET . 0.6 OUTLIER -158.92 134.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.181 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.69 137.64 95.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.431 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 10.2 Cg_endo -52.69 -37.9 75.98 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.847 2.365 . . . . 0.0 112.068 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.0 -30.97 72.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.306 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -55.4 134.16 50.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.855 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -61.19 146.34 47.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.664 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.634 ' HA ' HG23 ' B' ' 26' ' ' VAL . 63.8 mt -57.86 -30.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.128 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -65.83 -36.65 84.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.905 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 3.5 m120 -72.29 -47.13 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.264 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' B' ' 23' ' ' ILE . 32.9 m -58.02 -41.45 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.935 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.622 ' N ' HG21 ' B' ' 26' ' ' VAL . 68.1 mttm -66.6 -39.98 88.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.927 0.394 . . . . 0.0 110.619 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.622 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -53.44 -42.29 66.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.277 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.619 ' HB2' HD12 ' B' ' 15' ' ' LEU . 45.5 mttm -64.29 -42.8 96.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.042 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.689 HG23 HD12 ' B' ' 36' ' ' ILE . 67.3 mt -55.26 -35.86 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.849 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 68.9 mt-30 -62.26 -42.16 99.08 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.93 -35.27 79.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.405 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 17.1 mmtp -60.43 -37.83 82.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.564 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -141.52 -60.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.297 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.59 45.16 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.724 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.2 OUTLIER -112.13 130.63 23.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.56 0.219 . . . . 0.0 111.544 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.444 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 62.9 Cg_exo -51.97 139.6 50.83 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.434 2.09 . . . . 0.0 111.744 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.499 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 15.1 Cg_endo -57.22 -32.21 92.91 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.6 -35.93 82.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.724 ' NE2' HG23 ' B' ' 36' ' ' ILE . 25.9 mt-30 -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.703 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.736 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -60.07 124.48 20.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.319 . . . . 0.0 110.711 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 72.5 mtt-85 -91.69 126.65 36.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.053 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.517 ' HA ' HD11 ' B' ' 43' ' ' LEU . 10.5 tp -80.28 129.89 34.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.939 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 69.8 mt -143.64 136.98 24.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.741 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -121.37 146.71 46.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.471 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.646 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.5 123.91 6.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.357 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.417 ' HA3' ' C ' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--N 1.331 0.262 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.899 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.719 ' HE3' HD13 ' B' ' 43' ' ' LEU . 21.4 ptm . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.951 0.405 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.04 125.0 25.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.498 HG12 ' HG ' ' A' ' 15' ' ' LEU . 32.3 pt -91.91 139.27 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.493 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.67 130.14 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.807 HG22 HD12 ' A' ' 30' ' ' ILE . 44.8 t -145.24 133.81 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -93.06 120.61 33.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.2 p -72.48 -157.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.738 0.304 . . . . 0.0 111.395 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 36' ' ' ILE . 31.6 mt -80.6 -51.47 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.044 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -69.01 -45.17 71.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.593 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.89 -34.12 0.74 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.761 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -49.27 130.33 19.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.59 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 13' ' ' ILE . 28.9 m -80.15 146.85 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.349 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.719 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.0 pt -126.05 129.53 72.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.775 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 p -107.85 142.65 37.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.422 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.537 HD21 ' HD3' ' A' ' 33' ' ' LYS . 2.8 pp -165.41 122.32 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 1' ' ' MET . 11.4 pt-20 -75.71 140.97 42.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.427 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 26' ' ' VAL . 3.4 m -153.21 133.53 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.162 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -59.74 138.83 90.07 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.074 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.25 -39.07 92.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.937 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 t -64.15 -30.57 71.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.122 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -54.6 136.28 45.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.618 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -64.96 144.46 57.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.557 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.512 HD11 HD12 ' A' ' 43' ' ' LEU . 67.3 mt -55.85 -38.69 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -56.18 -44.93 79.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.046 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.2 m120 -65.43 -46.35 80.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.69 HG23 HG22 ' A' ' 17' ' ' VAL . 6.5 t -53.61 -48.62 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.162 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.682 ' HE3' ' HB3' ' A' ' 38' ' ' PRO . 51.5 mtmt -68.62 -35.4 77.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.741 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.43 -40.29 71.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.458 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 25.5 mmmt -62.09 -43.75 98.16 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.334 0.588 . . . . 0.0 109.582 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 5' ' ' VAL . 62.2 mt -57.16 -35.9 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.748 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.741 HE21 ' HA ' ' A' ' 28' ' ' ALA . 69.1 mt-30 -58.97 -43.97 91.46 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.25 -37.5 83.61 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.942 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.537 ' HD3' HD21 ' A' ' 15' ' ' LEU . 28.9 mtpp -76.8 3.45 11.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.815 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.521 ' HB3' HD13 ' A' ' 36' ' ' ILE . 17.6 tp10 -169.22 -102.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.145 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.71 49.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.422 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.666 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -121.99 127.17 26.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.64 0.257 . . . . 0.0 111.437 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.595 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 79.0 Cg_exo -48.89 144.3 15.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.219 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.682 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -56.45 -37.74 96.64 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.569 2.18 . . . . 0.0 112.406 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.82 -38.88 92.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.309 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.666 ' NE2' HG23 ' A' ' 36' ' ' ILE . 26.2 mt-30 -63.54 -39.45 94.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.509 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 71.3 mt-30 -59.75 110.79 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -81.88 130.82 35.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.321 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.512 HD12 HD11 ' A' ' 23' ' ' ILE . 33.0 mt -80.05 135.7 36.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.987 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 81.0 mt -143.28 133.84 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.35 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.843 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 6.8 m-85 -127.53 140.98 51.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.694 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -151.63 126.05 9.42 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.093 0.473 . . . . 0.0 111.843 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.302 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.729 179.809 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.525 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.2 ptm . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.866 0.365 . . . . 0.0 111.519 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.61 ' HB2' HG23 ' B' ' 14' ' ' THR . 3.3 pt20 -67.3 127.91 34.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.226 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.617 HG12 ' O ' ' B' ' 15' ' ' LEU . 24.2 pt -97.35 136.69 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.975 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -89.97 126.82 35.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.122 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.554 HG23 HD13 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.45 132.55 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.999 0.428 . . . . 0.0 111.5 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -84.83 129.7 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.074 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.684 HG21 HD12 ' B' ' 13' ' ' ILE . 77.9 p -77.54 -157.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.163 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.527 HD22 HG22 ' B' ' 36' ' ' ILE . 53.6 mt -81.42 -50.76 9.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.197 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -71.33 -45.26 63.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.693 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.88 -35.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.841 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.448 ' O ' HG22 ' B' ' 7' ' ' THR . 86.9 tttt -48.61 130.47 17.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.342 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 62.1 m -82.48 134.17 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.141 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.684 HD12 HG21 ' B' ' 7' ' ' THR . 0.0 OUTLIER -100.76 131.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 111.624 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.61 HG23 ' HB2' ' B' ' 2' ' ' GLN . 1.3 m -105.27 134.23 48.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.633 HD13 HG12 ' B' ' 17' ' ' VAL . 0.2 OUTLIER -162.53 115.04 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -178.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.5 pt-20 -78.39 140.26 38.73 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.196 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.633 HG12 HD13 ' B' ' 15' ' ' LEU . 11.5 m -153.03 136.2 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.242 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -59.91 140.07 90.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.077 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.471 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 12.9 Cg_endo -56.75 -40.01 87.34 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.799 2.333 . . . . 0.0 112.032 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.7 t -64.08 -29.78 70.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.118 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.402 ' OD2' HG11 ' B' ' 26' ' ' VAL . 38.5 t70 -56.15 136.02 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 71.1 p -65.07 145.81 55.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.697 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.564 HD11 HD12 ' B' ' 43' ' ' LEU . 66.8 mt -55.84 -39.04 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.7 -40.0 74.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.17 -49.28 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 23' ' ' ILE . 15.7 m -57.24 -41.44 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.701 ' HE3' ' HB3' ' B' ' 38' ' ' PRO . 50.3 mtmt -69.82 -38.63 76.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 110.818 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.774 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -54.44 -41.52 69.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.737 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -68.26 -37.77 81.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.209 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.434 HD11 HG22 ' B' ' 30' ' ' ILE . 63.0 mt -57.62 -34.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.774 HE21 ' HA ' ' B' ' 28' ' ' ALA . 68.7 mt-30 -60.65 -41.41 94.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -67.23 -37.76 84.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.752 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.655 ' HE3' HG23 ' B' ' 13' ' ' ILE . 28.9 mtpp -78.0 3.24 15.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.637 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -168.53 -106.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 50.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.812 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.649 ' O ' HD11 ' B' ' 36' ' ' ILE . 0.7 OUTLIER -126.57 119.89 23.09 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.73 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 35.5 Cg_exo -38.89 146.3 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.296 2.664 . . . . 0.0 112.982 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.701 ' HB3' ' HE3' ' B' ' 27' ' ' LYS . 33.6 Cg_exo -58.83 -38.14 90.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.665 2.244 . . . . 0.0 112.646 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.56 -39.2 90.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.73 ' NE2' ' HD2' ' B' ' 37' ' ' PRO . 22.9 mt-30 -60.16 -44.99 94.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.391 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.843 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 71.4 mt-30 -54.37 115.75 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.982 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.694 ' H ' ' H ' ' A' ' 46' ' ' ALA . 56.2 ttp180 -87.49 124.3 33.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.818 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.719 HD13 ' HE3' ' A' ' 1' ' ' MET . 44.1 mt -72.87 133.34 44.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.968 0.414 . . . . 0.0 111.121 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.987 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 74.8 mt -143.51 131.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.466 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.7 ' HB2' HG12 ' A' ' 5' ' ' VAL . 4.7 m-85 -127.19 148.05 50.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.762 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.91 132.39 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.308 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.262 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.52 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.6 ptm . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.211 0.529 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.481 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 10.8 tt0 -72.63 134.63 45.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.492 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 15' ' ' LEU . 29.5 pt -117.6 145.3 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.027 0.442 . . . . 0.0 112.067 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.2 m-85 -89.3 133.91 34.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.761 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 13' ' ' ILE . 92.3 t -144.91 136.64 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.136 0.493 . . . . 0.0 111.781 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 40.4 ttmt -91.47 134.41 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.499 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.796 HG22 ' HB3' ' A' ' 11' ' ' LYS . 67.8 p -71.43 -157.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.515 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 mt -65.37 -63.91 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.519 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 10' ' ' GLY . 5.7 t -77.57 -45.18 26.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.412 ' N ' HG22 ' A' ' 9' ' ' THR . . . 155.49 108.05 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.329 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.796 ' HB3' HG22 ' A' ' 7' ' ' THR . 24.2 ttmm -167.19 127.84 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.724 0.297 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -73.27 133.39 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.729 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.1 pt -135.44 135.54 51.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.481 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 3.3 p -90.43 144.43 25.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.069 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 3' ' ' ILE . 10.7 tp -160.58 114.05 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.216 0.532 . . . . 0.0 111.76 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.6 pt-20 -85.35 132.45 34.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.671 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 26' ' ' VAL . 27.4 m -151.06 142.96 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.356 . . . . 0.0 111.141 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 21' ' ' ASP . 42.0 mt-10 -67.43 137.44 93.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.3 -36.14 88.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.807 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -64.44 -27.86 69.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.357 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 51.6 m-20 -58.96 133.1 55.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.686 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.3 p -63.06 145.95 54.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.498 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 56.1 mt -53.54 -38.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.63 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 16.1 pt-20 -60.44 -39.91 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.502 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.4 m120 -67.39 -48.81 66.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.646 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.587 HG13 HG22 ' A' ' 17' ' ' VAL . 30.3 m -61.34 -43.87 97.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.317 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.645 ' HE2' ' HB2' ' A' ' 38' ' ' PRO . 36.3 mtmm -62.6 -43.8 97.91 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.9 0.381 . . . . 0.0 110.044 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 31' ' ' GLN . . . -60.43 -29.25 68.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.451 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HZ1' ' HZ1' ' A' ' 33' ' ' LYS . 26.2 tptp -64.85 -43.03 94.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.744 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.571 HG23 ' NE2' ' A' ' 41' ' ' GLN . 51.3 mt -57.28 -31.83 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.723 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 37' ' ' PRO . 75.3 mt-30 -58.16 -48.01 81.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -61.32 -36.89 81.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.826 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 38.6 mmtm -67.49 -24.21 65.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.135 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -153.16 -90.0 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.092 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.78 61.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.888 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.712 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -139.54 118.27 8.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.559 0.218 . . . . 0.0 111.549 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.753 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 54.8 Cg_exo -40.27 146.03 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.152 2.568 . . . . 0.0 112.822 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 19.8 Cg_endo -60.04 -36.0 90.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.818 2.345 . . . . 0.0 112.61 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.44 -38.86 85.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.753 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 18.3 mt-30 -64.1 -40.49 96.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.244 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.571 ' NE2' HG23 ' A' ' 30' ' ' ILE . 8.4 mm100 -52.44 126.94 20.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.192 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.617 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.5 mtt180 -94.85 124.77 39.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.235 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' B' ' 3' ' ' ILE . 64.1 mt -78.35 132.03 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.384 . . . . 0.0 111.0 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.951 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 74.5 mt -143.57 131.96 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.539 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.681 ' HB2' HG23 ' B' ' 5' ' ' VAL . 4.8 m-85 -126.36 147.12 49.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.6 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.623 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.39 128.04 7.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 111.703 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.26 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.972 179.972 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.1 ptm . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.701 ' HB3' HG23 ' B' ' 14' ' ' THR . 87.5 mt-30 -62.25 145.13 54.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.688 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.654 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.1 pt -121.77 143.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.1 m-85 -88.05 131.28 34.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.84 ' HB ' HG22 ' B' ' 13' ' ' ILE . 84.4 t -142.43 146.04 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.091 0.472 . . . . 0.0 111.563 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.555 ' N ' HG11 ' B' ' 5' ' ' VAL . 40.3 ttmt -102.08 131.57 48.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.194 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.789 HG22 ' HB3' ' B' ' 11' ' ' LYS . 70.0 p -68.61 -157.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 111.457 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.423 HD22 HG22 ' B' ' 36' ' ' ILE . 75.1 mt -64.67 -65.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.221 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.403 HG22 ' N ' ' B' ' 10' ' ' GLY . 5.4 t -76.79 -45.25 29.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CG ' ' B' ' 6' ' ' LYS . . . 155.06 109.03 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.358 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.789 ' HB3' HG22 ' B' ' 7' ' ' THR . 24.2 ttmm -167.25 129.46 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.696 0.284 . . . . 0.0 110.903 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -73.37 134.34 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.756 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.84 HG22 ' HB ' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -137.85 122.49 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.266 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.701 HG23 ' HB3' ' B' ' 2' ' ' GLN . 0.1 OUTLIER -80.16 145.22 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.477 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.654 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.2 tt -162.72 112.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.21 0.529 . . . . 0.0 111.177 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.493 ' O ' HG11 ' B' ' 17' ' ' VAL . 12.4 pt-20 -82.92 141.11 32.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.955 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.711 HG22 HG22 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -157.65 145.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.557 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.459 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 44.7 mt-10 -71.13 133.99 85.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.992 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.97 -37.69 97.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.796 2.33 . . . . 0.0 112.2 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 80.5 p -63.89 -25.92 68.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.459 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 53.0 m-20 -60.81 131.44 50.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -60.8 146.55 45.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.545 ' HA ' HG13 ' B' ' 26' ' ' VAL . 54.8 mt -55.36 -37.79 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.099 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.635 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 15.9 pt-20 -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.3 m120 -67.7 -46.3 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.452 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.711 HG22 HG22 ' B' ' 17' ' ' VAL . 7.8 p -61.93 -41.21 90.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.638 ' HE2' ' HB2' ' B' ' 38' ' ' PRO . 36.8 mtmm -66.61 -44.55 81.79 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.01 0.433 . . . . 0.0 110.203 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 31' ' ' GLN . . . -57.87 -27.29 63.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.509 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.455 ' HZ1' ' HZ1' ' B' ' 33' ' ' LYS . 25.8 tptp -64.87 -43.89 91.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.817 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.581 ' HA ' ' HB2' ' B' ' 33' ' ' LYS . 51.5 mt -57.57 -30.95 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.824 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 74.2 mt-30 -58.05 -48.49 79.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.5 -37.34 83.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.767 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 38.5 mmtm -66.48 -25.1 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -152.03 -87.23 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.15 57.3 0.02 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.248 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.679 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.5 OUTLIER -134.9 125.56 17.32 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.705 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 70.5 Cg_exo -44.28 145.16 2.51 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.0 2.467 . . . . 0.0 112.386 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.638 ' HB2' ' HE2' ' B' ' 27' ' ' LYS . 20.2 Cg_endo -60.27 -35.13 92.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.497 2.131 . . . . 0.0 112.223 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.64 -38.15 89.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.705 ' NE2' ' HD2' ' B' ' 37' ' ' PRO . 26.3 mt-30 -64.19 -37.23 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.608 ' NE2' HD12 ' B' ' 36' ' ' ILE . 8.7 mm100 -54.54 129.26 35.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.623 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.3 mtt180 -97.52 124.67 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.251 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.419 HD13 ' HE3' ' A' ' 1' ' ' MET . 50.7 mt -79.46 132.71 36.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.399 . . . . 0.0 111.115 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.951 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.1 mt -143.54 131.27 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.367 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.622 ' HB2' HG12 ' A' ' 5' ' ' VAL . 4.8 m-85 -125.28 143.99 50.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.617 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -153.43 129.94 10.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.526 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.784 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.906 0.384 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.763 ' HB2' HG21 ' A' ' 14' ' ' THR . 3.2 pt20 -71.47 122.73 20.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -86.15 144.16 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.556 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -88.89 134.98 33.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.972 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.731 HG13 HD13 ' A' ' 13' ' ' ILE . 59.5 t -148.2 132.74 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.865 0.364 . . . . 0.0 111.145 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.83 126.43 43.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.1 m -67.62 150.55 48.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 36' ' ' ILE . 4.2 mp -45.02 -45.2 10.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -75.46 -45.5 38.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.392 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.43 0.53 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.88 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -44.02 131.59 5.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -74.15 141.72 45.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.731 HD13 HG13 ' A' ' 5' ' ' VAL . 1.1 mt -128.62 139.12 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.028 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.763 HG21 ' HB2' ' A' ' 2' ' ' GLN . 7.2 m -133.52 142.86 48.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.818 HD12 ' HD2' ' A' ' 33' ' ' LYS . 5.8 tp -157.02 114.95 3.19 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 16.9 pt-20 -71.89 130.51 41.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.736 HG22 HG13 ' A' ' 26' ' ' VAL . 18.7 m -152.57 138.65 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 48.5 mt-10 -69.16 140.87 91.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.72 -36.37 81.59 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.969 2.446 . . . . 0.0 112.239 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.402 ' O ' HG21 ' B' ' 22' ' ' THR . 46.0 t -64.3 -32.04 73.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 54.5 m-20 -56.27 132.59 51.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -60.06 147.18 40.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.642 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.555 HG22 HD22 ' A' ' 43' ' ' LEU . 61.5 mt -54.38 -36.95 35.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.788 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.66 -32.22 72.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -69.28 -47.46 64.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.208 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.736 HG13 HG22 ' A' ' 17' ' ' VAL . 22.7 m -60.22 -39.28 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.969 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.585 ' N ' HG21 ' A' ' 26' ' ' VAL . 99.3 mttt -67.13 -38.75 86.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.538 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -49.84 -38.62 35.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.427 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.673 ' HD2' HD22 ' A' ' 15' ' ' LEU . 80.0 mttt -67.79 -41.07 83.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -55.14 -36.83 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.357 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.538 HE21 ' HA ' ' A' ' 28' ' ' ALA . 68.2 mt-30 -63.28 -45.0 93.49 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.94 -33.01 74.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.712 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.818 ' HD2' HD12 ' A' ' 15' ' ' LEU . 29.6 mtpp -71.71 -31.56 66.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.935 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -135.63 -60.18 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.11 57.06 0.19 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.083 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.866 HG22 HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -145.07 131.43 9.78 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 120.819 0.342 . . . . 0.0 111.352 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.577 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 60.6 Cg_exo -40.89 139.46 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.29 2.66 . . . . 0.0 113.229 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 18.0 Cg_endo -60.36 -36.2 88.18 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.922 2.414 . . . . 0.0 112.663 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.25 -37.19 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.577 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 16.0 mt-30 -59.27 -45.41 91.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.34 124.37 15.74 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.73 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.595 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.9 ttm180 -91.46 123.18 34.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.555 HD22 HG22 ' A' ' 23' ' ' ILE . 9.3 mp -73.49 132.04 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 79.9 mt -143.61 134.65 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.678 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 8.3 m-85 -128.62 144.81 51.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.818 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.629 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.04 129.4 10.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.994 0.426 . . . . 0.0 111.439 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' B' ' 8' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.897 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.888 0.375 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.667 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 3.1 pt20 -69.22 124.33 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' B' ' 14' ' ' THR . 37.4 pt -88.33 145.83 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.831 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.76 135.51 33.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.153 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.881 HG13 HD13 ' B' ' 13' ' ' ILE . 57.6 t -148.47 138.31 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 111.132 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.9 125.55 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 90.4 m -67.03 151.32 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.484 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.763 HD23 HG12 ' B' ' 36' ' ' ILE . 0.4 OUTLIER -47.26 -42.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.663 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 67.4 p -75.92 -45.36 35.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.86 -30.44 0.61 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.911 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -45.29 134.62 6.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 39.1 m -79.94 143.82 33.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.0 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.881 HD13 HG13 ' B' ' 5' ' ' VAL . 4.4 pt -142.78 135.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.142 0.496 . . . . 0.0 111.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.564 ' CG2' ' HB2' ' B' ' 2' ' ' GLN . 6.0 m -139.75 141.74 36.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.07 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -150.69 130.8 13.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.022 0.439 . . . . 0.0 111.193 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 11.1 pt-20 -69.85 132.78 46.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.963 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.607 HG22 HG13 ' B' ' 26' ' ' VAL . 17.3 m -150.43 136.83 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.485 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 48.1 mt-10 -69.5 138.8 88.85 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.257 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.22 -36.05 65.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.061 2.507 . . . . 0.0 112.261 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.6 t -64.01 -32.69 74.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 55.3 m-20 -56.0 132.54 50.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.824 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 20' ' ' SER . 69.0 p -59.49 148.26 33.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.67 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.59 HG22 HD22 ' B' ' 43' ' ' LEU . 61.3 mt -54.59 -36.89 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.38 -31.05 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.774 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -65.96 -52.04 53.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.061 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.607 HG13 HG22 ' B' ' 17' ' ' VAL . 24.4 m -58.29 -39.7 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.262 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.597 ' N ' HG21 ' B' ' 26' ' ' VAL . 98.8 mttt -66.88 -37.99 85.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.53 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -50.74 -40.74 55.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.314 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.507 ' HZ1' HG11 ' B' ' 17' ' ' VAL . 78.7 mttt -68.23 -40.4 82.06 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -54.34 -36.69 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.168 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 67.6 mt-30 -63.79 -44.54 93.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.394 0.616 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -67.46 -32.48 73.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.62 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 29' ' ' LYS . 29.6 mtpp -70.61 -32.41 69.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.092 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.896 ' HB2' HD13 ' B' ' 36' ' ' ILE . 56.8 mm-40 -138.14 -55.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.678 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.77 54.89 0.23 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.62 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.896 HD13 ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -135.44 135.63 22.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.578 0.228 . . . . 0.0 111.057 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.557 ' HB2' ' HG3' ' B' ' 40' ' ' GLN . 75.7 Cg_exo -50.04 138.54 35.52 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.45 2.1 . . . . 0.0 112.028 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' B' ' 27' ' ' LYS . 18.5 Cg_endo -58.03 -35.55 98.67 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.817 2.345 . . . . 0.0 112.496 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.18 -36.12 79.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.259 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.715 ' NE2' HG23 ' B' ' 36' ' ' ILE . 23.3 mt-30 -62.82 -44.2 96.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.57 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.678 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.79 126.42 22.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.785 0.326 . . . . 0.0 110.488 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.629 ' H ' ' H ' ' A' ' 46' ' ' ALA . 38.8 ttm180 -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.664 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.59 HD22 HG22 ' B' ' 23' ' ' ILE . 8.9 mp -74.49 132.5 41.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 76.7 mt -143.55 134.21 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.689 ' HB2' HG23 ' A' ' 5' ' ' VAL . 8.1 m-85 -128.4 144.32 51.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.595 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 132.39 13.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.954 0.407 . . . . 0.0 111.413 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.64 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 17.0 ptm . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.986 0.422 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.506 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 3.3 pt20 -61.86 129.45 41.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.629 HG23 HD21 ' B' ' 43' ' ' LEU . 36.7 pt -97.49 135.04 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.76 125.5 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.831 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.2 t -147.79 134.44 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.692 0.282 . . . . 0.0 111.681 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -93.52 119.62 32.81 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -66.53 -159.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.484 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.644 ' H ' HD21 ' A' ' 8' ' ' LEU . 2.3 mm? -81.59 -47.02 13.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -73.47 -45.44 54.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.394 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -35.7 0.55 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.806 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.2 133.01 15.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.967 0.413 . . . . 0.0 111.591 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 m -84.77 132.88 34.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.04 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.831 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -99.97 134.43 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.888 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.506 ' CG2' ' HB2' ' A' ' 2' ' ' GLN . 1.1 m -109.01 133.86 52.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 3' ' ' ILE . 5.4 tp -159.84 114.85 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 112.099 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 1' ' ' MET . 16.9 pt-20 -79.01 137.13 37.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.219 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.82 HG22 HG13 ' A' ' 26' ' ' VAL . 15.4 m -154.27 135.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -57.88 140.99 81.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.507 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 12.2 Cg_endo -56.34 -40.03 87.38 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.818 2.345 . . . . 0.0 112.127 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -64.14 -28.81 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.064 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.526 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 8.3 t70 -53.53 132.33 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.8 p -62.94 144.37 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.875 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CG2' ' HE3' ' A' ' 27' ' ' LYS . 64.7 mt -55.4 -36.33 40.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.279 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.492 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 23.8 pt-20 -62.97 -35.67 80.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.4 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 m120 -72.93 -48.03 40.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.621 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.82 HG13 HG22 ' A' ' 17' ' ' VAL . 32.7 m -57.47 -44.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.138 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' N ' HG21 ' A' ' 26' ' ' VAL . 99.3 mttt -65.06 -38.44 90.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 110.461 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.714 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.26 -37.73 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.151 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' HD23 ' A' ' 15' ' ' LEU . 29.8 mmtp -66.48 -39.67 88.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.996 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 62.2 mt -56.32 -35.94 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.886 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.714 HE21 ' HA ' ' A' ' 28' ' ' ALA . 71.4 mt-30 -59.66 -44.6 93.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.07 -34.17 77.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.133 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 73.1 mmtt -66.27 -25.04 66.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.85 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -150.27 -79.59 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.943 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.43 57.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.236 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.541 HG23 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -140.97 129.28 12.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.465 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 59.7 Cg_exo -41.63 142.47 1.24 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.263 2.642 . . . . 0.0 113.179 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 25.7 Cg_endo -61.63 -37.26 70.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.958 2.438 . . . . 0.0 112.742 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.09 -36.22 72.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.636 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 18.1 mt-30 -60.5 -44.98 95.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.63 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.98 125.64 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 99.2 mtt180 -89.2 126.68 35.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.511 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.458 HD21 ' HA ' ' A' ' 43' ' ' LEU . 26.7 mt -75.66 130.3 38.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.343 . . . . 0.0 110.857 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.912 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.4 mt -143.59 132.03 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.05 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 3.3 m-85 -127.34 145.39 50.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.577 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.612 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -149.98 125.47 10.25 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.872 0.368 . . . . 0.0 111.417 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.22 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.106 -179.699 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.8 ptm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.97 0.414 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.465 ' NE2' HG23 ' B' ' 14' ' ' THR . 3.2 pt20 -61.7 130.35 45.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.908 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.64 HG12 ' HB3' ' B' ' 15' ' ' LEU . 35.3 pt -97.27 131.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.278 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.717 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -88.97 120.85 30.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.865 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -150.91 130.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.063 0.459 . . . . 0.0 111.765 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -83.13 126.64 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.385 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -70.57 -157.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.309 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.815 HD13 HG22 ' B' ' 36' ' ' ILE . 2.0 mm? -83.0 -48.33 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p -71.77 -45.29 62.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.27 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 -34.22 0.62 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.763 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -49.43 130.91 20.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.863 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 37.2 m -80.92 147.27 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.901 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.463 HG13 ' CG1' ' B' ' 5' ' ' VAL . 18.6 pt -129.36 124.78 60.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 0.0 112.477 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.465 HG23 ' NE2' ' B' ' 2' ' ' GLN . 1.2 p -92.88 146.89 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.178 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.651 HD12 ' HB2' ' B' ' 29' ' ' LYS . 5.3 tt -164.2 114.62 1.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.829 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.3 pt-20 -78.02 138.05 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.622 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.617 HG22 HG13 ' B' ' 26' ' ' VAL . 1.0 OUTLIER -157.25 133.41 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.943 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -59.14 138.28 88.11 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.436 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 9.3 Cg_endo -52.51 -39.06 75.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.917 2.412 . . . . 0.0 112.106 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.5 t -63.93 -29.8 70.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.155 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.534 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.2 t70 -53.81 131.87 40.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 0.0 110.526 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -62.42 144.01 56.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.916 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 19' ' ' PRO . 65.2 mt -55.22 -35.72 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 24.4 pt-20 -63.15 -36.14 82.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.347 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.534 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 3.5 m120 -72.7 -48.37 39.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.602 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.617 HG13 HG22 ' B' ' 17' ' ' VAL . 31.0 m -57.23 -43.76 82.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.492 ' N ' HG21 ' B' ' 26' ' ' VAL . 99.0 mttt -65.09 -38.34 90.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.694 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -55.18 -37.07 66.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.651 ' HB2' HD12 ' B' ' 15' ' ' LEU . 58.0 mmtt -64.56 -43.5 93.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.465 ' HA ' ' HB2' ' B' ' 33' ' ' LYS . 65.4 mt -53.5 -36.29 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.147 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.694 HE21 ' HA ' ' B' ' 28' ' ' ALA . 71.8 mt-30 -59.82 -45.57 91.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -67.57 -33.46 75.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.229 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 72.7 mmtt -65.44 -25.29 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.169 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.561 ' HB3' HD13 ' B' ' 36' ' ' ILE . 17.7 tp10 -152.61 -68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.299 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.403 ' H ' HD13 ' B' ' 36' ' ' ILE . . . 139.85 55.7 0.04 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.72 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.815 HG22 HD13 ' B' ' 8' ' ' LEU . 0.1 OUTLIER -133.89 133.33 22.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.51 0.195 . . . . 0.0 111.28 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.621 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 71.7 Cg_exo -51.04 139.59 41.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.451 2.101 . . . . 0.0 112.092 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.556 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 19.8 Cg_endo -58.29 -35.75 98.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.831 2.354 . . . . 0.0 112.679 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.719 ' NE2' HG23 ' B' ' 36' ' ' ILE . 27.1 mt-30 -63.33 -41.96 98.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -56.25 126.36 25.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.834 0.349 . . . . 0.0 110.488 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 99.4 mtt180 -86.16 127.04 34.65 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.51 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.629 HD21 HG23 ' A' ' 3' ' ' ILE . 5.4 tp -78.3 127.6 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.656 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.912 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 70.5 mt -143.71 138.15 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-O 120.88 0.371 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.705 ' HB2' HG12 ' A' ' 5' ' ' VAL . 3.6 m-85 -131.24 148.67 52.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.563 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.9 124.26 8.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.292 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.356 -179.632 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.3 ptm . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 121.233 0.539 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.464 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 36.5 tt0 -62.95 120.79 12.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.629 HD12 HD13 ' A' ' 15' ' ' LEU . 36.3 pt -99.7 143.07 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 112.22 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.4 m-85 -89.86 135.31 33.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.124 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.779 ' HB ' HG13 ' A' ' 13' ' ' ILE . 67.4 t -148.79 132.76 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -92.46 129.22 38.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.698 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 61.5 p -77.37 -157.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 110.908 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.426 ' H ' ' HB ' ' A' ' 7' ' ' THR . 51.7 mt -83.45 -53.49 5.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.57 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -73.16 -45.28 57.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.32 -27.15 0.25 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.325 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -43.24 130.36 4.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 111.952 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -89.21 138.84 31.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.981 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.779 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.2 pt -125.4 133.85 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.271 0.558 . . . . 0.0 111.907 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 4.7 p -117.72 144.27 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.623 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.629 HD13 HD12 ' A' ' 3' ' ' ILE . 3.3 pp -168.0 124.73 1.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.292 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -77.15 143.01 39.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -179.344 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 26' ' ' VAL . 3.7 m -150.97 132.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.86 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.63 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 85.5 mt-10 -63.38 137.83 97.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.75 -36.19 61.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.13 2.553 . . . . 0.0 112.5 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -63.87 -33.23 75.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.094 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.63 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -56.47 133.23 53.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -60.27 148.47 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.826 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 69.0 mt -54.67 -45.33 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.432 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 12.1 pt-20 -59.82 -36.09 76.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.509 HD21 ' HB3' ' A' ' 21' ' ' ASP . 42.7 t30 -63.59 -48.25 78.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 17' ' ' VAL . 11.0 m -64.82 -41.01 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.171 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.589 ' N ' HG21 ' A' ' 26' ' ' VAL . 49.6 mtmt -63.42 -39.21 93.89 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.666 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -55.24 -37.45 67.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HE3' HG13 ' A' ' 17' ' ' VAL . 48.4 mttm -63.64 -41.95 98.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.643 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.561 HD11 ' HG2' ' A' ' 41' ' ' GLN . 70.8 mt -55.09 -39.33 49.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.421 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 43.1 tt0 -61.17 -47.13 87.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.153 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -60.01 -37.38 79.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.051 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 4.5 mmmp? -66.18 -42.42 88.91 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.948 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -124.55 -70.21 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.083 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.0 -37.34 0.42 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.254 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.765 HG21 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.61 126.09 4.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.674 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -47.1 142.73 11.1 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.305 2.67 . . . . 0.0 112.761 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 46.8 Cg_exo -56.33 -37.34 97.1 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.766 2.311 . . . . 0.0 112.475 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.75 -38.32 81.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.765 HE22 HG21 ' A' ' 36' ' ' ILE . 26.0 mt-30 -60.51 -39.27 87.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.743 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.706 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.64 124.09 15.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 99.3 mtt180 -89.54 128.57 36.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.431 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.678 ' HG ' ' HE3' ' B' ' 1' ' ' MET . 23.7 mt -74.27 130.55 39.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.838 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.929 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 76.6 mt -143.88 133.04 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.749 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.2 m-85 -130.33 147.23 52.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.618 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.82 123.99 5.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 111.562 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.678 ' HE3' ' HG ' ' A' ' 43' ' ' LEU . 20.6 ptm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.779 0.323 . . . . 0.0 111.465 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.417 ' NE2' HG22 ' B' ' 14' ' ' THR . 27.6 mt-30 -62.03 130.52 45.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.249 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.696 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.1 pt -104.09 139.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.592 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.0 m-85 -88.86 129.78 35.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.686 ' HB ' HG13 ' B' ' 13' ' ' ILE . 62.0 t -144.07 134.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 111.462 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -96.09 127.73 42.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 66.3 p -76.54 -157.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.961 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.611 HD12 HG22 ' B' ' 36' ' ' ILE . 7.7 mp -83.04 -52.63 6.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.519 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -74.27 -45.27 48.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.67 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.07 -28.45 0.27 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.559 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -42.96 130.68 4.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.768 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.686 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -106.22 129.5 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.115 0.483 . . . . 0.0 112.002 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.417 HG22 ' NE2' ' B' ' 2' ' ' GLN . 1.9 m -107.46 136.33 47.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.696 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -163.36 115.64 1.49 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.864 -178.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' B' ' 1' ' ' MET . 23.9 pt-20 -76.92 139.27 40.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.439 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.438 ' CG1' HD13 ' B' ' 15' ' ' LEU . 21.7 m -151.26 138.09 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.636 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 85.5 mt-10 -67.33 140.52 95.31 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.03 -37.62 86.56 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.082 2.521 . . . . 0.0 112.497 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.3 t -63.85 -32.97 74.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.188 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.636 ' OD1' ' HB2' ' B' ' 18' ' ' GLU . 1.0 OUTLIER -56.21 132.93 51.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 80.4 p -60.65 149.07 36.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.792 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 67.1 mt -55.2 -45.07 77.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.12 -41.62 88.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.834 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' B' ' 21' ' ' ASP . 37.5 t30 -61.4 -44.14 97.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.515 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.403 HG23 ' CG2' ' B' ' 17' ' ' VAL . 16.8 t -61.47 -47.85 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.388 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.573 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 47.7 mtmt -65.08 -36.38 84.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.303 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -56.51 -32.65 65.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.152 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.599 ' HB2' HD23 ' B' ' 15' ' ' LEU . 50.4 mttm -69.26 -33.84 73.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.183 0.516 . . . . 0.0 109.735 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.631 HG23 HD11 ' B' ' 36' ' ' ILE . 60.9 mt -61.75 -42.18 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.597 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.7 pt20 -66.35 -45.33 80.57 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.413 ' N ' ' HG3' ' B' ' 31' ' ' GLN . 63.7 t0 -58.77 -31.73 68.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -73.27 -32.23 64.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.556 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -139.31 -64.76 0.49 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.004 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 159.07 -32.56 0.46 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.343 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.706 HG21 ' NE2' ' B' ' 40' ' ' GLN . 0.3 OUTLIER -49.74 128.95 20.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.475 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 50.4 Cg_exo -54.57 140.58 75.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.68 2.254 . . . . 0.0 111.668 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.591 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 53.6 Cg_exo -52.75 -37.26 75.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.563 2.175 . . . . 0.0 112.665 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -61.11 -37.4 82.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.564 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.706 ' NE2' HG21 ' B' ' 36' ' ' ILE . 24.5 mt-30 -62.87 -38.97 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.749 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.68 126.43 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.698 0.285 . . . . 0.0 110.588 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.646 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 99.4 mtt180 -92.35 127.48 37.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.992 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 3' ' ' ILE . 7.7 mp -72.86 129.07 37.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.226 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.929 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 77.9 mt -143.89 131.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 5.3 m-85 -128.94 145.86 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.747 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.506 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -155.81 126.09 6.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 111.461 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.443 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 ptm . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.733 ' HB2' HG23 ' A' ' 14' ' ' THR . 19.3 pt20 -69.05 130.12 41.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 15' ' ' LEU . 5.0 pt -99.75 147.05 7.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.79 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 4.6 m-85 -89.57 126.98 35.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.911 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.699 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.1 t -149.5 137.28 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.277 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -104.62 129.67 52.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.391 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -68.38 -157.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.117 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.452 HD22 ' CG2' ' A' ' 36' ' ' ILE . 3.6 mp -86.57 -51.58 6.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.242 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.8 p -72.11 -45.48 60.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.729 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 -29.73 0.26 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -43.97 129.91 5.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.967 0.413 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -90.27 137.53 32.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.339 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.699 HG13 ' HB ' ' A' ' 5' ' ' VAL . 3.7 pt -122.87 134.63 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 111.344 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 2' ' ' GLN . 3.8 m -127.0 105.1 8.37 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -123.68 127.91 48.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 1' ' ' MET . 12.5 pt-20 -72.39 139.27 47.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.83 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.705 HG22 HG23 ' A' ' 26' ' ' VAL . 19.0 m -150.26 135.17 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 80.4 mt-10 -64.22 137.9 97.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.235 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.34 -36.58 97.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.831 2.354 . . . . 0.0 112.031 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.491 ' O ' HG21 ' B' ' 22' ' ' THR . 43.4 t -64.19 -33.94 76.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.898 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.623 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 30.2 m-20 -57.99 133.33 55.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.485 HG21 ' O ' ' B' ' 20' ' ' SER . 76.1 p -58.49 149.51 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.453 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.528 HD11 HD22 ' A' ' 43' ' ' LEU . 63.2 mt -53.33 -38.23 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.846 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.59 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 17.1 tp10 -59.27 -42.29 90.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.452 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.71 -44.9 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 HG22 ' A' ' 17' ' ' VAL . 24.3 t -57.34 -48.93 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.176 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HZ2' ' HA ' ' A' ' 24' ' ' GLU . 36.8 mtmm -66.04 -35.56 80.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.802 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.27 -38.43 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.178 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.677 ' HE2' ' HZ2' ' A' ' 33' ' ' LYS . 87.9 tttt -67.28 -38.86 85.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.04 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.699 HD11 ' HG2' ' A' ' 41' ' ' GLN . 58.4 mt -58.12 -34.29 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.891 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.802 HE21 ' HA ' ' A' ' 28' ' ' ALA . 54.7 mt-30 -64.08 -44.46 92.31 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 -32.58 71.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.677 ' HZ2' ' HE2' ' A' ' 29' ' ' LYS . 36.2 mmtm -71.67 -30.09 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.03 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' HB3' HD13 ' A' ' 36' ' ' ILE . 17.7 tp10 -140.96 -66.49 0.43 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.204 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 150.86 -32.15 0.98 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.901 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.761 HG23 HE21 ' A' ' 40' ' ' GLN . 0.6 OUTLIER -48.66 127.05 13.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HD2' ' HG3' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -46.63 158.76 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.014 2.476 . . . . 0.0 112.43 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.651 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 17.1 Cg_endo -57.74 -37.37 96.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.598 2.198 . . . . 0.0 112.262 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.08 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.761 HE21 HG23 ' A' ' 36' ' ' ILE . 15.3 mm100 -52.26 -55.94 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.699 ' HG2' HD11 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -56.79 128.24 35.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.675 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.2 mmt180 -96.83 125.65 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 23' ' ' ILE . 9.4 mp -68.81 122.52 18.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.539 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 62.4 mt -143.75 130.48 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.072 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.677 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 8.8 m-85 -130.03 145.12 51.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.794 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.679 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -146.42 127.45 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 111.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.482 ' HA3' ' C ' ' B' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.304 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.3 ptm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.9 0.381 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.651 ' HB2' HG23 ' B' ' 14' ' ' THR . 19.2 pt20 -68.97 127.02 31.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.495 HG12 ' O ' ' B' ' 15' ' ' LEU . 26.1 pt -99.86 150.04 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.479 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 3.5 m-85 -89.1 129.43 35.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.358 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.708 ' HB ' HG13 ' B' ' 13' ' ' ILE . 87.8 t -149.74 137.27 13.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -104.38 130.27 52.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.288 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -70.62 -157.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.406 . . . . 0.0 111.678 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.646 HD11 ' N ' ' B' ' 8' ' ' LEU . 4.8 mp -82.44 -56.66 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.433 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -71.2 -45.44 63.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.881 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.29 -28.64 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.8 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -43.62 128.09 5.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.305 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -87.53 137.17 32.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.708 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.5 pt -123.59 128.44 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 111.441 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.651 HG23 ' HB2' ' B' ' 2' ' ' GLN . 7.5 m -124.01 110.51 14.87 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.661 ' H ' HD21 ' B' ' 15' ' ' LEU . 1.5 pt? -136.19 131.17 34.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.406 0.622 . . . . 0.0 111.846 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.8 pt-20 -70.03 142.96 52.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.883 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.771 HG22 HG13 ' B' ' 26' ' ' VAL . 21.2 m -152.27 134.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.191 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.458 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 86.6 mt-10 -61.97 137.45 95.48 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.645 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.11 -39.19 81.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.831 2.354 . . . . 0.0 111.914 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.485 ' O ' HG21 ' A' ' 22' ' ' THR . 47.1 t -64.15 -30.64 71.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.458 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 46.5 m-20 -59.77 132.71 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 20' ' ' SER . 74.5 p -57.44 149.59 20.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.502 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.502 ' O ' HG23 ' B' ' 26' ' ' VAL . 64.4 mt -54.27 -37.78 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 109.705 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.601 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 4.6 tp10 -60.22 -37.4 80.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.453 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -66.58 -48.43 69.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.576 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.771 HG13 HG22 ' B' ' 17' ' ' VAL . 9.4 m -60.65 -42.24 91.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.031 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.601 ' HZ2' ' HA ' ' B' ' 24' ' ' GLU . 36.8 mtmm -65.68 -38.1 88.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.922 0.391 . . . . 0.0 110.258 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.811 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -55.91 -36.44 67.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.492 ' HE2' ' HZ3' ' B' ' 33' ' ' LYS . 88.3 tttt -68.51 -39.51 81.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.044 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' B' ' 41' ' ' GLN . 59.3 mt -57.67 -33.86 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.685 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.811 HE21 ' HA ' ' B' ' 28' ' ' ALA . 59.6 mt-30 -63.34 -47.18 83.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.16 -31.01 68.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.63 ' HG3' HD12 ' B' ' 15' ' ' LEU . 25.7 mmtp -75.18 -27.07 59.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -141.48 -66.74 0.41 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.158 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 149.31 -32.04 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.041 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.793 HG23 HE21 ' B' ' 40' ' ' GLN . 0.7 OUTLIER -50.41 129.53 25.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.51 ' HD2' ' HG3' ' B' ' 40' ' ' GLN . 91.0 Cg_exo -47.17 157.98 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.979 2.452 . . . . 0.0 112.323 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.669 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 13.9 Cg_endo -58.14 -36.06 98.2 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.451 2.101 . . . . 0.0 112.152 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -60.4 -33.45 72.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.793 HE21 HG23 ' B' ' 36' ' ' ILE . 15.4 mm100 -52.2 -55.52 20.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.029 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.684 ' HG2' HD11 ' B' ' 30' ' ' ILE . 0.5 OUTLIER -56.65 127.92 33.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.679 ' H ' ' H ' ' A' ' 46' ' ' ALA . 37.5 mmt180 -96.1 126.23 41.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.513 HD11 ' N ' ' B' ' 43' ' ' LEU . 8.9 mp -69.57 122.05 18.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.415 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 76.0 mt -143.79 130.1 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 8.7 m-85 -129.93 144.63 51.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.74 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.675 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -144.97 128.11 16.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.451 ' HA3' ' C ' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.347 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' HG3' ' A' ' 1' ' ' MET . 15.7 tpt . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.028 0.442 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.585 ' HB2' HG23 ' A' ' 14' ' ' THR . 18.9 pt20 -61.84 111.13 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.746 HG23 HD21 ' B' ' 43' ' ' LEU . 34.9 pt -84.87 141.59 14.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -87.82 130.16 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.717 ' HB ' HG22 ' A' ' 13' ' ' ILE . 86.6 t -145.17 145.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.027 0.441 . . . . 0.0 111.553 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 67.3 mttm -108.33 129.81 55.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.323 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.29 -156.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.324 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.33 -52.06 66.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.5 t -76.63 -45.1 31.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.995 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 143.21 32.76 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.488 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 61.8 tttp -81.32 131.12 35.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -73.04 136.79 45.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.437 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.717 HG22 ' HB ' ' A' ' 5' ' ' VAL . 1.3 tt -139.49 124.08 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 111.749 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.585 HG23 ' HB2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -86.54 144.12 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.984 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.581 HD12 HD12 ' A' ' 30' ' ' ILE . 5.0 tt -158.32 113.31 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.805 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 17' ' ' VAL . 25.7 pt-20 -88.18 132.64 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.588 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.509 HG12 HD22 ' A' ' 15' ' ' LEU . 2.9 m -159.92 146.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.73 139.24 76.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 33.5 Cg_endo -61.9 -40.06 46.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.358 . . . . 0.0 112.348 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 m -63.85 -20.55 65.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.795 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -57.51 134.21 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.5 p -56.6 142.87 37.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.485 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.516 HG12 HG12 ' B' ' 23' ' ' ILE . 66.2 mt -57.75 -40.62 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.77 -44.57 90.65 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.138 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.61 -44.52 86.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.415 HG22 HD13 ' B' ' 23' ' ' ILE . 60.3 t -59.16 -49.28 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.33 -36.76 84.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.518 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -53.81 -36.12 62.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.875 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 86.7 tttt -69.54 -39.17 77.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.117 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.708 ' HB ' HE22 ' A' ' 41' ' ' GLN . 36.9 mm -54.87 -38.55 45.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.101 0.477 . . . . 0.0 109.775 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -60.37 -48.96 79.51 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.32 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.91 -30.52 71.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.449 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 30.7 mmmt -72.05 -32.1 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.23 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -138.91 -65.69 0.49 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.983 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.98 -40.39 0.52 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.73 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.9 OUTLIER -45.06 126.78 5.49 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.803 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 87.2 Cg_exo -45.93 139.64 10.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.019 2.479 . . . . 0.0 112.399 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 45.6 Cg_exo -56.26 -40.6 83.72 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.37 2.046 . . . . 0.0 111.879 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.32 -36.04 81.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.803 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 6.5 tt0 -60.28 -37.15 79.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.092 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.822 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.6 mt-30 -56.33 132.05 49.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 56.3 ttp180 -91.82 125.61 36.59 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.602 HD11 HG23 ' B' ' 3' ' ' ILE . 14.5 mt -74.46 132.17 41.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.705 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.926 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 75.8 mt -143.73 133.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.808 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 15.4 m-85 -129.69 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.434 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.16 127.37 6.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.964 0.412 . . . . 0.0 111.722 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.541 179.669 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' B' ' 1' ' ' MET . 15.7 tpt . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.895 0.378 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' GLN . . . . . 0.502 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 18.4 pt20 -61.72 111.82 2.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.235 0.541 . . . . 0.0 110.841 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ILE . . . . . 0.602 HG23 HD11 ' A' ' 43' ' ' LEU . 30.5 pt -85.53 142.29 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -88.25 126.59 35.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.689 ' HB ' HG12 ' B' ' 13' ' ' ILE . 89.6 t -142.61 139.44 28.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.156 0.503 . . . . 0.0 111.519 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' LYS . . . . . 0.581 ' HB3' ' HA3' ' B' ' 10' ' ' GLY . 67.1 mttm -102.96 131.52 49.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.547 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -67.8 -156.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.0 mt -62.01 -50.5 71.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 110.708 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -75.62 -45.17 38.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.047 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.581 ' HA3' ' HB3' ' B' ' 6' ' ' LYS . . . 142.89 34.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.652 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 60.5 tttp -82.4 128.4 34.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.776 0.322 . . . . 0.0 111.181 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' THR . . . . . 0.445 ' C ' HG21 ' B' ' 13' ' ' ILE . 87.7 m -73.07 135.84 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.62 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.689 HG12 ' HB ' ' B' ' 5' ' ' VAL . 4.2 pt -137.44 134.94 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.097 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.25 144.28 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.688 HD13 HG12 ' B' ' 17' ' ' VAL . 6.0 tp -156.82 113.01 2.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -86.67 129.16 34.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.961 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.688 HG12 HD13 ' B' ' 15' ' ' LEU . 6.6 m -157.11 143.99 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.664 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.52 137.0 76.91 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.61 -39.63 72.84 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.824 2.349 . . . . 0.0 112.187 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -64.07 -24.6 67.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -54.01 134.06 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -56.48 143.19 36.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.518 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 23' ' ' ILE . 66.4 mt -58.09 -40.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.436 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -59.03 -44.87 91.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.051 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.35 -44.36 87.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.15 -48.81 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.255 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 49.4 mtmt -65.07 -35.82 82.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.678 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.632 ' HA ' ' HG3' ' B' ' 38' ' ' PRO . . . -54.31 -34.46 61.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.673 ' HD3' HD12 ' B' ' 15' ' ' LEU . 87.1 tttt -73.79 -32.27 63.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.384 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.735 ' HB ' HE22 ' B' ' 41' ' ' GLN . 40.8 mm -56.94 -44.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.426 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 23.9 pt20 -64.99 -39.15 93.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.64 -32.31 72.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 29' ' ' LYS . 31.0 mmmt -74.97 -31.17 61.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.799 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.678 ' HB3' HD13 ' B' ' 36' ' ' ILE . 5.1 tp10 -139.13 -64.03 0.51 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 156.61 -32.71 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.11 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.7 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -47.95 124.03 10.3 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' B' ' 40' ' ' GLN . 2.3 Cg_endo -48.64 137.82 25.98 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.586 2.19 . . . . 0.0 111.412 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.632 ' HG3' ' HA ' ' B' ' 28' ' ' ALA . 50.2 Cg_exo -53.47 -39.91 80.47 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.472 2.115 . . . . 0.0 112.412 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.03 -35.93 79.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.635 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLN . . . . . 0.7 ' NE2' HG23 ' B' ' 36' ' ' ILE . 7.0 tt0 -60.74 -36.69 79.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 111.145 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' GLN . . . . . 0.735 HE22 ' HB ' ' B' ' 30' ' ' ILE . 70.8 mt-30 -57.23 132.13 52.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 56.4 ttp180 -91.64 127.55 37.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.657 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 3' ' ' ILE . 8.3 mp -75.86 130.88 39.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.926 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -143.52 134.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.822 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 9.9 m-85 -129.94 141.78 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.294 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . 0.569 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.54 123.18 6.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.093 0.473 . . . . 0.0 112.068 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.436 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 52.6 m -61.33 -44.82 96.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.55 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.5 tpt -167.02 52.89 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.23 0.538 . . . . 0.0 110.739 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 17.4 pt20 -61.58 110.56 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.405 0.621 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 15' ' ' LEU . 37.0 pt -72.49 146.21 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.098 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -87.84 130.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.625 ' O ' HG21 ' A' ' 13' ' ' ILE . 64.8 t -144.55 151.05 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.96 117.95 29.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.325 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.594 HG22 ' HZ3' ' A' ' 11' ' ' LYS . 74.1 p -68.68 152.74 44.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.4 mt -50.29 -37.67 37.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.735 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -66.63 -44.99 80.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.499 ' H ' ' HG1' ' A' ' 7' ' ' THR . . . 144.02 -40.12 1.21 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.444 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.594 ' HZ3' HG22 ' A' ' 7' ' ' THR . 21.8 pttp -52.13 139.66 22.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 111.668 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 13' ' ' ILE . 58.4 m -73.34 148.1 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.62 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.625 HG21 ' O ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -134.83 133.33 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.274 0.559 . . . . 0.0 112.024 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.464 HG23 ' NE2' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -106.17 145.25 31.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.299 178.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.851 HD13 ' HG3' ' A' ' 33' ' ' LYS . 3.9 tt -155.31 113.76 3.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.339 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 25.4 pt-20 -80.43 136.69 36.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.422 . . . . 0.0 111.906 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 1' ' ' MET . 2.4 m -158.21 143.5 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.491 ' HB2' ' CG ' ' A' ' 21' ' ' ASP . 41.4 mt-10 -62.75 133.76 95.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.18 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.716 2.277 . . . . 0.0 111.851 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.5 t -64.72 -31.64 72.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.947 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.491 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 63.6 m-20 -52.44 135.33 33.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -56.71 143.79 35.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.769 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.691 HG12 HG12 ' B' ' 23' ' ' ILE . 60.7 mt -57.27 -44.45 83.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.98 -41.92 79.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.705 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -65.73 -43.01 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.648 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG12 HG23 ' A' ' 17' ' ' VAL . 59.9 t -59.55 -49.77 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 54.0 mttp -62.51 -39.79 94.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.827 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -35.72 67.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.328 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.626 ' HD2' HD23 ' A' ' 15' ' ' LEU . 24.4 ttmm -65.39 -36.48 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.031 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.712 HD11 ' HG2' ' A' ' 41' ' ' GLN . 51.1 mt -55.81 -31.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.561 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 68.9 mt-30 -61.09 -52.52 64.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.39 -34.67 72.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.25 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.851 ' HG3' HD13 ' A' ' 15' ' ' LEU . 43.9 mmtm -65.89 -33.43 75.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.298 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -141.66 -70.69 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.289 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.48 54.27 0.03 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.776 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.57 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -138.35 128.12 14.88 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 111.728 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.718 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 78.0 Cg_exo -44.03 141.21 4.68 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.961 2.44 . . . . 0.0 112.703 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 11.9 Cg_endo -57.85 -35.01 99.01 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.765 2.31 . . . . 0.0 112.711 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.99 -37.87 80.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.718 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 19.9 mt-30 -60.7 -44.91 95.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.579 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.712 ' HG2' HD11 ' A' ' 30' ' ' ILE . 0.6 OUTLIER -54.33 125.48 19.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.343 . . . . 0.0 110.771 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.696 ' HE ' ' HG3' ' B' ' 48' ' ' LYS . 70.0 mtt-85 -85.84 122.02 29.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.908 HD13 HD13 ' B' ' 43' ' ' LEU . 13.8 tp -84.31 132.98 34.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.7 mt -143.16 145.53 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 111.672 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 17.2 m-85 -133.9 140.07 46.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.23 119.21 5.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.094 0.473 . . . . 0.0 111.648 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.78 138.78 23.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.72 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.63 ' HG3' ' HE ' ' B' ' 42' ' ' ARG . 75.2 mmtt -149.26 74.55 1.25 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.434 0.635 . . . . 0.0 110.988 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.1 pt20 -67.33 103.64 1.32 Allowed 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.834 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 48' ' ' LYS . 3.4 mm? -45.09 80.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.713 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 49' ' ' GLN . 40.4 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 53.0 m -61.42 -43.46 98.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.759 0.314 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.536 ' O ' ' HG3' ' B' ' 1' ' ' MET . 15.4 tpt -168.29 51.76 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.317 0.58 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.713 ' HB2' HG23 ' B' ' 14' ' ' THR . 16.9 pt20 -61.46 110.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.129 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.577 HG12 ' O ' ' B' ' 15' ' ' LEU . 35.1 pt -72.96 147.48 9.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -87.87 130.15 34.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.617 ' O ' HG21 ' B' ' 13' ' ' ILE . 61.9 t -141.95 152.74 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -123.1 117.44 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.927 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.597 HG21 HG23 ' B' ' 13' ' ' ILE . 77.1 p -69.9 150.7 46.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.723 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -48.38 -37.81 17.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.979 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -66.81 -45.23 79.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.48 ' H ' ' HG1' ' B' ' 7' ' ' THR . . . 143.75 -41.92 1.1 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.517 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' B' ' 11' ' ' LYS . 0.0 OUTLIER -54.07 140.1 32.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.126 0.489 . . . . 0.0 111.67 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.525 HG21 ' N ' ' B' ' 13' ' ' ILE . 50.7 m -72.4 147.35 46.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.543 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.617 HG21 ' O ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -130.56 141.6 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.195 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.713 HG23 ' HB2' ' B' ' 2' ' ' GLN . 0.2 OUTLIER -119.21 143.97 46.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.019 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.577 ' O ' HG12 ' B' ' 3' ' ' ILE . 3.5 tp -155.67 114.01 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.666 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 15.1 pt-20 -77.91 134.42 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' B' ' 1' ' ' MET . 13.9 m -155.54 141.52 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.214 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.516 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 41.8 mt-10 -61.26 135.09 93.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.352 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.1 -39.55 90.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.777 2.318 . . . . 0.0 111.894 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.7 t -64.38 -30.55 71.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.912 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.516 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 63.0 m-20 -53.95 134.74 43.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 74.1 p -55.91 142.95 33.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.695 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.691 HG12 HG12 ' A' ' 23' ' ' ILE . 60.1 mt -57.16 -43.61 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.032 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.33 -42.47 81.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.552 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -65.81 -42.01 91.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.615 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.418 HG12 HG23 ' B' ' 17' ' ' VAL . 94.1 t -59.89 -48.78 86.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.535 ' HE2' HG21 ' B' ' 23' ' ' ILE . 64.5 mttm -64.26 -40.09 95.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.923 0.392 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.86 65.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.398 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.442 ' HD3' ' HZ2' ' B' ' 33' ' ' LYS . 24.6 ttmm -65.87 -35.32 80.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.66 HD11 ' HG2' ' B' ' 41' ' ' GLN . 50.2 mt -56.46 -30.69 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.689 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 66.6 mt-30 -61.12 -52.4 65.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -34.43 72.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.134 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.442 ' HZ2' ' HD3' ' B' ' 29' ' ' LYS . 43.5 mmtm -65.79 -33.04 74.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.258 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -143.31 -68.43 0.34 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.746 0.307 . . . . 0.0 111.252 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.83 53.2 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.311 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.756 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -133.23 132.23 22.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.688 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 72.1 Cg_exo -50.87 142.39 33.3 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.729 2.286 . . . . 0.0 111.998 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.689 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 32.4 Cg_exo -56.66 -35.73 97.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.675 2.25 . . . . 0.0 112.482 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.36 -37.52 86.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.756 ' NE2' HG23 ' B' ' 36' ' ' ILE . 27.6 mt-30 -63.08 -42.52 99.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.692 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.66 ' HG2' HD11 ' B' ' 30' ' ' ILE . 0.6 OUTLIER -56.52 127.28 30.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.745 0.307 . . . . 0.0 110.489 179.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.63 ' HE ' ' HG3' ' A' ' 48' ' ' LYS . 70.9 mtt-85 -86.84 123.44 31.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.433 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.908 HD13 HD13 ' A' ' 43' ' ' LEU . 14.3 tp -85.5 132.7 34.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 66.4 mt -143.22 145.64 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.894 0.378 . . . . 0.0 111.823 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 16.0 m-85 -134.53 139.98 45.82 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.993 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.589 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 117.34 5.03 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.084 0.469 . . . . 0.0 111.645 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.48 137.49 23.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.501 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.696 ' HG3' ' HE ' ' A' ' 42' ' ' ARG . 75.1 mmtt -149.68 74.79 1.24 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.219 0.533 . . . . 0.0 111.08 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.2 pt20 -66.02 115.92 6.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.031 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.33 79.92 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.341 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.4 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.628 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 53.3 m -67.97 -125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.604 0.24 . . . . 0.0 110.656 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 ptm -158.58 116.8 2.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.018 0.437 . . . . 0.0 110.975 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.739 ' HB2' HG23 ' A' ' 14' ' ' THR . 3.3 pt20 -61.91 130.19 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.236 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.615 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.2 pt -103.72 140.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.39 124.77 34.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.784 ' HB ' HG12 ' A' ' 13' ' ' ILE . 35.2 t -141.89 143.7 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 111.43 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.663 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 67.5 mttm -111.45 128.3 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.291 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 ' HB3' ' A' ' 11' ' ' LYS . 81.3 p -63.81 -156.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.008 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.574 HD22 HG22 ' A' ' 36' ' ' ILE . 34.0 mt -61.06 -53.6 55.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.849 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -72.99 -44.89 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.663 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 142.2 35.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.61 ' HB3' HG22 ' A' ' 7' ' ' THR . 60.9 tttp -80.61 126.02 30.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.311 . . . . 0.0 110.861 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.488 ' C ' HG21 ' A' ' 13' ' ' ILE . 84.9 m -72.88 134.49 44.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.611 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.784 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.6 pt -136.18 138.05 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.739 HG23 ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -95.81 144.01 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.729 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 29' ' ' LYS . 5.3 tt -161.55 114.34 1.85 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 24.5 pt-20 -87.99 136.28 33.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 16' ' ' GLU . 3.3 m -156.92 151.9 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.766 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.562 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 50.9 mt-10 -72.71 136.9 80.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.43 -32.32 72.45 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.734 2.289 . . . . 0.0 111.959 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.487 ' O ' HG21 ' B' ' 22' ' ' THR . 69.1 m -63.97 -31.78 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -57.22 128.81 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.788 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.495 HG21 ' O ' ' B' ' 20' ' ' SER . 76.2 p -57.18 150.71 17.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.992 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HA ' HG23 ' A' ' 26' ' ' VAL . 67.4 mt -57.28 -31.11 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.541 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 19.0 tt0 -64.72 -36.89 85.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.877 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.46 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.3 m120 -73.71 -47.6 38.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.374 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 23' ' ' ILE . 33.2 m -57.82 -43.55 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.131 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HE3' ' HB3' ' A' ' 38' ' ' PRO . 53.4 mtmt -72.02 -34.9 69.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.678 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 24' ' ' GLU . . . -55.52 -38.9 69.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.7 ' HB2' HD12 ' A' ' 15' ' ' LEU . 41.2 mtpt -65.6 -38.48 89.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.617 ' HB ' HE22 ' A' ' 41' ' ' GLN . 48.3 mm -54.68 -31.96 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.628 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.685 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 64.9 mt-30 -61.13 -51.82 67.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.05 -34.62 75.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.254 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -65.26 -32.1 73.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.399 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -145.46 -68.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.61 61.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.205 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.574 HG22 HD22 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -146.43 124.42 6.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.933 0.396 . . . . 0.0 112.003 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 39.7 Cg_exo -39.8 143.14 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.461 2.774 . . . . 0.0 112.979 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.685 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 38.3 Cg_exo -60.64 -37.79 76.85 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.805 2.336 . . . . 0.0 112.743 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.4 -35.54 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.008 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.637 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 19.7 mt-30 -62.03 -42.95 99.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.208 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.617 HE22 ' HB ' ' A' ' 30' ' ' ILE . 73.5 mt-30 -58.06 126.04 25.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 18.7 ttm105 -87.7 126.78 35.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.566 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' N ' HD21 ' A' ' 43' ' ' LEU . 3.2 mm? -75.78 131.16 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.468 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.933 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 71.3 mt -143.24 136.03 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.777 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.5 m-85 -131.62 141.07 49.55 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.635 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -155.14 122.24 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.019 0.438 . . . . 0.0 111.951 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' B' ' 40' ' ' GLN . . . -76.76 -134.84 0.61 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.611 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -68.52 74.72 0.26 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.258 0.551 . . . . 0.0 110.977 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.618 ' O ' ' N ' ' A' ' 51' ' ' GLU . 17.0 pt20 -65.41 96.29 0.24 Allowed 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -44.27 80.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.702 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.618 ' N ' ' O ' ' A' ' 49' ' ' GLN . 86.9 tt0 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.979 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.706 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 53.3 m -68.07 -125.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.619 0.247 . . . . 0.0 110.831 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.7 ptm -159.93 116.41 2.49 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.95 0.405 . . . . 0.0 111.393 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.538 ' NE2' HG23 ' B' ' 14' ' ' THR . 3.1 pt20 -62.39 128.92 38.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.807 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.57 HD13 HD13 ' B' ' 30' ' ' ILE . 32.7 pt -101.44 137.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.011 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.77 124.25 33.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.707 ' O ' HG21 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.79 140.11 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 0.0 111.419 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.651 ' HB3' ' HA3' ' B' ' 10' ' ' GLY . 66.6 mttm -100.78 136.09 41.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.137 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.599 HG22 ' HB3' ' B' ' 11' ' ' LYS . 82.2 p -68.86 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.336 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 mt -59.26 -53.2 60.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.6 p -75.95 -45.45 34.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 110.812 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.651 ' HA3' ' HB3' ' B' ' 6' ' ' LYS . . . 144.32 32.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.418 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.599 ' HB3' HG22 ' B' ' 7' ' ' THR . 61.4 tttp -79.63 127.25 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -73.51 136.52 44.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.707 HG21 ' O ' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -142.72 124.35 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.538 HG23 ' NE2' ' B' ' 2' ' ' GLN . 1.9 p -85.07 147.55 26.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.962 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' B' ' 29' ' ' LYS . 7.1 tp -160.66 113.22 1.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.706 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 24.6 pt-20 -80.14 140.27 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 p -169.13 133.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.7 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.466 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 52.9 mt-10 -56.35 139.17 74.19 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.612 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.11 -32.29 91.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.976 2.45 . . . . 0.0 112.226 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.495 ' O ' HG21 ' A' ' 22' ' ' THR . 33.8 t -63.37 -21.82 66.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.165 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 65.8 m-20 -66.18 133.02 49.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.734 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.487 HG21 ' O ' ' A' ' 20' ' ' SER . 66.9 p -59.12 148.5 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.607 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.483 ' HA ' HG23 ' B' ' 26' ' ' VAL . 65.5 mt -55.41 -30.86 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.433 0.635 . . . . 0.0 109.698 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' B' ' 28' ' ' ALA . 82.9 tt0 -63.57 -37.83 88.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.91 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.474 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 3.2 m120 -72.94 -48.64 35.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.607 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.486 HG21 ' N ' ' B' ' 27' ' ' LYS . 34.7 m -56.52 -44.59 80.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.223 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' B' ' 38' ' ' PRO . 53.6 mtmt -70.91 -34.26 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' B' ' 24' ' ' GLU . . . -57.1 -38.05 72.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.989 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HB2' HD23 ' B' ' 15' ' ' LEU . 32.4 mtpt -64.66 -40.1 94.84 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.608 ' HB ' HE22 ' B' ' 41' ' ' GLN . 50.6 mm -54.47 -32.05 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.902 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.674 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 66.5 mt-30 -60.79 -53.32 58.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.53 -32.03 72.06 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.309 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.477 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 72.7 mmtt -66.41 -31.62 72.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.448 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -147.48 -61.93 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.578 0.228 . . . . 0.0 111.428 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.483 ' H ' HD13 ' B' ' 36' ' ' ILE . . . 135.77 58.11 0.06 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.79 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.659 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -137.99 129.87 16.14 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.633 0.254 . . . . 0.0 111.309 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.635 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -50.27 142.18 29.61 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.619 2.213 . . . . 0.0 112.128 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.674 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 35.6 Cg_exo -58.31 -38.87 88.8 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.744 2.296 . . . . 0.0 112.608 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.53 -35.45 76.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.659 ' NE2' HG23 ' B' ' 36' ' ' ILE . 27.2 mt-30 -64.96 -39.7 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.315 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.777 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 73.2 mt-30 -60.09 128.11 35.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.661 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.642 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 18.5 ttm105 -88.97 126.26 35.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.186 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.57 ' N ' HD21 ' B' ' 43' ' ' LEU . 3.0 mm? -75.77 131.53 39.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.531 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.933 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.3 mt -144.04 138.3 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.632 ' HB2' HG12 ' A' ' 5' ' ' VAL . 13.5 m-85 -133.9 143.55 48.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.433 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.439 ' C ' ' HA ' ' A' ' 41' ' ' GLN . . . -156.25 120.27 4.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.11 -135.31 0.18 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.649 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.7 75.58 1.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.247 0.546 . . . . 0.0 111.27 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' B' ' 51' ' ' GLU . 18.9 pt20 -64.4 107.03 1.24 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.319 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.54 79.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.7 tt0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.893 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.436 ' HA3' ' HG3' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.572 -0.211 . . . . 0.0 112.572 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.466 ' OG ' ' HD3' ' A' ' 19' ' ' PRO . 48.4 t -168.71 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.662 0.268 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.2 ptt? -172.67 121.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.739 ' HB2' HG21 ' A' ' 14' ' ' THR . 16.7 pt20 -74.95 111.79 10.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.871 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 15' ' ' LEU . 33.5 pt -72.25 135.91 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.479 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.41 129.03 35.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.788 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.7 t -146.51 135.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.809 0.338 . . . . 0.0 111.593 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.45 123.05 36.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -70.41 -157.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.351 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.617 HD22 HG22 ' A' ' 36' ' ' ILE . 2.2 mm? -86.05 -48.97 8.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.125 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -71.08 -45.11 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.86 -36.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.787 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -49.22 131.16 19.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.897 0.38 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -84.76 132.3 34.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.788 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -96.65 130.04 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.696 179.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.739 HG21 ' HB2' ' A' ' 2' ' ' GLN . 1.4 m -107.5 129.13 54.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.715 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -159.56 114.56 2.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.106 0.479 . . . . 0.0 111.283 -178.06 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -76.39 144.32 40.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.389 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.409 ' CG2' HG13 ' A' ' 26' ' ' VAL . 30.9 m -149.7 145.99 17.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -68.55 143.52 95.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.154 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.466 ' HD3' ' OG ' ' A' ' 0' ' ' SER . 18.2 Cg_endo -58.78 -39.47 81.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.67 2.247 . . . . 0.0 112.189 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.436 ' O ' HG21 ' B' ' 22' ' ' THR . 47.0 t -64.42 -29.59 70.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.001 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -55.91 130.02 42.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.412 HG21 ' O ' ' B' ' 20' ' ' SER . 70.5 p -62.35 148.48 45.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.724 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.545 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 66.6 mt -54.91 -42.2 62.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -62.89 -29.59 70.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.25 -49.29 51.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.626 HG21 ' N ' ' A' ' 27' ' ' LYS . 35.3 m -62.54 -42.04 94.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.15 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.626 ' N ' HG21 ' A' ' 26' ' ' VAL . 57.8 mtpt -60.88 -37.18 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.404 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.66 79.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.488 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' NZ ' ' HA ' ' A' ' 26' ' ' VAL . 49.3 mttp -62.21 -41.5 98.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.622 HD12 HG23 ' A' ' 5' ' ' VAL . 60.3 mt -54.96 -31.79 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.893 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 60.9 mt-30 -63.09 -51.35 66.93 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.31 -32.96 70.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.794 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 31.3 mmmt -69.79 -31.88 70.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.916 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -140.52 -68.31 0.41 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.166 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.14 -32.57 1.05 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.452 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.631 HG23 ' NE2' ' A' ' 40' ' ' GLN . 1.0 OUTLIER -47.79 132.62 11.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.727 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 87.7 Cg_exo -49.88 155.72 3.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.418 2.746 . . . . 0.0 112.743 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 16.9 Cg_exo -66.79 -39.44 14.97 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.899 2.399 . . . . 0.0 112.944 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.1 -40.07 76.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.727 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 23.2 mt-30 -61.03 -42.22 98.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.411 . . . . 0.0 110.665 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 67.2 mt-30 -57.51 143.28 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.182 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.65 ' H ' ' H ' ' B' ' 46' ' ' ALA . 64.6 mtt85 -135.98 110.83 8.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.427 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.563 ' H ' HD21 ' A' ' 43' ' ' LEU . 1.4 pt? -77.46 138.71 39.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.575 ' H ' ' H ' ' B' ' 44' ' ' ILE . 62.9 mt -136.42 112.36 12.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.293 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 4.3 m-85 -84.65 146.69 27.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.601 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.85 126.42 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.401 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.2 -133.58 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.039 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.502 ' O ' HD23 ' A' ' 50' ' ' LEU . 4.1 tppp? -67.31 75.91 0.15 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.92 0.39 . . . . 0.0 111.646 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 51' ' ' GLU . 72.7 mt-30 -64.01 101.56 0.4 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 48' ' ' LYS . 3.5 mm? -44.71 84.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.619 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' GLN . 47.6 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . 0.568 ' HA3' ' HG3' ' B' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.487 ' HB2' ' OE1' ' B' ' 18' ' ' GLU . 47.5 t -171.41 -48.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.564 0.221 . . . . 0.0 110.971 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.2 ptt? -174.28 120.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.242 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 16.4 pt20 -71.87 112.47 7.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 110.393 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.562 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.6 pt -72.64 133.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.825 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.48 125.07 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.114 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.722 ' HB ' ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -150.86 131.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.662 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.7 130.97 34.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.46 HG23 ' HG3' ' B' ' 34' ' ' GLU . 74.5 p -74.53 -157.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.491 HD13 HG22 ' B' ' 36' ' ' ILE . 2.0 mm? -86.05 -48.66 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -70.67 -45.23 65.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.575 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.94 -35.9 0.62 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -49.86 130.54 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 0.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -82.26 140.87 33.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.397 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.501 HG13 HG11 ' B' ' 5' ' ' VAL . 15.4 pt -116.98 130.17 72.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.291 0.567 . . . . 0.0 111.779 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -112.35 137.51 50.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.153 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.562 ' O ' HG12 ' B' ' 3' ' ' ILE . 2.6 pp -162.8 118.62 1.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.568 ' HG3' ' HA3' ' B' ' -1' ' ' GLY . 0.0 OUTLIER -70.73 146.03 50.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.761 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.726 HG22 HG13 ' B' ' 26' ' ' VAL . 8.4 m -150.88 141.8 16.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.523 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 46.5 mm-40 -67.45 143.05 96.91 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.425 ' HD3' ' OG ' ' B' ' 0' ' ' SER . 12.9 Cg_endo -57.01 -36.72 99.44 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.752 2.302 . . . . 0.0 112.099 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.412 ' O ' HG21 ' A' ' 22' ' ' THR . 44.1 t -64.49 -31.49 72.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.159 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 47.2 m-20 -54.67 130.78 41.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 20' ' ' SER . 72.9 p -63.21 148.36 48.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.502 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.544 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 68.1 mt -54.27 -42.11 55.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -63.1 -29.83 71.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.22 -49.48 49.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.726 HG13 HG22 ' B' ' 17' ' ' VAL . 35.5 m -62.52 -41.32 91.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.61 ' N ' HG21 ' B' ' 26' ' ' VAL . 58.3 mtpt -61.52 -38.23 86.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.56 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.77 75.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.554 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.548 ' NZ ' ' HA ' ' B' ' 26' ' ' VAL . 50.1 mttp -62.57 -41.09 98.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.426 HD11 HG22 ' B' ' 30' ' ' ILE . 59.3 mt -54.78 -32.13 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.903 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.524 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 61.9 mt-30 -62.93 -51.27 67.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.9 -32.07 70.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.956 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 31.1 mmmt -69.75 -31.97 70.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.463 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.636 ' HB2' HD13 ' B' ' 36' ' ' ILE . 5.5 mm-40 -141.27 -61.32 0.48 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.714 0.292 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 126.79 40.93 0.32 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.453 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.679 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -110.46 135.94 20.63 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.558 0.218 . . . . 0.0 111.063 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.609 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 65.8 Cg_exo -51.55 143.71 35.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.451 2.1 . . . . 0.0 111.896 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.524 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -60.89 -37.61 76.06 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.727 2.285 . . . . 0.0 112.697 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -60.47 -39.11 86.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.155 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.679 ' NE2' HG23 ' B' ' 36' ' ' ILE . 26.8 mt-30 -63.56 -39.04 93.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -60.9 144.82 52.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.735 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.601 ' H ' ' H ' ' A' ' 46' ' ' ALA . 64.1 mtt85 -137.87 114.56 10.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -78.27 145.4 35.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.973 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.575 ' H ' ' H ' ' A' ' 44' ' ' ILE . 69.3 mt -142.46 108.51 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.01 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.686 ' HB2' HG12 ' A' ' 5' ' ' VAL . 4.0 m-85 -82.91 145.24 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.75 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.65 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -157.51 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.224 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.63 -134.42 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.016 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -67.27 75.94 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.944 0.402 . . . . 0.0 111.528 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' B' ' 51' ' ' GLU . 71.6 mt-30 -64.01 110.87 2.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -52.22 79.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.347 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' B' ' 49' ' ' GLN . 21.4 pt-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.998 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 32.6 t 56.03 -128.36 2.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.484 0.183 . . . . 0.0 110.622 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm -165.54 117.13 1.1 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.118 0.485 . . . . 0.0 111.23 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 18.7 pt20 -68.99 135.53 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.958 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.629 HG12 HD21 ' A' ' 15' ' ' LEU . 35.5 pt -108.31 144.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.648 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -89.11 129.28 35.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.986 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.536 HG13 HD12 ' A' ' 13' ' ' ILE . 87.1 t -149.13 129.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.46 126.69 34.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 11' ' ' LYS . 74.8 p -73.13 -157.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.94 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 36' ' ' ILE . 54.2 mt -74.25 -50.39 19.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.998 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -73.35 -45.43 55.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.575 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.94 -31.81 0.55 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.807 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 7' ' ' THR . 58.6 tttp -46.35 129.98 10.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.908 0.385 . . . . 0.0 111.578 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -85.43 134.87 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.895 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.536 HD12 HG13 ' A' ' 5' ' ' VAL . 8.7 pt -101.3 128.23 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 112.014 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.456 HG21 ' HB2' ' A' ' 2' ' ' GLN . 1.9 m -93.05 116.91 29.49 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 3' ' ' ILE . 2.4 tt -143.67 115.21 8.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.263 0.554 . . . . 0.0 111.993 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 0' ' ' SER . 16.8 pt-20 -76.66 143.76 39.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.951 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.414 HG12 HG13 ' A' ' 26' ' ' VAL . 10.8 p -168.45 138.15 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -51.72 140.17 28.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.007 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.91 -42.58 11.12 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.83 2.353 . . . . 0.0 111.954 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.45 ' O ' HG21 ' B' ' 22' ' ' THR . 50.6 m -63.67 -23.05 67.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.402 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.593 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 7.7 t70 -54.16 131.86 42.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.362 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.448 HG21 ' O ' ' B' ' 20' ' ' SER . 72.7 p -56.82 142.37 41.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.867 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.476 HD11 HD22 ' A' ' 43' ' ' LEU . 65.9 mt -54.63 -35.73 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.913 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 16.9 pt-20 -63.43 -37.05 85.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.386 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.593 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 3.5 m120 -74.54 -49.17 22.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.775 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG13 HG12 ' A' ' 17' ' ' VAL . 30.4 m -54.06 -42.67 56.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.687 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 50.9 mtmt -70.43 -38.92 74.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -56.66 -35.13 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HE2' HD13 ' A' ' 15' ' ' LEU . 88.3 tttt -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.871 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.733 HG23 HD12 ' A' ' 36' ' ' ILE . 59.4 mt -58.32 -36.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 41.4 tt0 -60.76 -50.97 71.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.922 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.88 -33.09 71.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.901 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG3' HD11 ' A' ' 15' ' ' LEU . 30.6 mmmt -69.41 -35.73 76.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.267 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -135.08 -66.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.959 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.59 -39.53 0.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.347 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.736 HG22 HD22 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -45.04 121.45 4.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.714 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 82.8 Cg_exo -46.41 147.46 4.08 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.097 2.531 . . . . 0.0 112.251 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 18.0 Cg_endo -59.41 -36.51 93.72 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.475 2.117 . . . . 0.0 112.298 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.08 -36.79 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.413 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.714 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 27.8 mt-30 -61.58 -36.24 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.421 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.765 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 99.6 mm-40 -51.3 122.03 7.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.697 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 87.2 mtm180 -85.11 121.27 27.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.648 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 43' ' ' LEU . 8.9 mp -69.13 122.6 19.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.404 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.826 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 61.4 mt -143.64 132.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.744 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 39.1 m-85 -136.63 148.76 47.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.562 ' HB2' ' HE ' ' B' ' 42' ' ' ARG . . . -153.06 131.34 12.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.984 0.421 . . . . 0.0 111.55 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.62 143.65 48.69 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.74 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.662 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 14.5 mmmm -67.19 74.93 0.13 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 111.281 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 51' ' ' GLU . 55.7 tp60 -66.73 97.93 0.49 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.4 mm? -44.88 80.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.654 0.596 . . . . 0.0 112.141 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 49' ' ' GLN . 12.7 pt-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.837 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.865 ' HB3' ' HB2' ' B' ' 16' ' ' GLU . 33.2 t 56.88 -127.82 1.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.603 -0.147 . . . . 0.0 110.603 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.4 ptm -166.64 115.74 0.89 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.016 0.436 . . . . 0.0 111.464 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.525 ' NE2' HG23 ' B' ' 14' ' ' THR . 18.2 pt20 -67.84 130.97 44.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.596 HG12 ' HG ' ' B' ' 15' ' ' LEU . 39.5 pt -102.31 143.13 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.32 129.37 35.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.44 HG21 ' O ' ' B' ' 4' ' ' PHE . 97.4 t -148.92 127.7 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 111.34 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -83.23 126.45 32.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.554 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.456 HG22 ' O ' ' B' ' 11' ' ' LYS . 70.8 p -73.29 -157.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 54.1 mt -74.34 -49.83 21.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -74.28 -45.35 48.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.95 -31.33 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.773 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.456 ' O ' HG22 ' B' ' 7' ' ' THR . 55.9 tttp -47.05 129.88 12.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.691 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 40.7 m -82.63 143.97 30.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.427 HG12 ' O ' ' B' ' 5' ' ' VAL . 28.7 pt -119.24 129.31 75.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.14 0.495 . . . . 0.0 112.079 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.525 HG23 ' NE2' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -100.63 128.0 46.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.07 178.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.596 ' HG ' HG12 ' B' ' 3' ' ' ILE . 2.5 pp -152.9 120.16 5.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.865 ' HB2' ' HB3' ' B' ' 0' ' ' SER . 11.2 pt-20 -73.06 138.18 45.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.029 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' B' ' 15' ' ' LEU . 2.2 m -157.65 137.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.416 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' B' ' 21' ' ' ASP . 92.6 mt-10 -53.99 139.34 53.8 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.19 -41.73 26.29 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.621 2.214 . . . . 0.0 111.799 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 22' ' ' THR . 60.9 m -64.14 -21.87 66.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.494 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.577 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.0 t70 -55.06 132.34 47.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 20' ' ' SER . 77.1 p -57.98 142.43 46.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.807 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.517 HD11 HD22 ' B' ' 43' ' ' LEU . 65.7 mt -54.74 -36.09 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.88 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.452 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 11.4 pt-20 -63.43 -36.86 85.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.577 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 3.5 m120 -73.74 -50.05 22.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 19.6 m -53.75 -42.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.591 ' HD2' ' HB2' ' B' ' 41' ' ' GLN . 50.7 mtmt -70.58 -38.73 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.376 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -58.03 -28.67 64.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' B' ' 33' ' ' LYS . 87.4 tttt -74.66 -32.91 62.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 109.906 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.618 HG23 HD12 ' B' ' 36' ' ' ILE . 53.0 mt -61.9 -41.0 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.155 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.698 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.3 pt20 -63.91 -42.83 97.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -58.47 -34.29 70.71 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.4 mmmt -72.35 -33.09 67.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.924 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -136.96 -65.86 0.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 161.42 -34.77 0.38 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.37 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.651 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -48.78 122.75 11.26 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.664 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 84.2 Cg_exo -50.13 146.57 17.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.804 2.336 . . . . 0.0 111.897 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.463 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 18.4 Cg_endo -57.98 -38.28 92.67 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.529 2.153 . . . . 0.0 112.693 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.41 -37.26 86.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.468 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.664 ' NE2' ' HD2' ' B' ' 37' ' ' PRO . 27.3 mt-30 -61.38 -35.41 77.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.629 0.252 . . . . 0.0 111.482 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.744 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 6.1 mm-40 -54.6 124.55 16.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 110.876 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 87.0 mtm180 -85.93 123.24 31.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.832 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.517 HD22 HD11 ' B' ' 23' ' ' ILE . 8.9 mp -70.57 123.14 21.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.199 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.826 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 61.5 mt -143.35 132.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.765 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 41.1 m-85 -136.9 148.38 47.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.591 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.639 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.15 134.75 15.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.024 0.44 . . . . 0.0 111.789 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.52 141.74 47.95 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.567 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.593 ' H ' ' HB3' ' A' ' 40' ' ' GLN . 14.4 mmmm -70.35 74.94 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.679 0.276 . . . . 0.0 111.657 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.2 mm100 -64.25 115.85 5.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.627 HD21 ' N ' ' B' ' 50' ' ' LEU . 2.9 mm? -56.9 79.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.939 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' B' ' 49' ' ' GLN . 22.4 pt-20 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 16' ' ' GLU . 68.3 p -65.85 -120.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.46 0.171 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.553 ' HE3' ' HG ' ' B' ' 43' ' ' LEU . 18.1 ptm -155.24 120.32 4.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.017 0.437 . . . . 0.0 111.654 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -63.31 139.05 58.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.79 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.602 HG12 ' O ' ' A' ' 15' ' ' LEU . 32.0 pt -114.47 153.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -87.45 131.13 34.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.697 ' HB ' HG22 ' A' ' 13' ' ' ILE . 50.1 t -142.28 155.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.671 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 89.3 mttt -141.22 122.24 14.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 51.4 p -69.16 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.589 ' HB3' ' NE2' ' B' ' 49' ' ' GLN . 4.1 mp -68.79 -46.51 68.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.785 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -83.44 26.8 0.63 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.107 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.88 37.1 83.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.594 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 22.0 ttmm -76.05 128.28 34.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.597 0.237 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -72.83 134.72 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.53 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.697 HG22 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -151.3 133.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.234 0.54 . . . . 0.0 112.233 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -97.64 149.63 22.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.509 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 3' ' ' ILE . 12.4 tp -155.83 113.19 3.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.0 pt-20 -81.53 130.22 34.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.268 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.582 HG13 ' NZ ' ' A' ' 29' ' ' LYS . 5.6 m -156.72 131.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.495 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 25.4 pt-20 -55.55 141.59 63.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.84 -37.82 91.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.813 2.342 . . . . 0.0 112.313 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.8 m -63.67 -21.8 66.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.623 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' OD2' HG11 ' A' ' 26' ' ' VAL . 38.7 t70 -61.47 134.29 56.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 p -64.67 146.33 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.473 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.698 HG21 ' HZ1' ' A' ' 27' ' ' LYS . 60.4 mt -55.43 -37.17 43.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.241 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.705 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 16.3 pt-20 -58.13 -35.62 71.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.209 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.499 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 m120 -75.12 -48.36 24.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.748 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 23' ' ' ILE . 34.5 m -56.02 -42.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.561 0.219 . . . . 0.0 111.146 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.705 ' HZ2' ' HA ' ' A' ' 24' ' ' GLU . 35.4 mtmm -69.8 -38.44 76.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.408 . . . . 0.0 110.569 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.21 77.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.638 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.582 ' NZ ' HG13 ' A' ' 17' ' ' VAL . 83.3 mttt -63.66 -38.29 90.55 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.53 HG22 HG13 ' A' ' 5' ' ' VAL . 72.8 mt -56.06 -34.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.731 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.42 ' OE1' ' HG3' ' A' ' 38' ' ' PRO . 20.7 mt-30 -61.52 -43.14 99.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -63.89 -39.82 95.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.26 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HD3' HD13 ' A' ' 13' ' ' ILE . 67.4 mttm -78.08 3.4 15.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.124 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -169.05 -109.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.197 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.46 51.28 0.03 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.354 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -123.09 129.26 25.02 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.451 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.721 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 91.8 Cg_exo -45.84 150.09 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.997 2.465 . . . . 0.0 112.509 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 32.1 Cg_exo -57.15 -34.33 97.56 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.518 2.146 . . . . 0.0 112.07 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.96 -39.49 93.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.03 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.721 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 27.3 mt-30 -60.89 -36.64 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.257 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.666 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 4.1 mm-40 -53.07 122.73 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.807 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 79.5 mtp180 -91.38 121.31 33.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.656 HD13 ' HE3' ' B' ' 1' ' ' MET . 8.0 mt -82.28 129.91 34.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 1.002 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 63.3 mt -143.14 140.77 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.948 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 42.0 m-85 -135.14 138.87 44.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.676 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.86 138.47 21.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 111.512 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.66 -133.62 0.02 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.908 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -159.74 82.29 0.73 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.354 0.597 . . . . 0.0 111.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.3 tp-100 -65.82 98.07 0.38 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.493 ' CD2' ' H ' ' A' ' 50' ' ' LEU . 2.3 mm? -44.14 81.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.973 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 49' ' ' GLN . 94.7 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.868 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.441 ' HB2' ' C ' ' B' ' 17' ' ' VAL . 70.7 p -65.69 -121.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.527 0.203 . . . . 0.0 110.875 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.656 ' HE3' HD13 ' A' ' 43' ' ' LEU . 18.5 ptm -153.97 120.67 5.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.09 0.472 . . . . 0.0 111.513 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.742 ' HB2' HG23 ' B' ' 14' ' ' THR . 19.1 pt20 -62.28 142.75 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.656 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.4 pt -118.28 152.23 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.757 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -87.37 132.41 33.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.621 ' HB ' HG22 ' B' ' 13' ' ' ILE . 48.8 t -143.82 154.62 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.003 0.43 . . . . 0.0 111.349 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 57.9 mttp -139.04 123.22 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.186 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' B' ' 11' ' ' LYS . 56.2 p -72.72 -156.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.173 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.575 HD11 ' N ' ' B' ' 8' ' ' LEU . 6.5 mp -64.07 -50.91 66.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -82.8 28.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.335 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.02 36.66 68.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.485 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.65 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 21.6 ttmm -73.95 128.67 36.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 111.001 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -72.88 131.76 42.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.376 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.621 HG22 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -145.02 136.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.342 0.591 . . . . 0.0 111.85 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.742 HG23 ' HB2' ' B' ' 2' ' ' GLN . 0.3 OUTLIER -101.18 147.16 26.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.912 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.656 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.8 tt -157.62 114.13 2.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.153 0.502 . . . . 0.0 111.15 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.518 ' O ' HG11 ' B' ' 17' ' ' VAL . 24.5 pt-20 -83.39 134.23 34.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.778 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.604 HG13 ' NZ ' ' B' ' 29' ' ' LYS . 1.8 m -159.47 133.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' B' ' 21' ' ' ASP . 14.4 pt-20 -56.25 141.06 70.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.411 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.75 -37.86 95.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.921 2.414 . . . . 0.0 112.169 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 51.0 m -63.66 -24.45 67.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.715 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.521 ' HB2' ' HG3' ' B' ' 18' ' ' GLU . 63.2 t0 -58.95 133.46 56.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 76.8 p -64.12 146.86 53.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.637 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.698 HG21 ' HZ1' ' B' ' 27' ' ' LYS . 60.4 mt -56.07 -37.0 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.292 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.7 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 16.3 pt-20 -58.23 -36.54 73.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.363 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.1 m120 -74.88 -48.9 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.701 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' B' ' 23' ' ' ILE . 34.4 m -55.12 -41.73 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.634 0.254 . . . . 0.0 111.017 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.7 ' HZ2' ' HA ' ' B' ' 24' ' ' GLU . 35.4 mtmm -70.21 -38.4 75.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.403 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.89 73.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.471 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.604 ' NZ ' HG13 ' B' ' 17' ' ' VAL . 84.5 mttt -66.16 -37.22 85.12 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.56 HG22 HG13 ' B' ' 5' ' ' VAL . 67.8 mt -57.68 -32.12 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.643 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 21.8 mt-30 -61.58 -46.81 88.28 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.44 -33.89 77.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.57 ' HG3' HD13 ' B' ' 15' ' ' LEU . 71.9 mmtt -68.78 -18.08 64.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.435 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -157.72 -90.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.742 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.07 48.53 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.607 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.811 HG23 HE21 ' B' ' 40' ' ' GLN . 0.4 OUTLIER -118.35 134.51 23.42 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.614 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 71.0 Cg_exo -51.57 147.64 22.82 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.771 2.314 . . . . 0.0 111.851 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HG3' ' OE1' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -56.95 -34.44 97.37 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.448 2.098 . . . . 0.0 112.075 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.33 -35.03 78.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.561 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.811 HE21 HG23 ' B' ' 36' ' ' ILE . 26.5 mt-30 -66.96 -37.48 84.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.676 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' B' ' 27' ' ' LYS . 0.0 OUTLIER -52.26 126.93 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.788 0.327 . . . . 0.0 110.675 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.676 ' H ' ' H ' ' A' ' 46' ' ' ALA . 80.0 mtp180 -90.17 125.98 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.164 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.553 ' HG ' ' HE3' ' A' ' 1' ' ' MET . 0.7 OUTLIER -80.87 125.4 30.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 1.002 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 63.2 mt -143.25 138.82 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.408 . . . . 0.0 111.307 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 35.3 m-85 -136.93 140.26 42.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.543 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.02 136.4 17.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.605 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.87 -134.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.216 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -160.24 111.4 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.257 0.551 . . . . 0.0 111.777 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.589 ' NE2' ' HB3' ' A' ' 8' ' ' LEU . 48.0 mm-40 -85.18 115.82 23.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.746 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.435 ' H ' HD21 ' B' ' 50' ' ' LEU . 2.7 mm? -59.62 79.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.015 0.436 . . . . 0.0 110.588 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' B' ' 49' ' ' GLN . 93.2 mt-10 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.917 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.791 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 56.7 m -67.46 -125.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.504 0.192 . . . . 0.0 110.756 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.63 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.6 ptt? -160.35 124.76 3.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.993 0.425 . . . . 0.0 111.05 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.594 ' HB3' HG21 ' A' ' 14' ' ' THR . 15.2 mt-30 -66.49 111.23 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.58 HG23 HD21 ' B' ' 43' ' ' LEU . 44.7 pt -84.14 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.203 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.677 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -88.0 133.01 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.72 ' HB ' HG13 ' A' ' 13' ' ' ILE . 88.6 t -149.07 126.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -82.28 116.04 21.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.54 ' HG1' HG21 ' A' ' 9' ' ' THR . 72.7 p -67.7 -159.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.432 . . . . 0.0 110.911 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD13 HG22 ' A' ' 36' ' ' ILE . 1.3 mp -82.45 -44.63 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.72 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.54 HG21 ' HG1' ' A' ' 7' ' ' THR . 5.9 t -73.15 -44.84 59.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.312 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.75 -39.96 0.64 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.998 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -51.86 135.12 30.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 111.565 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 p -81.18 138.65 35.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.6 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.72 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -96.4 129.33 46.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.594 HG21 ' HB3' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -96.76 137.0 36.51 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.853 HD12 ' HD2' ' A' ' 29' ' ' LYS . 2.0 tp -162.32 115.1 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 111.975 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.791 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 25.4 pt-20 -85.06 132.68 34.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.359 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.562 HG22 HG13 ' A' ' 26' ' ' VAL . 6.9 m -157.27 139.76 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.747 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.64 144.03 89.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.431 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.94 -37.7 52.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.769 2.313 . . . . 0.0 112.159 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -63.13 -23.23 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.374 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -60.96 134.84 57.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 p -61.69 141.57 57.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.71 HG12 HG12 ' B' ' 23' ' ' ILE . 57.6 mt -53.83 -41.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.124 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 22.3 pt-20 -55.29 -39.99 70.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.334 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.472 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.5 m120 -66.34 -51.02 61.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.822 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 17' ' ' VAL . 11.5 m -60.08 -40.05 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.022 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.687 ' NZ ' ' HB2' ' A' ' 41' ' ' GLN . 29.5 mtpp -64.02 -43.7 94.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.733 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -58.37 -42.37 86.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.11 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.853 ' HD2' HD12 ' A' ' 15' ' ' LEU . 39.5 ttmt -62.71 -36.5 83.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 26' ' ' VAL . 62.8 mt -55.51 -37.05 43.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.733 HE21 ' HA ' ' A' ' 28' ' ' ALA . 68.1 mt-30 -58.83 -40.43 84.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.77 -39.83 95.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.649 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 4.8 mmmp? -61.22 -40.0 92.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.71 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.35 -89.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.442 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 45.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.578 HG23 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -122.68 126.43 26.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.641 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 65.8 Cg_exo -43.13 141.7 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.089 2.526 . . . . 0.0 112.706 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.589 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 28.0 Cg_endo -62.14 -33.84 80.87 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.641 2.227 . . . . 0.0 112.125 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.641 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 15.6 mt-30 -63.33 -39.92 95.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.581 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.687 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 6.6 mm100 -53.06 132.26 37.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.705 ' H ' ' H ' ' B' ' 46' ' ' ALA . 22.1 tpp180 -107.53 119.67 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.34 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.497 HD21 HG23 ' B' ' 3' ' ' ILE . 11.0 mp -66.88 126.79 30.19 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.158 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.827 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.9 mt -144.21 123.25 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 4.0 m-85 -121.84 148.6 44.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.425 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.652 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.64 130.28 14.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 0.0 111.916 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.86 137.51 13.7 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.394 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.586 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -161.49 73.8 0.45 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.426 0.631 . . . . 0.0 111.281 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.597 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.6 tp-100 -68.53 105.43 2.22 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.545 ' N ' HD21 ' A' ' 50' ' ' LEU . 3.4 mm? -45.38 80.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.662 0.601 . . . . 0.0 111.774 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 49' ' ' GLN . 56.2 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.887 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.835 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 52.0 m -67.75 -125.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.549 0.214 . . . . 0.0 110.731 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.1 ptt? -163.54 115.3 1.43 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.533 ' NE2' HG23 ' B' ' 14' ' ' THR . 17.2 pt20 -65.4 110.72 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.302 0.572 . . . . 0.0 110.868 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.519 HG12 ' HB3' ' B' ' 15' ' ' LEU . 37.4 pt -76.99 141.04 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.08 131.29 34.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.657 ' HB ' HG13 ' B' ' 13' ' ' ILE . 98.4 t -149.04 124.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 111.353 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -82.49 120.53 25.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.253 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.625 ' HG1' HG21 ' B' ' 9' ' ' THR . 73.5 p -69.96 -160.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.65 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.858 HD13 HG22 ' B' ' 36' ' ' ILE . 6.3 mp -82.14 -42.87 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.625 HG21 ' HG1' ' B' ' 7' ' ' THR . 5.8 t -71.58 -44.79 63.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.91 -39.66 0.72 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.036 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -52.04 134.95 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 111.961 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -82.12 142.71 32.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.021 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.657 HG13 ' HB ' ' B' ' 5' ' ' VAL . 11.4 pt -114.15 122.86 69.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.308 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.533 HG23 ' NE2' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -87.51 148.67 24.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.67 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.527 ' C ' ' HA ' ' B' ' 2' ' ' GLN . 5.3 tt -162.94 112.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.429 . . . . 0.0 110.659 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.835 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 14.5 pt-20 -82.78 132.16 35.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.821 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.55 HG22 HG23 ' B' ' 26' ' ' VAL . 2.4 m -159.44 139.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.617 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.86 142.75 88.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.452 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.454 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 26.3 Cg_endo -60.22 -37.24 84.49 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.878 2.385 . . . . 0.0 112.141 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.8 m -63.63 -26.48 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.659 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -56.64 135.26 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.343 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -61.87 142.27 57.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.71 HG12 HG12 ' A' ' 23' ' ' ILE . 58.8 mt -54.61 -40.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.533 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 12.0 pt-20 -55.16 -44.46 75.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.533 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.2 m120 -64.13 -47.95 77.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.55 HG23 HG22 ' B' ' 17' ' ' VAL . 24.6 t -56.34 -45.17 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.224 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.657 ' NZ ' ' HB2' ' B' ' 41' ' ' GLN . 28.2 mtpp -66.25 -41.16 90.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.203 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.703 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -58.28 -40.97 83.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.58 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -63.41 -34.89 78.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.397 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 26' ' ' VAL . 59.2 mt -58.19 -35.69 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.274 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.703 HE21 ' HA ' ' B' ' 28' ' ' ALA . 68.7 mt-30 -60.48 -47.74 84.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.66 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.687 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' B' ' 33' ' ' LYS . 22.8 tptp -65.65 -32.57 74.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.931 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.418 ' HB3' HD13 ' B' ' 36' ' ' ILE . 5.3 tp10 -144.89 -68.25 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.684 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.89 47.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.737 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.858 HG22 HD13 ' B' ' 8' ' ' LEU . 0.1 OUTLIER -124.94 128.88 24.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.5 0.19 . . . . 0.0 111.394 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.641 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 54.2 Cg_exo -51.77 138.35 50.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.341 2.028 . . . . 0.0 111.554 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.562 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 19.0 Cg_endo -58.88 -34.0 98.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.577 2.185 . . . . 0.0 112.202 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.84 -39.15 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.643 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.699 ' NE2' HG23 ' B' ' 36' ' ' ILE . 22.9 mt-30 -65.79 -38.21 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.657 ' HB2' ' NZ ' ' B' ' 27' ' ' LYS . 7.0 mm100 -54.31 133.78 45.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.652 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.1 tpp180 -108.49 121.79 45.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.58 HD21 HG23 ' A' ' 3' ' ' ILE . 10.8 mp -68.94 127.41 33.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.189 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.827 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -144.14 122.44 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.034 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.638 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.1 m-85 -120.97 146.03 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.705 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -148.25 128.9 14.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 111.696 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.76 137.7 13.61 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.302 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.617 ' N ' ' HD2' ' B' ' 48' ' ' LYS . 0.0 OUTLIER -160.27 73.97 0.54 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.509 0.671 . . . . 0.0 111.463 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.559 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.9 tp-100 -66.61 110.87 3.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.743 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.792 ' H ' HD21 ' B' ' 50' ' ' LEU . 3.3 mm? -50.47 80.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.497 0.498 . . . . 0.0 111.545 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' B' ' 49' ' ' GLN . 56.1 mt-10 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.828 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 52.7 m -60.45 -40.04 89.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 110.963 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' HG3' ' A' ' 1' ' ' MET . 15.1 tpt -163.83 57.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.209 0.528 . . . . 0.0 110.958 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.417 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 3.2 pt20 -61.72 127.34 30.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 15' ' ' LEU . 28.8 pt -95.47 132.44 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.576 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -88.83 128.77 35.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.76 HG12 ' HB2' ' B' ' 45' ' ' PHE . 63.4 t -148.49 138.49 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.151 0.501 . . . . 0.0 112.242 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' N ' HG11 ' A' ' 5' ' ' VAL . 35.8 mtmm -99.44 127.71 45.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.725 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.6 HG22 ' HB3' ' A' ' 11' ' ' LYS . 73.1 p -68.49 -156.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 111.302 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.649 ' H ' HD13 ' A' ' 8' ' ' LEU . 2.7 mp -64.36 -51.15 64.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -78.61 -45.73 20.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.866 0.365 . . . . 0.0 111.067 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 28.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.315 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HB3' HG22 ' A' ' 7' ' ' THR . 15.8 tppt? -77.37 122.65 25.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 m -75.38 138.71 41.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.548 HG13 ' HB ' ' A' ' 5' ' ' VAL . 12.4 pt -140.07 128.69 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.215 0.531 . . . . 0.0 112.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -97.37 145.99 25.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.67 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 3' ' ' ILE . 5.8 tt -163.94 114.05 1.27 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.04 0.448 . . . . 0.0 110.656 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' HG11 ' A' ' 17' ' ' VAL . 11.9 pt-20 -79.4 138.1 37.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.499 HG11 ' O ' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -159.46 137.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.84 135.45 89.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -35.93 76.77 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 111.749 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -63.77 -29.18 70.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.11 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.52 135.27 50.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.249 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.631 HG23 ' HG2' ' A' ' 24' ' ' GLU . 21.4 m -59.68 148.84 32.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 111.482 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 64.3 mt -60.34 -43.44 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.226 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.631 ' HG2' HG23 ' A' ' 22' ' ' THR . 12.6 pt-20 -59.25 -30.46 68.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 2.0 m120 -71.26 -52.25 20.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.498 HG21 ' N ' ' A' ' 27' ' ' LYS . 34.4 m -59.97 -40.98 84.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.43 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 58.4 mtpt -62.39 -42.79 99.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -57.93 -34.8 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.349 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.3 mttm -66.6 -45.56 78.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.053 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.726 HD11 HG23 ' A' ' 5' ' ' VAL . 79.0 mt -55.15 -36.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 45.8 tt0 -61.92 -49.5 75.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.085 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -62.09 -32.27 72.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.058 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HG3' HD13 ' A' ' 15' ' ' LEU . 30.7 mmmt -68.49 -36.46 78.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.215 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.37 -67.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.789 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.33 -35.22 0.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.427 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.676 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.73 122.55 4.63 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.72 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 89.2 Cg_exo -47.22 147.07 5.95 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.161 2.574 . . . . 0.0 112.469 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.98 -35.62 98.27 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.463 2.109 . . . . 0.0 111.993 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -61.69 -38.34 87.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.72 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 26.2 mt-30 -65.72 -44.03 87.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.566 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.0 mt-30 -54.69 125.67 20.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.951 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.655 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 70.6 mtt-85 -97.36 127.99 43.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.524 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.555 ' HG ' ' HE1' ' A' ' 45' ' ' PHE . 10.8 tp -75.07 128.91 36.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 66.2 mt -143.5 139.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.935 0.397 . . . . 0.0 111.885 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.696 ' HB2' HG12 ' B' ' 5' ' ' VAL . 4.2 m-85 -128.19 147.72 50.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.612 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.4 124.66 5.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 111.596 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' HA3' ' C ' ' B' ' 40' ' ' GLN . . . -71.6 -135.5 0.15 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.243 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.47 ' O ' HD23 ' A' ' 50' ' ' LEU . 28.0 tptp -69.5 75.28 0.4 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.744 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 51' ' ' GLU . 85.2 mt-30 -64.41 102.33 0.53 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 48' ' ' LYS . 3.4 mm? -44.99 80.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.766 0.666 . . . . 0.0 111.741 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 49' ' ' GLN . 88.0 tt0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.836 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 53.0 m -60.99 -45.85 93.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.549 ' O ' ' HG3' ' B' ' 1' ' ' MET . 14.2 tpt -156.37 57.6 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.247 0.546 . . . . 0.0 110.945 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 3.3 pt20 -61.81 126.62 27.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.549 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.633 HD13 HD22 ' B' ' 15' ' ' LEU . 29.8 pt -95.62 133.39 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.92 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.36 129.63 35.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.714 ' HB ' HG13 ' B' ' 13' ' ' ILE . 61.0 t -147.8 143.97 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.053 0.454 . . . . 0.0 112.086 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.473 ' N ' HG11 ' B' ' 5' ' ' VAL . 36.4 mtmm -104.97 126.6 52.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.825 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -69.53 -156.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.868 0.366 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.4 ' H ' HD11 ' B' ' 8' ' ' LEU . 5.6 mp -59.96 -57.17 14.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -74.86 -45.49 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.64 30.59 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.003 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -82.43 130.99 35.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.408 . . . . 0.0 111.011 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -75.72 131.16 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.234 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.714 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -118.54 130.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.854 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -104.25 135.15 46.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.573 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.633 HD22 HD13 ' B' ' 3' ' ' ILE . 3.9 tp -161.35 113.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.169 0.509 . . . . 0.0 111.705 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.469 ' O ' HD13 ' B' ' 15' ' ' LEU . 12.4 pt-20 -77.78 142.4 38.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.703 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' B' ' 1' ' ' MET . 12.3 p -165.42 135.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -54.64 133.27 64.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.868 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 11.1 Cg_endo -55.94 -36.63 96.05 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.871 2.381 . . . . 0.0 111.843 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.424 ' O ' HG21 ' A' ' 22' ' ' THR . 46.1 t -63.74 -27.81 69.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -56.15 135.42 53.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.73 ' HB ' HD21 ' B' ' 25' ' ' ASN . 23.4 m -58.24 150.27 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.492 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 64.2 mt -62.3 -43.92 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.546 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.623 ' HG2' HG23 ' B' ' 22' ' ' THR . 12.5 pt-20 -57.4 -33.19 67.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.649 0.261 . . . . 0.0 111.195 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.73 HD21 ' HB ' ' B' ' 22' ' ' THR . 70.4 m-80 -73.05 -50.21 24.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.409 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.486 HG21 ' N ' ' B' ' 27' ' ' LYS . 33.0 m -58.66 -38.06 69.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 59.0 mtpt -65.96 -43.64 87.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.044 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -59.31 -25.69 64.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.628 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 53.9 mttm -74.12 -39.79 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 109.918 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.665 HD11 HG23 ' B' ' 5' ' ' VAL . 69.4 mt -59.59 -41.74 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.283 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.9 pt20 -65.43 -40.18 92.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.33 -32.48 72.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.6 mmmt -73.92 -31.44 63.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.769 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.505 ' HB3' HD13 ' B' ' 36' ' ' ILE . 48.3 tp10 -135.55 -67.19 0.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 151.85 -25.88 0.92 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.163 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.707 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -51.13 123.58 20.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.688 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -52.39 144.93 38.31 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.804 2.336 . . . . 0.0 111.85 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.48 -35.49 96.69 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.501 2.134 . . . . 0.0 112.246 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.15 -38.6 89.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.189 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.707 ' NE2' HG23 ' B' ' 36' ' ' ILE . 26.9 mt-30 -66.55 -41.63 88.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.417 ' HA ' ' C ' ' A' ' 46' ' ' ALA . 71.3 mt-30 -56.77 130.93 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.612 ' H ' ' H ' ' A' ' 46' ' ' ALA . 71.6 mtt-85 -106.48 133.08 51.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.973 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.566 HD11 HG23 ' A' ' 3' ' ' ILE . 23.3 mt -76.61 131.83 39.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.896 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 65.4 mt -143.75 128.93 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.76 ' HB2' HG12 ' A' ' 5' ' ' VAL . 2.7 m-85 -121.45 142.41 50.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.648 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.44 125.66 9.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.048 0.452 . . . . 0.0 111.593 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.503 ' HA3' ' C ' ' A' ' 40' ' ' GLN . . . -70.74 -136.77 0.13 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.012 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -69.6 75.89 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 111.592 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' B' ' 51' ' ' GLU . 85.9 mt-30 -64.01 108.71 1.58 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -49.62 80.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.581 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.1 tt0 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 51.7 m -68.77 -135.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.649 0.261 . . . . 0.0 110.981 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt -78.02 57.32 1.75 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.105 0.479 . . . . 0.0 110.988 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.873 ' HB2' HG21 ' A' ' 14' ' ' THR . 3.1 pt20 -66.58 110.59 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.295 0.569 . . . . 0.0 111.083 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 15' ' ' LEU . 18.8 pt -77.44 140.99 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.774 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -89.5 131.97 35.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.949 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 13' ' ' ILE . 2.3 p -149.86 135.04 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.804 0.335 . . . . 0.0 111.383 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -100.11 131.19 46.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.698 HG23 ' HG3' ' A' ' 34' ' ' GLU . 74.6 p -67.21 -158.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.735 0.302 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.427 ' CD1' HG22 ' A' ' 36' ' ' ILE . 4.8 mp -89.28 -46.85 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.475 HG21 ' N ' ' A' ' 10' ' ' GLY . 6.0 t -72.05 -45.15 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' N ' HG21 ' A' ' 9' ' ' THR . . . 158.58 -31.37 0.47 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.927 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 12' ' ' THR . 7.0 tmtm? -45.48 126.95 7.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.905 0.384 . . . . 0.0 110.748 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.505 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 66.9 m -83.24 138.02 33.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.787 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -118.8 139.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.873 HG21 ' HB2' ' A' ' 2' ' ' GLN . 6.8 m -127.37 137.99 52.9 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.656 HD22 HG11 ' A' ' 17' ' ' VAL . 4.0 tt -159.82 121.97 3.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.048 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 22.8 pt-20 -72.13 143.42 48.98 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.75 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.656 HG11 HD22 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -158.36 140.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.414 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.34 143.24 90.44 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.086 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.85 -37.63 95.59 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.811 2.341 . . . . 0.0 112.14 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -64.17 -31.84 73.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.852 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -56.2 130.69 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.569 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.411 HG23 ' O ' ' B' ' 20' ' ' SER . 70.3 p -63.5 147.7 50.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.74 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.594 HG12 HG12 ' B' ' 23' ' ' ILE . 65.5 mt -54.58 -37.9 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.253 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 12.6 pt-20 -62.06 -31.7 72.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.95 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.48 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.4 m120 -74.62 -49.33 21.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.669 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.538 HG21 ' N ' ' A' ' 27' ' ' LYS . 26.8 m -57.15 -42.63 80.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.162 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' N ' HG21 ' A' ' 26' ' ' VAL . 51.1 mtmt -67.15 -37.71 84.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.464 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.485 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . . . -53.7 -36.86 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.262 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.556 ' HZ3' HG13 ' A' ' 17' ' ' VAL . 80.5 mttt -69.13 -42.55 75.86 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.474 HG23 HD13 ' A' ' 36' ' ' ILE . 61.4 mt -57.93 -30.35 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.578 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 15.6 mt-30 -60.83 -44.53 96.82 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.722 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 72.5 mmtt -61.52 -29.17 69.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.621 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG3' HG23 ' A' ' 7' ' ' THR . 58.6 mm-40 -146.78 -84.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.88 43.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.079 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.656 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -113.28 124.04 32.22 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.784 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 56.8 Cg_exo -41.78 143.78 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.994 2.463 . . . . 0.0 112.334 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 11.8 Cg_endo -57.21 -35.53 98.91 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.494 2.129 . . . . 0.0 112.066 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -64.51 -39.65 94.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.683 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.784 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 27.8 mt-30 -60.22 -39.87 88.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.464 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 70.7 mt-30 -61.15 119.81 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.93 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 22.5 tpp180 -90.44 128.49 36.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.569 HD12 HG23 ' A' ' 23' ' ' ILE . 21.7 mt -80.82 136.24 36.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 111.01 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.959 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.1 mt -143.27 126.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.959 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.645 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 1.9 m-85 -116.48 142.08 47.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -145.13 123.23 12.12 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.992 0.425 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 139.79 44.3 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.819 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 54.8 tptt -77.1 74.1 3.68 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.125 0.488 . . . . 0.0 110.883 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 51' ' ' GLU . 38.6 tt0 -67.48 90.57 0.25 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.496 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -45.93 79.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.983 0.802 . . . . 0.0 111.584 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 49' ' ' GLN . 39.5 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.067 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.737 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 52.2 m -68.47 -133.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.58 0.229 . . . . 0.0 110.932 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.536 ' HG2' ' O ' ' B' ' 1' ' ' MET . 28.2 ttt -80.26 53.39 1.76 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.13 0.49 . . . . 0.0 110.824 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.694 ' HB2' HG21 ' B' ' 14' ' ' THR . 3.0 pt20 -62.27 110.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.428 HG23 HD13 ' A' ' 43' ' ' LEU . 13.7 pt -80.09 140.74 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.105 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -89.12 130.13 35.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.012 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.83 HG11 HG13 ' B' ' 13' ' ' ILE . 1.6 p -150.07 131.52 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.335 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -93.38 131.58 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.732 HG23 ' HG3' ' B' ' 34' ' ' GLU . 74.1 p -68.44 -157.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 111.263 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -85.96 -48.89 8.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.055 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.459 HG21 ' N ' ' B' ' 10' ' ' GLY . 5.7 t -74.69 -45.2 46.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.827 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.459 ' N ' HG21 ' B' ' 9' ' ' THR . . . 159.49 -30.73 0.42 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.732 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.503 ' HD3' ' N ' ' B' ' 12' ' ' THR . 7.3 tmtm? -45.65 127.87 8.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.97 0.414 . . . . 0.0 110.767 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.503 ' N ' ' HD3' ' B' ' 11' ' ' LYS . 34.0 m -84.46 140.55 31.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.687 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.83 HG13 HG11 ' B' ' 5' ' ' VAL . 7.1 pt -134.67 140.62 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.022 0.439 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.694 HG21 ' HB2' ' B' ' 2' ' ' GLN . 4.1 m -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.727 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.477 ' C ' ' HA ' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -153.94 134.92 13.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.737 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 12.5 pt-20 -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.174 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' B' ' 1' ' ' MET . 7.5 m -154.81 137.47 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.064 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.527 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 4.5 mm-40 -69.74 143.66 92.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.29 -35.82 98.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.778 2.319 . . . . 0.0 112.232 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 22' ' ' THR . 43.5 t -63.88 -31.5 72.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.986 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.527 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 49.7 m-20 -57.49 130.33 45.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.652 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -62.9 147.39 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.594 HG12 HG12 ' A' ' 23' ' ' ILE . 65.9 mt -53.28 -37.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.468 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 22.2 pt-20 -62.42 -32.61 73.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.468 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.4 m120 -73.39 -49.22 28.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.687 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.521 HG21 ' N ' ' B' ' 27' ' ' LYS . 28.2 m -57.86 -42.85 83.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.64 0.257 . . . . 0.0 111.158 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.521 ' N ' HG21 ' B' ' 26' ' ' VAL . 51.8 mtmt -66.42 -37.25 84.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.508 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HA ' ' CD ' ' B' ' 31' ' ' GLN . . . -54.9 -37.48 66.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -67.63 -42.22 82.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 62.8 mt -58.45 -30.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.594 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.582 ' OE1' ' HD3' ' B' ' 38' ' ' PRO . 16.3 mt-30 -61.2 -45.57 94.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.61 -35.87 82.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.772 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 72.5 mmtt -61.01 -29.32 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.523 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.732 ' HG3' HG23 ' B' ' 7' ' ' THR . 57.4 mm-40 -147.41 -81.15 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.2 44.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.751 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.706 HG23 HE21 ' B' ' 40' ' ' GLN . 0.4 OUTLIER -112.96 124.44 31.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.616 0.246 . . . . 0.0 111.479 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.785 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 97.1 Cg_exo -44.78 143.66 4.09 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.818 2.346 . . . . 0.0 112.043 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.582 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 11.6 Cg_endo -56.65 -35.74 97.62 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.194 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -64.99 -39.24 93.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.785 ' NE2' ' HD2' ' B' ' 37' ' ' PRO . 27.9 mt-30 -61.56 -39.76 92.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.468 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.488 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 70.5 mt-30 -59.72 124.41 20.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.532 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 22.4 tpp180 -95.43 123.47 38.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.73 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.533 HD12 HG23 ' B' ' 23' ' ' ILE . 27.1 mt -75.49 135.31 40.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.088 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.959 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 71.7 mt -143.39 124.99 11.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.2 m-85 -115.64 146.52 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.584 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.5 129.59 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.529 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.97 132.61 34.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.524 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.566 ' H ' ' HB3' ' A' ' 40' ' ' GLN . 57.3 tptt -82.92 74.11 9.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.679 0.276 . . . . 0.0 111.172 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' B' ' 51' ' ' GLU . 18.7 pt20 -73.51 116.33 13.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.61 79.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.399 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' B' ' 49' ' ' GLN . 39.3 tt0 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.4 m -60.9 -40.42 93.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.8 tpt -163.42 49.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.088 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 pt20 -61.18 111.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.183 0.516 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 15' ' ' LEU . 24.6 pt -75.56 132.86 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.98 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -89.08 131.56 35.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.798 ' HB ' HG13 ' A' ' 13' ' ' ILE . 64.9 t -143.79 131.39 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 111.665 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.72 123.46 35.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.184 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 11' ' ' LYS . 71.5 p -70.48 -157.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.103 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.763 HD22 HG22 ' A' ' 36' ' ' ILE . 2.3 mm? -82.37 -48.13 11.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.778 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -73.18 -45.28 57.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.02 -31.64 0.5 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.881 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 7' ' ' THR . 40.2 ttmt -46.66 130.08 11.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.985 0.421 . . . . 0.0 111.757 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.491 HG21 ' N ' ' A' ' 13' ' ' ILE . 43.3 m -90.76 145.01 25.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.753 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.798 HG13 ' HB ' ' A' ' 5' ' ' VAL . 2.3 pt -119.44 126.64 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.516 HG23 ' OE1' ' A' ' 2' ' ' GLN . 0.8 OUTLIER -97.68 132.04 43.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 29' ' ' LYS . 9.0 tp -153.59 113.18 3.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.157 0.503 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 39.3 tt0 -70.3 133.9 47.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.501 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 1' ' ' MET . 16.2 m -154.26 137.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.33 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.485 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 4.5 mm-40 -72.05 139.72 82.62 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.229 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.31 -38.0 61.37 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.817 2.345 . . . . 0.0 111.751 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 t -64.06 -33.68 76.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.017 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 36.3 m-20 -55.23 130.89 43.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.98 0.419 . . . . 0.0 110.627 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.4 p -59.49 146.79 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.905 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.646 ' HA ' HG23 ' A' ' 26' ' ' VAL . 63.3 mt -57.91 -29.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.022 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.02 -37.32 85.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.4 m120 -72.1 -46.83 55.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 23' ' ' ILE . 32.7 m -58.35 -41.69 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.961 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.616 ' N ' HG21 ' A' ' 26' ' ' VAL . 68.1 mttm -66.7 -40.79 88.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 0.0 110.606 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.621 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -53.55 -40.29 65.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.406 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.62 ' HB2' HD23 ' A' ' 15' ' ' LEU . 50.0 mttm -64.74 -41.36 96.0 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.991 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 30' ' ' ILE . 67.4 mt -57.46 -35.93 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.621 HE21 ' HA ' ' A' ' 28' ' ' ALA . 70.1 mt-30 -61.45 -45.63 93.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.011 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -64.65 -31.69 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.725 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -144.89 -67.2 0.32 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 48.97 0.06 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.972 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.763 HG22 HD22 ' A' ' 8' ' ' LEU . 2.3 pt -125.05 129.03 24.68 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.611 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 95.2 Cg_exo -45.88 140.67 9.69 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.793 2.329 . . . . 0.0 112.242 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 17.3 Cg_endo -58.57 -32.62 96.99 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.429 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.37 -36.51 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.611 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 21.9 mt-30 -60.02 -45.64 92.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.549 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.741 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -58.8 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 111.144 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.646 ' H ' ' H ' ' B' ' 46' ' ' ALA . 72.2 mtt-85 -97.44 128.89 44.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 43' ' ' LEU . 27.1 mt -78.62 131.4 36.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 0.0 111.448 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 66.4 mt -143.97 127.5 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.626 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.736 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 0.5 OUTLIER -115.35 145.09 42.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.389 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -152.22 122.88 7.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.05 -136.62 0.11 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.921 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.8 121.56 15.73 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.107 0.479 . . . . 0.0 111.744 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 51' ' ' GLU . 71.1 mt-30 -72.61 96.57 2.0 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.885 ' H ' HD21 ' A' ' 50' ' ' LEU . 3.1 mm? -47.33 80.03 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.41 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 49' ' ' GLN . 88.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.873 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 53.2 p -60.63 -44.61 96.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.578 0.227 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.603 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.6 tpt -155.87 51.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.25 0.547 . . . . 0.0 110.919 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 16.3 pt20 -61.32 110.44 1.42 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.617 HG12 ' O ' ' B' ' 15' ' ' LEU . 21.2 pt -76.74 131.43 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.069 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.26 132.91 34.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 45' ' ' PHE . 66.3 t -145.08 131.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.757 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.26 123.5 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.196 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -71.05 -157.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.286 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.51 ' H ' HD21 ' B' ' 8' ' ' LEU . 2.6 mm? -81.15 -49.83 10.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -72.19 -45.35 60.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.575 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.61 -31.42 0.52 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.769 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.58 128.58 10.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.997 0.427 . . . . 0.0 111.627 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 42.9 m -89.46 139.3 30.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.602 HG13 ' HB ' ' B' ' 5' ' ' VAL . 13.4 pt -113.75 127.25 71.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 112.022 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -96.37 137.15 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' B' ' 29' ' ' LYS . 5.0 tt -158.3 114.65 2.78 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.614 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 40.7 tt0 -71.91 138.6 48.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' B' ' 1' ' ' MET . 0.6 OUTLIER -158.92 134.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.181 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.69 137.64 95.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.431 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 10.2 Cg_endo -52.69 -37.9 75.98 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.847 2.365 . . . . 0.0 112.068 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.0 -30.97 72.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.306 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -55.4 134.16 50.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.855 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -61.19 146.34 47.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.664 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.634 ' HA ' HG23 ' B' ' 26' ' ' VAL . 63.8 mt -57.86 -30.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.128 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -65.83 -36.65 84.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.905 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 3.5 m120 -72.29 -47.13 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.264 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' B' ' 23' ' ' ILE . 32.9 m -58.02 -41.45 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.935 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.622 ' N ' HG21 ' B' ' 26' ' ' VAL . 68.1 mttm -66.6 -39.98 88.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.927 0.394 . . . . 0.0 110.619 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.622 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -53.44 -42.29 66.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.277 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.619 ' HB2' HD12 ' B' ' 15' ' ' LEU . 45.5 mttm -64.29 -42.8 96.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.042 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.689 HG23 HD12 ' B' ' 36' ' ' ILE . 67.3 mt -55.26 -35.86 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.849 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 68.9 mt-30 -62.26 -42.16 99.08 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.93 -35.27 79.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.405 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 17.1 mmtp -60.43 -37.83 82.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.564 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -141.52 -60.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.297 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.59 45.16 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.724 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.2 OUTLIER -112.13 130.63 23.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.56 0.219 . . . . 0.0 111.544 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.444 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 62.9 Cg_exo -51.97 139.6 50.83 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.434 2.09 . . . . 0.0 111.744 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.499 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 15.1 Cg_endo -57.22 -32.21 92.91 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.6 -35.93 82.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.724 ' NE2' HG23 ' B' ' 36' ' ' ILE . 25.9 mt-30 -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.703 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.736 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -60.07 124.48 20.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.319 . . . . 0.0 110.711 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 72.5 mtt-85 -91.69 126.65 36.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.053 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.517 ' HA ' HD11 ' B' ' 43' ' ' LEU . 10.5 tp -80.28 129.89 34.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.939 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 69.8 mt -143.64 136.98 24.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.741 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -121.37 146.71 46.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.471 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.646 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.5 123.91 6.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.357 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.417 ' HA3' ' C ' ' A' ' 40' ' ' GLN . . . -72.29 -138.79 0.27 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.899 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.36 123.6 20.02 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.121 0.486 . . . . 0.0 111.356 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' B' ' 51' ' ' GLU . 71.1 mt-30 -74.35 104.8 5.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.773 ' H ' HD21 ' B' ' 50' ' ' LEU . 3.4 mm? -52.74 80.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.394 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' B' ' 49' ' ' GLN . 37.3 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.874 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 18' ' ' GLU . 47.3 t -61.6 -57.88 10.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.604 0.24 . . . . 0.0 111.051 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.719 ' HE3' HD13 ' B' ' 43' ' ' LEU . 21.4 ptm 178.54 106.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.419 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.04 125.0 25.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.498 HG12 ' HG ' ' A' ' 15' ' ' LEU . 32.3 pt -91.91 139.27 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.493 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.67 130.14 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.807 HG22 HD12 ' A' ' 30' ' ' ILE . 44.8 t -145.24 133.81 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -93.06 120.61 33.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.2 p -72.48 -157.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.738 0.304 . . . . 0.0 111.395 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 36' ' ' ILE . 31.6 mt -80.6 -51.47 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.044 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -69.01 -45.17 71.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.593 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.89 -34.12 0.74 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.761 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -49.27 130.33 19.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.59 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 13' ' ' ILE . 28.9 m -80.15 146.85 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.349 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.719 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.0 pt -126.05 129.53 72.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.775 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 p -107.85 142.65 37.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.422 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.537 HD21 ' HD3' ' A' ' 33' ' ' LYS . 2.8 pp -165.41 122.32 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 1' ' ' MET . 11.4 pt-20 -75.71 140.97 42.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.427 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.69 HG22 HG23 ' A' ' 26' ' ' VAL . 3.4 m -153.21 133.53 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.162 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 87.0 mt-10 -59.74 138.83 90.07 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.074 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.25 -39.07 92.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.937 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 t -64.15 -30.57 71.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.122 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -54.6 136.28 45.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.618 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -64.96 144.46 57.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.557 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.512 HD11 HD12 ' A' ' 43' ' ' LEU . 67.3 mt -55.85 -38.69 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -56.18 -44.93 79.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.046 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.2 m120 -65.43 -46.35 80.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.69 HG23 HG22 ' A' ' 17' ' ' VAL . 6.5 t -53.61 -48.62 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.162 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.682 ' HE3' ' HB3' ' A' ' 38' ' ' PRO . 51.5 mtmt -68.62 -35.4 77.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.741 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.43 -40.29 71.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.458 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 25.5 mmmt -62.09 -43.75 98.16 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.334 0.588 . . . . 0.0 109.582 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.807 HD12 HG22 ' A' ' 5' ' ' VAL . 62.2 mt -57.16 -35.9 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.748 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.741 HE21 ' HA ' ' A' ' 28' ' ' ALA . 69.1 mt-30 -58.97 -43.97 91.46 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.25 -37.5 83.61 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.942 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.537 ' HD3' HD21 ' A' ' 15' ' ' LEU . 28.9 mtpp -76.8 3.45 11.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.815 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.521 ' HB3' HD13 ' A' ' 36' ' ' ILE . 17.6 tp10 -169.22 -102.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.145 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.71 49.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.422 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.666 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -121.99 127.17 26.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.64 0.257 . . . . 0.0 111.437 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.595 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 79.0 Cg_exo -48.89 144.3 15.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.219 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.682 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -56.45 -37.74 96.64 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.569 2.18 . . . . 0.0 112.406 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.82 -38.88 92.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.309 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.666 ' NE2' HG23 ' A' ' 36' ' ' ILE . 26.2 mt-30 -63.54 -39.45 94.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.509 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 71.3 mt-30 -59.75 110.79 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -81.88 130.82 35.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.321 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.512 HD12 HD11 ' A' ' 23' ' ' ILE . 33.0 mt -80.05 135.7 36.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.987 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 81.0 mt -143.28 133.84 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.35 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.843 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 6.8 m-85 -127.53 140.98 51.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.694 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -151.63 126.05 9.42 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.093 0.473 . . . . 0.0 111.843 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.09 141.2 48.1 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.729 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' O ' HD23 ' A' ' 50' ' ' LEU . 31.8 mmmt -69.2 74.59 0.33 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.014 0.435 . . . . 0.0 111.639 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.3 mm100 -69.32 103.01 1.86 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.423 ' CD2' ' H ' ' A' ' 50' ' ' LEU . 3.4 mm? -45.05 80.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.795 0.684 . . . . 0.0 111.69 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' GLN . 56.1 mt-10 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' B' ' 18' ' ' GLU . 47.5 t -60.94 -58.31 8.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.678 0.275 . . . . 0.0 110.978 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.525 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.2 ptm 179.67 106.61 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.519 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.61 ' HB2' HG23 ' B' ' 14' ' ' THR . 3.3 pt20 -67.3 127.91 34.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.226 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.617 HG12 ' O ' ' B' ' 15' ' ' LEU . 24.2 pt -97.35 136.69 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.975 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.637 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -89.97 126.82 35.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.122 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.554 HG23 HD13 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.45 132.55 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.999 0.428 . . . . 0.0 111.5 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -84.83 129.7 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.074 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.684 HG21 HD12 ' B' ' 13' ' ' ILE . 77.9 p -77.54 -157.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.163 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.527 HD22 HG22 ' B' ' 36' ' ' ILE . 53.6 mt -81.42 -50.76 9.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.197 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -71.33 -45.26 63.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.693 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.88 -35.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.841 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.448 ' O ' HG22 ' B' ' 7' ' ' THR . 86.9 tttt -48.61 130.47 17.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.342 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 62.1 m -82.48 134.17 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.141 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.684 HD12 HG21 ' B' ' 7' ' ' THR . 0.0 OUTLIER -100.76 131.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 111.624 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.61 HG23 ' HB2' ' B' ' 2' ' ' GLN . 1.3 m -105.27 134.23 48.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.633 HD13 HG12 ' B' ' 17' ' ' VAL . 0.2 OUTLIER -162.53 115.04 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -178.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.5 pt-20 -78.39 140.26 38.73 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.196 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.633 HG12 HD13 ' B' ' 15' ' ' LEU . 11.5 m -153.03 136.2 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.242 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.456 ' HA ' ' OG ' ' B' ' 0' ' ' SER . 87.4 mt-10 -59.91 140.07 90.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.077 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.471 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 12.9 Cg_endo -56.75 -40.01 87.34 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.799 2.333 . . . . 0.0 112.032 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.7 t -64.08 -29.78 70.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.118 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.402 ' OD2' HG11 ' B' ' 26' ' ' VAL . 38.5 t70 -56.15 136.02 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 71.1 p -65.07 145.81 55.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.697 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.564 HD11 HD12 ' B' ' 43' ' ' LEU . 66.8 mt -55.84 -39.04 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.7 -40.0 74.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.17 -49.28 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 23' ' ' ILE . 15.7 m -57.24 -41.44 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.701 ' HE3' ' HB3' ' B' ' 38' ' ' PRO . 50.3 mtmt -69.82 -38.63 76.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 110.818 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.774 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -54.44 -41.52 69.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.737 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -68.26 -37.77 81.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.209 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.434 HD11 HG22 ' B' ' 30' ' ' ILE . 63.0 mt -57.62 -34.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.774 HE21 ' HA ' ' B' ' 28' ' ' ALA . 68.7 mt-30 -60.65 -41.41 94.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -67.23 -37.76 84.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.752 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.655 ' HE3' HG23 ' B' ' 13' ' ' ILE . 28.9 mtpp -78.0 3.24 15.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.637 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -168.53 -106.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 50.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.812 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.649 ' O ' HD11 ' B' ' 36' ' ' ILE . 0.7 OUTLIER -126.57 119.89 23.09 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.73 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 35.5 Cg_exo -38.89 146.3 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.296 2.664 . . . . 0.0 112.982 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.701 ' HB3' ' HE3' ' B' ' 27' ' ' LYS . 33.6 Cg_exo -58.83 -38.14 90.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.665 2.244 . . . . 0.0 112.646 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.56 -39.2 90.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.73 ' NE2' ' HD2' ' B' ' 37' ' ' PRO . 22.9 mt-30 -60.16 -44.99 94.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.391 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.843 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 71.4 mt-30 -54.37 115.75 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.982 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.694 ' H ' ' H ' ' A' ' 46' ' ' ALA . 56.2 ttp180 -87.49 124.3 33.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.818 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.719 HD13 ' HE3' ' A' ' 1' ' ' MET . 44.1 mt -72.87 133.34 44.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.968 0.414 . . . . 0.0 111.121 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.987 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 74.8 mt -143.51 131.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.466 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.7 ' HB2' HG12 ' A' ' 5' ' ' VAL . 4.7 m-85 -127.19 148.05 50.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.762 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.91 132.39 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.308 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.05 141.8 43.91 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.52 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 40' ' ' GLN . 32.2 mmmt -69.19 74.89 0.34 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.899 0.38 . . . . 0.0 111.803 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.3 mm100 -68.16 111.8 4.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -52.85 80.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.452 0.47 . . . . 0.0 111.368 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' B' ' 49' ' ' GLN . 55.4 mt-10 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.961 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' A' ' 18' ' ' GLU . 47.8 t -65.46 -56.72 10.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.688 0.28 . . . . 0.0 111.069 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.6 ptm -175.54 115.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.211 0.529 . . . . 0.0 111.303 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.481 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 10.8 tt0 -72.63 134.63 45.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.492 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 15' ' ' LEU . 29.5 pt -117.6 145.3 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.027 0.442 . . . . 0.0 112.067 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.2 m-85 -89.3 133.91 34.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.761 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.729 ' HB ' HG12 ' A' ' 13' ' ' ILE . 92.3 t -144.91 136.64 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.136 0.493 . . . . 0.0 111.781 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 40.4 ttmt -91.47 134.41 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.499 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.796 HG22 ' HB3' ' A' ' 11' ' ' LYS . 67.8 p -71.43 -157.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.515 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 mt -65.37 -63.91 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.519 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 10' ' ' GLY . 5.7 t -77.57 -45.18 26.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.412 ' N ' HG22 ' A' ' 9' ' ' THR . . . 155.49 108.05 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.329 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.796 ' HB3' HG22 ' A' ' 7' ' ' THR . 24.2 ttmm -167.19 127.84 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.724 0.297 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -73.27 133.39 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.729 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.1 pt -135.44 135.54 51.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.481 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 3.3 p -90.43 144.43 25.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.069 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 3' ' ' ILE . 10.7 tp -160.58 114.05 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.216 0.532 . . . . 0.0 111.76 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.6 pt-20 -85.35 132.45 34.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.671 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.587 HG22 HG13 ' A' ' 26' ' ' VAL . 27.4 m -151.06 142.96 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.356 . . . . 0.0 111.141 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 42.0 mt-10 -67.43 137.44 93.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.3 -36.14 88.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.807 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -64.44 -27.86 69.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.357 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 51.6 m-20 -58.96 133.1 55.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.686 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.3 p -63.06 145.95 54.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.498 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 56.1 mt -53.54 -38.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.63 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 16.1 pt-20 -60.44 -39.91 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.502 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.4 m120 -67.39 -48.81 66.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.646 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.587 HG13 HG22 ' A' ' 17' ' ' VAL . 30.3 m -61.34 -43.87 97.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.317 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.645 ' HE2' ' HB2' ' A' ' 38' ' ' PRO . 36.3 mtmm -62.6 -43.8 97.91 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.9 0.381 . . . . 0.0 110.044 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 31' ' ' GLN . . . -60.43 -29.25 68.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.451 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HZ1' ' HZ1' ' A' ' 33' ' ' LYS . 26.2 tptp -64.85 -43.03 94.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.744 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.571 HG23 ' NE2' ' A' ' 41' ' ' GLN . 51.3 mt -57.28 -31.83 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.723 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 37' ' ' PRO . 75.3 mt-30 -58.16 -48.01 81.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -61.32 -36.89 81.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.826 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 38.6 mmtm -67.49 -24.21 65.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.135 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -153.16 -90.0 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.092 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.78 61.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.888 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.712 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -139.54 118.27 8.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.559 0.218 . . . . 0.0 111.549 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.753 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 54.8 Cg_exo -40.27 146.03 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.152 2.568 . . . . 0.0 112.822 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 19.8 Cg_endo -60.04 -36.0 90.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.818 2.345 . . . . 0.0 112.61 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.44 -38.86 85.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.753 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 18.3 mt-30 -64.1 -40.49 96.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.244 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.571 ' NE2' HG23 ' A' ' 30' ' ' ILE . 8.4 mm100 -52.44 126.94 20.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.192 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.617 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.5 mtt180 -94.85 124.77 39.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.235 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' B' ' 3' ' ' ILE . 64.1 mt -78.35 132.03 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.384 . . . . 0.0 111.0 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.951 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 74.5 mt -143.57 131.96 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.539 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.681 ' HB2' HG23 ' B' ' 5' ' ' VAL . 4.8 m-85 -126.36 147.12 49.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.6 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.623 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.39 128.04 7.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 111.703 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.531 ' N ' HE22 ' A' ' 49' ' ' GLN . . . -68.18 -138.04 0.07 OUTLIER Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.972 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.4 ' O ' HD23 ' A' ' 50' ' ' LEU . 23.4 tptm -96.75 74.82 2.72 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.084 0.469 . . . . 0.0 111.701 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 51' ' ' GLU . 14.3 mp0 -69.06 103.59 1.91 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' CD2' ' H ' ' A' ' 50' ' ' LEU . 3.5 mm? -44.9 80.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.745 0.653 . . . . 0.0 111.772 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 49' ' ' GLN . 24.2 pt-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.96 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.544 ' OG ' ' HA ' ' B' ' 18' ' ' GLU . 46.8 t -65.06 -56.41 13.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.462 0.172 . . . . 0.0 111.013 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.1 ptm 179.56 108.45 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 112.044 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.701 ' HB3' HG23 ' B' ' 14' ' ' THR . 87.5 mt-30 -62.25 145.13 54.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.688 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.654 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.1 pt -121.77 143.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.1 m-85 -88.05 131.28 34.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.84 ' HB ' HG22 ' B' ' 13' ' ' ILE . 84.4 t -142.43 146.04 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.091 0.472 . . . . 0.0 111.563 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.555 ' N ' HG11 ' B' ' 5' ' ' VAL . 40.3 ttmt -102.08 131.57 48.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.194 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.789 HG22 ' HB3' ' B' ' 11' ' ' LYS . 70.0 p -68.61 -157.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 111.457 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.423 HD22 HG22 ' B' ' 36' ' ' ILE . 75.1 mt -64.67 -65.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.221 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.403 HG22 ' N ' ' B' ' 10' ' ' GLY . 5.4 t -76.79 -45.25 29.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.415 ' HA3' ' CG ' ' B' ' 6' ' ' LYS . . . 155.06 109.03 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.358 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.789 ' HB3' HG22 ' B' ' 7' ' ' THR . 24.2 ttmm -167.25 129.46 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.696 0.284 . . . . 0.0 110.903 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -73.37 134.34 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.756 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.84 HG22 ' HB ' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -137.85 122.49 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.266 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.701 HG23 ' HB3' ' B' ' 2' ' ' GLN . 0.1 OUTLIER -80.16 145.22 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.477 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.654 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.2 tt -162.72 112.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.21 0.529 . . . . 0.0 111.177 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.493 ' O ' HG11 ' B' ' 17' ' ' VAL . 12.4 pt-20 -82.92 141.11 32.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.955 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.711 HG22 HG22 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -157.65 145.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.557 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.544 ' HA ' ' OG ' ' B' ' 0' ' ' SER . 44.7 mt-10 -71.13 133.99 85.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.992 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.97 -37.69 97.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.796 2.33 . . . . 0.0 112.2 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 80.5 p -63.89 -25.92 68.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.459 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 53.0 m-20 -60.81 131.44 50.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -60.8 146.55 45.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.545 ' HA ' HG13 ' B' ' 26' ' ' VAL . 54.8 mt -55.36 -37.79 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.099 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.635 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 15.9 pt-20 -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.537 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.3 m120 -67.7 -46.3 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.452 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.711 HG22 HG22 ' B' ' 17' ' ' VAL . 7.8 p -61.93 -41.21 90.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.638 ' HE2' ' HB2' ' B' ' 38' ' ' PRO . 36.8 mtmm -66.61 -44.55 81.79 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.01 0.433 . . . . 0.0 110.203 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 31' ' ' GLN . . . -57.87 -27.29 63.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.509 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.455 ' HZ1' ' HZ1' ' B' ' 33' ' ' LYS . 25.8 tptp -64.87 -43.89 91.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.817 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.581 ' HA ' ' HB2' ' B' ' 33' ' ' LYS . 51.5 mt -57.57 -30.95 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.824 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 74.2 mt-30 -58.05 -48.49 79.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.5 -37.34 83.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.767 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 38.5 mmtm -66.48 -25.1 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -152.03 -87.23 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.15 57.3 0.02 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.248 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.679 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.5 OUTLIER -134.9 125.56 17.32 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.705 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 70.5 Cg_exo -44.28 145.16 2.51 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.0 2.467 . . . . 0.0 112.386 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.638 ' HB2' ' HE2' ' B' ' 27' ' ' LYS . 20.2 Cg_endo -60.27 -35.13 92.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.497 2.131 . . . . 0.0 112.223 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.64 -38.15 89.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.705 ' NE2' ' HD2' ' B' ' 37' ' ' PRO . 26.3 mt-30 -64.19 -37.23 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.608 ' NE2' HD12 ' B' ' 36' ' ' ILE . 8.7 mm100 -54.54 129.26 35.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.623 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.3 mtt180 -97.52 124.67 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.251 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.419 HD13 ' HE3' ' A' ' 1' ' ' MET . 50.7 mt -79.46 132.71 36.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.399 . . . . 0.0 111.115 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.951 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.1 mt -143.54 131.27 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.367 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.622 ' HB2' HG12 ' A' ' 5' ' ' VAL . 4.8 m-85 -125.28 143.99 50.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.617 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -153.43 129.94 10.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.526 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.566 ' N ' HE22 ' B' ' 49' ' ' GLN . . . -68.91 -138.22 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.784 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -98.23 74.9 2.25 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.052 0.454 . . . . 0.0 111.693 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.566 HE22 ' N ' ' B' ' 47' ' ' GLY . 14.3 mp0 -68.09 112.58 5.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -51.45 80.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.551 0.532 . . . . 0.0 111.467 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' B' ' 49' ' ' GLN . 24.1 pt-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 52.3 m -58.39 141.14 52.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.849 0.357 . . . . 0.0 110.834 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm -72.27 116.53 12.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.763 ' HB2' HG21 ' A' ' 14' ' ' THR . 3.2 pt20 -71.47 122.73 20.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -86.15 144.16 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.556 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -88.89 134.98 33.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.972 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.731 HG13 HD13 ' A' ' 13' ' ' ILE . 59.5 t -148.2 132.74 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.865 0.364 . . . . 0.0 111.145 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.83 126.43 43.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.1 m -67.62 150.55 48.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.866 HD23 HG22 ' A' ' 36' ' ' ILE . 4.2 mp -45.02 -45.2 10.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -75.46 -45.5 38.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.392 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.43 0.53 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.88 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -44.02 131.59 5.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -74.15 141.72 45.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.731 HD13 HG13 ' A' ' 5' ' ' VAL . 1.1 mt -128.62 139.12 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.028 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.763 HG21 ' HB2' ' A' ' 2' ' ' GLN . 7.2 m -133.52 142.86 48.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.818 HD12 ' HD2' ' A' ' 33' ' ' LYS . 5.8 tp -157.02 114.95 3.19 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 16.9 pt-20 -71.89 130.51 41.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.736 HG22 HG13 ' A' ' 26' ' ' VAL . 18.7 m -152.57 138.65 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 48.5 mt-10 -69.16 140.87 91.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.72 -36.37 81.59 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.969 2.446 . . . . 0.0 112.239 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.402 ' O ' HG21 ' B' ' 22' ' ' THR . 46.0 t -64.3 -32.04 73.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 54.5 m-20 -56.27 132.59 51.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -60.06 147.18 40.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.642 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.555 HG22 HD22 ' A' ' 43' ' ' LEU . 61.5 mt -54.38 -36.95 35.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.788 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.66 -32.22 72.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -69.28 -47.46 64.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.208 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.736 HG13 HG22 ' A' ' 17' ' ' VAL . 22.7 m -60.22 -39.28 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.969 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.585 ' N ' HG21 ' A' ' 26' ' ' VAL . 99.3 mttt -67.13 -38.75 86.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.538 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -49.84 -38.62 35.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.427 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.673 ' HD2' HD22 ' A' ' 15' ' ' LEU . 80.0 mttt -67.79 -41.07 83.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -55.14 -36.83 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.357 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.538 HE21 ' HA ' ' A' ' 28' ' ' ALA . 68.2 mt-30 -63.28 -45.0 93.49 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.94 -33.01 74.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.712 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.818 ' HD2' HD12 ' A' ' 15' ' ' LEU . 29.6 mtpp -71.71 -31.56 66.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.935 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -135.63 -60.18 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.11 57.06 0.19 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.083 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.866 HG22 HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -145.07 131.43 9.78 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 120.819 0.342 . . . . 0.0 111.352 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.577 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 60.6 Cg_exo -40.89 139.46 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.29 2.66 . . . . 0.0 113.229 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 18.0 Cg_endo -60.36 -36.2 88.18 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.922 2.414 . . . . 0.0 112.663 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.25 -37.19 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.577 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 16.0 mt-30 -59.27 -45.41 91.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.34 124.37 15.74 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.73 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.595 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.9 ttm180 -91.46 123.18 34.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.555 HD22 HG22 ' A' ' 23' ' ' ILE . 9.3 mp -73.49 132.04 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 79.9 mt -143.61 134.65 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.678 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 8.3 m-85 -128.62 144.81 51.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.818 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.629 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.04 129.4 10.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.994 0.426 . . . . 0.0 111.439 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' B' ' 8' ' ' LEU . . . -56.75 138.39 47.04 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.897 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.715 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 28.1 tptp -71.1 74.54 0.66 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.028 0.442 . . . . 0.0 111.36 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 51' ' ' GLU . 73.5 mt-30 -66.34 99.8 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.738 HD23 ' H ' ' A' ' 50' ' ' LEU . 2.7 mm? -44.91 80.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.754 0.658 . . . . 0.0 111.859 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.92 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.715 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 54.3 m -58.53 144.19 43.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.822 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptm -76.12 113.52 13.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.149 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.667 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 3.1 pt20 -69.22 124.33 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' B' ' 14' ' ' THR . 37.4 pt -88.33 145.83 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.831 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.76 135.51 33.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.153 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.881 HG13 HD13 ' B' ' 13' ' ' ILE . 57.6 t -148.47 138.31 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 111.132 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.9 125.55 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 90.4 m -67.03 151.32 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.484 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.763 HD23 HG12 ' B' ' 36' ' ' ILE . 0.4 OUTLIER -47.26 -42.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.663 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 67.4 p -75.92 -45.36 35.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.86 -30.44 0.61 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.911 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -45.29 134.62 6.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 39.1 m -79.94 143.82 33.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.0 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.881 HD13 HG13 ' B' ' 5' ' ' VAL . 4.4 pt -142.78 135.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.142 0.496 . . . . 0.0 111.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.564 ' CG2' ' HB2' ' B' ' 2' ' ' GLN . 6.0 m -139.75 141.74 36.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.07 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -150.69 130.8 13.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.022 0.439 . . . . 0.0 111.193 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.715 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 11.1 pt-20 -69.85 132.78 46.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.963 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.607 HG22 HG13 ' B' ' 26' ' ' VAL . 17.3 m -150.43 136.83 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.485 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 48.1 mt-10 -69.5 138.8 88.85 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.257 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.22 -36.05 65.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.061 2.507 . . . . 0.0 112.261 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.6 t -64.01 -32.69 74.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.485 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 55.3 m-20 -56.0 132.54 50.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.824 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 20' ' ' SER . 69.0 p -59.49 148.26 33.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.67 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.59 HG22 HD22 ' B' ' 43' ' ' LEU . 61.3 mt -54.59 -36.89 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.38 -31.05 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.774 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -65.96 -52.04 53.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.061 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.607 HG13 HG22 ' B' ' 17' ' ' VAL . 24.4 m -58.29 -39.7 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.262 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.597 ' N ' HG21 ' B' ' 26' ' ' VAL . 98.8 mttt -66.88 -37.99 85.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.53 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -50.74 -40.74 55.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.314 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.507 ' HZ1' HG11 ' B' ' 17' ' ' VAL . 78.7 mttt -68.23 -40.4 82.06 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -54.34 -36.69 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.168 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 67.6 mt-30 -63.79 -44.54 93.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.394 0.616 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -67.46 -32.48 73.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.62 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 29' ' ' LYS . 29.6 mtpp -70.61 -32.41 69.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.092 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.896 ' HB2' HD13 ' B' ' 36' ' ' ILE . 56.8 mm-40 -138.14 -55.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.678 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.77 54.89 0.23 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.62 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.896 HD13 ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -135.44 135.63 22.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.578 0.228 . . . . 0.0 111.057 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.557 ' HB2' ' HG3' ' B' ' 40' ' ' GLN . 75.7 Cg_exo -50.04 138.54 35.52 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.45 2.1 . . . . 0.0 112.028 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' B' ' 27' ' ' LYS . 18.5 Cg_endo -58.03 -35.55 98.67 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.817 2.345 . . . . 0.0 112.496 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.18 -36.12 79.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.259 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.715 ' NE2' HG23 ' B' ' 36' ' ' ILE . 23.3 mt-30 -62.82 -44.2 96.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.57 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.678 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.79 126.42 22.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.785 0.326 . . . . 0.0 110.488 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.629 ' H ' ' H ' ' A' ' 46' ' ' ALA . 38.8 ttm180 -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.664 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.59 HD22 HG22 ' B' ' 23' ' ' ILE . 8.9 mp -74.49 132.5 41.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 76.7 mt -143.55 134.21 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.689 ' HB2' HG23 ' A' ' 5' ' ' VAL . 8.1 m-85 -128.4 144.32 51.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.595 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 132.39 13.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.954 0.407 . . . . 0.0 111.413 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.7 135.75 51.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.64 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.462 ' H ' ' HB3' ' A' ' 40' ' ' GLN . 28.1 tptp -71.19 74.7 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.98 0.419 . . . . 0.0 111.235 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' B' ' 51' ' ' GLU . 73.7 mt-30 -65.43 111.72 3.2 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.683 ' H ' HD21 ' B' ' 50' ' ' LEU . 2.8 mm? -53.12 80.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.366 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' B' ' 49' ' ' GLN . 9.8 mp0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.67 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 67.0 m -164.25 -126.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.509 0.195 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 17.0 ptm -160.19 117.38 2.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.986 0.422 . . . . 0.0 110.979 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.506 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 3.3 pt20 -61.86 129.45 41.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.629 HG23 HD21 ' B' ' 43' ' ' LEU . 36.7 pt -97.49 135.04 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.76 125.5 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.831 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.2 t -147.79 134.44 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.692 0.282 . . . . 0.0 111.681 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.748 ' HD2' HE22 ' B' ' 49' ' ' GLN . 24.8 ttmm -93.52 119.62 32.81 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -66.53 -159.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.484 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.644 ' H ' HD21 ' A' ' 8' ' ' LEU . 2.3 mm? -81.59 -47.02 13.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -73.47 -45.44 54.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.394 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -35.7 0.55 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.806 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.2 133.01 15.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.967 0.413 . . . . 0.0 111.591 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 m -84.77 132.88 34.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.04 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.831 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -99.97 134.43 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.888 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.506 ' CG2' ' HB2' ' A' ' 2' ' ' GLN . 1.1 m -109.01 133.86 52.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.602 ' O ' HG12 ' A' ' 3' ' ' ILE . 5.4 tp -159.84 114.85 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 112.099 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 16.9 pt-20 -79.01 137.13 37.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.219 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.82 HG22 HG13 ' A' ' 26' ' ' VAL . 15.4 m -154.27 135.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -57.88 140.99 81.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 12.2 Cg_endo -56.34 -40.03 87.38 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.818 2.345 . . . . 0.0 112.127 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -64.14 -28.81 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.064 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.526 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 8.3 t70 -53.53 132.33 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.8 p -62.94 144.37 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.875 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CG2' ' HE3' ' A' ' 27' ' ' LYS . 64.7 mt -55.4 -36.33 40.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.279 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.492 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 23.8 pt-20 -62.97 -35.67 80.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.4 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 m120 -72.93 -48.03 40.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.621 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.82 HG13 HG22 ' A' ' 17' ' ' VAL . 32.7 m -57.47 -44.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.138 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' N ' HG21 ' A' ' 26' ' ' VAL . 99.3 mttt -65.06 -38.44 90.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 110.461 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.714 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.26 -37.73 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.151 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' HD23 ' A' ' 15' ' ' LEU . 29.8 mmtp -66.48 -39.67 88.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.996 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.455 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 62.2 mt -56.32 -35.94 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.886 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.714 HE21 ' HA ' ' A' ' 28' ' ' ALA . 71.4 mt-30 -59.66 -44.6 93.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.07 -34.17 77.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.133 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 73.1 mmtt -66.27 -25.04 66.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.85 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -150.27 -79.59 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.943 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.43 57.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.236 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.541 HG23 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -140.97 129.28 12.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.465 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 59.7 Cg_exo -41.63 142.47 1.24 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.263 2.642 . . . . 0.0 113.179 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 25.7 Cg_endo -61.63 -37.26 70.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.958 2.438 . . . . 0.0 112.742 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.09 -36.22 72.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.636 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 18.1 mt-30 -60.5 -44.98 95.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.63 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.98 125.64 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.587 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 99.2 mtt180 -89.2 126.68 35.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.511 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.458 HD21 ' HA ' ' A' ' 43' ' ' LEU . 26.7 mt -75.66 130.3 38.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.343 . . . . 0.0 110.857 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.912 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.4 mt -143.59 132.03 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.05 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.683 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 3.3 m-85 -127.34 145.39 50.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.577 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.612 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -149.98 125.47 10.25 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.872 0.368 . . . . 0.0 111.417 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.88 -139.13 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.106 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -70.8 74.88 0.61 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.984 0.421 . . . . 0.0 111.507 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.602 HE22 ' HD2' ' B' ' 6' ' ' LYS . 11.4 mm100 -65.4 99.46 0.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.465 ' CD2' ' H ' ' A' ' 50' ' ' LEU . 2.6 mm? -44.79 80.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.797 0.685 . . . . 0.0 111.718 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.587 ' N ' ' O ' ' A' ' 49' ' ' GLN . 16.3 tp10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.943 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.551 -0.22 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.872 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 68.6 m -164.4 -124.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.446 0.165 . . . . 0.0 110.646 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.8 ptm -163.32 117.16 1.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.465 ' NE2' HG23 ' B' ' 14' ' ' THR . 3.2 pt20 -61.7 130.35 45.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.908 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.64 HG12 ' HB3' ' B' ' 15' ' ' LEU . 35.3 pt -97.27 131.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.278 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.717 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -88.97 120.85 30.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.865 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -150.91 130.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.063 0.459 . . . . 0.0 111.765 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.602 ' HD2' HE22 ' A' ' 49' ' ' GLN . 24.6 ttmm -83.13 126.64 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.385 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -70.57 -157.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.309 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.815 HD13 HG22 ' B' ' 36' ' ' ILE . 2.0 mm? -83.0 -48.33 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p -71.77 -45.29 62.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.27 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 -34.22 0.62 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.763 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -49.43 130.91 20.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.863 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 37.2 m -80.92 147.27 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.901 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.463 HG13 ' CG1' ' B' ' 5' ' ' VAL . 18.6 pt -129.36 124.78 60.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 0.0 112.477 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.465 HG23 ' NE2' ' B' ' 2' ' ' GLN . 1.2 p -92.88 146.89 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.178 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.651 HD12 ' HB2' ' B' ' 29' ' ' LYS . 5.3 tt -164.2 114.62 1.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.829 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.872 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 11.3 pt-20 -78.02 138.05 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.622 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.617 HG22 HG13 ' B' ' 26' ' ' VAL . 1.0 OUTLIER -157.25 133.41 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.943 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -59.14 138.28 88.11 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.436 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 9.3 Cg_endo -52.51 -39.06 75.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.917 2.412 . . . . 0.0 112.106 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.5 t -63.93 -29.8 70.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.155 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.534 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.2 t70 -53.81 131.87 40.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 0.0 110.526 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -62.42 144.01 56.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.916 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 19' ' ' PRO . 65.2 mt -55.22 -35.72 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 24.4 pt-20 -63.15 -36.14 82.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.347 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.534 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 3.5 m120 -72.7 -48.37 39.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.602 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.617 HG13 HG22 ' B' ' 17' ' ' VAL . 31.0 m -57.23 -43.76 82.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.492 ' N ' HG21 ' B' ' 26' ' ' VAL . 99.0 mttt -65.09 -38.34 90.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.694 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -55.18 -37.07 66.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.651 ' HB2' HD12 ' B' ' 15' ' ' LEU . 58.0 mmtt -64.56 -43.5 93.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.465 ' HA ' ' HB2' ' B' ' 33' ' ' LYS . 65.4 mt -53.5 -36.29 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.147 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.694 HE21 ' HA ' ' B' ' 28' ' ' ALA . 71.8 mt-30 -59.82 -45.57 91.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -67.57 -33.46 75.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.229 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 72.7 mmtt -65.44 -25.29 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.169 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.561 ' HB3' HD13 ' B' ' 36' ' ' ILE . 17.7 tp10 -152.61 -68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.299 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.403 ' H ' HD13 ' B' ' 36' ' ' ILE . . . 139.85 55.7 0.04 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.72 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.815 HG22 HD13 ' B' ' 8' ' ' LEU . 0.1 OUTLIER -133.89 133.33 22.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.51 0.195 . . . . 0.0 111.28 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.621 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 71.7 Cg_exo -51.04 139.59 41.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.451 2.101 . . . . 0.0 112.092 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.556 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 19.8 Cg_endo -58.29 -35.75 98.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.831 2.354 . . . . 0.0 112.679 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.719 ' NE2' HG23 ' B' ' 36' ' ' ILE . 27.1 mt-30 -63.33 -41.96 98.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -56.25 126.36 25.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.834 0.349 . . . . 0.0 110.488 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 99.4 mtt180 -86.16 127.04 34.65 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.51 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.629 HD21 HG23 ' A' ' 3' ' ' ILE . 5.4 tp -78.3 127.6 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.656 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.912 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 70.5 mt -143.71 138.15 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-O 120.88 0.371 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.705 ' HB2' HG12 ' A' ' 5' ' ' VAL . 3.6 m-85 -131.24 148.67 52.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.563 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.9 124.26 8.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.94 -140.43 0.05 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.356 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -71.62 75.05 0.81 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 111.553 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.748 HE22 ' HD2' ' A' ' 6' ' ' LYS . 11.3 mm100 -64.41 111.07 2.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.435 ' H ' ' CD2' ' B' ' 50' ' ' LEU . 2.7 mm? -52.76 80.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.559 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' B' ' 49' ' ' GLN . 38.3 tp10 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.007 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.505 ' C ' ' HB2' ' A' ' 16' ' ' GLU . 47.9 t -171.46 -50.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.726 0.298 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.3 ptm -100.12 112.75 25.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.233 0.539 . . . . 0.0 111.248 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.464 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 36.5 tt0 -62.95 120.79 12.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.629 HD12 HD13 ' A' ' 15' ' ' LEU . 36.3 pt -99.7 143.07 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 112.22 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.4 m-85 -89.86 135.31 33.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.124 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.779 ' HB ' HG13 ' A' ' 13' ' ' ILE . 67.4 t -148.79 132.76 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -92.46 129.22 38.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.698 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 61.5 p -77.37 -157.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 110.908 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.426 ' H ' ' HB ' ' A' ' 7' ' ' THR . 51.7 mt -83.45 -53.49 5.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.57 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -73.16 -45.28 57.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.32 -27.15 0.25 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.325 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -43.24 130.36 4.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 111.952 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -89.21 138.84 31.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.981 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.779 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.2 pt -125.4 133.85 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.271 0.558 . . . . 0.0 111.907 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 4.7 p -117.72 144.27 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.623 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.629 HD13 HD12 ' A' ' 3' ' ' ILE . 3.3 pp -168.0 124.73 1.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.292 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -77.15 143.01 39.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -179.344 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.668 HG22 HG13 ' A' ' 26' ' ' VAL . 3.7 m -150.97 132.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.86 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.63 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 85.5 mt-10 -63.38 137.83 97.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.75 -36.19 61.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.13 2.553 . . . . 0.0 112.5 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -63.87 -33.23 75.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.094 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.63 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -56.47 133.23 53.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -60.27 148.47 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.826 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 69.0 mt -54.67 -45.33 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 12.1 pt-20 -59.82 -36.09 76.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.509 HD21 ' HB3' ' A' ' 21' ' ' ASP . 42.7 t30 -63.59 -48.25 78.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 17' ' ' VAL . 11.0 m -64.82 -41.01 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.171 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.589 ' N ' HG21 ' A' ' 26' ' ' VAL . 49.6 mtmt -63.42 -39.21 93.89 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.666 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -55.24 -37.45 67.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HE3' HG13 ' A' ' 17' ' ' VAL . 48.4 mttm -63.64 -41.95 98.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.643 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.561 HD11 ' HG2' ' A' ' 41' ' ' GLN . 70.8 mt -55.09 -39.33 49.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.421 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 43.1 tt0 -61.17 -47.13 87.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.153 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -60.01 -37.38 79.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.051 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HB3' ' HZ3' ' A' ' 33' ' ' LYS . 4.5 mmmp? -66.18 -42.42 88.91 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.948 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -124.55 -70.21 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.083 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.0 -37.34 0.42 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.254 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.765 HG21 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.61 126.09 4.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.674 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -47.1 142.73 11.1 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.305 2.67 . . . . 0.0 112.761 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 46.8 Cg_exo -56.33 -37.34 97.1 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.766 2.311 . . . . 0.0 112.475 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.75 -38.32 81.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.765 HE22 HG21 ' A' ' 36' ' ' ILE . 26.0 mt-30 -60.51 -39.27 87.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.743 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.706 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.64 124.09 15.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 99.3 mtt180 -89.54 128.57 36.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.431 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.678 ' HG ' ' HE3' ' B' ' 1' ' ' MET . 23.7 mt -74.27 130.55 39.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.838 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.929 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 76.6 mt -143.88 133.04 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.749 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.2 m-85 -130.33 147.23 52.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.618 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.82 123.99 5.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 111.562 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.31 138.08 47.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 97.5 mttt -59.26 120.41 9.2 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.794 0.807 . . . . 0.0 111.317 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.598 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.9 pt20 -149.16 99.78 2.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.986 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.601 ' H ' HD21 ' A' ' 50' ' ' LEU . 3.5 mm? -44.96 80.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.692 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 49' ' ' GLN . 5.6 tp10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.422 ' N ' ' HB2' ' B' ' 16' ' ' GLU . 48.0 t -173.0 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.702 0.287 . . . . 0.0 111.156 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.678 ' HE3' ' HG ' ' A' ' 43' ' ' LEU . 20.6 ptm -109.63 117.53 34.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.465 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.417 ' NE2' HG22 ' B' ' 14' ' ' THR . 27.6 mt-30 -62.03 130.52 45.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.249 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.696 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.1 pt -104.09 139.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.592 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.0 m-85 -88.86 129.78 35.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.686 ' HB ' HG13 ' B' ' 13' ' ' ILE . 62.0 t -144.07 134.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 111.462 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -96.09 127.73 42.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 66.3 p -76.54 -157.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.961 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.611 HD12 HG22 ' B' ' 36' ' ' ILE . 7.7 mp -83.04 -52.63 6.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.519 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -74.27 -45.27 48.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.67 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.07 -28.45 0.27 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.559 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -42.96 130.68 4.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.768 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.686 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -106.22 129.5 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.115 0.483 . . . . 0.0 112.002 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.417 HG22 ' NE2' ' B' ' 2' ' ' GLN . 1.9 m -107.46 136.33 47.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.696 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -163.36 115.64 1.49 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.864 -178.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' B' ' 1' ' ' MET . 23.9 pt-20 -76.92 139.27 40.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.439 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.438 ' CG1' HD13 ' B' ' 15' ' ' LEU . 21.7 m -151.26 138.09 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.636 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 85.5 mt-10 -67.33 140.52 95.31 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.03 -37.62 86.56 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.082 2.521 . . . . 0.0 112.497 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.3 t -63.85 -32.97 74.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.188 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.636 ' OD1' ' HB2' ' B' ' 18' ' ' GLU . 1.0 OUTLIER -56.21 132.93 51.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 80.4 p -60.65 149.07 36.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.792 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 67.1 mt -55.2 -45.07 77.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.12 -41.62 88.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.834 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' B' ' 21' ' ' ASP . 37.5 t30 -61.4 -44.14 97.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.515 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.403 HG23 ' CG2' ' B' ' 17' ' ' VAL . 16.8 t -61.47 -47.85 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.388 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.573 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 47.7 mtmt -65.08 -36.38 84.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.303 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -56.51 -32.65 65.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.152 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.599 ' HB2' HD23 ' B' ' 15' ' ' LEU . 50.4 mttm -69.26 -33.84 73.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.183 0.516 . . . . 0.0 109.735 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.631 HG23 HD11 ' B' ' 36' ' ' ILE . 60.9 mt -61.75 -42.18 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.597 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.664 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.7 pt20 -66.35 -45.33 80.57 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.413 ' N ' ' HG3' ' B' ' 31' ' ' GLN . 63.7 t0 -58.77 -31.73 68.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 tptp -73.27 -32.23 64.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.556 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -139.31 -64.76 0.49 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.004 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 159.07 -32.56 0.46 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.343 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.706 HG21 ' NE2' ' B' ' 40' ' ' GLN . 0.3 OUTLIER -49.74 128.95 20.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.475 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 50.4 Cg_exo -54.57 140.58 75.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.68 2.254 . . . . 0.0 111.668 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.591 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 53.6 Cg_exo -52.75 -37.26 75.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.563 2.175 . . . . 0.0 112.665 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -61.11 -37.4 82.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.564 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.706 ' NE2' HG21 ' B' ' 36' ' ' ILE . 24.5 mt-30 -62.87 -38.97 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.749 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.68 126.43 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.698 0.285 . . . . 0.0 110.588 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.646 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 99.4 mtt180 -92.35 127.48 37.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.992 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 3' ' ' ILE . 7.7 mp -72.86 129.07 37.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.226 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.929 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 77.9 mt -143.89 131.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 5.3 m-85 -128.94 145.86 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.747 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.506 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -155.81 126.09 6.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 111.461 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.76 137.84 46.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.443 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.457 ' HG2' ' HE ' ' A' ' 42' ' ' ARG . 98.2 mttt -59.7 122.42 14.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.551 0.691 . . . . 0.0 111.375 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.0 pt20 -149.63 114.28 5.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.035 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.77 ' H ' HD21 ' B' ' 50' ' ' LEU . 3.4 mm? -56.32 79.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' B' ' 49' ' ' GLN . 5.6 tp10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.711 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.412 ' HA2' ' CD ' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.411 ' HG ' ' H ' ' A' ' 1' ' ' MET . 81.0 p -61.79 -60.45 3.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 ptm 177.61 112.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.702 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.733 ' HB2' HG23 ' A' ' 14' ' ' THR . 19.3 pt20 -69.05 130.12 41.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 15' ' ' LEU . 5.0 pt -99.75 147.05 7.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.79 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 4.6 m-85 -89.57 126.98 35.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.911 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.699 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.1 t -149.5 137.28 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.277 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -104.62 129.67 52.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.391 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -68.38 -157.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.117 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.452 HD22 ' CG2' ' A' ' 36' ' ' ILE . 3.6 mp -86.57 -51.58 6.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.242 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.8 p -72.11 -45.48 60.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.729 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 -29.73 0.26 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -43.97 129.91 5.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.967 0.413 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -90.27 137.53 32.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.339 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.699 HG13 ' HB ' ' A' ' 5' ' ' VAL . 3.7 pt -122.87 134.63 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 111.344 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 2' ' ' GLN . 3.8 m -127.0 105.1 8.37 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -123.68 127.91 48.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 1' ' ' MET . 12.5 pt-20 -72.39 139.27 47.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.83 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.705 HG22 HG23 ' A' ' 26' ' ' VAL . 19.0 m -150.26 135.17 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 80.4 mt-10 -64.22 137.9 97.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.235 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.34 -36.58 97.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.831 2.354 . . . . 0.0 112.031 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.491 ' O ' HG21 ' B' ' 22' ' ' THR . 43.4 t -64.19 -33.94 76.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.898 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.623 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 30.2 m-20 -57.99 133.33 55.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.485 HG21 ' O ' ' B' ' 20' ' ' SER . 76.1 p -58.49 149.51 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.453 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.528 HD11 HD22 ' A' ' 43' ' ' LEU . 63.2 mt -53.33 -38.23 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.846 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.59 ' HA ' ' HZ2' ' A' ' 27' ' ' LYS . 17.1 tp10 -59.27 -42.29 90.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.452 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.71 -44.9 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 HG22 ' A' ' 17' ' ' VAL . 24.3 t -57.34 -48.93 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.176 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HZ2' ' HA ' ' A' ' 24' ' ' GLU . 36.8 mtmm -66.04 -35.56 80.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.802 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.27 -38.43 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.178 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.677 ' HE2' ' HZ2' ' A' ' 33' ' ' LYS . 87.9 tttt -67.28 -38.86 85.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.04 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.699 HD11 ' HG2' ' A' ' 41' ' ' GLN . 58.4 mt -58.12 -34.29 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.891 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.802 HE21 ' HA ' ' A' ' 28' ' ' ALA . 54.7 mt-30 -64.08 -44.46 92.31 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 -32.58 71.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.677 ' HZ2' ' HE2' ' A' ' 29' ' ' LYS . 36.2 mmtm -71.67 -30.09 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.03 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' HB3' HD13 ' A' ' 36' ' ' ILE . 17.7 tp10 -140.96 -66.49 0.43 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.204 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 150.86 -32.15 0.98 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.901 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.761 HG23 HE21 ' A' ' 40' ' ' GLN . 0.6 OUTLIER -48.66 127.05 13.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HD2' ' HG3' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -46.63 158.76 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.014 2.476 . . . . 0.0 112.43 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.651 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 17.1 Cg_endo -57.74 -37.37 96.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.598 2.198 . . . . 0.0 112.262 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.08 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.761 HE21 HG23 ' A' ' 36' ' ' ILE . 15.3 mm100 -52.26 -55.94 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.699 ' HG2' HD11 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -56.79 128.24 35.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.675 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.2 mmt180 -96.83 125.65 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.528 HD22 HD11 ' A' ' 23' ' ' ILE . 9.4 mp -68.81 122.52 18.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.539 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 62.4 mt -143.75 130.48 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.072 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.677 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 8.8 m-85 -130.03 145.12 51.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.794 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.679 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -146.42 127.45 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 111.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.482 ' HA3' ' C ' ' B' ' 40' ' ' GLN . . . -69.62 -141.85 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.304 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -71.92 75.18 0.9 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.917 0.389 . . . . 0.0 111.274 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 51' ' ' GLU . 85.6 mt-30 -65.32 102.02 0.63 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mp -44.83 80.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.714 0.634 . . . . 0.0 111.712 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 49' ' ' GLN . 5.0 mm-40 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . 0.41 ' HA2' ' CD ' ' B' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.416 ' HG ' ' HB2' ' B' ' 16' ' ' GLU . 79.6 p -62.43 -59.75 4.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.295 . . . . 0.0 110.866 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.3 ptm 177.69 110.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.964 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.651 ' HB2' HG23 ' B' ' 14' ' ' THR . 19.2 pt20 -68.97 127.02 31.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.495 HG12 ' O ' ' B' ' 15' ' ' LEU . 26.1 pt -99.86 150.04 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.479 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.593 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 3.5 m-85 -89.1 129.43 35.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.358 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.708 ' HB ' HG13 ' B' ' 13' ' ' ILE . 87.8 t -149.74 137.27 13.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -104.38 130.27 52.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.288 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -70.62 -157.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.406 . . . . 0.0 111.678 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.646 HD11 ' N ' ' B' ' 8' ' ' LEU . 4.8 mp -82.44 -56.66 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.433 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -71.2 -45.44 63.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.881 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.29 -28.64 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.8 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -43.62 128.09 5.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.305 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -87.53 137.17 32.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.708 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.5 pt -123.59 128.44 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 111.441 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.651 HG23 ' HB2' ' B' ' 2' ' ' GLN . 7.5 m -124.01 110.51 14.87 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.661 ' H ' HD21 ' B' ' 15' ' ' LEU . 1.5 pt? -136.19 131.17 34.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.406 0.622 . . . . 0.0 111.846 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.8 pt-20 -70.03 142.96 52.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.883 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.771 HG22 HG13 ' B' ' 26' ' ' VAL . 21.2 m -152.27 134.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.191 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.458 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 86.6 mt-10 -61.97 137.45 95.48 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.645 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.11 -39.19 81.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.831 2.354 . . . . 0.0 111.914 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.485 ' O ' HG21 ' A' ' 22' ' ' THR . 47.1 t -64.15 -30.64 71.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.458 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 46.5 m-20 -59.77 132.71 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 20' ' ' SER . 74.5 p -57.44 149.59 20.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.502 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.502 ' O ' HG23 ' B' ' 26' ' ' VAL . 64.4 mt -54.27 -37.78 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 109.705 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.601 ' HA ' ' HZ2' ' B' ' 27' ' ' LYS . 4.6 tp10 -60.22 -37.4 80.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.453 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -66.58 -48.43 69.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.576 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.771 HG13 HG22 ' B' ' 17' ' ' VAL . 9.4 m -60.65 -42.24 91.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.031 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.601 ' HZ2' ' HA ' ' B' ' 24' ' ' GLU . 36.8 mtmm -65.68 -38.1 88.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.922 0.391 . . . . 0.0 110.258 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.811 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -55.91 -36.44 67.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.492 ' HE2' ' HZ3' ' B' ' 33' ' ' LYS . 88.3 tttt -68.51 -39.51 81.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.044 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' B' ' 41' ' ' GLN . 59.3 mt -57.67 -33.86 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.685 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.811 HE21 ' HA ' ' B' ' 28' ' ' ALA . 59.6 mt-30 -63.34 -47.18 83.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.16 -31.01 68.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.63 ' HG3' HD12 ' B' ' 15' ' ' LEU . 25.7 mmtp -75.18 -27.07 59.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -141.48 -66.74 0.41 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.158 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 149.31 -32.04 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.041 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.793 HG23 HE21 ' B' ' 40' ' ' GLN . 0.7 OUTLIER -50.41 129.53 25.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.51 ' HD2' ' HG3' ' B' ' 40' ' ' GLN . 91.0 Cg_exo -47.17 157.98 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.979 2.452 . . . . 0.0 112.323 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.669 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 13.9 Cg_endo -58.14 -36.06 98.2 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.451 2.101 . . . . 0.0 112.152 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -60.4 -33.45 72.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.793 HE21 HG23 ' B' ' 36' ' ' ILE . 15.4 mm100 -52.2 -55.52 20.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.029 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.684 ' HG2' HD11 ' B' ' 30' ' ' ILE . 0.5 OUTLIER -56.65 127.92 33.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.679 ' H ' ' H ' ' A' ' 46' ' ' ALA . 37.5 mmt180 -96.1 126.23 41.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.513 HD11 ' N ' ' B' ' 43' ' ' LEU . 8.9 mp -69.57 122.05 18.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.415 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 76.0 mt -143.79 130.1 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 8.7 m-85 -129.93 144.63 51.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.74 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.675 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -144.97 128.11 16.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.451 ' HA3' ' C ' ' A' ' 40' ' ' GLN . . . -70.03 -142.07 0.17 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.347 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -74.73 74.82 2.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.007 0.432 . . . . 0.0 111.572 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' B' ' 51' ' ' GLU . 82.6 mt-30 -64.84 112.01 3.07 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.51 ' H ' HD21 ' B' ' 50' ' ' LEU . 1.4 mm? -52.5 80.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.296 0.372 . . . . 0.0 111.428 -178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' B' ' 49' ' ' GLN . 5.0 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.788 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 53.6 m 56.05 -140.19 0.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.515 0.198 . . . . 0.0 111.05 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' HG3' ' A' ' 1' ' ' MET . 15.7 tpt -82.23 48.81 1.31 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.028 0.442 . . . . 0.0 111.176 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.585 ' HB2' HG23 ' A' ' 14' ' ' THR . 18.9 pt20 -61.84 111.13 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.746 HG23 HD21 ' B' ' 43' ' ' LEU . 34.9 pt -84.87 141.59 14.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -87.82 130.16 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.717 ' HB ' HG22 ' A' ' 13' ' ' ILE . 86.6 t -145.17 145.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.027 0.441 . . . . 0.0 111.553 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 67.3 mttm -108.33 129.81 55.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.323 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.29 -156.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.324 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.33 -52.06 66.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.5 t -76.63 -45.1 31.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.995 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 143.21 32.76 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.488 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 61.8 tttp -81.32 131.12 35.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -73.04 136.79 45.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.437 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.717 HG22 ' HB ' ' A' ' 5' ' ' VAL . 1.3 tt -139.49 124.08 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 111.749 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.585 HG23 ' HB2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -86.54 144.12 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.984 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.581 HD12 HD12 ' A' ' 30' ' ' ILE . 5.0 tt -158.32 113.31 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.805 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 25.7 pt-20 -88.18 132.64 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.588 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.509 HG12 HD22 ' A' ' 15' ' ' LEU . 2.9 m -159.92 146.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.73 139.24 76.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 33.5 Cg_endo -61.9 -40.06 46.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.358 . . . . 0.0 112.348 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 m -63.85 -20.55 65.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.795 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -57.51 134.21 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.5 p -56.6 142.87 37.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.485 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.516 HG12 HG12 ' B' ' 23' ' ' ILE . 66.2 mt -57.75 -40.62 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.77 -44.57 90.65 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.138 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.61 -44.52 86.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.415 HG22 HD13 ' B' ' 23' ' ' ILE . 60.3 t -59.16 -49.28 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.33 -36.76 84.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.518 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.542 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -53.81 -36.12 62.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.875 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 86.7 tttt -69.54 -39.17 77.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.117 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.708 ' HB ' HE22 ' A' ' 41' ' ' GLN . 36.9 mm -54.87 -38.55 45.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.101 0.477 . . . . 0.0 109.775 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -60.37 -48.96 79.51 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.32 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.91 -30.52 71.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.449 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 30.7 mmmt -72.05 -32.1 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.23 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -138.91 -65.69 0.49 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.983 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.98 -40.39 0.52 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.73 HG23 ' NE2' ' A' ' 40' ' ' GLN . 0.9 OUTLIER -45.06 126.78 5.49 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.803 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 87.2 Cg_exo -45.93 139.64 10.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.019 2.479 . . . . 0.0 112.399 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 45.6 Cg_exo -56.26 -40.6 83.72 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.37 2.046 . . . . 0.0 111.879 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.32 -36.04 81.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.803 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 6.5 tt0 -60.28 -37.15 79.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.092 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.822 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.6 mt-30 -56.33 132.05 49.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 56.3 ttp180 -91.82 125.61 36.59 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.602 HD11 HG23 ' B' ' 3' ' ' ILE . 14.5 mt -74.46 132.17 41.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.705 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.926 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 75.8 mt -143.73 133.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.808 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 15.4 m-85 -129.69 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.434 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.16 127.37 6.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.964 0.412 . . . . 0.0 111.722 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.65 138.88 25.58 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.541 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.714 ' H ' ' HG2' ' B' ' 40' ' ' GLN . 23.4 tptm -159.91 74.67 0.59 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.554 0.692 . . . . 0.0 111.089 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.1 pt20 -71.27 105.14 3.35 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.839 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.404 ' H ' ' CD2' ' A' ' 50' ' ' LEU . 2.2 mm? -48.81 80.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.462 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' GLN . 40.5 tt0 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.843 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -1' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' B' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 0' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 55.8 m 56.04 -140.61 0.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.541 0.21 . . . . 0.0 111.021 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' B' ' 1' ' ' MET . 15.7 tpt -82.14 48.84 1.3 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.895 0.378 . . . . 0.0 111.205 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . 0.502 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 18.4 pt20 -61.72 111.82 2.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.235 0.541 . . . . 0.0 110.841 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.602 HG23 HD11 ' A' ' 43' ' ' LEU . 30.5 pt -85.53 142.29 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -88.25 126.59 35.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.689 ' HB ' HG12 ' B' ' 13' ' ' ILE . 89.6 t -142.61 139.44 28.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.156 0.503 . . . . 0.0 111.519 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.581 ' HB3' ' HA3' ' B' ' 10' ' ' GLY . 67.1 mttm -102.96 131.52 49.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.547 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -67.8 -156.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.0 mt -62.01 -50.5 71.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 110.708 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 5.8 t -75.62 -45.17 38.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.047 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.581 ' HA3' ' HB3' ' B' ' 6' ' ' LYS . . . 142.89 34.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.652 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 60.5 tttp -82.4 128.4 34.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.776 0.322 . . . . 0.0 111.181 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' THR . . . . . 0.445 ' C ' HG21 ' B' ' 13' ' ' ILE . 87.7 m -73.07 135.84 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.62 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.689 HG12 ' HB ' ' B' ' 5' ' ' VAL . 4.2 pt -137.44 134.94 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.097 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.25 144.28 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.688 HD13 HG12 ' B' ' 17' ' ' VAL . 6.0 tp -156.82 113.01 2.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 15.5 pt-20 -86.67 129.16 34.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.961 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.688 HG12 HD13 ' B' ' 15' ' ' LEU . 6.6 m -157.11 143.99 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.664 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.52 137.0 76.91 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.61 -39.63 72.84 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.824 2.349 . . . . 0.0 112.187 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -64.07 -24.6 67.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -54.01 134.06 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -56.48 143.19 36.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.518 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 23' ' ' ILE . 66.4 mt -58.09 -40.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.436 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -59.03 -44.87 91.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.051 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.35 -44.36 87.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.15 -48.81 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.255 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 49.4 mtmt -65.07 -35.82 82.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.678 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.632 ' HA ' ' HG3' ' B' ' 38' ' ' PRO . . . -54.31 -34.46 61.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.673 ' HD3' HD12 ' B' ' 15' ' ' LEU . 87.1 tttt -73.79 -32.27 63.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.384 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.735 ' HB ' HE22 ' B' ' 41' ' ' GLN . 40.8 mm -56.94 -44.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.426 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 23.9 pt20 -64.99 -39.15 93.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.64 -32.31 72.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 29' ' ' LYS . 31.0 mmmt -74.97 -31.17 61.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.799 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.678 ' HB3' HD13 ' B' ' 36' ' ' ILE . 5.1 tp10 -139.13 -64.03 0.51 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 156.61 -32.71 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.11 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.7 HG23 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -47.95 124.03 10.3 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.68 ' HG2' ' HB2' ' B' ' 40' ' ' GLN . 2.3 Cg_endo -48.64 137.82 25.98 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.586 2.19 . . . . 0.0 111.412 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.632 ' HG3' ' HA ' ' B' ' 28' ' ' ALA . 50.2 Cg_exo -53.47 -39.91 80.47 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.472 2.115 . . . . 0.0 112.412 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.03 -35.93 79.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.635 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.714 ' HG2' ' H ' ' A' ' 48' ' ' LYS . 7.0 tt0 -60.74 -36.69 79.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 111.145 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.735 HE22 ' HB ' ' B' ' 30' ' ' ILE . 70.8 mt-30 -57.23 132.13 52.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 56.4 ttp180 -91.64 127.55 37.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.657 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 3' ' ' ILE . 8.3 mp -75.86 130.88 39.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.926 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -143.52 134.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.822 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 9.9 m-85 -129.94 141.78 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.294 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.569 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.54 123.18 6.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.093 0.473 . . . . 0.0 112.068 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HG2' ' A' ' 40' ' ' GLN . . . -70.8 137.54 27.16 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.436 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.622 ' H ' ' HG2' ' A' ' 40' ' ' GLN . 23.5 tptm -159.81 74.82 0.6 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.357 0.599 . . . . 0.0 110.883 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.1 pt20 -68.3 115.5 7.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.197 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.626 ' H ' HD21 ' B' ' 50' ' ' LEU . 3.0 mm? -55.89 79.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.287 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.6 tt0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.5 tpt . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.23 0.538 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 17.4 pt20 -61.58 110.56 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.405 0.621 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.668 HG22 HD23 ' B' ' 43' ' ' LEU . 37.0 pt -72.49 146.21 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.098 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -87.84 130.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.881 ' HB ' HG23 ' A' ' 13' ' ' ILE . 64.8 t -144.55 151.05 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.96 117.95 29.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.325 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.465 HG21 ' NZ ' ' A' ' 11' ' ' LYS . 74.1 p -68.68 152.74 44.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.4 mt -50.29 -37.67 37.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.735 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -66.63 -44.99 80.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.02 -40.12 1.21 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.444 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG21 ' A' ' 7' ' ' THR . 21.8 pttp -52.13 139.66 22.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 111.668 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -73.34 148.1 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.62 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.881 HG23 ' HB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -134.83 133.33 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.274 0.559 . . . . 0.0 112.024 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 145.25 31.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.299 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.86 HD12 ' HG3' ' A' ' 33' ' ' LYS . 3.9 tt -155.31 113.76 3.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.339 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 25.4 pt-20 -80.43 136.69 36.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.422 . . . . 0.0 111.906 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.764 HG21 HG13 ' A' ' 26' ' ' VAL . 2.4 m -158.21 143.5 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.496 ' HB2' ' CG ' ' A' ' 21' ' ' ASP . 41.4 mt-10 -62.75 133.76 95.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.18 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 10.6 Cg_endo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.716 2.277 . . . . 0.0 111.851 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.5 t -64.72 -31.64 72.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.947 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.496 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 63.6 m-20 -52.44 135.33 33.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.4 p -56.71 143.79 35.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.769 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.727 HG12 HG12 ' B' ' 23' ' ' ILE . 60.7 mt -57.27 -44.45 83.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.98 -41.92 79.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.705 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -65.73 -43.01 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.648 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.764 HG13 HG21 ' A' ' 17' ' ' VAL . 59.9 t -59.55 -49.77 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.608 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 54.0 mttp -62.51 -39.79 94.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.827 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HA ' ' NE2' ' A' ' 31' ' ' GLN . . . -56.19 -35.72 67.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.328 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.76 ' HD2' HD21 ' A' ' 15' ' ' LEU . 24.4 ttmm -65.39 -36.48 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.031 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.719 HG22 HD11 ' A' ' 36' ' ' ILE . 51.1 mt -55.81 -31.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 33.4 mt-30 -61.09 -52.52 64.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.39 -34.67 72.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.25 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.86 ' HG3' HD12 ' A' ' 15' ' ' LEU . 43.9 mmtm -65.89 -33.43 75.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.298 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -141.66 -70.69 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.289 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.48 54.27 0.03 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.776 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.719 HD11 HG22 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -138.35 128.12 14.88 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 111.728 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.561 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 78.0 Cg_exo -44.03 141.21 4.68 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.961 2.44 . . . . 0.0 112.703 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 11.9 Cg_endo -57.85 -35.01 99.01 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.765 2.31 . . . . 0.0 112.711 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.99 -37.87 80.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.561 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 83.2 mt-30 -60.7 -44.91 95.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.579 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.563 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.6 OUTLIER -54.33 125.48 19.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.343 . . . . 0.0 110.771 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.707 ' H ' ' H ' ' B' ' 46' ' ' ALA . 70.0 mtt-85 -85.84 122.02 29.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.664 HD23 HG22 ' B' ' 3' ' ' ILE . 13.8 tp -84.31 132.98 34.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.721 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.7 mt -143.16 145.53 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 111.672 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' B' ' 5' ' ' VAL . 17.2 m-85 -133.9 140.07 46.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.665 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.23 119.21 5.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.094 0.473 . . . . 0.0 111.648 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.72 179.722 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.531 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.4 tpt . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.317 0.58 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.972 ' HB2' HG22 ' B' ' 14' ' ' THR . 4.6 pt20 -61.46 110.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.129 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.664 HG22 HD23 ' A' ' 43' ' ' LEU . 35.1 pt -72.96 147.48 9.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -87.87 130.15 34.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 45' ' ' PHE . 61.9 t -141.95 152.74 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -123.1 117.44 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.927 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.514 HG21 ' CE ' ' B' ' 11' ' ' LYS . 77.1 p -69.9 150.7 46.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.723 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -48.38 -37.81 17.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.979 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -66.81 -45.23 79.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.75 -41.92 1.1 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.517 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.514 ' CE ' HG21 ' B' ' 7' ' ' THR . 0.0 OUTLIER -54.07 140.1 32.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.126 0.489 . . . . 0.0 111.67 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 50.7 m -72.4 147.35 46.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.543 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.531 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -130.56 141.6 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.195 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.972 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.2 OUTLIER -119.21 143.97 46.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.019 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.699 HD11 ' HD2' ' B' ' 29' ' ' LYS . 3.5 tp -155.67 114.01 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 15.1 pt-20 -77.91 134.42 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.62 HG21 HG13 ' B' ' 26' ' ' VAL . 13.9 m -155.54 141.52 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.214 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.521 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 41.8 mt-10 -61.26 135.09 93.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.352 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.1 -39.55 90.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.777 2.318 . . . . 0.0 111.894 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 22' ' ' THR . 45.7 t -64.38 -30.55 71.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.912 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.521 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 63.0 m-20 -53.95 134.74 43.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.454 ' O ' HG23 ' B' ' 26' ' ' VAL . 74.1 p -55.91 142.95 33.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.695 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.749 HD11 HG21 ' A' ' 26' ' ' VAL . 60.1 mt -57.16 -43.61 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.032 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.33 -42.47 81.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.552 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -65.81 -42.01 91.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.615 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 23' ' ' ILE . 94.1 t -59.89 -48.78 86.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.624 ' NZ ' HD13 ' B' ' 43' ' ' LEU . 64.5 mttm -64.26 -40.09 95.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.923 0.392 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.403 ' HA ' ' NE2' ' B' ' 31' ' ' GLN . . . -55.35 -35.86 65.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.398 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.699 ' HD2' HD11 ' B' ' 15' ' ' LEU . 24.6 ttmm -65.87 -35.32 80.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.527 HG22 ' CD1' ' B' ' 36' ' ' ILE . 50.2 mt -56.46 -30.69 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 32.7 mt-30 -61.12 -52.4 65.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -34.43 72.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.134 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.533 ' HE2' HD13 ' B' ' 15' ' ' LEU . 43.5 mmtm -65.79 -33.04 74.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.258 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -143.31 -68.43 0.34 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.746 0.307 . . . . 0.0 111.252 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.83 53.2 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.311 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.782 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -133.23 132.23 22.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.556 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 72.1 Cg_exo -50.87 142.39 33.3 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.729 2.286 . . . . 0.0 111.998 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.555 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 32.4 Cg_exo -56.66 -35.73 97.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.675 2.25 . . . . 0.0 112.482 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.36 -37.52 86.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.782 ' OE1' HG22 ' B' ' 36' ' ' ILE . 90.0 mt-30 -63.08 -42.52 99.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.692 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.414 ' OE1' ' N ' ' B' ' 41' ' ' GLN . 0.6 OUTLIER -56.52 127.28 30.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.745 0.307 . . . . 0.0 110.489 179.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.665 ' H ' ' H ' ' A' ' 46' ' ' ALA . 70.9 mtt-85 -86.84 123.44 31.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.433 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.668 HD23 HG22 ' A' ' 3' ' ' ILE . 14.3 tp -85.5 132.7 34.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.721 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 66.4 mt -143.22 145.64 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.894 0.378 . . . . 0.0 111.823 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.761 ' HB2' HG22 ' A' ' 5' ' ' VAL . 16.0 m-85 -134.53 139.98 45.82 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.993 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.707 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 117.34 5.03 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.084 0.469 . . . . 0.0 111.645 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.501 179.69 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 ptm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.018 0.437 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.934 ' HB2' HG22 ' A' ' 14' ' ' THR . 19.5 pt20 -61.91 130.19 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.236 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.2 pt -103.72 140.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.39 124.77 34.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.789 ' HB ' HG12 ' A' ' 13' ' ' ILE . 35.2 t -141.89 143.7 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 111.43 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.681 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 67.5 mttm -111.45 128.3 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.291 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -63.81 -156.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.06 -53.6 55.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.849 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -72.99 -44.89 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 142.2 35.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 60.9 tttp -80.61 126.02 30.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.311 . . . . 0.0 110.861 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -72.88 134.49 44.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.611 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.789 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.6 pt -136.18 138.05 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.934 HG22 ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -95.81 144.01 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.729 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 29' ' ' LYS . 5.3 tt -161.55 114.34 1.85 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.5 pt-20 -87.99 136.28 33.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.553 HG13 ' CD2' ' A' ' 15' ' ' LEU . 3.3 m -156.92 151.9 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.766 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 50.9 mt-10 -72.71 136.9 80.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.43 -32.32 72.45 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.734 2.289 . . . . 0.0 111.959 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.51 ' O ' HG22 ' B' ' 22' ' ' THR . 69.1 m -63.97 -31.78 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.568 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -57.22 128.81 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.788 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.525 HG22 ' O ' ' B' ' 20' ' ' SER . 76.2 p -57.18 150.71 17.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.992 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.706 HG22 ' HE2' ' A' ' 27' ' ' LYS . 67.4 mt -57.28 -31.11 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.541 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -64.72 -36.89 85.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.877 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 45.8 m-20 -73.71 -47.6 38.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.374 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 17' ' ' VAL . 33.2 m -57.82 -43.55 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.131 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.706 ' HE2' HG22 ' A' ' 23' ' ' ILE . 53.4 mtmt -72.02 -34.9 69.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.678 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.52 ' HA ' ' NE2' ' A' ' 31' ' ' GLN . . . -55.52 -38.9 69.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HB2' HD11 ' A' ' 15' ' ' LEU . 41.2 mtpt -65.6 -38.48 89.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.656 ' HB ' HE22 ' A' ' 41' ' ' GLN . 48.3 mm -54.68 -31.96 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.628 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.543 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 31.5 mt-30 -61.13 -51.82 67.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.05 -34.62 75.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.254 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' HD12 ' A' ' 15' ' ' LEU . 73.6 mmtt -65.26 -32.1 73.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.399 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -145.46 -68.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.61 61.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.205 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.652 HD11 HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -146.43 124.42 6.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.933 0.396 . . . . 0.0 112.003 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 39.7 Cg_exo -39.8 143.14 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.461 2.774 . . . . 0.0 112.979 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 38.3 Cg_exo -60.64 -37.79 76.85 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.805 2.336 . . . . 0.0 112.743 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.4 -35.54 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.008 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.487 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 83.1 mt-30 -62.03 -42.95 99.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.208 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.656 HE22 ' HB ' ' A' ' 30' ' ' ILE . 73.5 mt-30 -58.06 126.04 25.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.445 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 18.7 ttm105 -87.7 126.78 35.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.566 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.2 mm? -75.78 131.16 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.468 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.954 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 71.3 mt -143.24 136.03 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.781 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.5 m-85 -131.62 141.07 49.55 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.735 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -155.14 122.24 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.019 0.438 . . . . 0.0 111.951 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' B' ' 40' ' ' GLN . . . . . . . . 0 C--N 1.331 0.267 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.611 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.7 ptm . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.95 0.405 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.46 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 20.5 pt20 -62.39 128.92 38.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.807 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.772 HD11 HD23 ' B' ' 15' ' ' LEU . 32.7 pt -101.44 137.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.011 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.77 124.25 33.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 1.006 HG13 HG23 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.79 140.11 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 0.0 111.419 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.665 ' HB3' ' HA2' ' B' ' 10' ' ' GLY . 66.6 mttm -100.78 136.09 41.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.137 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.86 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.336 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 mt -59.26 -53.2 60.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.6 p -75.95 -45.45 34.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 110.812 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.665 ' HA2' ' HB3' ' B' ' 6' ' ' LYS . . . 144.32 32.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.418 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 61.4 tttp -79.63 127.25 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -73.51 136.52 44.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 1.006 HG23 HG13 ' B' ' 5' ' ' VAL . 0.9 OUTLIER -142.72 124.35 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -85.07 147.55 26.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.962 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.772 HD23 HD11 ' B' ' 3' ' ' ILE . 7.1 tp -160.66 113.22 1.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.6 pt-20 -80.14 140.27 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.682 HG21 HG12 ' B' ' 26' ' ' VAL . 2.8 p -169.13 133.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.7 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.467 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 52.9 mt-10 -56.35 139.17 74.19 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.612 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.11 -32.29 91.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.976 2.45 . . . . 0.0 112.226 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 22' ' ' THR . 33.8 t -63.37 -21.82 66.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.165 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 65.8 m-20 -66.18 133.02 49.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.734 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 20' ' ' SER . 66.9 p -59.12 148.5 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.607 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.725 HG22 ' HE2' ' B' ' 27' ' ' LYS . 65.5 mt -55.41 -30.86 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.433 0.635 . . . . 0.0 109.698 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.57 -37.83 88.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.91 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.493 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 44.0 m-20 -72.94 -48.64 35.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.607 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.682 HG12 HG21 ' B' ' 17' ' ' VAL . 34.7 m -56.52 -44.59 80.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.223 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.725 ' HE2' HG22 ' B' ' 23' ' ' ILE . 53.6 mtmt -70.91 -34.26 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.528 ' HA ' ' NE2' ' B' ' 31' ' ' GLN . . . -57.1 -38.05 72.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.989 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.574 ' HB2' HD21 ' B' ' 15' ' ' LEU . 32.4 mtpt -64.66 -40.1 94.84 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.637 ' HB ' HE22 ' B' ' 41' ' ' GLN . 50.6 mm -54.47 -32.05 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.902 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.541 ' OE1' ' HD3' ' B' ' 38' ' ' PRO . 32.4 mt-30 -60.79 -53.32 58.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.53 -32.03 72.06 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.309 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 72.7 mmtt -66.41 -31.62 72.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.448 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.522 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.9 tp10 -147.48 -61.93 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.578 0.228 . . . . 0.0 111.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.77 58.11 0.06 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.79 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.728 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -137.99 129.87 16.14 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.633 0.254 . . . . 0.0 111.309 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.495 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -50.27 142.18 29.61 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.619 2.213 . . . . 0.0 112.128 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.605 ' HB3' ' HE3' ' B' ' 27' ' ' LYS . 35.6 Cg_exo -58.31 -38.87 88.8 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.744 2.296 . . . . 0.0 112.608 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.53 -35.45 76.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.728 ' OE1' HG22 ' B' ' 36' ' ' ILE . 87.6 mt-30 -64.96 -39.7 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.315 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 73.2 mt-30 -60.09 128.11 35.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.661 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.735 ' H ' ' H ' ' A' ' 46' ' ' ALA . 18.5 ttm105 -88.97 126.26 35.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.186 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.505 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.0 mm? -75.77 131.53 39.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.531 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.954 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.3 mt -144.04 138.3 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.57 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 13.5 m-85 -133.9 143.55 48.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.433 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.45 ' C ' ' HA ' ' A' ' 41' ' ' GLN . . . -156.25 120.27 4.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.649 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.2 ptt? . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.88 0.372 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.693 ' HB2' HG22 ' A' ' 14' ' ' THR . 16.7 pt20 -74.95 111.79 10.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.871 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 15' ' ' LEU . 33.5 pt -72.25 135.91 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.479 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.41 129.03 35.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.795 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.7 t -146.51 135.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.809 0.338 . . . . 0.0 111.593 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.45 123.05 36.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -70.41 -157.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.351 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.938 HD11 HG21 ' A' ' 36' ' ' ILE . 2.2 mm? -86.05 -48.97 8.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.125 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.8 t -71.08 -45.11 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 9' ' ' THR . . . 156.86 -36.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.787 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -49.22 131.16 19.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.897 0.38 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -84.76 132.3 34.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.795 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -96.65 130.04 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.696 179.357 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.693 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.4 m -107.5 129.13 54.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.727 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -159.56 114.56 2.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.106 0.479 . . . . 0.0 111.283 -178.06 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -76.39 144.32 40.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.389 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.417 HG22 HG23 ' A' ' 3' ' ' ILE . 30.9 m -149.7 145.99 17.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -68.55 143.52 95.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.154 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.78 -39.47 81.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.67 2.247 . . . . 0.0 112.189 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.578 ' O ' HG22 ' B' ' 22' ' ' THR . 47.0 t -64.42 -29.59 70.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.001 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -55.91 130.02 42.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 20' ' ' SER . 70.5 p -62.35 148.48 45.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.724 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.539 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 66.6 mt -54.91 -42.2 62.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -62.89 -29.59 70.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.25 -49.29 51.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.009 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 35.3 m -62.54 -42.04 94.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.15 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 57.8 mtpt -60.88 -37.18 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.404 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HA ' ' NE2' ' A' ' 31' ' ' GLN . . . -60.75 -36.66 79.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.488 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 1.009 ' HZ3' ' HA ' ' A' ' 26' ' ' VAL . 49.3 mttp -62.21 -41.5 98.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.603 HD13 HG11 ' A' ' 5' ' ' VAL . 60.3 mt -54.96 -31.79 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.893 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 28' ' ' ALA . 30.9 mt-30 -63.09 -51.35 66.93 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.31 -32.96 70.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.794 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 31.3 mmmt -69.79 -31.88 70.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.916 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -140.52 -68.31 0.41 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.166 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.14 -32.57 1.05 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.452 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.938 HG21 HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -47.79 132.62 11.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.587 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 87.7 Cg_exo -49.88 155.72 3.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.418 2.746 . . . . 0.0 112.743 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 16.9 Cg_exo -66.79 -39.44 14.97 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.899 2.399 . . . . 0.0 112.944 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.1 -40.07 76.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.587 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 86.4 mt-30 -61.03 -42.22 98.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.411 . . . . 0.0 110.665 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' OE1' HD12 ' A' ' 30' ' ' ILE . 67.2 mt-30 -57.51 143.28 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.182 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.787 ' H ' ' H ' ' B' ' 46' ' ' ALA . 64.6 mtt85 -135.98 110.83 8.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.427 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.471 ' H ' ' CD2' ' A' ' 43' ' ' LEU . 1.4 pt? -77.46 138.71 39.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.716 ' H ' ' H ' ' B' ' 44' ' ' ILE . 62.9 mt -136.42 112.36 12.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.293 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.738 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 4.3 m-85 -84.65 146.69 27.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.735 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.85 126.42 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.401 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.039 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.2 ptt? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.861 0.362 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 16.4 pt20 -71.87 112.47 7.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 110.393 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.578 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.6 pt -72.64 133.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.825 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.48 125.07 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.114 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 1.011 HG13 HG13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -150.86 131.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.662 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.7 130.97 34.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -74.53 -157.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.767 HD21 HG12 ' B' ' 36' ' ' ILE . 2.0 mm? -86.05 -48.66 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.423 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.9 t -70.67 -45.23 65.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.575 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.423 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.94 -35.9 0.62 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -49.86 130.54 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 0.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -82.26 140.87 33.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.397 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 1.011 HG13 HG13 ' B' ' 5' ' ' VAL . 15.4 pt -116.98 130.17 72.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.291 0.567 . . . . 0.0 111.779 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -112.35 137.51 50.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.153 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.578 ' O ' HG12 ' B' ' 3' ' ' ILE . 2.6 pp -162.8 118.62 1.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -70.73 146.03 50.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.761 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.537 HG13 HD12 ' B' ' 15' ' ' LEU . 8.4 m -150.88 141.8 16.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.518 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 46.5 mm-40 -67.45 143.05 96.91 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.01 -36.72 99.44 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.752 2.302 . . . . 0.0 112.099 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.554 ' O ' HG22 ' A' ' 22' ' ' THR . 44.1 t -64.49 -31.49 72.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.159 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 47.2 m-20 -54.67 130.78 41.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 20' ' ' SER . 72.9 p -63.21 148.36 48.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.502 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 68.1 mt -54.27 -42.11 55.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -63.1 -29.83 71.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.22 -49.48 49.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.854 ' HA ' ' HZ2' ' B' ' 29' ' ' LYS . 35.5 m -62.52 -41.32 91.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 58.3 mtpt -61.52 -38.23 86.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.56 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.543 ' HA ' ' NE2' ' B' ' 31' ' ' GLN . . . -59.67 -35.77 75.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.554 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.854 ' HZ2' ' HA ' ' B' ' 26' ' ' VAL . 50.1 mttp -62.57 -41.09 98.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.634 HD13 HG21 ' B' ' 5' ' ' VAL . 59.3 mt -54.78 -32.13 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.903 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' B' ' 28' ' ' ALA . 30.8 mt-30 -62.93 -51.27 67.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.9 -32.07 70.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.956 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 31.1 mmmt -69.75 -31.97 70.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.463 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.664 ' HB2' HD11 ' B' ' 36' ' ' ILE . 5.5 mm-40 -141.27 -61.32 0.48 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.714 0.292 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 126.79 40.93 0.32 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.453 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.796 HD12 ' H ' ' B' ' 36' ' ' ILE . 0.1 OUTLIER -110.46 135.94 20.63 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.558 0.218 . . . . 0.0 111.063 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 65.8 Cg_exo -51.55 143.71 35.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.451 2.1 . . . . 0.0 111.896 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' B' ' 37' ' ' PRO . 31.8 Cg_exo -60.89 -37.61 76.06 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.727 2.285 . . . . 0.0 112.697 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -60.47 -39.11 86.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.155 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.66 ' OE1' HG22 ' B' ' 36' ' ' ILE . 87.2 mt-30 -63.56 -39.04 93.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.53 ' OE1' HD12 ' B' ' 30' ' ' ILE . 69.1 mt-30 -60.9 144.82 52.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.735 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.735 ' H ' ' H ' ' A' ' 46' ' ' ALA . 64.1 mtt85 -137.87 114.56 10.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.457 ' O ' HD12 ' B' ' 43' ' ' LEU . 0.4 OUTLIER -78.27 145.4 35.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.973 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.716 ' H ' ' H ' ' A' ' 44' ' ' ILE . 69.3 mt -142.46 108.51 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.01 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.0 m-85 -82.91 145.24 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.75 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.787 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -157.51 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.224 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.016 -179.754 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.118 0.485 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.589 ' HB2' HG22 ' A' ' 14' ' ' THR . 18.7 pt20 -68.99 135.53 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.958 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.528 HG22 HD22 ' B' ' 43' ' ' LEU . 35.5 pt -108.31 144.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -89.11 129.28 35.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.986 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.604 HG13 ' O ' ' B' ' 45' ' ' PHE . 87.1 t -149.13 129.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.46 126.69 34.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -73.13 -157.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.94 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 36' ' ' ILE . 54.2 mt -74.25 -50.39 19.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.998 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -73.35 -45.43 55.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.575 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.94 -31.81 0.55 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.807 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -46.35 129.98 10.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.908 0.385 . . . . 0.0 111.578 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -85.43 134.87 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.895 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.571 ' CD1' HG23 ' A' ' 30' ' ' ILE . 8.7 pt -101.3 128.23 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 112.014 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.9 m -93.05 116.91 29.49 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.672 ' O ' HD23 ' A' ' 15' ' ' LEU . 2.4 tt -143.67 115.21 8.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.263 0.554 . . . . 0.0 111.993 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 1' ' ' MET . 16.8 pt-20 -76.66 143.76 39.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.951 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 26' ' ' VAL . 10.8 p -168.45 138.15 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 38.7 mt-10 -51.72 140.17 28.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.007 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.91 -42.58 11.12 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.83 2.353 . . . . 0.0 111.954 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.585 ' O ' HG22 ' B' ' 22' ' ' THR . 50.6 m -63.67 -23.05 67.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.402 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.614 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 7.7 t70 -54.16 131.86 42.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.362 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.604 HG22 ' O ' ' B' ' 20' ' ' SER . 72.7 p -56.82 142.37 41.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.867 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.66 HG22 ' HE2' ' A' ' 27' ' ' LYS . 65.9 mt -54.63 -35.73 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.913 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -63.43 -37.05 85.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.386 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.614 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 52.4 m-20 -74.54 -49.17 22.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.775 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 17' ' ' VAL . 30.4 m -54.06 -42.67 56.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.716 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 50.9 mtmt -70.43 -38.92 74.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -56.66 -35.13 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HG2' HD11 ' A' ' 15' ' ' LEU . 88.3 tttt -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.871 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.571 HG23 ' CD1' ' A' ' 13' ' ' ILE . 59.4 mt -58.32 -36.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 41.4 tt0 -60.76 -50.97 71.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.922 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.88 -33.09 71.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.901 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 30.6 mmmt -69.41 -35.73 76.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.267 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -135.08 -66.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.959 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.59 -39.53 0.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.347 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.696 HG22 ' OE1' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -45.04 121.45 4.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 82.8 Cg_exo -46.41 147.46 4.08 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.097 2.531 . . . . 0.0 112.251 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 18.0 Cg_endo -59.41 -36.51 93.72 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.475 2.117 . . . . 0.0 112.298 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.08 -36.79 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.413 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.696 ' OE1' HG22 ' A' ' 36' ' ' ILE . 90.5 mt-30 -61.58 -36.24 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.421 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.76 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 99.6 mm-40 -51.3 122.03 7.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.749 ' H ' ' H ' ' B' ' 46' ' ' ALA . 87.2 mtm180 -85.11 121.27 27.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.648 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.468 HD22 HG22 ' B' ' 3' ' ' ILE . 8.9 mp -69.13 122.6 19.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.404 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 61.4 mt -143.64 132.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.765 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 39.1 m-85 -136.63 148.76 47.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.706 ' HB3' ' HE ' ' B' ' 42' ' ' ARG . . . -153.06 131.34 12.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.984 0.421 . . . . 0.0 111.55 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.241 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.74 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.4 ptm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.016 0.436 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.84 130.97 44.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.605 HG12 ' HG ' ' B' ' 15' ' ' LEU . 39.5 pt -102.31 143.13 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.32 129.37 35.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 45' ' ' PHE . 97.4 t -148.92 127.7 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 111.34 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -83.23 126.45 32.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.554 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -73.29 -157.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 54.1 mt -74.34 -49.83 21.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -74.28 -45.35 48.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.95 -31.33 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.773 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -47.05 129.88 12.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.691 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 40.7 m -82.63 143.97 30.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.48 ' CD1' HG23 ' B' ' 30' ' ' ILE . 28.7 pt -119.24 129.31 75.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.14 0.495 . . . . 0.0 112.079 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.63 128.0 46.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.07 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.605 ' HG ' HG12 ' B' ' 3' ' ' ILE . 2.5 pp -152.9 120.16 5.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.2 pt-20 -73.06 138.18 45.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.029 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.412 HG13 ' O ' ' B' ' 16' ' ' GLU . 2.2 m -157.65 137.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.416 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' B' ' 21' ' ' ASP . 92.6 mt-10 -53.99 139.34 53.8 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.19 -41.73 26.29 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.621 2.214 . . . . 0.0 111.799 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.604 ' O ' HG22 ' A' ' 22' ' ' THR . 60.9 m -64.14 -21.87 66.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.494 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.596 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.0 t70 -55.06 132.34 47.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 20' ' ' SER . 77.1 p -57.98 142.43 46.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.807 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.658 HG22 ' HE2' ' B' ' 27' ' ' LYS . 65.7 mt -54.74 -36.09 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.88 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.43 -36.86 85.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.443 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.596 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 53.4 m-20 -73.74 -50.05 22.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.426 HG13 ' OD1' ' B' ' 21' ' ' ASP . 19.6 m -53.75 -42.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.658 ' HE2' HG22 ' B' ' 23' ' ' ILE . 50.7 mtmt -70.58 -38.73 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.376 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.714 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -58.03 -28.67 64.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.496 ' HD3' HD13 ' B' ' 15' ' ' LEU . 87.4 tttt -74.66 -32.91 62.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 109.906 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.578 HG21 ' NE2' ' B' ' 41' ' ' GLN . 53.0 mt -61.9 -41.0 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.155 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.714 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 20.8 pt20 -63.91 -42.83 97.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -58.47 -34.29 70.71 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.4 mmmt -72.35 -33.09 67.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.924 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -136.96 -65.86 0.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 161.42 -34.77 0.38 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.37 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.653 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -48.78 122.75 11.26 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.525 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 84.2 Cg_exo -50.13 146.57 17.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.804 2.336 . . . . 0.0 111.897 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 18.4 Cg_endo -57.98 -38.28 92.67 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.529 2.153 . . . . 0.0 112.693 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.41 -37.26 86.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.468 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.653 ' OE1' HG22 ' B' ' 36' ' ' ILE . 85.5 mt-30 -61.38 -35.41 77.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.629 0.252 . . . . 0.0 111.482 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.765 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 6.1 mm-40 -54.6 124.55 16.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 110.876 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.706 ' HE ' ' HB3' ' A' ' 46' ' ' ALA . 87.0 mtm180 -85.93 123.24 31.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.832 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 3' ' ' ILE . 8.9 mp -70.57 123.14 21.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.199 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 61.5 mt -143.35 132.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 41.1 m-85 -136.9 148.38 47.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.591 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.749 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.15 134.75 15.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.024 0.44 . . . . 0.0 111.789 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.567 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 18.1 ptm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.017 0.437 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.407 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 18.7 pt20 -63.31 139.05 58.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 15' ' ' LEU . 32.0 pt -114.47 153.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -87.45 131.13 34.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.892 ' HB ' HG23 ' A' ' 13' ' ' ILE . 50.1 t -142.28 155.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 89.3 mttt -141.22 122.24 14.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 51.4 p -69.16 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.706 ' H ' HD12 ' A' ' 8' ' ' LEU . 4.1 mp -68.79 -46.51 68.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.785 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -83.44 26.8 0.63 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.107 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.88 37.1 83.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.594 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 22.0 ttmm -76.05 128.28 34.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.597 0.237 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -72.83 134.72 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.53 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.892 HG23 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -151.3 133.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.234 0.54 . . . . 0.0 112.233 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -97.64 149.63 22.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.509 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 3' ' ' ILE . 12.4 tp -155.83 113.19 3.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.0 pt-20 -81.53 130.22 34.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.268 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.574 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 5.6 m -156.72 131.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.495 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 25.4 pt-20 -55.55 141.59 63.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.84 -37.82 91.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.813 2.342 . . . . 0.0 112.313 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.411 ' O ' HG22 ' B' ' 22' ' ' THR . 62.8 m -63.67 -21.8 66.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' ' CG ' ' A' ' 18' ' ' GLU . 38.7 t70 -61.47 134.29 56.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.448 HG22 ' O ' ' B' ' 20' ' ' SER . 73.5 p -64.67 146.33 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.473 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.676 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 60.4 mt -55.43 -37.17 43.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.241 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 16.3 pt-20 -58.13 -35.62 71.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.209 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 m120 -75.12 -48.36 24.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.748 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG11 HD11 ' B' ' 23' ' ' ILE . 34.5 m -56.02 -42.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.561 0.219 . . . . 0.0 111.146 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 35.4 mtmm -69.8 -38.44 76.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.408 . . . . 0.0 110.569 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.21 77.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.638 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.574 ' NZ ' HG12 ' A' ' 17' ' ' VAL . 83.3 mttt -63.66 -38.29 90.55 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.509 HG22 HD11 ' A' ' 36' ' ' ILE . 72.8 mt -56.06 -34.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.731 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.421 ' OE1' ' HG3' ' A' ' 38' ' ' PRO . 20.7 mt-30 -61.52 -43.14 99.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -63.89 -39.82 95.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.26 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' HD11 ' A' ' 13' ' ' ILE . 67.4 mttm -78.08 3.4 15.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.124 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -169.05 -109.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.197 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.46 51.28 0.03 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.354 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.845 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -123.09 129.26 25.02 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.451 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.583 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 91.8 Cg_exo -45.84 150.09 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.997 2.465 . . . . 0.0 112.509 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 32.1 Cg_exo -57.15 -34.33 97.56 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.518 2.146 . . . . 0.0 112.07 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.96 -39.49 93.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.03 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.583 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 88.5 mt-30 -60.89 -36.64 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.257 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.693 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 4.1 mm-40 -53.07 122.73 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.807 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.685 ' H ' ' H ' ' B' ' 46' ' ' ALA . 79.5 mtp180 -91.38 121.31 33.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.488 HD12 HG22 ' B' ' 3' ' ' ILE . 8.0 mt -82.28 129.91 34.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.026 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 63.3 mt -143.14 140.77 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.948 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 42.0 m-85 -135.14 138.87 44.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.802 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.86 138.47 21.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 111.512 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.337 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.908 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.5 ptm . . . . . 0 C--O 1.23 0.038 0 CA-C-O 121.09 0.472 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.992 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.1 pt20 -62.28 142.75 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.665 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.4 pt -118.28 152.23 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.757 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -87.37 132.41 33.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' B' ' 13' ' ' ILE . 48.8 t -143.82 154.62 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.003 0.43 . . . . 0.0 111.349 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 57.9 mttp -139.04 123.22 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.186 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' B' ' 11' ' ' LYS . 56.2 p -72.72 -156.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.173 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.442 HD12 ' N ' ' B' ' 8' ' ' LEU . 6.5 mp -64.07 -50.91 66.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -82.8 28.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.335 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.02 36.66 68.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.485 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 21.6 ttmm -73.95 128.67 36.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 111.001 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -72.88 131.76 42.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.376 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.756 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -145.02 136.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.342 0.591 . . . . 0.0 111.85 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.992 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.3 OUTLIER -101.18 147.16 26.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.912 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.665 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.8 tt -157.62 114.13 2.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.153 0.502 . . . . 0.0 111.15 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.5 pt-20 -83.39 134.23 34.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.778 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.592 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 1.8 m -159.47 133.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' B' ' 21' ' ' ASP . 14.4 pt-20 -56.25 141.06 70.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.411 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.75 -37.86 95.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.921 2.414 . . . . 0.0 112.169 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 22' ' ' THR . 51.0 m -63.66 -24.45 67.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.715 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.561 ' HB2' ' HG3' ' B' ' 18' ' ' GLU . 63.2 t0 -58.95 133.46 56.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 20' ' ' SER . 76.8 p -64.12 146.86 53.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.637 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.681 HG22 ' NZ ' ' B' ' 27' ' ' LYS . 60.4 mt -56.07 -37.0 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.292 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.439 ' HG3' ' OD1' ' B' ' 25' ' ' ASN . 16.3 pt-20 -58.23 -36.54 73.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.363 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.504 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.1 m120 -74.88 -48.9 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.701 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 23' ' ' ILE . 34.4 m -55.12 -41.73 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.634 0.254 . . . . 0.0 111.017 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.681 ' NZ ' HG22 ' B' ' 23' ' ' ILE . 35.4 mtmm -70.21 -38.4 75.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.403 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.89 73.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.471 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.592 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 84.5 mttt -66.16 -37.22 85.12 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.807 HG22 HD11 ' B' ' 36' ' ' ILE . 67.8 mt -57.68 -32.12 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.643 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 21.8 mt-30 -61.58 -46.81 88.28 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.44 -33.89 77.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 71.9 mmtt -68.78 -18.08 64.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.435 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -157.72 -90.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.742 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.07 48.53 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.607 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.823 HD12 ' H ' ' B' ' 36' ' ' ILE . 0.4 OUTLIER -118.35 134.51 23.42 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.481 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 71.0 Cg_exo -51.57 147.64 22.82 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.771 2.314 . . . . 0.0 111.851 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.463 ' HG3' ' OE1' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -56.95 -34.44 97.37 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.448 2.098 . . . . 0.0 112.075 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.33 -35.03 78.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.561 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.758 ' OE1' HG22 ' B' ' 36' ' ' ILE . 82.6 mt-30 -66.96 -37.48 84.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.676 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.486 ' NE2' HD13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -52.26 126.93 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.788 0.327 . . . . 0.0 110.675 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.802 ' H ' ' H ' ' A' ' 46' ' ' ALA . 80.0 mtp180 -90.17 125.98 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.164 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 125.4 30.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 1.026 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 63.2 mt -143.25 138.82 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.408 . . . . 0.0 111.307 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 35.3 m-85 -136.93 140.26 42.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.685 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.02 136.4 17.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.605 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.216 179.747 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.646 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.6 ptt? . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.993 0.425 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.672 ' HB3' HG22 ' A' ' 14' ' ' THR . 57.5 mt-30 -66.49 111.23 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.69 HD11 HD23 ' A' ' 15' ' ' LEU . 44.7 pt -84.14 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.203 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -88.0 133.01 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.712 ' HB ' HG13 ' A' ' 13' ' ' ILE . 88.6 t -149.07 126.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -82.28 116.04 21.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.458 HG23 HG12 ' A' ' 13' ' ' ILE . 72.7 p -67.7 -159.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.432 . . . . 0.0 110.911 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 36' ' ' ILE . 1.3 mp -82.45 -44.63 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.72 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.9 t -73.15 -44.84 59.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.312 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 9' ' ' THR . . . 154.75 -39.96 0.64 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.998 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -51.86 135.12 30.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 111.565 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 p -81.18 138.65 35.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.6 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.712 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -96.4 129.33 46.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.672 HG22 ' HB3' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -96.76 137.0 36.51 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.69 HD23 HD11 ' A' ' 3' ' ' ILE . 2.0 tp -162.32 115.1 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 111.975 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 1' ' ' MET . 25.4 pt-20 -85.06 132.68 34.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.359 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 15' ' ' LEU . 6.9 m -157.27 139.76 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.747 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.64 144.03 89.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.431 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.94 -37.7 52.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.769 2.313 . . . . 0.0 112.159 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -63.13 -23.23 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.374 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -60.96 134.84 57.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 p -61.69 141.57 57.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.747 HG12 HG12 ' B' ' 23' ' ' ILE . 57.6 mt -53.83 -41.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.124 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -55.29 -39.99 70.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.334 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -66.34 -51.02 61.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.822 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 23' ' ' ILE . 11.5 m -60.08 -40.05 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.022 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.699 ' NZ ' ' HB2' ' A' ' 41' ' ' GLN . 29.5 mtpp -64.02 -43.7 94.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.37 -42.37 86.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.11 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HD2' HD11 ' A' ' 15' ' ' LEU . 39.5 ttmt -62.71 -36.5 83.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG23 HD12 ' A' ' 13' ' ' ILE . 62.8 mt -55.51 -37.05 43.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.478 ' CD ' ' HD3' ' A' ' 38' ' ' PRO . 34.8 mt-30 -58.83 -40.43 84.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.77 -39.83 95.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.649 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 33' ' ' LYS . 4.8 mmmp? -61.22 -40.0 92.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.71 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.35 -89.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.442 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 45.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -122.68 126.43 26.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 65.8 Cg_exo -43.13 141.7 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.089 2.526 . . . . 0.0 112.706 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 28.0 Cg_endo -62.14 -33.84 80.87 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.641 2.227 . . . . 0.0 112.125 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.482 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 74.4 mt-30 -63.33 -39.92 95.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.581 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.699 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 6.6 mm100 -53.06 132.26 37.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.816 ' H ' ' H ' ' B' ' 46' ' ' ALA . 22.1 tpp180 -107.53 119.67 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.34 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.88 126.79 30.19 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.158 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.83 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.9 mt -144.21 123.25 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.672 ' HB2' HG22 ' B' ' 5' ' ' VAL . 4.0 m-85 -121.84 148.6 44.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.425 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.749 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.64 130.28 14.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 0.0 111.916 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.394 179.313 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.1 ptt? . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.54 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 4.4 pt20 -65.4 110.72 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.302 0.572 . . . . 0.0 110.868 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' B' ' 15' ' ' LEU . 37.4 pt -76.99 141.04 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.08 131.29 34.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' B' ' 13' ' ' ILE . 98.4 t -149.04 124.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 111.353 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -82.49 120.53 25.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.253 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -69.96 -160.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.534 HD11 ' CG2' ' B' ' 36' ' ' ILE . 6.3 mp -82.14 -42.87 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.409 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -71.58 -44.79 63.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.409 ' N ' HG23 ' B' ' 9' ' ' THR . . . 152.91 -39.66 0.72 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.036 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -52.04 134.95 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 111.961 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -82.12 142.71 32.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.021 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.677 HG13 ' HB ' ' B' ' 5' ' ' VAL . 11.4 pt -114.15 122.86 69.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.308 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -87.51 148.67 24.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.67 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.596 ' C ' HD23 ' B' ' 15' ' ' LEU . 5.3 tt -162.94 112.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.429 . . . . 0.0 110.659 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' B' ' 1' ' ' MET . 14.5 pt-20 -82.78 132.16 35.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.821 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.588 HG21 HG22 ' B' ' 26' ' ' VAL . 2.4 m -159.44 139.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.617 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.86 142.75 88.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.452 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.466 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 26.3 Cg_endo -60.22 -37.24 84.49 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.878 2.385 . . . . 0.0 112.141 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.8 m -63.63 -26.48 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.659 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -56.64 135.26 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.343 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -61.87 142.27 57.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.747 HG12 HG12 ' A' ' 23' ' ' ILE . 58.8 mt -54.61 -40.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.16 -44.46 75.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.271 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -64.13 -47.95 77.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.588 HG22 HG21 ' B' ' 17' ' ' VAL . 24.6 t -56.34 -45.17 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.224 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.668 ' NZ ' ' HB2' ' B' ' 41' ' ' GLN . 28.2 mtpp -66.25 -41.16 90.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.203 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.97 83.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.58 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.453 ' CG ' HD11 ' B' ' 15' ' ' LEU . 39.2 ttmt -63.41 -34.89 78.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.397 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 26' ' ' VAL . 59.2 mt -58.19 -35.69 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.274 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 35.1 mt-30 -60.48 -47.74 84.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.66 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.687 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' B' ' 33' ' ' LYS . 22.8 tptp -65.65 -32.57 74.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.931 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.3 tp10 -144.89 -68.25 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.684 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.89 47.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.737 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.742 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -124.94 128.88 24.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.5 0.19 . . . . 0.0 111.394 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 54.2 Cg_exo -51.77 138.35 50.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.341 2.028 . . . . 0.0 111.554 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' CD ' ' B' ' 31' ' ' GLN . 19.0 Cg_endo -58.88 -34.0 98.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.577 2.185 . . . . 0.0 112.202 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.84 -39.15 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.643 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.742 ' OE1' HG22 ' B' ' 36' ' ' ILE . 84.1 mt-30 -65.79 -38.21 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.668 ' HB2' ' NZ ' ' B' ' 27' ' ' LYS . 0.7 OUTLIER -54.31 133.78 45.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.749 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.1 tpp180 -108.49 121.79 45.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 3' ' ' ILE . 10.8 mp -68.94 127.41 33.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.189 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.83 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -144.14 122.44 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.034 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.67 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.1 m-85 -120.97 146.03 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.816 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -148.25 128.9 14.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 111.696 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.302 179.526 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 1' ' ' MET . 15.1 tpt . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.209 0.528 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.429 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 20.8 pt20 -61.72 127.34 30.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.672 HD12 HD11 ' A' ' 30' ' ' ILE . 28.8 pt -95.47 132.44 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.576 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -88.83 128.77 35.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.756 HG21 HD13 ' A' ' 30' ' ' ILE . 63.4 t -148.49 138.49 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.151 0.501 . . . . 0.0 112.242 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -99.44 127.71 45.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.725 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.569 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 73.1 p -68.49 -156.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 111.302 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.729 ' H ' HD12 ' A' ' 8' ' ' LEU . 2.7 mp -64.36 -51.15 64.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -78.61 -45.73 20.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.866 0.365 . . . . 0.0 111.067 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 28.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.315 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 15.8 tppt? -77.37 122.65 25.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 m -75.38 138.71 41.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.557 HG13 ' HB ' ' A' ' 5' ' ' VAL . 12.4 pt -140.07 128.69 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.215 0.531 . . . . 0.0 112.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -97.37 145.99 25.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.67 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 3' ' ' ILE . 5.8 tt -163.94 114.05 1.27 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.04 0.448 . . . . 0.0 110.656 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' HG13 ' A' ' 17' ' ' VAL . 11.9 pt-20 -79.4 138.1 37.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -159.46 137.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.84 135.45 89.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -35.93 76.77 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 111.749 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' HG23 ' B' ' 22' ' ' THR . 45.0 t -63.77 -29.18 70.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.11 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.52 135.27 50.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.249 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.549 HG23 ' O ' ' B' ' 20' ' ' SER . 21.4 m -59.68 148.84 32.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 111.482 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 64.3 mt -60.34 -43.44 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.226 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.521 ' HG2' ' CG2' ' A' ' 22' ' ' THR . 12.6 pt-20 -59.25 -30.46 68.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.534 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 21.1 m-20 -71.26 -52.25 20.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 23' ' ' ILE . 34.4 m -59.97 -40.98 84.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.43 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 58.4 mtpt -62.39 -42.79 99.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -57.93 -34.8 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.349 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.3 mttm -66.6 -45.56 78.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.053 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.756 HD13 HG21 ' A' ' 5' ' ' VAL . 79.0 mt -55.15 -36.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 45.8 tt0 -61.92 -49.5 75.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.085 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -62.09 -32.27 72.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.058 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HG3' HD12 ' A' ' 15' ' ' LEU . 30.7 mmmt -68.49 -36.46 78.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.215 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.37 -67.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.789 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.33 -35.22 0.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.427 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.65 HG22 ' OE1' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.73 122.55 4.63 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.577 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 89.2 Cg_exo -47.22 147.07 5.95 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.161 2.574 . . . . 0.0 112.469 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.98 -35.62 98.27 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.463 2.109 . . . . 0.0 111.993 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -61.69 -38.34 87.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.65 ' OE1' HG22 ' A' ' 36' ' ' ILE . 88.5 mt-30 -65.72 -44.03 87.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.0 mt-30 -54.69 125.67 20.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.951 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.733 ' H ' ' H ' ' B' ' 46' ' ' ALA . 70.6 mtt-85 -97.36 127.99 43.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.524 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.57 HD23 HG22 ' B' ' 3' ' ' ILE . 10.8 tp -75.07 128.91 36.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.843 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 66.2 mt -143.5 139.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.935 0.397 . . . . 0.0 111.885 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 4.2 m-85 -128.19 147.72 50.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.697 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.4 124.66 5.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 111.596 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' HA2' ' C ' ' B' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.243 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.538 ' O ' ' HG3' ' B' ' 1' ' ' MET . 14.2 tpt . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.247 0.546 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.673 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.6 pt20 -61.81 126.62 27.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.549 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.747 HD11 HD23 ' B' ' 15' ' ' LEU . 29.8 pt -95.62 133.39 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.92 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.36 129.63 35.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.728 HG21 HD13 ' B' ' 30' ' ' ILE . 61.0 t -147.8 143.97 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.053 0.454 . . . . 0.0 112.086 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -104.97 126.6 52.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.825 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -69.53 -156.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.868 0.366 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.444 HD12 ' N ' ' B' ' 8' ' ' LEU . 5.6 mp -59.96 -57.17 14.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -74.86 -45.49 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.64 30.59 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.003 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -82.43 130.99 35.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.408 . . . . 0.0 111.011 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -75.72 131.16 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.234 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.705 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -118.54 130.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.854 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.673 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -104.25 135.15 46.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.573 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.747 HD23 HD11 ' B' ' 3' ' ' ILE . 3.9 tp -161.35 113.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.169 0.509 . . . . 0.0 111.705 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.78 142.4 38.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.703 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.748 HG21 HG12 ' B' ' 26' ' ' VAL . 12.3 p -165.42 135.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -54.64 133.27 64.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.868 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.528 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 11.1 Cg_endo -55.94 -36.63 96.05 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.871 2.381 . . . . 0.0 111.843 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 22' ' ' THR . 46.1 t -63.74 -27.81 69.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -56.15 135.42 53.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 20' ' ' SER . 23.4 m -58.24 150.27 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.492 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.559 ' O ' HG22 ' B' ' 26' ' ' VAL . 64.2 mt -62.3 -43.92 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.546 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HG2' ' CG2' ' B' ' 22' ' ' THR . 12.5 pt-20 -57.4 -33.19 67.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.649 0.261 . . . . 0.0 111.195 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 29.5 m120 -73.05 -50.21 24.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.409 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.748 HG12 HG21 ' B' ' 17' ' ' VAL . 33.0 m -58.66 -38.06 69.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 59.0 mtpt -65.96 -43.64 87.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.044 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -59.31 -25.69 64.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.628 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 53.9 mttm -74.12 -39.79 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 109.918 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.728 HD13 HG21 ' B' ' 5' ' ' VAL . 69.4 mt -59.59 -41.74 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.283 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 21.8 pt20 -65.43 -40.18 92.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.33 -32.48 72.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.6 mmmt -73.92 -31.44 63.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.769 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -135.55 -67.19 0.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 151.85 -25.88 0.92 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.163 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.688 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -51.13 123.58 20.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.553 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -52.39 144.93 38.31 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.804 2.336 . . . . 0.0 111.85 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.48 -35.49 96.69 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.501 2.134 . . . . 0.0 112.246 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' B' ' 40' ' ' GLN . 2.5 p30 -62.15 -38.6 89.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.189 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.688 ' OE1' HG22 ' B' ' 36' ' ' ILE . 88.0 mt-30 -66.55 -41.63 88.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.437 ' OE1' HD12 ' B' ' 30' ' ' ILE . 71.3 mt-30 -56.77 130.93 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.697 ' H ' ' H ' ' A' ' 46' ' ' ALA . 71.6 mtt-85 -106.48 133.08 51.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.973 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.415 HD12 HG22 ' A' ' 3' ' ' ILE . 23.3 mt -76.61 131.83 39.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.896 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.843 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 65.4 mt -143.75 128.93 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.7 m-85 -121.45 142.41 50.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.733 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.44 125.66 9.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.048 0.452 . . . . 0.0 111.593 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.513 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.012 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.105 0.479 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.863 ' HB2' HG22 ' A' ' 14' ' ' THR . 20.0 pt20 -66.58 110.59 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.295 0.569 . . . . 0.0 111.083 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 15' ' ' LEU . 18.8 pt -77.44 140.99 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.774 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -89.5 131.97 35.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.949 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 13' ' ' ILE . 2.3 p -149.86 135.04 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.804 0.335 . . . . 0.0 111.383 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -100.11 131.19 46.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.619 HG22 ' HG3' ' A' ' 34' ' ' GLU . 74.6 p -67.21 -158.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.735 0.302 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 36' ' ' ILE . 4.8 mp -89.28 -46.85 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 10' ' ' GLY . 6.0 t -72.05 -45.15 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 9' ' ' THR . . . 158.58 -31.37 0.47 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.927 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 12' ' ' THR . 7.0 tmtm? -45.48 126.95 7.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.905 0.384 . . . . 0.0 110.748 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.518 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 66.9 m -83.24 138.02 33.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.787 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.59 HG13 ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -118.8 139.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.863 HG22 ' HB2' ' A' ' 2' ' ' GLN . 6.8 m -127.37 137.99 52.9 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 3' ' ' ILE . 4.0 tt -159.82 121.97 3.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.048 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 22.8 pt-20 -72.13 143.42 48.98 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.75 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.584 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -158.36 140.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.414 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.34 143.24 90.44 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.086 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.85 -37.63 95.59 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.811 2.341 . . . . 0.0 112.14 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -64.17 -31.84 73.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.852 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -56.2 130.69 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.569 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -63.5 147.7 50.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.74 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.704 HG21 HD11 ' A' ' 43' ' ' LEU . 65.5 mt -54.58 -37.9 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.253 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.06 -31.7 72.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -74.62 -49.33 21.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.669 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG12 HG11 ' A' ' 17' ' ' VAL . 26.8 m -57.15 -42.63 80.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.162 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtmt -67.15 -37.71 84.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.464 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.497 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . . . -53.7 -36.86 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.262 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.584 ' NZ ' HG12 ' A' ' 17' ' ' VAL . 80.5 mttt -69.13 -42.55 75.86 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.648 HG22 HD11 ' A' ' 36' ' ' ILE . 61.4 mt -57.93 -30.35 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.571 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 15.6 mt-30 -60.83 -44.53 96.82 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.722 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HE3' HD12 ' A' ' 15' ' ' LEU . 72.5 mmtt -61.52 -29.17 69.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.621 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.619 ' HG3' HG22 ' A' ' 7' ' ' THR . 58.6 mm-40 -146.78 -84.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.88 43.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.079 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.684 HG22 ' OE1' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -113.28 124.04 32.22 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.64 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 56.8 Cg_exo -41.78 143.78 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.994 2.463 . . . . 0.0 112.334 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 11.8 Cg_endo -57.21 -35.53 98.91 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.494 2.129 . . . . 0.0 112.066 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -64.51 -39.65 94.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.683 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.684 ' OE1' HG22 ' A' ' 36' ' ' ILE . 90.1 mt-30 -60.22 -39.87 88.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.464 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.563 ' OE1' HD12 ' A' ' 30' ' ' ILE . 70.7 mt-30 -61.15 119.81 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.93 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 22.5 tpp180 -90.44 128.49 36.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.704 HD11 HG21 ' A' ' 23' ' ' ILE . 21.7 mt -80.82 136.24 36.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 111.01 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.97 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.1 mt -143.27 126.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.959 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.659 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 1.9 m-85 -116.48 142.08 47.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.7 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -145.13 123.23 12.12 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.992 0.425 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.311 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.819 179.748 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.54 ' O ' ' HG2' ' B' ' 1' ' ' MET . 28.2 ttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.13 0.49 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.942 ' HB2' HG22 ' B' ' 14' ' ' THR . 21.6 pt20 -62.27 110.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 43' ' ' LEU . 13.7 pt -80.09 140.74 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.105 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -89.12 130.13 35.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.012 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 1.076 HG13 HG13 ' B' ' 13' ' ' ILE . 1.6 p -150.07 131.52 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.335 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -93.38 131.58 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.599 HG22 ' HG3' ' B' ' 34' ' ' GLU . 74.1 p -68.44 -157.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 111.263 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.427 HD11 HG23 ' B' ' 36' ' ' ILE . 1.2 mt -85.96 -48.89 8.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.055 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.413 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.7 t -74.69 -45.2 46.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.827 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.413 ' N ' HG23 ' B' ' 9' ' ' THR . . . 159.49 -30.73 0.42 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.732 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' B' ' 12' ' ' THR . 7.3 tmtm? -45.65 127.87 8.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.97 0.414 . . . . 0.0 110.767 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' THR . . . . . 0.505 ' N ' ' HD3' ' B' ' 11' ' ' LYS . 34.0 m -84.46 140.55 31.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.687 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 1.076 HG13 HG13 ' B' ' 5' ' ' VAL . 7.1 pt -134.67 140.62 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.022 0.439 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.942 HG22 ' HB2' ' B' ' 2' ' ' GLN . 4.1 m -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.727 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.491 ' C ' ' HA ' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -153.94 134.92 13.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 12.5 pt-20 -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.174 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.561 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 7.5 m -154.81 137.47 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.064 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 4.5 mm-40 -69.74 143.66 92.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.29 -35.82 98.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.778 2.319 . . . . 0.0 112.232 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.5 t -63.88 -31.5 72.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.986 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 49.7 m-20 -57.49 130.33 45.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.652 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -62.9 147.39 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.693 HG21 HD11 ' B' ' 43' ' ' LEU . 65.9 mt -53.28 -37.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -62.42 -32.61 73.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -73.39 -49.22 28.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.687 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 23' ' ' ILE . 28.2 m -57.86 -42.85 83.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.64 0.257 . . . . 0.0 111.158 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' B' ' 31' ' ' GLN . 51.8 mtmt -66.42 -37.25 84.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.508 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HA ' ' CD ' ' B' ' 31' ' ' GLN . . . -54.9 -37.48 66.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.561 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 78.9 mttt -67.63 -42.22 82.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.529 HG22 HD11 ' B' ' 36' ' ' ILE . 62.8 mt -58.45 -30.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.594 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.579 ' OE1' ' HD3' ' B' ' 38' ' ' PRO . 16.3 mt-30 -61.2 -45.57 94.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.61 -35.87 82.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.772 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 72.5 mmtt -61.01 -29.32 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.523 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.599 ' HG3' HG22 ' B' ' 7' ' ' THR . 57.4 mm-40 -147.41 -81.15 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.2 44.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.751 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.765 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -112.96 124.44 31.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.616 0.246 . . . . 0.0 111.479 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.638 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 97.1 Cg_exo -44.78 143.66 4.09 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.818 2.346 . . . . 0.0 112.043 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 11.6 Cg_endo -56.65 -35.74 97.62 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.194 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -64.99 -39.24 93.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.765 ' OE1' HG22 ' B' ' 36' ' ' ILE . 89.1 mt-30 -61.56 -39.76 92.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.468 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.519 ' OE1' HD12 ' B' ' 30' ' ' ILE . 70.5 mt-30 -59.72 124.41 20.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.532 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.4 tpp180 -95.43 123.47 38.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.73 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.693 HD11 HG21 ' B' ' 23' ' ' ILE . 27.1 mt -75.49 135.31 40.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.088 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.97 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 71.7 mt -143.39 124.99 11.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.578 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.2 m-85 -115.64 146.52 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.584 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.5 129.59 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.529 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.524 179.754 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.556 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.8 tpt . . . . . 0 CA--C 1.532 0.275 0 CA-C-O 121.062 0.458 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 pt20 -61.18 111.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.183 0.516 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 15' ' ' LEU . 24.6 pt -75.56 132.86 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.98 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -89.08 131.56 35.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.797 ' HB ' HG13 ' A' ' 13' ' ' ILE . 64.9 t -143.79 131.39 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 111.665 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.72 123.46 35.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.184 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -70.48 -157.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 36' ' ' ILE . 2.3 mm? -82.37 -48.13 11.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.778 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -73.18 -45.28 57.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.02 -31.64 0.5 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.881 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.66 130.08 11.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.985 0.421 . . . . 0.0 111.757 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 m -90.76 145.01 25.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.753 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.797 HG13 ' HB ' ' A' ' 5' ' ' VAL . 2.3 pt -119.44 126.64 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.68 132.04 43.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 3' ' ' ILE . 9.0 tp -153.59 113.18 3.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.157 0.503 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 39.3 tt0 -70.3 133.9 47.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.501 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 1' ' ' MET . 16.2 m -154.26 137.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.33 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 4.5 mm-40 -72.05 139.72 82.62 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.229 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.31 -38.0 61.37 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.817 2.345 . . . . 0.0 111.751 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 t -64.06 -33.68 76.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.017 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 36.3 m-20 -55.23 130.89 43.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.98 0.419 . . . . 0.0 110.627 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.4 p -59.49 146.79 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.905 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.615 HG21 HD11 ' A' ' 43' ' ' LEU . 63.3 mt -57.91 -29.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.022 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.02 -37.32 85.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 50.3 m-20 -72.1 -46.83 55.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 23' ' ' ILE . 32.7 m -58.35 -41.69 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.961 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HZ2' ' HB2' ' A' ' 41' ' ' GLN . 68.1 mttm -66.7 -40.79 88.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 0.0 110.606 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . . . -53.55 -40.29 65.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.406 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB2' HD21 ' A' ' 15' ' ' LEU . 50.0 mttm -64.74 -41.36 96.0 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.991 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.459 HG23 ' CD1' ' A' ' 13' ' ' ILE . 67.4 mt -57.46 -35.93 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 34.7 mt-30 -61.45 -45.63 93.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.011 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -64.65 -31.69 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.725 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -144.89 -67.2 0.32 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 48.97 0.06 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.972 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.67 HG21 HD21 ' A' ' 8' ' ' LEU . 2.3 pt -125.05 129.03 24.68 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.553 ' HD2' ' CD ' ' A' ' 40' ' ' GLN . 95.2 Cg_exo -45.88 140.67 9.69 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.793 2.329 . . . . 0.0 112.242 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD3' ' CD ' ' A' ' 31' ' ' GLN . 17.3 Cg_endo -58.57 -32.62 96.99 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.429 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.37 -36.51 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.553 ' CD ' ' HD2' ' A' ' 37' ' ' PRO . 87.0 mt-30 -60.02 -45.64 92.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.549 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.742 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -58.8 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 111.144 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.731 ' H ' ' H ' ' B' ' 46' ' ' ALA . 72.2 mtt-85 -97.44 128.89 44.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 23' ' ' ILE . 27.1 mt -78.62 131.4 36.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 0.0 111.448 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 66.4 mt -143.97 127.5 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.626 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 0.5 OUTLIER -115.35 145.09 42.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.389 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -152.22 122.88 7.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.921 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.607 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.6 tpt . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 121.25 0.547 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.605 ' HB2' HG22 ' B' ' 14' ' ' THR . 16.3 pt20 -61.32 110.44 1.42 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.637 HG12 ' O ' ' B' ' 15' ' ' LEU . 21.2 pt -76.74 131.43 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.069 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.26 132.91 34.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' B' ' 13' ' ' ILE . 66.3 t -145.08 131.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.757 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.26 123.5 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.196 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -71.05 -157.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.286 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.567 HD22 ' N ' ' B' ' 8' ' ' LEU . 2.6 mm? -81.15 -49.83 10.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -72.19 -45.35 60.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.575 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.61 -31.42 0.52 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.769 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.58 128.58 10.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.997 0.427 . . . . 0.0 111.627 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 42.9 m -89.46 139.3 30.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.615 HG13 ' HB ' ' B' ' 5' ' ' VAL . 13.4 pt -113.75 127.25 71.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 112.022 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.605 HG22 ' HB2' ' B' ' 2' ' ' GLN . 1.8 m -96.37 137.15 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.637 ' O ' HG12 ' B' ' 3' ' ' ILE . 5.0 tt -158.3 114.65 2.78 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.614 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 40.7 tt0 -71.91 138.6 48.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.609 HG13 ' CD2' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -158.92 134.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.181 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.69 137.64 95.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 10.2 Cg_endo -52.69 -37.9 75.98 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.847 2.365 . . . . 0.0 112.068 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.0 -30.97 72.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.306 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -55.4 134.16 50.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.855 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -61.19 146.34 47.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.664 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.495 ' O ' HG22 ' B' ' 26' ' ' VAL . 63.8 mt -57.86 -30.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.128 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -65.83 -36.65 84.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.905 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 52.7 m-20 -72.29 -47.13 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.264 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 23' ' ' ILE . 32.9 m -58.02 -41.45 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.935 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.473 ' HZ2' ' HB2' ' B' ' 41' ' ' GLN . 68.1 mttm -66.6 -39.98 88.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.927 0.394 . . . . 0.0 110.619 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.429 ' HA ' ' OE1' ' B' ' 31' ' ' GLN . . . -53.44 -42.29 66.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.277 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.553 ' HB2' HD11 ' B' ' 15' ' ' LEU . 45.5 mttm -64.29 -42.8 96.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.042 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' B' ' 36' ' ' ILE . 67.3 mt -55.26 -35.86 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.849 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 34.0 mt-30 -62.26 -42.16 99.08 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.93 -35.27 79.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.405 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 17.1 mmtp -60.43 -37.83 82.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.564 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -141.52 -60.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.297 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.59 45.16 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.779 HD12 ' H ' ' B' ' 36' ' ' ILE . 0.2 OUTLIER -112.13 130.63 23.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.56 0.219 . . . . 0.0 111.544 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.439 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 62.9 Cg_exo -51.97 139.6 50.83 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.434 2.09 . . . . 0.0 111.744 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.5 ' HD3' ' CD ' ' B' ' 31' ' ' GLN . 15.1 Cg_endo -57.22 -32.21 92.91 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.6 -35.93 82.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.698 ' OE1' HG22 ' B' ' 36' ' ' ILE . 83.0 mt-30 -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.703 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -60.07 124.48 20.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.319 . . . . 0.0 110.711 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.689 ' H ' ' H ' ' A' ' 46' ' ' ALA . 72.5 mtt-85 -91.69 126.65 36.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.053 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.572 HD23 ' CG2' ' A' ' 3' ' ' ILE . 10.5 tp -80.28 129.89 34.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.939 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 69.8 mt -143.64 136.98 24.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -121.37 146.71 46.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.471 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.731 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.5 123.91 6.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.357 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--N 1.331 0.262 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.899 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.951 0.405 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.04 125.0 25.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.506 HG12 ' HG ' ' A' ' 15' ' ' LEU . 32.3 pt -91.91 139.27 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.493 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.67 130.14 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.735 ' HB ' HG13 ' A' ' 13' ' ' ILE . 44.8 t -145.24 133.81 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -93.06 120.61 33.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.2 p -72.48 -157.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.738 0.304 . . . . 0.0 111.395 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.502 HD21 HG23 ' A' ' 36' ' ' ILE . 31.6 mt -80.6 -51.47 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.044 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.8 t -69.01 -45.17 71.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.593 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 9' ' ' THR . . . 153.89 -34.12 0.74 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.761 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -49.27 130.33 19.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.59 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -80.15 146.85 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.349 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.735 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.0 pt -126.05 129.53 72.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.775 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 p -107.85 142.65 37.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.422 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 15' ' ' LEU . 2.8 pp -165.41 122.32 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 1' ' ' MET . 11.4 pt-20 -75.71 140.97 42.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.427 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.418 HG13 ' CD1' ' A' ' 15' ' ' LEU . 3.4 m -153.21 133.53 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.162 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -59.74 138.83 90.07 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.074 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.25 -39.07 92.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.937 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 t -64.15 -30.57 71.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.122 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' HG23 ' A' ' 26' ' ' VAL . 38.0 t70 -54.6 136.28 45.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.618 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -64.96 144.46 57.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.557 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 67.3 mt -55.85 -38.69 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -56.18 -44.93 79.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.046 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.2 m120 -65.43 -46.35 80.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.492 HG21 HD11 ' B' ' 23' ' ' ILE . 6.5 t -53.61 -48.62 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.162 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.692 ' HE3' ' HB3' ' A' ' 38' ' ' PRO . 51.5 mtmt -68.62 -35.4 77.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.29 71.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.458 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 25.5 mmmt -62.09 -43.75 98.16 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.334 0.588 . . . . 0.0 109.582 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.607 HD12 ' OE1' ' A' ' 41' ' ' GLN . 62.2 mt -57.16 -35.9 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.748 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 35.4 mt-30 -58.97 -43.97 91.46 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.25 -37.5 83.61 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.942 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 28.9 mtpp -76.8 3.45 11.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.815 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -169.22 -102.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.145 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.71 49.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.422 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.772 ' H ' HD12 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -121.99 127.17 26.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.64 0.257 . . . . 0.0 111.437 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 79.0 Cg_exo -48.89 144.3 15.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.219 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.692 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -56.45 -37.74 96.64 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.569 2.18 . . . . 0.0 112.406 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.82 -38.88 92.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.309 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.69 ' OE1' HG22 ' A' ' 36' ' ' ILE . 84.2 mt-30 -63.54 -39.45 94.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.607 ' OE1' HD12 ' A' ' 30' ' ' ILE . 71.3 mt-30 -59.75 110.79 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -81.88 130.82 35.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.321 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.513 ' HB2' HG22 ' B' ' 3' ' ' ILE . 33.0 mt -80.05 135.7 36.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 81.0 mt -143.28 133.84 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.35 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.831 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 6.8 m-85 -127.53 140.98 51.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.813 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -151.63 126.05 9.42 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.093 0.473 . . . . 0.0 111.843 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.302 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.729 179.809 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.2 ptm . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.866 0.365 . . . . 0.0 111.519 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.731 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.4 pt20 -67.3 127.91 34.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.226 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.622 HG12 ' O ' ' B' ' 15' ' ' LEU . 24.2 pt -97.35 136.69 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.975 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -89.97 126.82 35.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.122 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.936 HG13 HG13 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.45 132.55 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.999 0.428 . . . . 0.0 111.5 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -84.83 129.7 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.074 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.502 HG23 HG12 ' B' ' 13' ' ' ILE . 77.9 p -77.54 -157.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.163 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.402 ' H ' ' HB ' ' B' ' 7' ' ' THR . 53.6 mt -81.42 -50.76 9.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.197 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.425 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -71.33 -45.26 63.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.693 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.425 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.88 -35.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.841 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -48.61 130.47 17.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.342 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 62.1 m -82.48 134.17 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.141 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.936 HG13 HG13 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -100.76 131.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 111.624 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.731 HG22 ' HB2' ' B' ' 2' ' ' GLN . 1.3 m -105.27 134.23 48.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.622 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -162.53 115.04 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -178.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.5 pt-20 -78.39 140.26 38.73 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.196 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.03 136.2 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.242 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -59.91 140.07 90.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.077 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 12.9 Cg_endo -56.75 -40.01 87.34 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.799 2.333 . . . . 0.0 112.032 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.7 t -64.08 -29.78 70.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.118 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -56.15 136.02 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.61 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 71.1 p -65.07 145.81 55.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.697 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.591 ' O ' HG22 ' B' ' 26' ' ' VAL . 66.8 mt -55.84 -39.04 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.7 -40.0 74.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.17 -49.28 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 23' ' ' ILE . 15.7 m -57.24 -41.44 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.707 ' HE3' ' HB3' ' B' ' 38' ' ' PRO . 50.3 mtmt -69.82 -38.63 76.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 110.818 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.447 ' HA ' ' OE1' ' B' ' 31' ' ' GLN . . . -54.44 -41.52 69.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.737 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -68.26 -37.77 81.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.209 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.634 HG22 HD11 ' B' ' 36' ' ' ILE . 63.0 mt -57.62 -34.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.494 ' OE1' ' HG3' ' B' ' 38' ' ' PRO . 35.4 mt-30 -60.65 -41.41 94.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -67.23 -37.76 84.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.752 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -78.0 3.24 15.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.637 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -168.53 -106.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 50.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.812 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.634 HD11 HG22 ' B' ' 30' ' ' ILE . 0.7 OUTLIER -126.57 119.89 23.09 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.575 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 35.5 Cg_exo -38.89 146.3 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.296 2.664 . . . . 0.0 112.982 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.707 ' HB3' ' HE3' ' B' ' 27' ' ' LYS . 33.6 Cg_exo -58.83 -38.14 90.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.665 2.244 . . . . 0.0 112.646 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.56 -39.2 90.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.593 ' OE1' HG22 ' B' ' 36' ' ' ILE . 86.6 mt-30 -60.16 -44.99 94.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.391 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.831 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 71.4 mt-30 -54.37 115.75 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.982 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.813 ' H ' ' H ' ' A' ' 46' ' ' ALA . 56.2 ttp180 -87.49 124.3 33.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.818 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 3' ' ' ILE . 44.1 mt -72.87 133.34 44.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.968 0.414 . . . . 0.0 111.121 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 74.8 mt -143.51 131.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.466 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.582 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.7 m-85 -127.19 148.05 50.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.762 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.91 132.39 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.308 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.262 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.52 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.6 ptm . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.211 0.529 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.489 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 10.8 tt0 -72.63 134.63 45.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.492 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.658 HG12 ' O ' ' A' ' 15' ' ' LEU . 29.5 pt -117.6 145.3 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.027 0.442 . . . . 0.0 112.067 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.2 m-85 -89.3 133.91 34.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.761 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.745 ' HB ' HG12 ' A' ' 13' ' ' ILE . 92.3 t -144.91 136.64 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.136 0.493 . . . . 0.0 111.781 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 40.4 ttmt -91.47 134.41 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.499 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -71.43 -157.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.515 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.446 HD21 HG23 ' A' ' 36' ' ' ILE . 38.7 mt -65.37 -63.91 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.7 t -77.57 -45.18 26.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 9' ' ' THR . . . 155.49 108.05 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.329 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 24.2 ttmm -167.19 127.84 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.724 0.297 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -73.27 133.39 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.745 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.1 pt -135.44 135.54 51.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.489 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 3.3 p -90.43 144.43 25.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.069 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.658 ' O ' HG12 ' A' ' 3' ' ' ILE . 10.7 tp -160.58 114.05 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.216 0.532 . . . . 0.0 111.76 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.6 pt-20 -85.35 132.45 34.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.671 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -151.06 142.96 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.356 . . . . 0.0 111.141 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HB2' ' CG ' ' A' ' 21' ' ' ASP . 42.0 mt-10 -67.43 137.44 93.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.3 -36.14 88.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.807 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.475 ' O ' HG22 ' B' ' 22' ' ' THR . 79.8 p -64.44 -27.86 69.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.357 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 51.6 m-20 -58.96 133.1 55.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.686 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.418 HG22 ' O ' ' B' ' 20' ' ' SER . 59.3 p -63.06 145.95 54.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.695 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 56.1 mt -53.54 -38.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.44 -39.91 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.103 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -67.39 -48.81 66.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.646 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -61.34 -43.87 97.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.317 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.695 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 36.3 mtmm -62.6 -43.8 97.91 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.9 0.381 . . . . 0.0 110.044 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 31' ' ' GLN . . . -60.43 -29.25 68.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.451 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' NZ ' ' NZ ' ' A' ' 33' ' ' LYS . 26.2 tptp -64.85 -43.03 94.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.744 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.546 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 51.3 mt -57.28 -31.83 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.723 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' NE2' ' HA ' ' A' ' 37' ' ' PRO . 75.3 mt-30 -58.16 -48.01 81.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -61.32 -36.89 81.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.826 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 38.6 mmtm -67.49 -24.21 65.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.135 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -153.16 -90.0 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.092 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.78 61.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.888 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.754 HG22 ' OE1' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -139.54 118.27 8.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.559 0.218 . . . . 0.0 111.549 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.598 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 54.8 Cg_exo -40.27 146.03 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.152 2.568 . . . . 0.0 112.822 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.675 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 19.8 Cg_endo -60.04 -36.0 90.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.818 2.345 . . . . 0.0 112.61 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.44 -38.86 85.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.754 ' OE1' HG22 ' A' ' 36' ' ' ILE . 79.1 mt-30 -64.1 -40.49 96.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.244 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 1.1 mm-40 -52.44 126.94 20.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.192 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.743 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.5 mtt180 -94.85 124.77 39.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.235 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.458 ' HB2' HG22 ' B' ' 3' ' ' ILE . 64.1 mt -78.35 132.03 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.384 . . . . 0.0 111.0 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.966 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 74.5 mt -143.57 131.96 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.539 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.662 ' O ' HG13 ' B' ' 5' ' ' VAL . 4.8 m-85 -126.36 147.12 49.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.6 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.7 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.39 128.04 7.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 111.703 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.26 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.972 179.972 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.1 ptm . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.983 ' HB3' HG22 ' B' ' 14' ' ' THR . 87.5 mt-30 -62.25 145.13 54.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.688 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.666 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.1 pt -121.77 143.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.1 m-85 -88.05 131.28 34.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.856 ' HB ' HG23 ' B' ' 13' ' ' ILE . 84.4 t -142.43 146.04 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.091 0.472 . . . . 0.0 111.563 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.425 ' CG ' ' HA2' ' B' ' 10' ' ' GLY . 40.3 ttmt -102.08 131.57 48.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.194 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 70.0 p -68.61 -157.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 111.457 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.46 HD21 HG23 ' B' ' 36' ' ' ILE . 75.1 mt -64.67 -65.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.221 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.4 t -76.79 -45.25 29.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.427 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.06 109.03 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.358 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -167.25 129.46 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.696 0.284 . . . . 0.0 110.903 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -73.37 134.34 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.756 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.856 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -137.85 122.49 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.266 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.983 HG22 ' HB3' ' B' ' 2' ' ' GLN . 0.1 OUTLIER -80.16 145.22 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.477 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.666 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.2 tt -162.72 112.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.21 0.529 . . . . 0.0 111.177 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.4 pt-20 -82.92 141.11 32.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.955 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.934 HG11 HG23 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -157.65 145.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.557 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.465 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 44.7 mt-10 -71.13 133.99 85.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.992 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.97 -37.69 97.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.796 2.33 . . . . 0.0 112.2 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.418 ' O ' HG22 ' A' ' 22' ' ' THR . 80.5 p -63.89 -25.92 68.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.465 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 53.0 m-20 -60.81 131.44 50.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 20' ' ' SER . 65.9 p -60.8 146.55 45.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.723 HG22 ' NZ ' ' B' ' 27' ' ' LYS . 54.8 mt -55.36 -37.79 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.099 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.403 ' HG3' ' OD1' ' B' ' 25' ' ' ASN . 15.9 pt-20 -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.403 ' OD1' ' HG3' ' B' ' 24' ' ' GLU . 45.9 m-20 -67.7 -46.3 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.452 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.934 HG23 HG11 ' B' ' 17' ' ' VAL . 7.8 p -61.93 -41.21 90.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.723 ' NZ ' HG22 ' B' ' 23' ' ' ILE . 36.8 mtmm -66.61 -44.55 81.79 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.01 0.433 . . . . 0.0 110.203 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' B' ' 31' ' ' GLN . . . -57.87 -27.29 63.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.509 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -64.87 -43.89 91.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.817 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.66 HG22 HD11 ' B' ' 36' ' ' ILE . 51.5 mt -57.57 -30.95 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.824 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 74.2 mt-30 -58.05 -48.49 79.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.5 -37.34 83.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.767 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 38.5 mmtm -66.48 -25.1 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -152.03 -87.23 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.15 57.3 0.02 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.248 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.692 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.5 OUTLIER -134.9 125.56 17.32 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.56 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 70.5 Cg_exo -44.28 145.16 2.51 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.0 2.467 . . . . 0.0 112.386 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.663 ' HB2' ' HE2' ' B' ' 27' ' ' LYS . 20.2 Cg_endo -60.27 -35.13 92.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.497 2.131 . . . . 0.0 112.223 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.64 -38.15 89.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.692 ' OE1' HG22 ' B' ' 36' ' ' ILE . 89.4 mt-30 -64.19 -37.23 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' B' ' 27' ' ' LYS . 1.4 mm-40 -54.54 129.26 35.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.3 mtt180 -97.52 124.67 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.251 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 3' ' ' ILE . 50.7 mt -79.46 132.71 36.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.399 . . . . 0.0 111.115 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.966 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.1 mt -143.54 131.27 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.367 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.8 m-85 -125.28 143.99 50.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.743 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -153.43 129.94 10.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.526 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.784 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.468 ' HE1' HD13 ' B' ' 43' ' ' LEU . 20.4 ptm . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.906 0.384 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.812 ' HB2' HG22 ' A' ' 14' ' ' THR . 20.4 pt20 -71.47 122.73 20.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.574 HG22 HD22 ' B' ' 43' ' ' LEU . 38.0 pt -86.15 144.16 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.556 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -88.89 134.98 33.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.972 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.661 HG22 ' HB2' ' B' ' 45' ' ' PHE . 59.5 t -148.2 132.74 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.865 0.364 . . . . 0.0 111.145 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.83 126.43 43.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 9' ' ' THR . 91.1 m -67.62 150.55 48.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.872 HD21 HG21 ' A' ' 36' ' ' ILE . 4.2 mp -45.02 -45.2 10.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.438 ' H ' HG22 ' A' ' 7' ' ' THR . 72.0 p -75.46 -45.5 38.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.392 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.43 0.53 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.88 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -44.02 131.59 5.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -74.15 141.72 45.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 1.1 mt -128.62 139.12 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.028 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.812 HG22 ' HB2' ' A' ' 2' ' ' GLN . 7.2 m -133.52 142.86 48.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.9 HD13 ' HD2' ' A' ' 33' ' ' LYS . 5.8 tp -157.02 114.95 3.19 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 16.9 pt-20 -71.89 130.51 41.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.612 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 18.7 m -152.57 138.65 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 48.5 mt-10 -69.16 140.87 91.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.72 -36.37 81.59 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.969 2.446 . . . . 0.0 112.239 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.523 ' O ' HG22 ' B' ' 22' ' ' THR . 46.0 t -64.3 -32.04 73.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 54.5 m-20 -56.27 132.59 51.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.499 HG22 ' O ' ' B' ' 20' ' ' SER . 66.6 p -60.06 147.18 40.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.642 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 26' ' ' VAL . 61.5 mt -54.38 -36.95 35.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.788 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.66 -32.22 72.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -69.28 -47.46 64.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.208 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 23' ' ' ILE . 22.7 m -60.22 -39.28 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.969 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HE3' HG22 ' A' ' 23' ' ' ILE . 99.3 mttt -67.13 -38.75 86.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.84 -38.62 35.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.427 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.777 ' HD2' HD21 ' A' ' 15' ' ' LEU . 80.0 mttt -67.79 -41.07 83.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -55.14 -36.83 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.357 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' CD ' ' HD3' ' A' ' 38' ' ' PRO . 34.8 mt-30 -63.28 -45.0 93.49 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.94 -33.01 74.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.712 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.9 ' HD2' HD13 ' A' ' 15' ' ' LEU . 29.6 mtpp -71.71 -31.56 66.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.935 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -135.63 -60.18 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.11 57.06 0.19 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.083 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.872 HG21 HD21 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -145.07 131.43 9.78 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 120.819 0.342 . . . . 0.0 111.352 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 60.6 Cg_exo -40.89 139.46 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.29 2.66 . . . . 0.0 113.229 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HD3' ' CD ' ' A' ' 31' ' ' GLN . 18.0 Cg_endo -60.36 -36.2 88.18 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.922 2.414 . . . . 0.0 112.663 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.25 -37.19 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 76.8 mt-30 -59.27 -45.41 91.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.672 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.34 124.37 15.74 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.73 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.687 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.9 ttm180 -91.46 123.18 34.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.555 HD21 HG21 ' A' ' 23' ' ' ILE . 9.3 mp -73.49 132.04 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.949 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 79.9 mt -143.61 134.65 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.669 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 8.3 m-85 -128.62 144.81 51.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.818 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.72 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.04 129.4 10.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.994 0.426 . . . . 0.0 111.439 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' B' ' 8' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.897 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.492 ' HE1' HD13 ' A' ' 43' ' ' LEU . 20.2 ptm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.888 0.375 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.94 ' HB2' HG22 ' B' ' 14' ' ' THR . 21.3 pt20 -69.22 124.33 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.462 HG22 HD22 ' A' ' 43' ' ' LEU . 37.4 pt -88.33 145.83 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.831 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.76 135.51 33.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.153 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.717 ' HB ' HG13 ' B' ' 13' ' ' ILE . 57.6 t -148.47 138.31 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 111.132 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.9 125.55 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.437 HG22 ' H ' ' B' ' 9' ' ' THR . 90.4 m -67.03 151.32 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.484 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.798 HD22 ' H ' ' B' ' 8' ' ' LEU . 0.4 OUTLIER -47.26 -42.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.663 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.437 ' H ' HG22 ' B' ' 7' ' ' THR . 67.4 p -75.92 -45.36 35.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.86 -30.44 0.61 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.911 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -45.29 134.62 6.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 39.1 m -79.94 143.82 33.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.0 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.717 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.4 pt -142.78 135.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.142 0.496 . . . . 0.0 111.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.94 HG22 ' HB2' ' B' ' 2' ' ' GLN . 6.0 m -139.75 141.74 36.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.07 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.52 HD22 ' CD ' ' B' ' 33' ' ' LYS . 0.9 OUTLIER -150.69 130.8 13.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.022 0.439 . . . . 0.0 111.193 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 11.1 pt-20 -69.85 132.78 46.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.963 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.534 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 17.3 m -150.43 136.83 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.48 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 48.1 mt-10 -69.5 138.8 88.85 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.257 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.22 -36.05 65.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.061 2.507 . . . . 0.0 112.261 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 22' ' ' THR . 45.6 t -64.01 -32.69 74.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.05 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 55.3 m-20 -56.0 132.54 50.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.824 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 20' ' ' SER . 69.0 p -59.49 148.26 33.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.67 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.592 ' O ' HG22 ' B' ' 26' ' ' VAL . 61.3 mt -54.59 -36.89 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.38 -31.05 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.774 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -65.96 -52.04 53.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.061 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.592 HG22 ' O ' ' B' ' 23' ' ' ILE . 24.4 m -58.29 -39.7 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.262 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' B' ' 23' ' ' ILE . 98.8 mttt -66.88 -37.99 85.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.74 -40.74 55.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.314 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 78.7 mttt -68.23 -40.4 82.06 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' B' ' 27' ' ' LYS . 70.6 mt -54.34 -36.69 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.168 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 34.2 mt-30 -63.79 -44.54 93.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.394 0.616 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -67.46 -32.48 73.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.62 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.52 ' CD ' HD22 ' B' ' 15' ' ' LEU . 29.6 mtpp -70.61 -32.41 69.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.092 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.861 ' HB2' HD11 ' B' ' 36' ' ' ILE . 56.8 mm-40 -138.14 -55.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.678 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.77 54.89 0.23 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.62 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.861 HD11 ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -135.44 135.63 22.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.578 0.228 . . . . 0.0 111.057 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.566 ' HB2' ' HG3' ' B' ' 40' ' ' GLN . 75.7 Cg_exo -50.04 138.54 35.52 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.45 2.1 . . . . 0.0 112.028 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' B' ' 27' ' ' LYS . 18.5 Cg_endo -58.03 -35.55 98.67 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.817 2.345 . . . . 0.0 112.496 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.18 -36.12 79.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.259 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.566 ' OE1' HG22 ' B' ' 36' ' ' ILE . 77.6 mt-30 -62.82 -44.2 96.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.57 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.669 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.79 126.42 22.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.785 0.326 . . . . 0.0 110.488 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.72 ' H ' ' H ' ' A' ' 46' ' ' ALA . 38.8 ttm180 -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.664 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.574 HD22 HG22 ' A' ' 3' ' ' ILE . 8.9 mp -74.49 132.5 41.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.949 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 76.7 mt -143.55 134.21 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.672 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 8.1 m-85 -128.4 144.32 51.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.687 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 132.39 13.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.954 0.407 . . . . 0.0 111.413 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.64 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 17.0 ptm . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.986 0.422 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.655 ' HB2' HG22 ' A' ' 14' ' ' THR . 19.8 pt20 -61.86 129.45 41.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.702 HD11 HD23 ' A' ' 15' ' ' LEU . 36.7 pt -97.49 135.04 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.76 125.5 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.838 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.2 t -147.79 134.44 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.692 0.282 . . . . 0.0 111.681 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -93.52 119.62 32.81 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -66.53 -159.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.484 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.906 HD11 HG21 ' A' ' 36' ' ' ILE . 2.3 mm? -81.59 -47.02 13.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -73.47 -45.44 54.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.394 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -35.7 0.55 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.806 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.2 133.01 15.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.967 0.413 . . . . 0.0 111.591 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 m -84.77 132.88 34.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.04 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.838 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -99.97 134.43 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.888 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.1 m -109.01 133.86 52.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.702 HD23 HD11 ' A' ' 3' ' ' ILE . 5.4 tp -159.84 114.85 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 112.099 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 1' ' ' MET . 16.9 pt-20 -79.01 137.13 37.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.219 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.27 135.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -57.88 140.99 81.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 12.2 Cg_endo -56.34 -40.03 87.38 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.818 2.345 . . . . 0.0 112.127 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -64.14 -28.81 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.064 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 8.3 t70 -53.53 132.33 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.8 p -62.94 144.37 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.875 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 26' ' ' VAL . 64.7 mt -55.4 -36.33 40.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.279 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -62.97 -35.67 80.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.4 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.544 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 50.6 m-20 -72.93 -48.03 40.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.621 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 23' ' ' ILE . 32.7 m -57.47 -44.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.138 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 99.3 mttt -65.06 -38.44 90.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 110.461 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . . . -55.26 -37.73 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.151 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HB2' HD21 ' A' ' 15' ' ' LEU . 29.8 mmtp -66.48 -39.67 88.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.996 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.465 HG23 HD12 ' A' ' 13' ' ' ILE . 62.2 mt -56.32 -35.94 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.886 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 28' ' ' ALA . 35.2 mt-30 -59.66 -44.6 93.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.07 -34.17 77.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.133 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 73.1 mmtt -66.27 -25.04 66.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.85 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -150.27 -79.59 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.943 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.43 57.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.236 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.906 HG21 HD11 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -140.97 129.28 12.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.465 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 59.7 Cg_exo -41.63 142.47 1.24 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.263 2.642 . . . . 0.0 113.179 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 25.7 Cg_endo -61.63 -37.26 70.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.958 2.438 . . . . 0.0 112.742 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.09 -36.22 72.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.474 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 81.6 mt-30 -60.5 -44.98 95.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.63 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.98 125.64 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.673 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.2 mtt180 -89.2 126.68 35.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.511 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -75.66 130.3 38.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.343 . . . . 0.0 110.857 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.935 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.4 mt -143.59 132.03 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.05 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.691 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 3.3 m-85 -127.34 145.39 50.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.577 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.728 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -149.98 125.47 10.25 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.872 0.368 . . . . 0.0 111.417 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.22 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.106 -179.699 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.8 ptm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.97 0.414 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -61.7 130.35 45.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.648 HG12 ' HB3' ' B' ' 15' ' ' LEU . 35.3 pt -97.27 131.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.278 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.724 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -88.97 120.85 30.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.865 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.93 HG13 HG13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -150.91 130.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.063 0.459 . . . . 0.0 111.765 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -83.13 126.64 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.385 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -70.57 -157.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.309 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.699 HD21 HG12 ' B' ' 36' ' ' ILE . 2.0 mm? -83.0 -48.33 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p -71.77 -45.29 62.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.27 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 -34.22 0.62 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.763 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -49.43 130.91 20.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.863 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 37.2 m -80.92 147.27 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.901 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.93 HG13 HG13 ' B' ' 5' ' ' VAL . 18.6 pt -129.36 124.78 60.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 0.0 112.477 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -92.88 146.89 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.178 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.648 ' HB3' HG12 ' B' ' 3' ' ' ILE . 5.3 tt -164.2 114.62 1.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.829 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.3 pt-20 -78.02 138.05 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.622 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.584 HG13 ' CD2' ' B' ' 15' ' ' LEU . 1.0 OUTLIER -157.25 133.41 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.943 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -59.14 138.28 88.11 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.448 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 9.3 Cg_endo -52.51 -39.06 75.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.917 2.412 . . . . 0.0 112.106 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.5 t -63.93 -29.8 70.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.155 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.554 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.2 t70 -53.81 131.87 40.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 0.0 110.526 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -62.42 144.01 56.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.916 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 19' ' ' PRO . 65.2 mt -55.22 -35.72 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -63.15 -36.14 82.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.347 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.554 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 51.0 m-20 -72.7 -48.37 39.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.602 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 23' ' ' ILE . 31.0 m -57.23 -43.76 82.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.438 ' HE3' ' CG2' ' B' ' 23' ' ' ILE . 99.0 mttt -65.09 -38.34 90.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.413 ' HA ' ' OE1' ' B' ' 31' ' ' GLN . . . -55.18 -37.07 66.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.575 ' HB2' HD11 ' B' ' 15' ' ' LEU . 58.0 mmtt -64.56 -43.5 93.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' B' ' 33' ' ' LYS . 65.4 mt -53.5 -36.29 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.147 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 34.9 mt-30 -59.82 -45.57 91.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -67.57 -33.46 75.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.229 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.525 ' HG3' HD12 ' B' ' 15' ' ' LEU . 72.7 mmtt -65.44 -25.29 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.169 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' B' ' 36' ' ' ILE . 17.7 tp10 -152.61 -68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.299 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.85 55.7 0.04 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.72 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.739 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -133.89 133.33 22.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.51 0.195 . . . . 0.0 111.28 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.472 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 71.7 Cg_exo -51.04 139.59 41.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.451 2.101 . . . . 0.0 112.092 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.432 ' O ' ' HD3' ' B' ' 27' ' ' LYS . 19.8 Cg_endo -58.29 -35.75 98.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.831 2.354 . . . . 0.0 112.679 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.739 ' OE1' HG22 ' B' ' 36' ' ' ILE . 88.4 mt-30 -63.33 -41.96 98.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -56.25 126.36 25.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.834 0.349 . . . . 0.0 110.488 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.728 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.4 mtt180 -86.16 127.04 34.65 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.51 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.616 HD23 HG22 ' A' ' 3' ' ' ILE . 5.4 tp -78.3 127.6 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.656 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.935 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 70.5 mt -143.71 138.15 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-O 120.88 0.371 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.63 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 3.6 m-85 -131.24 148.67 52.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.673 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.9 124.26 8.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.292 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.356 -179.632 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.3 ptm . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 121.233 0.539 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.476 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 20.9 tt0 -62.95 120.79 12.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.3 pt -99.7 143.07 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 112.22 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.4 m-85 -89.86 135.31 33.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.124 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.799 ' HB ' HG13 ' A' ' 13' ' ' ILE . 67.4 t -148.79 132.76 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -92.46 129.22 38.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.698 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 11' ' ' LYS . 61.5 p -77.37 -157.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 110.908 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.865 HD21 HG21 ' A' ' 36' ' ' ILE . 51.7 mt -83.45 -53.49 5.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.57 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -73.16 -45.28 57.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.32 -27.15 0.25 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.325 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' HG23 ' A' ' 7' ' ' THR . 4.0 tppp? -43.24 130.36 4.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 111.952 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -89.21 138.84 31.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.981 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.799 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.2 pt -125.4 133.85 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.271 0.558 . . . . 0.0 111.907 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 4.7 p -117.72 144.27 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.623 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' O ' HG12 ' A' ' 3' ' ' ILE . 3.3 pp -168.0 124.73 1.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.292 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -77.15 143.01 39.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -179.344 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 15' ' ' LEU . 3.7 m -150.97 132.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.86 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 85.5 mt-10 -63.38 137.83 97.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.75 -36.19 61.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.13 2.553 . . . . 0.0 112.5 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.42 ' O ' HG22 ' B' ' 22' ' ' THR . 45.0 t -63.87 -33.23 75.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.094 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.637 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -56.47 133.23 53.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -60.27 148.47 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.826 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.723 HD11 HG21 ' B' ' 26' ' ' VAL . 69.0 mt -54.67 -45.33 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 12.1 pt-20 -59.82 -36.09 76.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -63.59 -48.25 78.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.752 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 23' ' ' ILE . 11.0 m -64.82 -41.01 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.171 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.42 -39.21 93.89 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.666 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -55.24 -37.45 67.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HE3' HG12 ' A' ' 17' ' ' VAL . 48.4 mttm -63.64 -41.95 98.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.643 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 13' ' ' ILE . 70.8 mt -55.09 -39.33 49.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.421 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 43.1 tt0 -61.17 -47.13 87.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.153 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -60.01 -37.38 79.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.051 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 4.5 mmmp? -66.18 -42.42 88.91 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.948 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -124.55 -70.21 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.083 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.0 -37.34 0.42 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.254 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.865 HG21 HD21 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -44.61 126.09 4.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.525 ' HD2' ' CD ' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -47.1 142.73 11.1 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.305 2.67 . . . . 0.0 112.761 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 46.8 Cg_exo -56.33 -37.34 97.1 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.766 2.311 . . . . 0.0 112.475 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.75 -38.32 81.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.624 ' OE1' HG22 ' A' ' 36' ' ' ILE . 89.6 mt-30 -60.51 -39.27 87.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.743 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.696 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.64 124.09 15.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 99.3 mtt180 -89.54 128.57 36.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.431 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HG22 ' B' ' 3' ' ' ILE . 23.7 mt -74.27 130.55 39.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.838 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 76.6 mt -143.88 133.04 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.2 m-85 -130.33 147.23 52.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.725 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.82 123.99 5.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 111.562 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.6 ptm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.779 0.323 . . . . 0.0 111.465 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.41 ' HB3' ' CG2' ' B' ' 14' ' ' THR . 89.5 mt-30 -62.03 130.52 45.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.249 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.709 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.1 pt -104.09 139.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.592 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.0 m-85 -88.86 129.78 35.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.685 ' HB ' HG13 ' B' ' 13' ' ' ILE . 62.0 t -144.07 134.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 111.462 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -96.09 127.73 42.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 66.3 p -76.54 -157.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.961 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.586 HD11 HG23 ' B' ' 36' ' ' ILE . 7.7 mp -83.04 -52.63 6.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.519 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -74.27 -45.27 48.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.67 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.07 -28.45 0.27 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.559 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -42.96 130.68 4.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.768 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.685 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -106.22 129.5 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.115 0.483 . . . . 0.0 112.002 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' B' ' 2' ' ' GLN . 1.9 m -107.46 136.33 47.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.709 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -163.36 115.64 1.49 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.864 -178.085 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' B' ' 1' ' ' MET . 23.9 pt-20 -76.92 139.27 40.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.439 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -151.26 138.09 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.645 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 85.5 mt-10 -67.33 140.52 95.31 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.03 -37.62 86.56 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.082 2.521 . . . . 0.0 112.497 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.3 t -63.85 -32.97 74.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.188 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.645 ' OD1' ' HB2' ' B' ' 18' ' ' GLU . 1.0 OUTLIER -56.21 132.93 51.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 20' ' ' SER . 80.4 p -60.65 149.07 36.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.792 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.816 HD13 HD21 ' B' ' 43' ' ' LEU . 67.1 mt -55.2 -45.07 77.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.12 -41.62 88.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.834 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 12.9 t-20 -61.4 -44.14 97.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.515 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.723 HG21 HD11 ' A' ' 23' ' ' ILE . 16.8 t -61.47 -47.85 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.388 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 47.7 mtmt -65.08 -36.38 84.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.303 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.683 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -56.51 -32.65 65.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.152 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 50.4 mttm -69.26 -33.84 73.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.183 0.516 . . . . 0.0 109.735 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.625 HG23 HD12 ' B' ' 13' ' ' ILE . 60.9 mt -61.75 -42.18 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.597 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 22.3 pt20 -66.35 -45.33 80.57 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' B' ' 31' ' ' GLN . 63.7 t0 -58.77 -31.73 68.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' B' ' 30' ' ' ILE . 22.9 tptp -73.27 -32.23 64.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.556 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.403 ' HB3' HD11 ' B' ' 36' ' ' ILE . 36.9 tp10 -139.31 -64.76 0.49 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.004 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 159.07 -32.56 0.46 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.343 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.666 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.3 OUTLIER -49.74 128.95 20.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.478 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 50.4 Cg_exo -54.57 140.58 75.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.68 2.254 . . . . 0.0 111.668 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.605 ' HB3' ' HB2' ' B' ' 27' ' ' LYS . 53.6 Cg_exo -52.75 -37.26 75.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.563 2.175 . . . . 0.0 112.665 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -61.11 -37.4 82.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.564 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.666 ' OE1' HG22 ' B' ' 36' ' ' ILE . 78.6 mt-30 -62.87 -38.97 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.75 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.68 126.43 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.698 0.285 . . . . 0.0 110.588 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.725 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.4 mtt180 -92.35 127.48 37.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.992 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.816 HD21 HD13 ' B' ' 23' ' ' ILE . 7.7 mp -72.86 129.07 37.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.226 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 77.9 mt -143.89 131.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.696 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 5.3 m-85 -128.94 145.86 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.747 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.616 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -155.81 126.09 6.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 111.461 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.443 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 ptm . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 1.041 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.8 pt20 -69.05 130.12 41.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 15' ' ' LEU . 5.0 pt -99.75 147.05 7.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.79 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 4.6 m-85 -89.57 126.98 35.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.911 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.709 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.1 t -149.5 137.28 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.277 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -104.62 129.67 52.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.391 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -68.38 -157.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.117 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.529 ' H ' HD12 ' A' ' 8' ' ' LEU . 3.6 mp -86.57 -51.58 6.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.242 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.8 p -72.11 -45.48 60.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.729 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 -29.73 0.26 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -43.97 129.91 5.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.967 0.413 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -90.27 137.53 32.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.339 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.709 HG13 ' HB ' ' A' ' 5' ' ' VAL . 3.7 pt -122.87 134.63 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 111.344 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.041 HG22 ' HB2' ' A' ' 2' ' ' GLN . 3.8 m -127.0 105.1 8.37 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -123.68 127.91 48.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 1' ' ' MET . 12.5 pt-20 -72.39 139.27 47.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.83 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -150.26 135.17 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 80.4 mt-10 -64.22 137.9 97.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.235 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.34 -36.58 97.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.831 2.354 . . . . 0.0 112.031 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.583 ' O ' HG22 ' B' ' 22' ' ' THR . 43.4 t -64.19 -33.94 76.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.898 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.621 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 30.2 m-20 -57.99 133.33 55.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.576 HG22 ' O ' ' B' ' 20' ' ' SER . 76.1 p -58.49 149.51 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.453 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.623 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 63.2 mt -53.33 -38.23 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.846 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.426 ' HA ' ' HZ1' ' A' ' 27' ' ' LYS . 17.1 tp10 -59.27 -42.29 90.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.452 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.71 -44.9 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.774 HG21 HD11 ' B' ' 23' ' ' ILE . 24.3 t -57.34 -48.93 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.176 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.623 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 36.8 mtmm -66.04 -35.56 80.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . . . -55.27 -38.43 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.178 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HE2' ' NZ ' ' A' ' 33' ' ' LYS . 87.9 tttt -67.28 -38.86 85.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.04 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.601 HD12 ' HG2' ' A' ' 41' ' ' GLN . 58.4 mt -58.12 -34.29 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.891 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 27.8 mt-30 -64.08 -44.46 92.31 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 -32.58 71.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' NZ ' ' HE2' ' A' ' 29' ' ' LYS . 36.2 mmtm -71.67 -30.09 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.03 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -140.96 -66.49 0.43 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.204 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 150.86 -32.15 0.98 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.901 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.653 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -48.66 127.05 13.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD2' ' HG3' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -46.63 158.76 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.014 2.476 . . . . 0.0 112.43 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 17.1 Cg_endo -57.74 -37.37 96.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.598 2.198 . . . . 0.0 112.262 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.08 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.539 ' HG3' ' HD2' ' A' ' 37' ' ' PRO . 1.9 mm-40 -52.26 -55.94 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -56.79 128.24 35.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.783 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.2 mmt180 -96.83 125.65 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 23' ' ' ILE . 9.4 mp -68.81 122.52 18.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.539 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 62.4 mt -143.75 130.48 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.072 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.716 ' HB2' HG22 ' B' ' 5' ' ' VAL . 8.8 m-85 -130.03 145.12 51.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.794 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.766 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -146.42 127.45 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 111.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' HA2' ' C ' ' B' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.304 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.3 ptm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.9 0.381 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.996 ' HB2' HG22 ' B' ' 14' ' ' THR . 4.8 pt20 -68.97 127.02 31.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.504 HG12 ' O ' ' B' ' 15' ' ' LEU . 26.1 pt -99.86 150.04 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.479 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 3.5 m-85 -89.1 129.43 35.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.358 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.716 HG22 ' HB2' ' A' ' 45' ' ' PHE . 87.8 t -149.74 137.27 13.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -104.38 130.27 52.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.288 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 76.6 p -70.62 -157.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.406 . . . . 0.0 111.678 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.52 HD11 HG21 ' B' ' 36' ' ' ILE . 4.8 mp -82.44 -56.66 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.433 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -71.2 -45.44 63.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.881 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.29 -28.64 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.8 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -43.62 128.09 5.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.305 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -87.53 137.17 32.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.715 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.5 pt -123.59 128.44 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 111.441 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.996 HG22 ' HB2' ' B' ' 2' ' ' GLN . 7.5 m -124.01 110.51 14.87 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.67 HD13 ' HG3' ' B' ' 33' ' ' LYS . 1.5 pt? -136.19 131.17 34.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.406 0.622 . . . . 0.0 111.846 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.8 pt-20 -70.03 142.96 52.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.883 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.528 ' HB ' HG12 ' B' ' 26' ' ' VAL . 21.2 m -152.27 134.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.191 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 86.6 mt-10 -61.97 137.45 95.48 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.645 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.11 -39.19 81.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.831 2.354 . . . . 0.0 111.914 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.576 ' O ' HG22 ' A' ' 22' ' ' THR . 47.1 t -64.15 -30.64 71.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.467 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 46.5 m-20 -59.77 132.71 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 20' ' ' SER . 74.5 p -57.44 149.59 20.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.502 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.774 HD11 HG21 ' A' ' 26' ' ' VAL . 64.4 mt -54.27 -37.78 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 109.705 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' NZ ' ' B' ' 27' ' ' LYS . 4.6 tp10 -60.22 -37.4 80.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.453 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -66.58 -48.43 69.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.576 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.626 HG22 ' O ' ' B' ' 23' ' ' ILE . 9.4 m -60.65 -42.24 91.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.031 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.637 ' HZ2' HG22 ' B' ' 23' ' ' ILE . 36.8 mtmm -65.68 -38.1 88.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.922 0.391 . . . . 0.0 110.258 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.485 ' HA ' ' OE1' ' B' ' 31' ' ' GLN . . . -55.91 -36.44 67.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.489 ' HG2' HD12 ' B' ' 15' ' ' LEU . 88.3 tttt -68.51 -39.51 81.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.044 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.623 HD12 ' HG2' ' B' ' 41' ' ' GLN . 59.3 mt -57.67 -33.86 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.685 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 30.0 mt-30 -63.34 -47.18 83.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.16 -31.01 68.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.67 ' HG3' HD13 ' B' ' 15' ' ' LEU . 25.7 mmtp -75.18 -27.07 59.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -141.48 -66.74 0.41 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.158 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 149.31 -32.04 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.041 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.641 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 0.7 OUTLIER -50.41 129.53 25.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' B' ' 40' ' ' GLN . 91.0 Cg_exo -47.17 157.98 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.979 2.452 . . . . 0.0 112.323 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.508 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 13.9 Cg_endo -58.14 -36.06 98.2 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.451 2.101 . . . . 0.0 112.152 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -60.4 -33.45 72.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.523 ' HG3' ' HD2' ' B' ' 37' ' ' PRO . 1.9 mm-40 -52.2 -55.52 20.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.029 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -56.65 127.92 33.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.766 ' H ' ' H ' ' A' ' 46' ' ' ALA . 37.5 mmt180 -96.1 126.23 41.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.401 ' N ' HD12 ' B' ' 43' ' ' LEU . 8.9 mp -69.57 122.05 18.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.415 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 76.0 mt -143.79 130.1 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.693 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.7 m-85 -129.93 144.63 51.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.74 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.783 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -144.97 128.11 16.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.459 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.347 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 1' ' ' MET . 15.7 tpt . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.028 0.442 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.614 ' HB2' HG22 ' A' ' 14' ' ' THR . 18.9 pt20 -61.84 111.13 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' LEU . 34.9 pt -84.87 141.59 14.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -87.82 130.16 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.751 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.6 t -145.17 145.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.027 0.441 . . . . 0.0 111.553 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 67.3 mttm -108.33 129.81 55.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.323 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.29 -156.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.324 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.33 -52.06 66.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.5 t -76.63 -45.1 31.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.995 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 143.21 32.76 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.488 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 61.8 tttp -81.32 131.12 35.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -73.04 136.79 45.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.437 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.751 HG23 ' HB ' ' A' ' 5' ' ' VAL . 1.3 tt -139.49 124.08 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 111.749 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -86.54 144.12 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.984 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 15' ' ' LEU . 5.0 tt -158.32 113.31 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.805 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 17' ' ' VAL . 25.7 pt-20 -88.18 132.64 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.588 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.684 HG21 HG13 ' A' ' 26' ' ' VAL . 2.9 m -159.92 146.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.73 139.24 76.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.492 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 33.5 Cg_endo -61.9 -40.06 46.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.358 . . . . 0.0 112.348 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 m -63.85 -20.55 65.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.795 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -57.51 134.21 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 26' ' ' VAL . 67.5 p -56.6 142.87 37.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.485 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.554 HG12 HG12 ' B' ' 23' ' ' ILE . 66.2 mt -57.75 -40.62 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.77 -44.57 90.65 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.138 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.61 -44.52 86.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG13 HG21 ' A' ' 17' ' ' VAL . 60.3 t -59.16 -49.28 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.33 -36.76 84.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.518 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.572 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -53.81 -36.12 62.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.875 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 86.7 tttt -69.54 -39.17 77.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.117 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.736 ' HB ' HE22 ' A' ' 41' ' ' GLN . 36.9 mm -54.87 -38.55 45.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.101 0.477 . . . . 0.0 109.775 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -60.37 -48.96 79.51 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.32 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.91 -30.52 71.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.449 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 30.7 mmmt -72.05 -32.1 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.23 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -138.91 -65.69 0.49 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.983 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.98 -40.39 0.52 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.571 HD11 HG22 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -45.06 126.78 5.49 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.66 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 87.2 Cg_exo -45.93 139.64 10.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.019 2.479 . . . . 0.0 112.399 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 45.6 Cg_exo -56.26 -40.6 83.72 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.37 2.046 . . . . 0.0 111.879 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.32 -36.04 81.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.66 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 51.3 tt0 -60.28 -37.15 79.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.092 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.845 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.6 mt-30 -56.33 132.05 49.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.692 ' H ' ' H ' ' B' ' 46' ' ' ALA . 56.3 ttp180 -91.82 125.61 36.59 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD21 ' HD3' ' A' ' 27' ' ' LYS . 14.5 mt -74.46 132.17 41.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.705 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 75.8 mt -143.73 133.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.808 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 15.4 m-85 -129.69 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.434 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.16 127.37 6.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.964 0.412 . . . . 0.0 111.722 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' B' ' 36' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.541 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' B' ' 1' ' ' MET . 15.7 tpt . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.895 0.378 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' GLN . . . . . 0.514 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 18.4 pt20 -61.72 111.82 2.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.235 0.541 . . . . 0.0 110.841 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ILE . . . . . 0.803 HD11 HD23 ' B' ' 15' ' ' LEU . 30.5 pt -85.53 142.29 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -88.25 126.59 35.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.695 ' HB ' HG12 ' B' ' 13' ' ' ILE . 89.6 t -142.61 139.44 28.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.156 0.503 . . . . 0.0 111.519 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' LYS . . . . . 0.6 ' HB3' ' HA2' ' B' ' 10' ' ' GLY . 67.1 mttm -102.96 131.52 49.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.547 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -67.8 -156.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.0 mt -62.01 -50.5 71.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 110.708 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -75.62 -45.17 38.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.047 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.6 ' HA2' ' HB3' ' B' ' 6' ' ' LYS . . . 142.89 34.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.652 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 60.5 tttp -82.4 128.4 34.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.776 0.322 . . . . 0.0 111.181 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -73.07 135.84 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.62 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.695 HG12 ' HB ' ' B' ' 5' ' ' VAL . 4.2 pt -137.44 134.94 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.097 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.25 144.28 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.803 HD23 HD11 ' B' ' 3' ' ' ILE . 6.0 tp -156.82 113.01 2.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLU . . . . . 0.409 ' O ' HG13 ' B' ' 17' ' ' VAL . 15.5 pt-20 -86.67 129.16 34.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.961 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.531 HG21 HG13 ' B' ' 26' ' ' VAL . 6.6 m -157.11 143.99 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.664 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.52 137.0 76.91 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.61 -39.63 72.84 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.824 2.349 . . . . 0.0 112.187 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 22' ' ' THR . 50.5 m -64.07 -24.6 67.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -54.01 134.06 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.432 ' O ' HG23 ' B' ' 26' ' ' VAL . 71.3 p -56.48 143.19 36.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.518 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.624 HG21 HD21 ' B' ' 43' ' ' LEU . 66.4 mt -58.09 -40.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.436 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -59.03 -44.87 91.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.051 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.35 -44.36 87.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.531 HG13 HG21 ' B' ' 17' ' ' VAL . 98.4 t -59.15 -48.81 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.255 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 49.4 mtmt -65.07 -35.82 82.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.678 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.657 ' HA ' ' HG3' ' B' ' 38' ' ' PRO . . . -54.31 -34.46 61.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.547 ' HD3' HD11 ' B' ' 15' ' ' LEU . 87.1 tttt -73.79 -32.27 63.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.384 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.756 ' HB ' HE22 ' B' ' 41' ' ' GLN . 40.8 mm -56.94 -44.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.426 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 11.3 pt20 -64.99 -39.15 93.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.64 -32.31 72.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' B' ' 29' ' ' LYS . 31.0 mmmt -74.97 -31.17 61.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.799 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.1 tp10 -139.13 -64.03 0.51 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 156.61 -32.71 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.11 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.695 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -47.95 124.03 10.3 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.702 ' HG2' ' HB2' ' B' ' 40' ' ' GLN . 2.3 Cg_endo -48.64 137.82 25.98 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.586 2.19 . . . . 0.0 111.412 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.657 ' HG3' ' HA ' ' B' ' 28' ' ' ALA . 50.2 Cg_exo -53.47 -39.91 80.47 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.472 2.115 . . . . 0.0 112.412 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.03 -35.93 79.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.635 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLN . . . . . 0.702 ' HB2' ' HG2' ' B' ' 37' ' ' PRO . 54.8 tt0 -60.74 -36.69 79.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 111.145 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' GLN . . . . . 0.756 HE22 ' HB ' ' B' ' 30' ' ' ILE . 70.8 mt-30 -57.23 132.13 52.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 56.4 ttp180 -91.64 127.55 37.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.657 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.624 HD21 HG21 ' B' ' 23' ' ' ILE . 8.3 mp -75.86 130.88 39.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -143.52 134.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.845 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 9.9 m-85 -129.94 141.78 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.294 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ALA . . . . . 0.692 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.54 123.18 6.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.093 0.473 . . . . 0.0 112.068 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.436 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 52.6 m -61.33 -44.82 96.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.5 tpt -167.02 52.89 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.23 0.538 . . . . 0.0 110.739 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 17.4 pt20 -61.58 110.56 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.405 0.621 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.668 HG22 HD23 ' B' ' 43' ' ' LEU . 37.0 pt -72.49 146.21 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.098 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -87.84 130.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.881 ' HB ' HG23 ' A' ' 13' ' ' ILE . 64.8 t -144.55 151.05 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.96 117.95 29.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.325 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 HG21 ' NZ ' ' A' ' 11' ' ' LYS . 74.1 p -68.68 152.74 44.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.4 mt -50.29 -37.67 37.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.735 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -66.63 -44.99 80.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.02 -40.12 1.21 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.444 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG21 ' A' ' 7' ' ' THR . 21.8 pttp -52.13 139.66 22.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 111.668 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -73.34 148.1 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.62 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.881 HG23 ' HB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -134.83 133.33 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.274 0.559 . . . . 0.0 112.024 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 145.25 31.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.299 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.86 HD12 ' HG3' ' A' ' 33' ' ' LYS . 3.9 tt -155.31 113.76 3.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.339 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 25.4 pt-20 -80.43 136.69 36.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.422 . . . . 0.0 111.906 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.764 HG21 HG13 ' A' ' 26' ' ' VAL . 2.4 m -158.21 143.5 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.496 ' HB2' ' CG ' ' A' ' 21' ' ' ASP . 41.4 mt-10 -62.75 133.76 95.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.18 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 10.6 Cg_endo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.716 2.277 . . . . 0.0 111.851 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.5 t -64.72 -31.64 72.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.947 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.496 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 63.6 m-20 -52.44 135.33 33.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.4 p -56.71 143.79 35.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.769 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.727 HG12 HG12 ' B' ' 23' ' ' ILE . 60.7 mt -57.27 -44.45 83.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.98 -41.92 79.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.705 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -65.73 -43.01 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.648 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.764 HG13 HG21 ' A' ' 17' ' ' VAL . 59.9 t -59.55 -49.77 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.608 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 54.0 mttp -62.51 -39.79 94.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.827 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HA ' ' NE2' ' A' ' 31' ' ' GLN . . . -56.19 -35.72 67.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.328 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.76 ' HD2' HD21 ' A' ' 15' ' ' LEU . 24.4 ttmm -65.39 -36.48 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.031 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.719 HG22 HD11 ' A' ' 36' ' ' ILE . 51.1 mt -55.81 -31.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 33.4 mt-30 -61.09 -52.52 64.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.39 -34.67 72.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.25 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.86 ' HG3' HD12 ' A' ' 15' ' ' LEU . 43.9 mmtm -65.89 -33.43 75.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.298 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -141.66 -70.69 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.289 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.48 54.27 0.03 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.776 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.719 HD11 HG22 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -138.35 128.12 14.88 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 111.728 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.561 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 78.0 Cg_exo -44.03 141.21 4.68 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.961 2.44 . . . . 0.0 112.703 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 11.9 Cg_endo -57.85 -35.01 99.01 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.765 2.31 . . . . 0.0 112.711 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.99 -37.87 80.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.561 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 83.2 mt-30 -60.7 -44.91 95.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.579 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.563 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.6 OUTLIER -54.33 125.48 19.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.343 . . . . 0.0 110.771 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.746 ' HE ' ' HG3' ' B' ' 48' ' ' LYS . 70.0 mtt-85 -85.84 122.02 29.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.664 HD23 HG22 ' B' ' 3' ' ' ILE . 13.8 tp -84.31 132.98 34.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.721 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.7 mt -143.16 145.53 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 111.672 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' B' ' 5' ' ' VAL . 17.2 m-85 -133.9 140.07 46.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.665 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.23 119.21 5.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.094 0.473 . . . . 0.0 111.648 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.78 138.78 23.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.72 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.683 ' HG3' ' HE ' ' B' ' 42' ' ' ARG . 75.2 mmtt -149.26 74.55 1.25 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.434 0.635 . . . . 0.0 110.988 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 51' ' ' GLU . 21.5 pt20 -67.33 103.64 1.32 Allowed 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.834 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.506 ' H ' ' CD2' ' A' ' 50' ' ' LEU . 3.4 mm? -45.09 80.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.713 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 49' ' ' GLN . 40.4 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 53.0 m -61.42 -43.46 98.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.759 0.314 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.531 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.4 tpt -168.29 51.76 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.317 0.58 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.972 ' HB2' HG22 ' B' ' 14' ' ' THR . 16.9 pt20 -61.46 110.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.129 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.664 HG22 HD23 ' A' ' 43' ' ' LEU . 35.1 pt -72.96 147.48 9.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -87.87 130.15 34.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 45' ' ' PHE . 61.9 t -141.95 152.74 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -123.1 117.44 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.927 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.514 HG21 ' CE ' ' B' ' 11' ' ' LYS . 77.1 p -69.9 150.7 46.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.723 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -48.38 -37.81 17.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.979 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -66.81 -45.23 79.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.75 -41.92 1.1 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.517 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.514 ' CE ' HG21 ' B' ' 7' ' ' THR . 0.0 OUTLIER -54.07 140.1 32.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.126 0.489 . . . . 0.0 111.67 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 50.7 m -72.4 147.35 46.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.543 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.531 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -130.56 141.6 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.195 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.972 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.2 OUTLIER -119.21 143.97 46.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.019 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.699 HD11 ' HD2' ' B' ' 29' ' ' LYS . 3.5 tp -155.67 114.01 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 15.1 pt-20 -77.91 134.42 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.62 HG21 HG13 ' B' ' 26' ' ' VAL . 13.9 m -155.54 141.52 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.214 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.521 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 41.8 mt-10 -61.26 135.09 93.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.352 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.1 -39.55 90.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.777 2.318 . . . . 0.0 111.894 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 22' ' ' THR . 45.7 t -64.38 -30.55 71.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.912 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.521 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 63.0 m-20 -53.95 134.74 43.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.454 ' O ' HG23 ' B' ' 26' ' ' VAL . 74.1 p -55.91 142.95 33.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.695 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.749 HD11 HG21 ' A' ' 26' ' ' VAL . 60.1 mt -57.16 -43.61 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.032 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.33 -42.47 81.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.552 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -65.81 -42.01 91.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.615 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 23' ' ' ILE . 94.1 t -59.89 -48.78 86.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.624 ' NZ ' HD13 ' B' ' 43' ' ' LEU . 64.5 mttm -64.26 -40.09 95.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.923 0.392 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.403 ' HA ' ' NE2' ' B' ' 31' ' ' GLN . . . -55.35 -35.86 65.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.398 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.699 ' HD2' HD11 ' B' ' 15' ' ' LEU . 24.6 ttmm -65.87 -35.32 80.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.527 HG22 ' CD1' ' B' ' 36' ' ' ILE . 50.2 mt -56.46 -30.69 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 32.7 mt-30 -61.12 -52.4 65.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -34.43 72.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.134 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.533 ' HE2' HD13 ' B' ' 15' ' ' LEU . 43.5 mmtm -65.79 -33.04 74.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.258 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -143.31 -68.43 0.34 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.746 0.307 . . . . 0.0 111.252 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.83 53.2 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.311 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.782 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -133.23 132.23 22.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.556 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 72.1 Cg_exo -50.87 142.39 33.3 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.729 2.286 . . . . 0.0 111.998 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.555 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 32.4 Cg_exo -56.66 -35.73 97.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.675 2.25 . . . . 0.0 112.482 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.36 -37.52 86.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.782 ' OE1' HG22 ' B' ' 36' ' ' ILE . 90.0 mt-30 -63.08 -42.52 99.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.692 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.414 ' OE1' ' N ' ' B' ' 41' ' ' GLN . 0.6 OUTLIER -56.52 127.28 30.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.745 0.307 . . . . 0.0 110.489 179.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.683 ' HE ' ' HG3' ' A' ' 48' ' ' LYS . 70.9 mtt-85 -86.84 123.44 31.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.433 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.668 HD23 HG22 ' A' ' 3' ' ' ILE . 14.3 tp -85.5 132.7 34.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.721 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 66.4 mt -143.22 145.64 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.894 0.378 . . . . 0.0 111.823 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.761 ' HB2' HG22 ' A' ' 5' ' ' VAL . 16.0 m-85 -134.53 139.98 45.82 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.993 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.707 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 117.34 5.03 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.084 0.469 . . . . 0.0 111.645 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.48 137.49 23.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.501 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.746 ' HG3' ' HE ' ' A' ' 42' ' ' ARG . 75.1 mmtt -149.68 74.79 1.24 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.219 0.533 . . . . 0.0 111.08 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' B' ' 51' ' ' GLU . 21.7 pt20 -66.02 115.92 6.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.031 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.448 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.6 mm? -54.33 79.92 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.341 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.4 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 53.3 m -67.97 -125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.604 0.24 . . . . 0.0 110.656 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 ptm -158.58 116.8 2.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.018 0.437 . . . . 0.0 110.975 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.934 ' HB2' HG22 ' A' ' 14' ' ' THR . 19.5 pt20 -61.91 130.19 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.236 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.2 pt -103.72 140.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.39 124.77 34.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.789 ' HB ' HG12 ' A' ' 13' ' ' ILE . 35.2 t -141.89 143.7 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 111.43 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.681 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 67.5 mttm -111.45 128.3 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.291 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -63.81 -156.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.06 -53.6 55.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.849 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -72.99 -44.89 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 142.2 35.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 60.9 tttp -80.61 126.02 30.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.311 . . . . 0.0 110.861 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -72.88 134.49 44.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.611 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.789 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.6 pt -136.18 138.05 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.934 HG22 ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -95.81 144.01 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.729 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 29' ' ' LYS . 5.3 tt -161.55 114.34 1.85 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 24.5 pt-20 -87.99 136.28 33.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.553 HG13 ' CD2' ' A' ' 15' ' ' LEU . 3.3 m -156.92 151.9 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.766 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 50.9 mt-10 -72.71 136.9 80.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.43 -32.32 72.45 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.734 2.289 . . . . 0.0 111.959 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.51 ' O ' HG22 ' B' ' 22' ' ' THR . 69.1 m -63.97 -31.78 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.568 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -57.22 128.81 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.788 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.525 HG22 ' O ' ' B' ' 20' ' ' SER . 76.2 p -57.18 150.71 17.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.992 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.706 HG22 ' HE2' ' A' ' 27' ' ' LYS . 67.4 mt -57.28 -31.11 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.541 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -64.72 -36.89 85.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.877 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 45.8 m-20 -73.71 -47.6 38.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.374 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 17' ' ' VAL . 33.2 m -57.82 -43.55 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.131 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.706 ' HE2' HG22 ' A' ' 23' ' ' ILE . 53.4 mtmt -72.02 -34.9 69.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.678 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.52 ' HA ' ' NE2' ' A' ' 31' ' ' GLN . . . -55.52 -38.9 69.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HB2' HD11 ' A' ' 15' ' ' LEU . 41.2 mtpt -65.6 -38.48 89.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.656 ' HB ' HE22 ' A' ' 41' ' ' GLN . 48.3 mm -54.68 -31.96 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.628 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.543 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 31.5 mt-30 -61.13 -51.82 67.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.05 -34.62 75.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.254 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' HD12 ' A' ' 15' ' ' LEU . 73.6 mmtt -65.26 -32.1 73.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.399 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -145.46 -68.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.61 61.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.205 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.652 HD11 HG22 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -146.43 124.42 6.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.933 0.396 . . . . 0.0 112.003 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 39.7 Cg_exo -39.8 143.14 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.461 2.774 . . . . 0.0 112.979 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 38.3 Cg_exo -60.64 -37.79 76.85 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.805 2.336 . . . . 0.0 112.743 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.4 -35.54 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.008 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.487 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 83.1 mt-30 -62.03 -42.95 99.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.208 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.656 HE22 ' HB ' ' A' ' 30' ' ' ILE . 73.5 mt-30 -58.06 126.04 25.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.445 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 18.7 ttm105 -87.7 126.78 35.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.566 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.2 mm? -75.78 131.16 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.468 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.954 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 71.3 mt -143.24 136.03 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.781 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.5 m-85 -131.62 141.07 49.55 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.735 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -155.14 122.24 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.019 0.438 . . . . 0.0 111.951 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' B' ' 40' ' ' GLN . . . -76.76 -134.84 0.61 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.611 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -68.52 74.72 0.26 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.258 0.551 . . . . 0.0 110.977 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.618 ' O ' ' N ' ' A' ' 51' ' ' GLU . 17.0 pt20 -65.41 96.29 0.24 Allowed 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -44.27 80.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.702 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.618 ' N ' ' O ' ' A' ' 49' ' ' GLN . 86.9 tt0 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.979 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.724 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 53.3 m -68.07 -125.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.619 0.247 . . . . 0.0 110.831 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.7 ptm -159.93 116.41 2.49 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.95 0.405 . . . . 0.0 111.393 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.46 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 20.5 pt20 -62.39 128.92 38.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.807 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.772 HD11 HD23 ' B' ' 15' ' ' LEU . 32.7 pt -101.44 137.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.011 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.77 124.25 33.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 1.006 HG13 HG23 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.79 140.11 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 0.0 111.419 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.665 ' HB3' ' HA2' ' B' ' 10' ' ' GLY . 66.6 mttm -100.78 136.09 41.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.137 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.86 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.336 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 mt -59.26 -53.2 60.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.6 p -75.95 -45.45 34.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 110.812 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.665 ' HA2' ' HB3' ' B' ' 6' ' ' LYS . . . 144.32 32.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.418 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 61.4 tttp -79.63 127.25 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -73.51 136.52 44.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 1.006 HG23 HG13 ' B' ' 5' ' ' VAL . 0.9 OUTLIER -142.72 124.35 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -85.07 147.55 26.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.962 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.772 HD23 HD11 ' B' ' 3' ' ' ILE . 7.1 tp -160.66 113.22 1.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 24.6 pt-20 -80.14 140.27 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.682 HG21 HG12 ' B' ' 26' ' ' VAL . 2.8 p -169.13 133.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.7 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.467 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 52.9 mt-10 -56.35 139.17 74.19 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.612 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.11 -32.29 91.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.976 2.45 . . . . 0.0 112.226 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 22' ' ' THR . 33.8 t -63.37 -21.82 66.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.165 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 65.8 m-20 -66.18 133.02 49.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.734 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 20' ' ' SER . 66.9 p -59.12 148.5 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.607 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.725 HG22 ' HE2' ' B' ' 27' ' ' LYS . 65.5 mt -55.41 -30.86 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.433 0.635 . . . . 0.0 109.698 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.57 -37.83 88.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.91 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.493 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 44.0 m-20 -72.94 -48.64 35.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.607 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.682 HG12 HG21 ' B' ' 17' ' ' VAL . 34.7 m -56.52 -44.59 80.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.223 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.725 ' HE2' HG22 ' B' ' 23' ' ' ILE . 53.6 mtmt -70.91 -34.26 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.528 ' HA ' ' NE2' ' B' ' 31' ' ' GLN . . . -57.1 -38.05 72.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.989 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.574 ' HB2' HD21 ' B' ' 15' ' ' LEU . 32.4 mtpt -64.66 -40.1 94.84 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.637 ' HB ' HE22 ' B' ' 41' ' ' GLN . 50.6 mm -54.47 -32.05 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.902 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.541 ' OE1' ' HD3' ' B' ' 38' ' ' PRO . 32.4 mt-30 -60.79 -53.32 58.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.53 -32.03 72.06 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.309 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 72.7 mmtt -66.41 -31.62 72.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.448 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.522 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.9 tp10 -147.48 -61.93 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.578 0.228 . . . . 0.0 111.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.77 58.11 0.06 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.79 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.728 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -137.99 129.87 16.14 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.633 0.254 . . . . 0.0 111.309 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.495 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -50.27 142.18 29.61 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.619 2.213 . . . . 0.0 112.128 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.605 ' HB3' ' HE3' ' B' ' 27' ' ' LYS . 35.6 Cg_exo -58.31 -38.87 88.8 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.744 2.296 . . . . 0.0 112.608 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.53 -35.45 76.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.728 ' OE1' HG22 ' B' ' 36' ' ' ILE . 87.6 mt-30 -64.96 -39.7 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.315 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 73.2 mt-30 -60.09 128.11 35.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.661 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.735 ' H ' ' H ' ' A' ' 46' ' ' ALA . 18.5 ttm105 -88.97 126.26 35.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.186 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.505 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.0 mm? -75.77 131.53 39.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.531 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.954 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.3 mt -144.04 138.3 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.57 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 13.5 m-85 -133.9 143.55 48.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.433 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.45 ' C ' ' HA ' ' A' ' 41' ' ' GLN . . . -156.25 120.27 4.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.11 -135.31 0.18 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.649 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.7 75.58 1.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.247 0.546 . . . . 0.0 111.27 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' B' ' 51' ' ' GLU . 18.9 pt20 -64.4 107.03 1.24 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.319 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.54 79.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.7 tt0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.893 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.469 ' HA2' ' HG3' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.572 -0.211 . . . . 0.0 112.572 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.496 ' OG ' ' HD3' ' A' ' 19' ' ' PRO . 48.4 t -168.71 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.662 0.268 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.2 ptt? -172.67 121.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.693 ' HB2' HG22 ' A' ' 14' ' ' THR . 16.7 pt20 -74.95 111.79 10.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.871 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 15' ' ' LEU . 33.5 pt -72.25 135.91 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.479 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.41 129.03 35.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.795 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.7 t -146.51 135.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.809 0.338 . . . . 0.0 111.593 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.45 123.05 36.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -70.41 -157.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.351 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.938 HD11 HG21 ' A' ' 36' ' ' ILE . 2.2 mm? -86.05 -48.97 8.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.125 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.8 t -71.08 -45.11 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 9' ' ' THR . . . 156.86 -36.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.787 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -49.22 131.16 19.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.897 0.38 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -84.76 132.3 34.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.795 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -96.65 130.04 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.696 179.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.693 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.4 m -107.5 129.13 54.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.727 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -159.56 114.56 2.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.106 0.479 . . . . 0.0 111.283 -178.06 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -76.39 144.32 40.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.389 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.417 HG22 HG23 ' A' ' 3' ' ' ILE . 30.9 m -149.7 145.99 17.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -68.55 143.52 95.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.154 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HD3' ' OG ' ' A' ' 0' ' ' SER . 18.2 Cg_endo -58.78 -39.47 81.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.67 2.247 . . . . 0.0 112.189 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.578 ' O ' HG22 ' B' ' 22' ' ' THR . 47.0 t -64.42 -29.59 70.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.001 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -55.91 130.02 42.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 20' ' ' SER . 70.5 p -62.35 148.48 45.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.724 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.539 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 66.6 mt -54.91 -42.2 62.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -62.89 -29.59 70.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.25 -49.29 51.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.009 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 35.3 m -62.54 -42.04 94.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.15 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 57.8 mtpt -60.88 -37.18 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.404 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.54 ' HA ' ' NE2' ' A' ' 31' ' ' GLN . . . -60.75 -36.66 79.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.488 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 1.009 ' HZ3' ' HA ' ' A' ' 26' ' ' VAL . 49.3 mttp -62.21 -41.5 98.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.603 HD13 HG11 ' A' ' 5' ' ' VAL . 60.3 mt -54.96 -31.79 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.893 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 28' ' ' ALA . 30.9 mt-30 -63.09 -51.35 66.93 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.31 -32.96 70.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.794 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 31.3 mmmt -69.79 -31.88 70.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.916 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -140.52 -68.31 0.41 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.166 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.14 -32.57 1.05 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.452 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.938 HG21 HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -47.79 132.62 11.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.587 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 87.7 Cg_exo -49.88 155.72 3.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.418 2.746 . . . . 0.0 112.743 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 16.9 Cg_exo -66.79 -39.44 14.97 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.899 2.399 . . . . 0.0 112.944 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.1 -40.07 76.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.587 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 86.4 mt-30 -61.03 -42.22 98.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.411 . . . . 0.0 110.665 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' OE1' HD12 ' A' ' 30' ' ' ILE . 67.2 mt-30 -57.51 143.28 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.182 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.787 ' H ' ' H ' ' B' ' 46' ' ' ALA . 64.6 mtt85 -135.98 110.83 8.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.427 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.471 ' H ' ' CD2' ' A' ' 43' ' ' LEU . 1.4 pt? -77.46 138.71 39.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.716 ' H ' ' H ' ' B' ' 44' ' ' ILE . 62.9 mt -136.42 112.36 12.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.293 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.738 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 4.3 m-85 -84.65 146.69 27.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.735 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.85 126.42 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.401 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.2 -133.58 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.039 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' O ' HD22 ' A' ' 50' ' ' LEU . 4.1 tppp? -67.31 75.91 0.15 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.92 0.39 . . . . 0.0 111.646 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 51' ' ' GLU . 35.9 mt-30 -64.01 101.56 0.4 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 48' ' ' LYS . 3.5 mm? -44.71 84.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.619 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' GLN . 47.6 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -1' ' ' GLY . . . . . 0.602 ' HA2' ' HG3' ' B' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.497 ' HB2' ' OE1' ' B' ' 18' ' ' GLU . 47.5 t -171.41 -48.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.564 0.221 . . . . 0.0 110.971 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.2 ptt? -174.28 120.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.242 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 16.4 pt20 -71.87 112.47 7.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 110.393 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.578 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.6 pt -72.64 133.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.825 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.48 125.07 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.114 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 1.011 HG13 HG13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -150.86 131.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.662 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.7 130.97 34.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -74.53 -157.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.767 HD21 HG12 ' B' ' 36' ' ' ILE . 2.0 mm? -86.05 -48.66 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.423 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.9 t -70.67 -45.23 65.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.575 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.423 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.94 -35.9 0.62 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -49.86 130.54 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 0.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -82.26 140.87 33.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.397 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 1.011 HG13 HG13 ' B' ' 5' ' ' VAL . 15.4 pt -116.98 130.17 72.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.291 0.567 . . . . 0.0 111.779 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -112.35 137.51 50.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.153 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.578 ' O ' HG12 ' B' ' 3' ' ' ILE . 2.6 pp -162.8 118.62 1.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.602 ' HG3' ' HA2' ' B' ' -1' ' ' GLY . 0.0 OUTLIER -70.73 146.03 50.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.761 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.537 HG13 HD12 ' B' ' 15' ' ' LEU . 8.4 m -150.88 141.8 16.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.518 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 46.5 mm-40 -67.45 143.05 96.91 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.452 ' HD3' ' OG ' ' B' ' 0' ' ' SER . 12.9 Cg_endo -57.01 -36.72 99.44 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.752 2.302 . . . . 0.0 112.099 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.554 ' O ' HG22 ' A' ' 22' ' ' THR . 44.1 t -64.49 -31.49 72.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.159 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 47.2 m-20 -54.67 130.78 41.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 20' ' ' SER . 72.9 p -63.21 148.36 48.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.502 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 68.1 mt -54.27 -42.11 55.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -63.1 -29.83 71.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.22 -49.48 49.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.854 ' HA ' ' HZ2' ' B' ' 29' ' ' LYS . 35.5 m -62.52 -41.32 91.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 58.3 mtpt -61.52 -38.23 86.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.56 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.543 ' HA ' ' NE2' ' B' ' 31' ' ' GLN . . . -59.67 -35.77 75.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.554 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.854 ' HZ2' ' HA ' ' B' ' 26' ' ' VAL . 50.1 mttp -62.57 -41.09 98.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.634 HD13 HG21 ' B' ' 5' ' ' VAL . 59.3 mt -54.78 -32.13 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.903 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' B' ' 28' ' ' ALA . 30.8 mt-30 -62.93 -51.27 67.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.9 -32.07 70.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.956 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 31.1 mmmt -69.75 -31.97 70.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.463 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.664 ' HB2' HD11 ' B' ' 36' ' ' ILE . 5.5 mm-40 -141.27 -61.32 0.48 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.714 0.292 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 126.79 40.93 0.32 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.453 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.796 HD12 ' H ' ' B' ' 36' ' ' ILE . 0.1 OUTLIER -110.46 135.94 20.63 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.558 0.218 . . . . 0.0 111.063 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 65.8 Cg_exo -51.55 143.71 35.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.451 2.1 . . . . 0.0 111.896 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' B' ' 37' ' ' PRO . 31.8 Cg_exo -60.89 -37.61 76.06 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.727 2.285 . . . . 0.0 112.697 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -60.47 -39.11 86.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.155 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.66 ' OE1' HG22 ' B' ' 36' ' ' ILE . 87.2 mt-30 -63.56 -39.04 93.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.53 ' OE1' HD12 ' B' ' 30' ' ' ILE . 69.1 mt-30 -60.9 144.82 52.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.735 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.735 ' H ' ' H ' ' A' ' 46' ' ' ALA . 64.1 mtt85 -137.87 114.56 10.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.457 ' O ' HD12 ' B' ' 43' ' ' LEU . 0.4 OUTLIER -78.27 145.4 35.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.973 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.716 ' H ' ' H ' ' A' ' 44' ' ' ILE . 69.3 mt -142.46 108.51 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.01 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.0 m-85 -82.91 145.24 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.75 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.787 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -157.51 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.224 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.63 -134.42 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.016 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -67.27 75.94 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.944 0.402 . . . . 0.0 111.528 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' B' ' 51' ' ' GLU . 35.7 mt-30 -64.01 110.87 2.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.453 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.5 mm? -52.22 79.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.347 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' B' ' 49' ' ' GLN . 21.4 pt-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.998 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 32.6 t 56.03 -128.36 2.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.484 0.183 . . . . 0.0 110.622 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm -165.54 117.13 1.1 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.118 0.485 . . . . 0.0 111.23 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.589 ' HB2' HG22 ' A' ' 14' ' ' THR . 18.7 pt20 -68.99 135.53 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.958 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.528 HG22 HD22 ' B' ' 43' ' ' LEU . 35.5 pt -108.31 144.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -89.11 129.28 35.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.986 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.604 HG13 ' O ' ' B' ' 45' ' ' PHE . 87.1 t -149.13 129.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.46 126.69 34.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -73.13 -157.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.94 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 36' ' ' ILE . 54.2 mt -74.25 -50.39 19.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.998 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -73.35 -45.43 55.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.575 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.94 -31.81 0.55 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.807 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -46.35 129.98 10.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.908 0.385 . . . . 0.0 111.578 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -85.43 134.87 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.895 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.571 ' CD1' HG23 ' A' ' 30' ' ' ILE . 8.7 pt -101.3 128.23 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 112.014 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.9 m -93.05 116.91 29.49 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.672 ' O ' HD23 ' A' ' 15' ' ' LEU . 2.4 tt -143.67 115.21 8.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.263 0.554 . . . . 0.0 111.993 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 0' ' ' SER . 16.8 pt-20 -76.66 143.76 39.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.951 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 26' ' ' VAL . 10.8 p -168.45 138.15 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 38.7 mt-10 -51.72 140.17 28.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.007 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.91 -42.58 11.12 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.83 2.353 . . . . 0.0 111.954 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.585 ' O ' HG22 ' B' ' 22' ' ' THR . 50.6 m -63.67 -23.05 67.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.402 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.614 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 7.7 t70 -54.16 131.86 42.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.362 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.604 HG22 ' O ' ' B' ' 20' ' ' SER . 72.7 p -56.82 142.37 41.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.867 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.66 HG22 ' HE2' ' A' ' 27' ' ' LYS . 65.9 mt -54.63 -35.73 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.913 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -63.43 -37.05 85.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.386 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.614 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 52.4 m-20 -74.54 -49.17 22.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.775 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 17' ' ' VAL . 30.4 m -54.06 -42.67 56.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.716 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 50.9 mtmt -70.43 -38.92 74.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -56.66 -35.13 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HG2' HD11 ' A' ' 15' ' ' LEU . 88.3 tttt -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.871 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.571 HG23 ' CD1' ' A' ' 13' ' ' ILE . 59.4 mt -58.32 -36.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 41.4 tt0 -60.76 -50.97 71.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.922 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.88 -33.09 71.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.901 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 30.6 mmmt -69.41 -35.73 76.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.267 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -135.08 -66.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.959 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.59 -39.53 0.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.347 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.696 HG22 ' OE1' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -45.04 121.45 4.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 82.8 Cg_exo -46.41 147.46 4.08 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.097 2.531 . . . . 0.0 112.251 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 18.0 Cg_endo -59.41 -36.51 93.72 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.475 2.117 . . . . 0.0 112.298 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.08 -36.79 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.413 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.696 ' OE1' HG22 ' A' ' 36' ' ' ILE . 90.5 mt-30 -61.58 -36.24 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.421 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.76 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 99.6 mm-40 -51.3 122.03 7.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.749 ' H ' ' H ' ' B' ' 46' ' ' ALA . 87.2 mtm180 -85.11 121.27 27.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.648 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.468 HD22 HG22 ' B' ' 3' ' ' ILE . 8.9 mp -69.13 122.6 19.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.404 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 61.4 mt -143.64 132.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.765 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 39.1 m-85 -136.63 148.76 47.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.706 ' HB3' ' HE ' ' B' ' 42' ' ' ARG . . . -153.06 131.34 12.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.984 0.421 . . . . 0.0 111.55 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.62 143.65 48.69 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.74 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.696 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 14.5 mmmm -67.19 74.93 0.13 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 111.281 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 51' ' ' GLU . 55.7 tp60 -66.73 97.93 0.49 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.804 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.4 mm? -44.88 80.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.654 0.596 . . . . 0.0 112.141 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 49' ' ' GLN . 12.7 pt-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.837 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.86 ' HB3' ' HB2' ' B' ' 16' ' ' GLU . 33.2 t 56.88 -127.82 1.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.603 -0.147 . . . . 0.0 110.603 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.4 ptm -166.64 115.74 0.89 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.016 0.436 . . . . 0.0 111.464 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.84 130.97 44.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.605 HG12 ' HG ' ' B' ' 15' ' ' LEU . 39.5 pt -102.31 143.13 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.32 129.37 35.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 45' ' ' PHE . 97.4 t -148.92 127.7 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 111.34 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -83.23 126.45 32.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.554 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -73.29 -157.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 54.1 mt -74.34 -49.83 21.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -74.28 -45.35 48.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.95 -31.33 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.773 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -47.05 129.88 12.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.691 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 40.7 m -82.63 143.97 30.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.48 ' CD1' HG23 ' B' ' 30' ' ' ILE . 28.7 pt -119.24 129.31 75.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.14 0.495 . . . . 0.0 112.079 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.63 128.0 46.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.07 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.605 ' HG ' HG12 ' B' ' 3' ' ' ILE . 2.5 pp -152.9 120.16 5.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.86 ' HB2' ' HB3' ' B' ' 0' ' ' SER . 11.2 pt-20 -73.06 138.18 45.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.029 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.412 HG13 ' O ' ' B' ' 16' ' ' GLU . 2.2 m -157.65 137.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.416 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' B' ' 21' ' ' ASP . 92.6 mt-10 -53.99 139.34 53.8 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.19 -41.73 26.29 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.621 2.214 . . . . 0.0 111.799 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.604 ' O ' HG22 ' A' ' 22' ' ' THR . 60.9 m -64.14 -21.87 66.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.494 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.596 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.0 t70 -55.06 132.34 47.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 20' ' ' SER . 77.1 p -57.98 142.43 46.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.807 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.658 HG22 ' HE2' ' B' ' 27' ' ' LYS . 65.7 mt -54.74 -36.09 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.88 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.43 -36.86 85.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.443 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.596 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 53.4 m-20 -73.74 -50.05 22.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.426 HG13 ' OD1' ' B' ' 21' ' ' ASP . 19.6 m -53.75 -42.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.658 ' HE2' HG22 ' B' ' 23' ' ' ILE . 50.7 mtmt -70.58 -38.73 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.376 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.714 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -58.03 -28.67 64.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.496 ' HD3' HD13 ' B' ' 15' ' ' LEU . 87.4 tttt -74.66 -32.91 62.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 109.906 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.578 HG21 ' NE2' ' B' ' 41' ' ' GLN . 53.0 mt -61.9 -41.0 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.155 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.714 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 20.8 pt20 -63.91 -42.83 97.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -58.47 -34.29 70.71 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.4 mmmt -72.35 -33.09 67.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.924 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -136.96 -65.86 0.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 161.42 -34.77 0.38 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.37 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.653 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -48.78 122.75 11.26 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.525 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 84.2 Cg_exo -50.13 146.57 17.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.804 2.336 . . . . 0.0 111.897 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 18.4 Cg_endo -57.98 -38.28 92.67 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.529 2.153 . . . . 0.0 112.693 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.41 -37.26 86.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.468 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.696 ' HB3' ' H ' ' A' ' 48' ' ' LYS . 85.5 mt-30 -61.38 -35.41 77.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.629 0.252 . . . . 0.0 111.482 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.765 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 6.1 mm-40 -54.6 124.55 16.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 110.876 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.706 ' HE ' ' HB3' ' A' ' 46' ' ' ALA . 87.0 mtm180 -85.93 123.24 31.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.832 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 3' ' ' ILE . 8.9 mp -70.57 123.14 21.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.199 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 61.5 mt -143.35 132.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 41.1 m-85 -136.9 148.38 47.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.591 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.749 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.15 134.75 15.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.024 0.44 . . . . 0.0 111.789 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.52 141.74 47.95 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.567 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.628 ' H ' ' HB3' ' A' ' 40' ' ' GLN . 14.4 mmmm -70.35 74.94 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.679 0.276 . . . . 0.0 111.657 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' B' ' 51' ' ' GLU . 42.2 mm-40 -64.25 115.85 5.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.498 HD22 ' N ' ' B' ' 50' ' ' LEU . 2.9 mm? -56.9 79.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.939 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' B' ' 49' ' ' GLN . 22.4 pt-20 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 16' ' ' GLU . 68.3 p -65.85 -120.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.46 0.171 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 18.1 ptm -155.24 120.32 4.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.017 0.437 . . . . 0.0 111.654 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 18.7 pt20 -63.31 139.05 58.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 15' ' ' LEU . 32.0 pt -114.47 153.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -87.45 131.13 34.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.892 ' HB ' HG23 ' A' ' 13' ' ' ILE . 50.1 t -142.28 155.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 89.3 mttt -141.22 122.24 14.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 51.4 p -69.16 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.706 ' H ' HD12 ' A' ' 8' ' ' LEU . 4.1 mp -68.79 -46.51 68.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.785 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -83.44 26.8 0.63 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.107 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.88 37.1 83.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.594 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 22.0 ttmm -76.05 128.28 34.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.597 0.237 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -72.83 134.72 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.53 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.892 HG23 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -151.3 133.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.234 0.54 . . . . 0.0 112.233 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -97.64 149.63 22.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.509 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 3' ' ' ILE . 12.4 tp -155.83 113.19 3.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.0 pt-20 -81.53 130.22 34.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.268 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.574 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 5.6 m -156.72 131.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.495 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 25.4 pt-20 -55.55 141.59 63.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.84 -37.82 91.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.813 2.342 . . . . 0.0 112.313 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.411 ' O ' HG22 ' B' ' 22' ' ' THR . 62.8 m -63.67 -21.8 66.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' ' CG ' ' A' ' 18' ' ' GLU . 38.7 t70 -61.47 134.29 56.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 HG22 ' O ' ' B' ' 20' ' ' SER . 73.5 p -64.67 146.33 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.473 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.676 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 60.4 mt -55.43 -37.17 43.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.241 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 16.3 pt-20 -58.13 -35.62 71.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.209 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 m120 -75.12 -48.36 24.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.748 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG11 HD11 ' B' ' 23' ' ' ILE . 34.5 m -56.02 -42.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.561 0.219 . . . . 0.0 111.146 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 35.4 mtmm -69.8 -38.44 76.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.408 . . . . 0.0 110.569 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.21 77.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.638 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.574 ' NZ ' HG12 ' A' ' 17' ' ' VAL . 83.3 mttt -63.66 -38.29 90.55 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.509 HG22 HD11 ' A' ' 36' ' ' ILE . 72.8 mt -56.06 -34.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.731 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.421 ' OE1' ' HG3' ' A' ' 38' ' ' PRO . 20.7 mt-30 -61.52 -43.14 99.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -63.89 -39.82 95.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.26 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' HD11 ' A' ' 13' ' ' ILE . 67.4 mttm -78.08 3.4 15.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.124 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -169.05 -109.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.197 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.46 51.28 0.03 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.354 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.845 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -123.09 129.26 25.02 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.451 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.583 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 91.8 Cg_exo -45.84 150.09 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.997 2.465 . . . . 0.0 112.509 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 32.1 Cg_exo -57.15 -34.33 97.56 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.518 2.146 . . . . 0.0 112.07 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.96 -39.49 93.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.03 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.583 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 88.5 mt-30 -60.89 -36.64 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.257 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.693 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 4.1 mm-40 -53.07 122.73 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.807 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.685 ' H ' ' H ' ' B' ' 46' ' ' ALA . 79.5 mtp180 -91.38 121.31 33.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.488 HD12 HG22 ' B' ' 3' ' ' ILE . 8.0 mt -82.28 129.91 34.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.026 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 63.3 mt -143.14 140.77 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.948 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 42.0 m-85 -135.14 138.87 44.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.802 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.86 138.47 21.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 111.512 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.66 -133.62 0.02 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.908 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -159.74 82.29 0.73 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.354 0.597 . . . . 0.0 111.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.3 tp-100 -65.82 98.07 0.38 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.851 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.3 mm? -44.14 81.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.973 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 49' ' ' GLN . 94.7 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.868 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.449 ' HB2' ' C ' ' B' ' 17' ' ' VAL . 70.7 p -65.69 -121.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.527 0.203 . . . . 0.0 110.875 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.5 ptm -153.97 120.67 5.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.09 0.472 . . . . 0.0 111.513 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.992 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.1 pt20 -62.28 142.75 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.665 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.4 pt -118.28 152.23 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.757 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -87.37 132.41 33.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' B' ' 13' ' ' ILE . 48.8 t -143.82 154.62 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.003 0.43 . . . . 0.0 111.349 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 57.9 mttp -139.04 123.22 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.186 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' B' ' 11' ' ' LYS . 56.2 p -72.72 -156.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.173 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.442 HD12 ' N ' ' B' ' 8' ' ' LEU . 6.5 mp -64.07 -50.91 66.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -82.8 28.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.335 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.02 36.66 68.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.485 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 21.6 ttmm -73.95 128.67 36.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 111.001 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -72.88 131.76 42.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.376 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.756 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -145.02 136.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.342 0.591 . . . . 0.0 111.85 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.992 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.3 OUTLIER -101.18 147.16 26.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.912 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.665 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.8 tt -157.62 114.13 2.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.153 0.502 . . . . 0.0 111.15 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.5 pt-20 -83.39 134.23 34.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.778 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.592 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 1.8 m -159.47 133.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' B' ' 21' ' ' ASP . 14.4 pt-20 -56.25 141.06 70.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.411 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.75 -37.86 95.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.921 2.414 . . . . 0.0 112.169 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 22' ' ' THR . 51.0 m -63.66 -24.45 67.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.715 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.561 ' HB2' ' HG3' ' B' ' 18' ' ' GLU . 63.2 t0 -58.95 133.46 56.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 20' ' ' SER . 76.8 p -64.12 146.86 53.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.637 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.681 HG22 ' NZ ' ' B' ' 27' ' ' LYS . 60.4 mt -56.07 -37.0 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.292 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.439 ' HG3' ' OD1' ' B' ' 25' ' ' ASN . 16.3 pt-20 -58.23 -36.54 73.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.363 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.504 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.1 m120 -74.88 -48.9 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.701 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 23' ' ' ILE . 34.4 m -55.12 -41.73 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.634 0.254 . . . . 0.0 111.017 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.681 ' NZ ' HG22 ' B' ' 23' ' ' ILE . 35.4 mtmm -70.21 -38.4 75.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.403 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.89 73.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.471 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.592 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 84.5 mttt -66.16 -37.22 85.12 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.807 HG22 HD11 ' B' ' 36' ' ' ILE . 67.8 mt -57.68 -32.12 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.643 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 21.8 mt-30 -61.58 -46.81 88.28 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.44 -33.89 77.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 71.9 mmtt -68.78 -18.08 64.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.435 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -157.72 -90.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.742 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.07 48.53 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.607 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.823 HD12 ' H ' ' B' ' 36' ' ' ILE . 0.4 OUTLIER -118.35 134.51 23.42 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.481 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 71.0 Cg_exo -51.57 147.64 22.82 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.771 2.314 . . . . 0.0 111.851 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.463 ' HG3' ' OE1' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -56.95 -34.44 97.37 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.448 2.098 . . . . 0.0 112.075 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.33 -35.03 78.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.561 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.758 ' OE1' HG22 ' B' ' 36' ' ' ILE . 82.6 mt-30 -66.96 -37.48 84.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.676 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.486 ' NE2' HD13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -52.26 126.93 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.788 0.327 . . . . 0.0 110.675 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.802 ' H ' ' H ' ' A' ' 46' ' ' ALA . 80.0 mtp180 -90.17 125.98 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.164 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 125.4 30.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 1.026 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 63.2 mt -143.25 138.82 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.408 . . . . 0.0 111.307 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 35.3 m-85 -136.93 140.26 42.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.685 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.02 136.4 17.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.605 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.87 -134.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.216 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -160.24 111.4 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.257 0.551 . . . . 0.0 111.777 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' B' ' 51' ' ' GLU . 13.4 mm100 -85.18 115.82 23.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.746 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.635 ' H ' HD22 ' B' ' 50' ' ' LEU . 2.7 mm? -59.62 79.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.015 0.436 . . . . 0.0 110.588 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' B' ' 49' ' ' GLN . 93.2 mt-10 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.917 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.808 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 56.7 m -67.46 -125.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.504 0.192 . . . . 0.0 110.756 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.646 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.6 ptt? -160.35 124.76 3.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.993 0.425 . . . . 0.0 111.05 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.672 ' HB3' HG22 ' A' ' 14' ' ' THR . 57.5 mt-30 -66.49 111.23 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.69 HD11 HD23 ' A' ' 15' ' ' LEU . 44.7 pt -84.14 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.203 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -88.0 133.01 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.712 ' HB ' HG13 ' A' ' 13' ' ' ILE . 88.6 t -149.07 126.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -82.28 116.04 21.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.458 HG23 HG12 ' A' ' 13' ' ' ILE . 72.7 p -67.7 -159.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.432 . . . . 0.0 110.911 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 36' ' ' ILE . 1.3 mp -82.45 -44.63 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.72 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.9 t -73.15 -44.84 59.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.312 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 9' ' ' THR . . . 154.75 -39.96 0.64 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.998 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -51.86 135.12 30.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 111.565 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 p -81.18 138.65 35.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.6 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.712 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -96.4 129.33 46.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.672 HG22 ' HB3' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -96.76 137.0 36.51 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.69 HD23 HD11 ' A' ' 3' ' ' ILE . 2.0 tp -162.32 115.1 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 111.975 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.808 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 25.4 pt-20 -85.06 132.68 34.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.359 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 15' ' ' LEU . 6.9 m -157.27 139.76 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.747 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.64 144.03 89.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.431 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.94 -37.7 52.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.769 2.313 . . . . 0.0 112.159 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -63.13 -23.23 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.374 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -60.96 134.84 57.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 p -61.69 141.57 57.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.747 HG12 HG12 ' B' ' 23' ' ' ILE . 57.6 mt -53.83 -41.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.124 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -55.29 -39.99 70.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.334 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -66.34 -51.02 61.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.822 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 23' ' ' ILE . 11.5 m -60.08 -40.05 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.022 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.699 ' NZ ' ' HB2' ' A' ' 41' ' ' GLN . 29.5 mtpp -64.02 -43.7 94.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.37 -42.37 86.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.11 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HD2' HD11 ' A' ' 15' ' ' LEU . 39.5 ttmt -62.71 -36.5 83.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG23 HD12 ' A' ' 13' ' ' ILE . 62.8 mt -55.51 -37.05 43.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.478 ' CD ' ' HD3' ' A' ' 38' ' ' PRO . 34.8 mt-30 -58.83 -40.43 84.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.77 -39.83 95.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.649 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 33' ' ' LYS . 4.8 mmmp? -61.22 -40.0 92.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.71 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.35 -89.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.442 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 45.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.552 ' H ' HD12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -122.68 126.43 26.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 65.8 Cg_exo -43.13 141.7 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.089 2.526 . . . . 0.0 112.706 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.516 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 28.0 Cg_endo -62.14 -33.84 80.87 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.641 2.227 . . . . 0.0 112.125 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.482 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 74.4 mt-30 -63.33 -39.92 95.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.581 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.699 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 6.6 mm100 -53.06 132.26 37.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.816 ' H ' ' H ' ' B' ' 46' ' ' ALA . 22.1 tpp180 -107.53 119.67 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.34 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.88 126.79 30.19 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.158 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.83 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.9 mt -144.21 123.25 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.672 ' HB2' HG22 ' B' ' 5' ' ' VAL . 4.0 m-85 -121.84 148.6 44.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.425 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.749 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.64 130.28 14.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 0.0 111.916 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.86 137.51 13.7 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.394 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.575 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -161.49 73.8 0.45 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.426 0.631 . . . . 0.0 111.281 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.648 ' HB2' ' NE2' ' B' ' 40' ' ' GLN . 3.6 tp-100 -68.53 105.43 2.22 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' H ' ' CD2' ' A' ' 50' ' ' LEU . 3.4 mm? -45.38 80.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.662 0.601 . . . . 0.0 111.774 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 49' ' ' GLN . 56.2 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.887 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.844 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 52.0 m -67.75 -125.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.549 0.214 . . . . 0.0 110.731 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.1 ptt? -163.54 115.3 1.43 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.54 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 4.4 pt20 -65.4 110.72 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.302 0.572 . . . . 0.0 110.868 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' B' ' 15' ' ' LEU . 37.4 pt -76.99 141.04 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.08 131.29 34.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' B' ' 13' ' ' ILE . 98.4 t -149.04 124.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 111.353 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -82.49 120.53 25.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.253 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -69.96 -160.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.534 HD11 ' CG2' ' B' ' 36' ' ' ILE . 6.3 mp -82.14 -42.87 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.409 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -71.58 -44.79 63.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.409 ' N ' HG23 ' B' ' 9' ' ' THR . . . 152.91 -39.66 0.72 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.036 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -52.04 134.95 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 111.961 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -82.12 142.71 32.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.021 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.677 HG13 ' HB ' ' B' ' 5' ' ' VAL . 11.4 pt -114.15 122.86 69.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.308 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -87.51 148.67 24.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.67 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.596 ' C ' HD23 ' B' ' 15' ' ' LEU . 5.3 tt -162.94 112.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.429 . . . . 0.0 110.659 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.844 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 14.5 pt-20 -82.78 132.16 35.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.821 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.588 HG21 HG22 ' B' ' 26' ' ' VAL . 2.4 m -159.44 139.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.617 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.86 142.75 88.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.452 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.466 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 26.3 Cg_endo -60.22 -37.24 84.49 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.878 2.385 . . . . 0.0 112.141 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.8 m -63.63 -26.48 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.659 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -56.64 135.26 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.343 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -61.87 142.27 57.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.747 HG12 HG12 ' A' ' 23' ' ' ILE . 58.8 mt -54.61 -40.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.16 -44.46 75.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.271 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -64.13 -47.95 77.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.588 HG22 HG21 ' B' ' 17' ' ' VAL . 24.6 t -56.34 -45.17 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.224 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.668 ' NZ ' ' HB2' ' B' ' 41' ' ' GLN . 28.2 mtpp -66.25 -41.16 90.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.203 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.97 83.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.58 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.453 ' CG ' HD11 ' B' ' 15' ' ' LEU . 39.2 ttmt -63.41 -34.89 78.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.397 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 26' ' ' VAL . 59.2 mt -58.19 -35.69 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.274 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 35.1 mt-30 -60.48 -47.74 84.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.66 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.687 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' B' ' 33' ' ' LYS . 22.8 tptp -65.65 -32.57 74.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.931 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.3 tp10 -144.89 -68.25 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.684 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.89 47.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.737 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.742 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -124.94 128.88 24.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.5 0.19 . . . . 0.0 111.394 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.5 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 54.2 Cg_exo -51.77 138.35 50.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.341 2.028 . . . . 0.0 111.554 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' CD ' ' B' ' 31' ' ' GLN . 19.0 Cg_endo -58.88 -34.0 98.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.577 2.185 . . . . 0.0 112.202 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.84 -39.15 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.643 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.742 ' OE1' HG22 ' B' ' 36' ' ' ILE . 84.1 mt-30 -65.79 -38.21 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.668 ' HB2' ' NZ ' ' B' ' 27' ' ' LYS . 0.7 OUTLIER -54.31 133.78 45.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.749 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.1 tpp180 -108.49 121.79 45.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 3' ' ' ILE . 10.8 mp -68.94 127.41 33.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.189 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.83 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -144.14 122.44 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.034 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.67 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.1 m-85 -120.97 146.03 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.816 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -148.25 128.9 14.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 111.696 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.76 137.7 13.61 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.302 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.608 ' HD2' ' N ' ' B' ' 48' ' ' LYS . 0.0 OUTLIER -160.27 73.97 0.54 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.509 0.671 . . . . 0.0 111.463 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.559 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.9 tp-100 -66.61 110.87 3.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.743 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.541 ' H ' HD22 ' B' ' 50' ' ' LEU . 3.3 mm? -50.47 80.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.497 0.498 . . . . 0.0 111.545 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' B' ' 49' ' ' GLN . 56.1 mt-10 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.828 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 52.7 m -60.45 -40.04 89.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 110.963 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 1' ' ' MET . 15.1 tpt -163.83 57.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.209 0.528 . . . . 0.0 110.958 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.429 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 20.8 pt20 -61.72 127.34 30.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.672 HD12 HD11 ' A' ' 30' ' ' ILE . 28.8 pt -95.47 132.44 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.576 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -88.83 128.77 35.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.756 HG21 HD13 ' A' ' 30' ' ' ILE . 63.4 t -148.49 138.49 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.151 0.501 . . . . 0.0 112.242 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -99.44 127.71 45.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.725 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.569 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 73.1 p -68.49 -156.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 111.302 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.729 ' H ' HD12 ' A' ' 8' ' ' LEU . 2.7 mp -64.36 -51.15 64.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -78.61 -45.73 20.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.866 0.365 . . . . 0.0 111.067 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 28.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.315 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 15.8 tppt? -77.37 122.65 25.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 m -75.38 138.71 41.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.557 HG13 ' HB ' ' A' ' 5' ' ' VAL . 12.4 pt -140.07 128.69 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.215 0.531 . . . . 0.0 112.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -97.37 145.99 25.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.67 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 3' ' ' ILE . 5.8 tt -163.94 114.05 1.27 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.04 0.448 . . . . 0.0 110.656 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' HG13 ' A' ' 17' ' ' VAL . 11.9 pt-20 -79.4 138.1 37.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -159.46 137.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.84 135.45 89.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -35.93 76.77 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 111.749 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' HG23 ' B' ' 22' ' ' THR . 45.0 t -63.77 -29.18 70.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.11 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.52 135.27 50.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.249 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.549 HG23 ' O ' ' B' ' 20' ' ' SER . 21.4 m -59.68 148.84 32.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 111.482 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 64.3 mt -60.34 -43.44 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.226 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.521 ' HG2' ' CG2' ' A' ' 22' ' ' THR . 12.6 pt-20 -59.25 -30.46 68.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.534 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 21.1 m-20 -71.26 -52.25 20.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 23' ' ' ILE . 34.4 m -59.97 -40.98 84.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.43 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 58.4 mtpt -62.39 -42.79 99.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -57.93 -34.8 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.349 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.3 mttm -66.6 -45.56 78.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.053 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.756 HD13 HG21 ' A' ' 5' ' ' VAL . 79.0 mt -55.15 -36.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 45.8 tt0 -61.92 -49.5 75.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.085 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -62.09 -32.27 72.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.058 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HG3' HD12 ' A' ' 15' ' ' LEU . 30.7 mmmt -68.49 -36.46 78.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.215 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.37 -67.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.789 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.33 -35.22 0.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.427 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.65 HG22 ' OE1' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.73 122.55 4.63 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.577 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 89.2 Cg_exo -47.22 147.07 5.95 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.161 2.574 . . . . 0.0 112.469 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.98 -35.62 98.27 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.463 2.109 . . . . 0.0 111.993 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -61.69 -38.34 87.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.65 ' OE1' HG22 ' A' ' 36' ' ' ILE . 88.5 mt-30 -65.72 -44.03 87.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.0 mt-30 -54.69 125.67 20.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.951 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.733 ' H ' ' H ' ' B' ' 46' ' ' ALA . 70.6 mtt-85 -97.36 127.99 43.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.524 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.57 HD23 HG22 ' B' ' 3' ' ' ILE . 10.8 tp -75.07 128.91 36.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.843 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 66.2 mt -143.5 139.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.935 0.397 . . . . 0.0 111.885 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 4.2 m-85 -128.19 147.72 50.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.697 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.4 124.66 5.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 111.596 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' HA2' ' C ' ' B' ' 40' ' ' GLN . . . -71.6 -135.5 0.15 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.243 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.498 ' O ' HD22 ' A' ' 50' ' ' LEU . 28.0 tptp -69.5 75.28 0.4 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.744 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 51' ' ' GLU . 85.2 mt-30 -64.41 102.33 0.53 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 50' ' ' LEU . 3.4 mm? -44.99 80.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.766 0.666 . . . . 0.0 111.741 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 49' ' ' GLN . 88.0 tt0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.836 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 53.0 m -60.99 -45.85 93.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.538 ' O ' ' HG3' ' B' ' 1' ' ' MET . 14.2 tpt -156.37 57.6 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.247 0.546 . . . . 0.0 110.945 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.673 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.6 pt20 -61.81 126.62 27.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.549 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.747 HD11 HD23 ' B' ' 15' ' ' LEU . 29.8 pt -95.62 133.39 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.92 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.36 129.63 35.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.728 HG21 HD13 ' B' ' 30' ' ' ILE . 61.0 t -147.8 143.97 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.053 0.454 . . . . 0.0 112.086 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -104.97 126.6 52.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.825 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -69.53 -156.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.868 0.366 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.444 HD12 ' N ' ' B' ' 8' ' ' LEU . 5.6 mp -59.96 -57.17 14.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -74.86 -45.49 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.64 30.59 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.003 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -82.43 130.99 35.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.408 . . . . 0.0 111.011 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -75.72 131.16 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.234 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.705 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -118.54 130.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.854 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.673 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -104.25 135.15 46.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.573 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.747 HD23 HD11 ' B' ' 3' ' ' ILE . 3.9 tp -161.35 113.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.169 0.509 . . . . 0.0 111.705 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.78 142.4 38.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.703 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.748 HG21 HG12 ' B' ' 26' ' ' VAL . 12.3 p -165.42 135.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -54.64 133.27 64.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.868 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.528 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 11.1 Cg_endo -55.94 -36.63 96.05 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.871 2.381 . . . . 0.0 111.843 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 22' ' ' THR . 46.1 t -63.74 -27.81 69.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -56.15 135.42 53.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 20' ' ' SER . 23.4 m -58.24 150.27 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.492 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.559 ' O ' HG22 ' B' ' 26' ' ' VAL . 64.2 mt -62.3 -43.92 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.546 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HG2' ' CG2' ' B' ' 22' ' ' THR . 12.5 pt-20 -57.4 -33.19 67.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.649 0.261 . . . . 0.0 111.195 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.551 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 29.5 m120 -73.05 -50.21 24.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.409 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.748 HG12 HG21 ' B' ' 17' ' ' VAL . 33.0 m -58.66 -38.06 69.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 59.0 mtpt -65.96 -43.64 87.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.044 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -59.31 -25.69 64.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.628 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 53.9 mttm -74.12 -39.79 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 109.918 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.728 HD13 HG21 ' B' ' 5' ' ' VAL . 69.4 mt -59.59 -41.74 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.283 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 21.8 pt20 -65.43 -40.18 92.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.33 -32.48 72.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.6 mmmt -73.92 -31.44 63.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.769 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -135.55 -67.19 0.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 151.85 -25.88 0.92 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.163 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.688 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -51.13 123.58 20.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.553 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -52.39 144.93 38.31 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.804 2.336 . . . . 0.0 111.85 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.48 -35.49 96.69 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.501 2.134 . . . . 0.0 112.246 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' B' ' 40' ' ' GLN . 2.5 p30 -62.15 -38.6 89.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.189 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.688 ' OE1' HG22 ' B' ' 36' ' ' ILE . 88.0 mt-30 -66.55 -41.63 88.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.437 ' OE1' HD12 ' B' ' 30' ' ' ILE . 71.3 mt-30 -56.77 130.93 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.697 ' H ' ' H ' ' A' ' 46' ' ' ALA . 71.6 mtt-85 -106.48 133.08 51.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.973 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.415 HD12 HG22 ' A' ' 3' ' ' ILE . 23.3 mt -76.61 131.83 39.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.896 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.843 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 65.4 mt -143.75 128.93 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.7 m-85 -121.45 142.41 50.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.733 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.44 125.66 9.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.048 0.452 . . . . 0.0 111.593 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.513 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . -70.74 -136.77 0.13 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.012 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -69.6 75.89 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 111.592 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' B' ' 51' ' ' GLU . 85.9 mt-30 -64.01 108.71 1.58 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.473 ' H ' HD22 ' B' ' 50' ' ' LEU . 3.3 mm? -49.62 80.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.581 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.1 tt0 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 51.7 m -68.77 -135.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.649 0.261 . . . . 0.0 110.981 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt -78.02 57.32 1.75 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.105 0.479 . . . . 0.0 110.988 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.863 ' HB2' HG22 ' A' ' 14' ' ' THR . 20.0 pt20 -66.58 110.59 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.295 0.569 . . . . 0.0 111.083 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 15' ' ' LEU . 18.8 pt -77.44 140.99 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.774 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -89.5 131.97 35.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.949 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 13' ' ' ILE . 2.3 p -149.86 135.04 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.804 0.335 . . . . 0.0 111.383 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -100.11 131.19 46.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.619 HG22 ' HG3' ' A' ' 34' ' ' GLU . 74.6 p -67.21 -158.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.735 0.302 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 36' ' ' ILE . 4.8 mp -89.28 -46.85 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 10' ' ' GLY . 6.0 t -72.05 -45.15 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 9' ' ' THR . . . 158.58 -31.37 0.47 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.927 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 12' ' ' THR . 7.0 tmtm? -45.48 126.95 7.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.905 0.384 . . . . 0.0 110.748 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.518 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 66.9 m -83.24 138.02 33.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.787 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.59 HG13 ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -118.8 139.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.863 HG22 ' HB2' ' A' ' 2' ' ' GLN . 6.8 m -127.37 137.99 52.9 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 3' ' ' ILE . 4.0 tt -159.82 121.97 3.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.048 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 22.8 pt-20 -72.13 143.42 48.98 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.75 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.584 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -158.36 140.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.414 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.34 143.24 90.44 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.086 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.85 -37.63 95.59 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.811 2.341 . . . . 0.0 112.14 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -64.17 -31.84 73.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.852 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -56.2 130.69 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.569 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -63.5 147.7 50.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.74 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.704 HG21 HD11 ' A' ' 43' ' ' LEU . 65.5 mt -54.58 -37.9 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.253 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.06 -31.7 72.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -74.62 -49.33 21.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.669 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG12 HG11 ' A' ' 17' ' ' VAL . 26.8 m -57.15 -42.63 80.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.162 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtmt -67.15 -37.71 84.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.464 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.497 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . . . -53.7 -36.86 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.262 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.584 ' NZ ' HG12 ' A' ' 17' ' ' VAL . 80.5 mttt -69.13 -42.55 75.86 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.648 HG22 HD11 ' A' ' 36' ' ' ILE . 61.4 mt -57.93 -30.35 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.571 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 15.6 mt-30 -60.83 -44.53 96.82 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.722 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HE3' HD12 ' A' ' 15' ' ' LEU . 72.5 mmtt -61.52 -29.17 69.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.621 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.619 ' HG3' HG22 ' A' ' 7' ' ' THR . 58.6 mm-40 -146.78 -84.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.88 43.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.079 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.684 HG22 ' OE1' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -113.28 124.04 32.22 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.64 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 56.8 Cg_exo -41.78 143.78 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.994 2.463 . . . . 0.0 112.334 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 11.8 Cg_endo -57.21 -35.53 98.91 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.494 2.129 . . . . 0.0 112.066 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -64.51 -39.65 94.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.683 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.684 ' OE1' HG22 ' A' ' 36' ' ' ILE . 90.1 mt-30 -60.22 -39.87 88.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.464 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.563 ' OE1' HD12 ' A' ' 30' ' ' ILE . 70.7 mt-30 -61.15 119.81 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.93 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 22.5 tpp180 -90.44 128.49 36.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.704 HD11 HG21 ' A' ' 23' ' ' ILE . 21.7 mt -80.82 136.24 36.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 111.01 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.97 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.1 mt -143.27 126.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.959 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.659 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 1.9 m-85 -116.48 142.08 47.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.7 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -145.13 123.23 12.12 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.992 0.425 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 139.79 44.3 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.819 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.487 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 54.8 tptt -77.1 74.1 3.68 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.125 0.488 . . . . 0.0 110.883 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 51' ' ' GLU . 38.6 tt0 -67.48 90.57 0.25 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.496 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -45.93 79.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.983 0.802 . . . . 0.0 111.584 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 49' ' ' GLN . 39.5 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.067 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.768 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 52.2 m -68.47 -133.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.58 0.229 . . . . 0.0 110.932 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.54 ' O ' ' HG2' ' B' ' 1' ' ' MET . 28.2 ttt -80.26 53.39 1.76 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.13 0.49 . . . . 0.0 110.824 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.942 ' HB2' HG22 ' B' ' 14' ' ' THR . 21.6 pt20 -62.27 110.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 43' ' ' LEU . 13.7 pt -80.09 140.74 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.105 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -89.12 130.13 35.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.012 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 1.076 HG13 HG13 ' B' ' 13' ' ' ILE . 1.6 p -150.07 131.52 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.335 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -93.38 131.58 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.599 HG22 ' HG3' ' B' ' 34' ' ' GLU . 74.1 p -68.44 -157.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 111.263 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.427 HD11 HG23 ' B' ' 36' ' ' ILE . 1.2 mt -85.96 -48.89 8.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.055 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.413 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.7 t -74.69 -45.2 46.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.827 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.413 ' N ' HG23 ' B' ' 9' ' ' THR . . . 159.49 -30.73 0.42 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.732 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' B' ' 12' ' ' THR . 7.3 tmtm? -45.65 127.87 8.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.97 0.414 . . . . 0.0 110.767 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' THR . . . . . 0.505 ' N ' ' HD3' ' B' ' 11' ' ' LYS . 34.0 m -84.46 140.55 31.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.687 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 1.076 HG13 HG13 ' B' ' 5' ' ' VAL . 7.1 pt -134.67 140.62 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.022 0.439 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.942 HG22 ' HB2' ' B' ' 2' ' ' GLN . 4.1 m -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.727 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.491 ' C ' ' HA ' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -153.94 134.92 13.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.768 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 12.5 pt-20 -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.174 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.561 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 7.5 m -154.81 137.47 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.064 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 4.5 mm-40 -69.74 143.66 92.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.29 -35.82 98.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.778 2.319 . . . . 0.0 112.232 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.5 t -63.88 -31.5 72.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.986 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 49.7 m-20 -57.49 130.33 45.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.652 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -62.9 147.39 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.693 HG21 HD11 ' B' ' 43' ' ' LEU . 65.9 mt -53.28 -37.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -62.42 -32.61 73.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -73.39 -49.22 28.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.687 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 23' ' ' ILE . 28.2 m -57.86 -42.85 83.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.64 0.257 . . . . 0.0 111.158 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' B' ' 31' ' ' GLN . 51.8 mtmt -66.42 -37.25 84.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.508 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HA ' ' CD ' ' B' ' 31' ' ' GLN . . . -54.9 -37.48 66.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.561 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 78.9 mttt -67.63 -42.22 82.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.529 HG22 HD11 ' B' ' 36' ' ' ILE . 62.8 mt -58.45 -30.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.594 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.579 ' OE1' ' HD3' ' B' ' 38' ' ' PRO . 16.3 mt-30 -61.2 -45.57 94.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.61 -35.87 82.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.772 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 72.5 mmtt -61.01 -29.32 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.523 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.599 ' HG3' HG22 ' B' ' 7' ' ' THR . 57.4 mm-40 -147.41 -81.15 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.2 44.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.751 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.765 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -112.96 124.44 31.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.616 0.246 . . . . 0.0 111.479 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.638 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 97.1 Cg_exo -44.78 143.66 4.09 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.818 2.346 . . . . 0.0 112.043 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 11.6 Cg_endo -56.65 -35.74 97.62 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.194 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -64.99 -39.24 93.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.765 ' OE1' HG22 ' B' ' 36' ' ' ILE . 89.1 mt-30 -61.56 -39.76 92.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.468 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.519 ' OE1' HD12 ' B' ' 30' ' ' ILE . 70.5 mt-30 -59.72 124.41 20.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.532 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.4 tpp180 -95.43 123.47 38.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.73 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.693 HD11 HG21 ' B' ' 23' ' ' ILE . 27.1 mt -75.49 135.31 40.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.088 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.97 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 71.7 mt -143.39 124.99 11.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.578 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.2 m-85 -115.64 146.52 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.584 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.5 129.59 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.529 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.97 132.61 34.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.524 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.63 ' H ' ' HB3' ' A' ' 40' ' ' GLN . 57.3 tptt -82.92 74.11 9.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.679 0.276 . . . . 0.0 111.172 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' B' ' 51' ' ' GLU . 18.7 pt20 -73.51 116.33 13.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.61 79.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.399 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' B' ' 49' ' ' GLN . 39.3 tt0 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.4 m -60.9 -40.42 93.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.8 tpt -163.42 49.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.088 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 pt20 -61.18 111.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.183 0.516 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 15' ' ' LEU . 24.6 pt -75.56 132.86 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.98 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -89.08 131.56 35.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.797 ' HB ' HG13 ' A' ' 13' ' ' ILE . 64.9 t -143.79 131.39 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 111.665 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.72 123.46 35.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.184 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -70.48 -157.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 36' ' ' ILE . 2.3 mm? -82.37 -48.13 11.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.778 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -73.18 -45.28 57.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.02 -31.64 0.5 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.881 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.66 130.08 11.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.985 0.421 . . . . 0.0 111.757 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 m -90.76 145.01 25.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.753 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.797 HG13 ' HB ' ' A' ' 5' ' ' VAL . 2.3 pt -119.44 126.64 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.68 132.04 43.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 3' ' ' ILE . 9.0 tp -153.59 113.18 3.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.157 0.503 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 39.3 tt0 -70.3 133.9 47.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.501 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 1' ' ' MET . 16.2 m -154.26 137.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.33 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 4.5 mm-40 -72.05 139.72 82.62 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.229 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.31 -38.0 61.37 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.817 2.345 . . . . 0.0 111.751 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 t -64.06 -33.68 76.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.017 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 36.3 m-20 -55.23 130.89 43.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.98 0.419 . . . . 0.0 110.627 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.4 p -59.49 146.79 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.905 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.615 HG21 HD11 ' A' ' 43' ' ' LEU . 63.3 mt -57.91 -29.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.022 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.02 -37.32 85.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 50.3 m-20 -72.1 -46.83 55.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 23' ' ' ILE . 32.7 m -58.35 -41.69 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.961 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HZ2' ' HB2' ' A' ' 41' ' ' GLN . 68.1 mttm -66.7 -40.79 88.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 0.0 110.606 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . . . -53.55 -40.29 65.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.406 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB2' HD21 ' A' ' 15' ' ' LEU . 50.0 mttm -64.74 -41.36 96.0 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.991 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.459 HG23 ' CD1' ' A' ' 13' ' ' ILE . 67.4 mt -57.46 -35.93 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 34.7 mt-30 -61.45 -45.63 93.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.011 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -64.65 -31.69 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.725 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -144.89 -67.2 0.32 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 48.97 0.06 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.972 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.67 HG21 HD21 ' A' ' 8' ' ' LEU . 2.3 pt -125.05 129.03 24.68 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.553 ' HD2' ' CD ' ' A' ' 40' ' ' GLN . 95.2 Cg_exo -45.88 140.67 9.69 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.793 2.329 . . . . 0.0 112.242 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD3' ' CD ' ' A' ' 31' ' ' GLN . 17.3 Cg_endo -58.57 -32.62 96.99 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.429 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.37 -36.51 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.553 ' CD ' ' HD2' ' A' ' 37' ' ' PRO . 87.0 mt-30 -60.02 -45.64 92.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.549 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.742 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -58.8 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 111.144 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.731 ' H ' ' H ' ' B' ' 46' ' ' ALA . 72.2 mtt-85 -97.44 128.89 44.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 23' ' ' ILE . 27.1 mt -78.62 131.4 36.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 0.0 111.448 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 66.4 mt -143.97 127.5 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.626 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 0.5 OUTLIER -115.35 145.09 42.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.389 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -152.22 122.88 7.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.05 -136.62 0.11 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.921 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.66 ' O ' HD22 ' A' ' 50' ' ' LEU . 97.9 mttt -66.8 121.56 15.73 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.107 0.479 . . . . 0.0 111.744 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 51' ' ' GLU . 35.4 mt-30 -72.61 96.57 2.0 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 48' ' ' LYS . 3.1 mm? -47.33 80.03 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.41 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 49' ' ' GLN . 88.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.873 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 53.2 p -60.63 -44.61 96.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.578 0.227 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.607 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.6 tpt -155.87 51.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.25 0.547 . . . . 0.0 110.919 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.605 ' HB2' HG22 ' B' ' 14' ' ' THR . 16.3 pt20 -61.32 110.44 1.42 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.637 HG12 ' O ' ' B' ' 15' ' ' LEU . 21.2 pt -76.74 131.43 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.069 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.26 132.91 34.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' B' ' 13' ' ' ILE . 66.3 t -145.08 131.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.757 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.26 123.5 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.196 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -71.05 -157.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.286 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.567 HD22 ' N ' ' B' ' 8' ' ' LEU . 2.6 mm? -81.15 -49.83 10.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -72.19 -45.35 60.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.575 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.61 -31.42 0.52 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.769 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.58 128.58 10.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.997 0.427 . . . . 0.0 111.627 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 42.9 m -89.46 139.3 30.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.615 HG13 ' HB ' ' B' ' 5' ' ' VAL . 13.4 pt -113.75 127.25 71.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 112.022 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.605 HG22 ' HB2' ' B' ' 2' ' ' GLN . 1.8 m -96.37 137.15 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.637 ' O ' HG12 ' B' ' 3' ' ' ILE . 5.0 tt -158.3 114.65 2.78 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.614 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 40.7 tt0 -71.91 138.6 48.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.609 HG13 ' CD2' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -158.92 134.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.181 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.69 137.64 95.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 10.2 Cg_endo -52.69 -37.9 75.98 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.847 2.365 . . . . 0.0 112.068 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.0 -30.97 72.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.306 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -55.4 134.16 50.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.855 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -61.19 146.34 47.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.664 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.495 ' O ' HG22 ' B' ' 26' ' ' VAL . 63.8 mt -57.86 -30.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.128 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -65.83 -36.65 84.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.905 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 52.7 m-20 -72.29 -47.13 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.264 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 23' ' ' ILE . 32.9 m -58.02 -41.45 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.935 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.473 ' HZ2' ' HB2' ' B' ' 41' ' ' GLN . 68.1 mttm -66.6 -39.98 88.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.927 0.394 . . . . 0.0 110.619 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.429 ' HA ' ' OE1' ' B' ' 31' ' ' GLN . . . -53.44 -42.29 66.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.277 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.553 ' HB2' HD11 ' B' ' 15' ' ' LEU . 45.5 mttm -64.29 -42.8 96.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.042 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' B' ' 36' ' ' ILE . 67.3 mt -55.26 -35.86 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.849 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 34.0 mt-30 -62.26 -42.16 99.08 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.93 -35.27 79.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.405 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 17.1 mmtp -60.43 -37.83 82.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.564 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -141.52 -60.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.297 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.59 45.16 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.779 HD12 ' H ' ' B' ' 36' ' ' ILE . 0.2 OUTLIER -112.13 130.63 23.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.56 0.219 . . . . 0.0 111.544 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.439 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 62.9 Cg_exo -51.97 139.6 50.83 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.434 2.09 . . . . 0.0 111.744 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.5 ' HD3' ' CD ' ' B' ' 31' ' ' GLN . 15.1 Cg_endo -57.22 -32.21 92.91 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.6 -35.93 82.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.698 ' OE1' HG22 ' B' ' 36' ' ' ILE . 83.0 mt-30 -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.703 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -60.07 124.48 20.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.319 . . . . 0.0 110.711 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.689 ' H ' ' H ' ' A' ' 46' ' ' ALA . 72.5 mtt-85 -91.69 126.65 36.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.053 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.572 HD23 ' CG2' ' A' ' 3' ' ' ILE . 10.5 tp -80.28 129.89 34.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.939 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 69.8 mt -143.64 136.98 24.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -121.37 146.71 46.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.471 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.731 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.5 123.91 6.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.357 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . -72.29 -138.79 0.27 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.899 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.42 ' O ' HD22 ' B' ' 50' ' ' LEU . 97.3 mttt -65.36 123.6 20.02 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.121 0.486 . . . . 0.0 111.356 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' B' ' 51' ' ' GLU . 35.4 mt-30 -74.35 104.8 5.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.461 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.4 mm? -52.74 80.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.394 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' B' ' 49' ' ' GLN . 37.3 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.874 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.401 ' HA2' ' OE1' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 18' ' ' GLU . 47.3 t -61.6 -57.88 10.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.604 0.24 . . . . 0.0 111.051 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm 178.54 106.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.419 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.04 125.0 25.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.506 HG12 ' HG ' ' A' ' 15' ' ' LEU . 32.3 pt -91.91 139.27 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.493 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.67 130.14 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.735 ' HB ' HG13 ' A' ' 13' ' ' ILE . 44.8 t -145.24 133.81 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -93.06 120.61 33.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.2 p -72.48 -157.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.738 0.304 . . . . 0.0 111.395 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.502 HD21 HG23 ' A' ' 36' ' ' ILE . 31.6 mt -80.6 -51.47 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.044 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.8 t -69.01 -45.17 71.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.593 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 9' ' ' THR . . . 153.89 -34.12 0.74 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.761 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -49.27 130.33 19.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.59 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -80.15 146.85 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.349 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.735 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.0 pt -126.05 129.53 72.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.775 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 p -107.85 142.65 37.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.422 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 15' ' ' LEU . 2.8 pp -165.41 122.32 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 1' ' ' MET . 11.4 pt-20 -75.71 140.97 42.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.427 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.418 HG13 ' CD1' ' A' ' 15' ' ' LEU . 3.4 m -153.21 133.53 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.162 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 87.0 mt-10 -59.74 138.83 90.07 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.074 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.25 -39.07 92.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.937 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 t -64.15 -30.57 71.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.122 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' HG23 ' A' ' 26' ' ' VAL . 38.0 t70 -54.6 136.28 45.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.618 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -64.96 144.46 57.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.557 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 67.3 mt -55.85 -38.69 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -56.18 -44.93 79.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.046 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.2 m120 -65.43 -46.35 80.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.492 HG21 HD11 ' B' ' 23' ' ' ILE . 6.5 t -53.61 -48.62 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.162 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.692 ' HE3' ' HB3' ' A' ' 38' ' ' PRO . 51.5 mtmt -68.62 -35.4 77.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.43 -40.29 71.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.458 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 25.5 mmmt -62.09 -43.75 98.16 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.334 0.588 . . . . 0.0 109.582 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.607 HD12 ' OE1' ' A' ' 41' ' ' GLN . 62.2 mt -57.16 -35.9 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.748 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 35.4 mt-30 -58.97 -43.97 91.46 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.25 -37.5 83.61 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.942 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 28.9 mtpp -76.8 3.45 11.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.815 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -169.22 -102.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.145 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.71 49.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.422 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.772 ' H ' HD12 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -121.99 127.17 26.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.64 0.257 . . . . 0.0 111.437 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 79.0 Cg_exo -48.89 144.3 15.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.219 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.692 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -56.45 -37.74 96.64 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.569 2.18 . . . . 0.0 112.406 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.82 -38.88 92.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.309 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.69 ' OE1' HG22 ' A' ' 36' ' ' ILE . 84.2 mt-30 -63.54 -39.45 94.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.607 ' OE1' HD12 ' A' ' 30' ' ' ILE . 71.3 mt-30 -59.75 110.79 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -81.88 130.82 35.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.321 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.513 ' HB2' HG22 ' B' ' 3' ' ' ILE . 33.0 mt -80.05 135.7 36.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 81.0 mt -143.28 133.84 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.35 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.831 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 6.8 m-85 -127.53 140.98 51.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.813 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -151.63 126.05 9.42 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.093 0.473 . . . . 0.0 111.843 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.09 141.2 48.1 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.729 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' O ' HD22 ' A' ' 50' ' ' LEU . 31.8 mmmt -69.2 74.59 0.33 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.014 0.435 . . . . 0.0 111.639 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 51' ' ' GLU . 47.8 mm-40 -69.32 103.01 1.86 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 50' ' ' LEU . 3.4 mm? -45.05 80.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.795 0.684 . . . . 0.0 111.69 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' GLN . 56.1 mt-10 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' B' ' 18' ' ' GLU . 47.5 t -60.94 -58.31 8.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.678 0.275 . . . . 0.0 110.978 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.2 ptm 179.67 106.61 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.519 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.731 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.4 pt20 -67.3 127.91 34.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.226 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.622 HG12 ' O ' ' B' ' 15' ' ' LEU . 24.2 pt -97.35 136.69 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.975 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -89.97 126.82 35.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.122 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.936 HG13 HG13 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.45 132.55 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.999 0.428 . . . . 0.0 111.5 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -84.83 129.7 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.074 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.502 HG23 HG12 ' B' ' 13' ' ' ILE . 77.9 p -77.54 -157.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.163 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.402 ' H ' ' HB ' ' B' ' 7' ' ' THR . 53.6 mt -81.42 -50.76 9.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.197 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.425 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -71.33 -45.26 63.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.693 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.425 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.88 -35.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.841 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -48.61 130.47 17.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.342 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 62.1 m -82.48 134.17 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.141 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.936 HG13 HG13 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -100.76 131.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 111.624 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.731 HG22 ' HB2' ' B' ' 2' ' ' GLN . 1.3 m -105.27 134.23 48.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.622 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -162.53 115.04 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -178.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.5 pt-20 -78.39 140.26 38.73 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.196 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.03 136.2 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.242 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.463 ' HA ' ' OG ' ' B' ' 0' ' ' SER . 87.4 mt-10 -59.91 140.07 90.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.077 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 12.9 Cg_endo -56.75 -40.01 87.34 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.799 2.333 . . . . 0.0 112.032 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.7 t -64.08 -29.78 70.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.118 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -56.15 136.02 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.61 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 71.1 p -65.07 145.81 55.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.697 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.591 ' O ' HG22 ' B' ' 26' ' ' VAL . 66.8 mt -55.84 -39.04 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.7 -40.0 74.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.17 -49.28 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 23' ' ' ILE . 15.7 m -57.24 -41.44 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.707 ' HE3' ' HB3' ' B' ' 38' ' ' PRO . 50.3 mtmt -69.82 -38.63 76.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 110.818 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.447 ' HA ' ' OE1' ' B' ' 31' ' ' GLN . . . -54.44 -41.52 69.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.737 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -68.26 -37.77 81.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.209 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.634 HG22 HD11 ' B' ' 36' ' ' ILE . 63.0 mt -57.62 -34.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.494 ' OE1' ' HG3' ' B' ' 38' ' ' PRO . 35.4 mt-30 -60.65 -41.41 94.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -67.23 -37.76 84.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.752 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -78.0 3.24 15.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.637 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -168.53 -106.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 50.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.812 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.634 HD11 HG22 ' B' ' 30' ' ' ILE . 0.7 OUTLIER -126.57 119.89 23.09 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.575 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 35.5 Cg_exo -38.89 146.3 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.296 2.664 . . . . 0.0 112.982 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.707 ' HB3' ' HE3' ' B' ' 27' ' ' LYS . 33.6 Cg_exo -58.83 -38.14 90.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.665 2.244 . . . . 0.0 112.646 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.56 -39.2 90.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.593 ' OE1' HG22 ' B' ' 36' ' ' ILE . 86.6 mt-30 -60.16 -44.99 94.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.391 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.831 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 71.4 mt-30 -54.37 115.75 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.982 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.813 ' H ' ' H ' ' A' ' 46' ' ' ALA . 56.2 ttp180 -87.49 124.3 33.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.818 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 3' ' ' ILE . 44.1 mt -72.87 133.34 44.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.968 0.414 . . . . 0.0 111.121 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 74.8 mt -143.51 131.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.466 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.582 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.7 m-85 -127.19 148.05 50.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.762 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.91 132.39 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.308 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.05 141.8 43.91 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.52 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 40' ' ' GLN . 32.2 mmmt -69.19 74.89 0.34 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.899 0.38 . . . . 0.0 111.803 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.3 mm100 -68.16 111.8 4.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.47 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.4 mm? -52.85 80.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.452 0.47 . . . . 0.0 111.368 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' B' ' 49' ' ' GLN . 55.4 mt-10 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.961 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 18' ' ' GLU . 47.8 t -65.46 -56.72 10.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.688 0.28 . . . . 0.0 111.069 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.6 ptm -175.54 115.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.211 0.529 . . . . 0.0 111.303 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.489 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 10.8 tt0 -72.63 134.63 45.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.492 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.658 HG12 ' O ' ' A' ' 15' ' ' LEU . 29.5 pt -117.6 145.3 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.027 0.442 . . . . 0.0 112.067 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.2 m-85 -89.3 133.91 34.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.761 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.745 ' HB ' HG12 ' A' ' 13' ' ' ILE . 92.3 t -144.91 136.64 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.136 0.493 . . . . 0.0 111.781 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 40.4 ttmt -91.47 134.41 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.499 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -71.43 -157.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.515 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.446 HD21 HG23 ' A' ' 36' ' ' ILE . 38.7 mt -65.37 -63.91 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.7 t -77.57 -45.18 26.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 9' ' ' THR . . . 155.49 108.05 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.329 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 24.2 ttmm -167.19 127.84 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.724 0.297 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -73.27 133.39 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.745 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.1 pt -135.44 135.54 51.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.489 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 3.3 p -90.43 144.43 25.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.069 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.658 ' O ' HG12 ' A' ' 3' ' ' ILE . 10.7 tp -160.58 114.05 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.216 0.532 . . . . 0.0 111.76 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.6 pt-20 -85.35 132.45 34.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.671 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -151.06 142.96 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.356 . . . . 0.0 111.141 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.579 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 42.0 mt-10 -67.43 137.44 93.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.3 -36.14 88.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.807 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.475 ' O ' HG22 ' B' ' 22' ' ' THR . 79.8 p -64.44 -27.86 69.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.357 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 51.6 m-20 -58.96 133.1 55.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.686 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.418 HG22 ' O ' ' B' ' 20' ' ' SER . 59.3 p -63.06 145.95 54.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.695 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 56.1 mt -53.54 -38.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -60.44 -39.91 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.103 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -67.39 -48.81 66.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.646 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -61.34 -43.87 97.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.317 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.695 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 36.3 mtmm -62.6 -43.8 97.91 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.9 0.381 . . . . 0.0 110.044 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 31' ' ' GLN . . . -60.43 -29.25 68.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.451 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' NZ ' ' NZ ' ' A' ' 33' ' ' LYS . 26.2 tptp -64.85 -43.03 94.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.744 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.546 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 51.3 mt -57.28 -31.83 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.723 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' NE2' ' HA ' ' A' ' 37' ' ' PRO . 75.3 mt-30 -58.16 -48.01 81.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -61.32 -36.89 81.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.826 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 38.6 mmtm -67.49 -24.21 65.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.135 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -153.16 -90.0 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.092 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.78 61.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.888 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.754 HG22 ' OE1' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -139.54 118.27 8.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.559 0.218 . . . . 0.0 111.549 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.598 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 54.8 Cg_exo -40.27 146.03 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.152 2.568 . . . . 0.0 112.822 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.675 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 19.8 Cg_endo -60.04 -36.0 90.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.818 2.345 . . . . 0.0 112.61 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.44 -38.86 85.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.754 ' OE1' HG22 ' A' ' 36' ' ' ILE . 79.1 mt-30 -64.1 -40.49 96.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.244 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 1.1 mm-40 -52.44 126.94 20.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.192 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.743 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.5 mtt180 -94.85 124.77 39.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.235 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.458 ' HB2' HG22 ' B' ' 3' ' ' ILE . 64.1 mt -78.35 132.03 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.384 . . . . 0.0 111.0 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.966 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 74.5 mt -143.57 131.96 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.539 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.662 ' O ' HG13 ' B' ' 5' ' ' VAL . 4.8 m-85 -126.36 147.12 49.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.6 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.7 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.39 128.04 7.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 111.703 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.18 -138.04 0.07 OUTLIER Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.972 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 50' ' ' LEU . 23.4 tptm -96.75 74.82 2.72 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.084 0.469 . . . . 0.0 111.701 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.59 ' NE2' ' HB1' ' A' ' 46' ' ' ALA . 4.3 mp0 -69.06 103.59 1.91 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.476 ' H ' ' CD2' ' A' ' 50' ' ' LEU . 3.5 mm? -44.9 80.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.745 0.653 . . . . 0.0 111.772 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 49' ' ' GLN . 24.2 pt-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.96 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.553 ' OG ' ' HA ' ' B' ' 18' ' ' GLU . 46.8 t -65.06 -56.41 13.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.462 0.172 . . . . 0.0 111.013 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.1 ptm 179.56 108.45 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 112.044 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.983 ' HB3' HG22 ' B' ' 14' ' ' THR . 87.5 mt-30 -62.25 145.13 54.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.688 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.666 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.1 pt -121.77 143.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.1 m-85 -88.05 131.28 34.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.856 ' HB ' HG23 ' B' ' 13' ' ' ILE . 84.4 t -142.43 146.04 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.091 0.472 . . . . 0.0 111.563 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.425 ' CG ' ' HA2' ' B' ' 10' ' ' GLY . 40.3 ttmt -102.08 131.57 48.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.194 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 70.0 p -68.61 -157.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 111.457 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.46 HD21 HG23 ' B' ' 36' ' ' ILE . 75.1 mt -64.67 -65.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.221 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.4 t -76.79 -45.25 29.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.427 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.06 109.03 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.358 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -167.25 129.46 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.696 0.284 . . . . 0.0 110.903 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -73.37 134.34 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.756 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.856 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -137.85 122.49 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.266 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.983 HG22 ' HB3' ' B' ' 2' ' ' GLN . 0.1 OUTLIER -80.16 145.22 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.477 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.666 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.2 tt -162.72 112.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.21 0.529 . . . . 0.0 111.177 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.4 pt-20 -82.92 141.11 32.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.955 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.934 HG11 HG23 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -157.65 145.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.557 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.553 ' HA ' ' OG ' ' B' ' 0' ' ' SER . 44.7 mt-10 -71.13 133.99 85.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.992 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.97 -37.69 97.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.796 2.33 . . . . 0.0 112.2 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.418 ' O ' HG22 ' A' ' 22' ' ' THR . 80.5 p -63.89 -25.92 68.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.465 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 53.0 m-20 -60.81 131.44 50.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 20' ' ' SER . 65.9 p -60.8 146.55 45.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.723 HG22 ' NZ ' ' B' ' 27' ' ' LYS . 54.8 mt -55.36 -37.79 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.099 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.403 ' HG3' ' OD1' ' B' ' 25' ' ' ASN . 15.9 pt-20 -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.403 ' OD1' ' HG3' ' B' ' 24' ' ' GLU . 45.9 m-20 -67.7 -46.3 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.452 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.934 HG23 HG11 ' B' ' 17' ' ' VAL . 7.8 p -61.93 -41.21 90.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.723 ' NZ ' HG22 ' B' ' 23' ' ' ILE . 36.8 mtmm -66.61 -44.55 81.79 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.01 0.433 . . . . 0.0 110.203 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' B' ' 31' ' ' GLN . . . -57.87 -27.29 63.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.509 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -64.87 -43.89 91.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.817 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.66 HG22 HD11 ' B' ' 36' ' ' ILE . 51.5 mt -57.57 -30.95 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.824 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 74.2 mt-30 -58.05 -48.49 79.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.5 -37.34 83.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.767 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 38.5 mmtm -66.48 -25.1 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -152.03 -87.23 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.15 57.3 0.02 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.248 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.692 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.5 OUTLIER -134.9 125.56 17.32 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.56 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 70.5 Cg_exo -44.28 145.16 2.51 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.0 2.467 . . . . 0.0 112.386 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.663 ' HB2' ' HE2' ' B' ' 27' ' ' LYS . 20.2 Cg_endo -60.27 -35.13 92.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.497 2.131 . . . . 0.0 112.223 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.64 -38.15 89.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.692 ' OE1' HG22 ' B' ' 36' ' ' ILE . 89.4 mt-30 -64.19 -37.23 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' B' ' 27' ' ' LYS . 1.4 mm-40 -54.54 129.26 35.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.3 mtt180 -97.52 124.67 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.251 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 3' ' ' ILE . 50.7 mt -79.46 132.71 36.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.399 . . . . 0.0 111.115 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.966 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.1 mt -143.54 131.27 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.367 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.8 m-85 -125.28 143.99 50.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.743 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -153.43 129.94 10.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.526 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.91 -138.22 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.784 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -98.23 74.9 2.25 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.052 0.454 . . . . 0.0 111.693 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.538 ' NE2' ' HB1' ' B' ' 46' ' ' ALA . 4.2 mp0 -68.09 112.58 5.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.466 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.4 mm? -51.45 80.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.551 0.532 . . . . 0.0 111.467 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' B' ' 49' ' ' GLN . 24.1 pt-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 52.3 m -58.39 141.14 52.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.849 0.357 . . . . 0.0 110.834 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HE1' HD13 ' B' ' 43' ' ' LEU . 20.4 ptm -72.27 116.53 12.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.812 ' HB2' HG22 ' A' ' 14' ' ' THR . 20.4 pt20 -71.47 122.73 20.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.574 HG22 HD22 ' B' ' 43' ' ' LEU . 38.0 pt -86.15 144.16 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.556 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -88.89 134.98 33.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.972 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.661 HG22 ' HB2' ' B' ' 45' ' ' PHE . 59.5 t -148.2 132.74 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.865 0.364 . . . . 0.0 111.145 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.83 126.43 43.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 9' ' ' THR . 91.1 m -67.62 150.55 48.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.872 HD21 HG21 ' A' ' 36' ' ' ILE . 4.2 mp -45.02 -45.2 10.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.438 ' H ' HG22 ' A' ' 7' ' ' THR . 72.0 p -75.46 -45.5 38.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.392 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.43 0.53 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.88 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -44.02 131.59 5.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -74.15 141.72 45.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 1.1 mt -128.62 139.12 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.028 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.812 HG22 ' HB2' ' A' ' 2' ' ' GLN . 7.2 m -133.52 142.86 48.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.9 HD13 ' HD2' ' A' ' 33' ' ' LYS . 5.8 tp -157.02 114.95 3.19 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 16.9 pt-20 -71.89 130.51 41.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.612 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 18.7 m -152.57 138.65 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 48.5 mt-10 -69.16 140.87 91.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.72 -36.37 81.59 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.969 2.446 . . . . 0.0 112.239 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.523 ' O ' HG22 ' B' ' 22' ' ' THR . 46.0 t -64.3 -32.04 73.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 54.5 m-20 -56.27 132.59 51.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.499 HG22 ' O ' ' B' ' 20' ' ' SER . 66.6 p -60.06 147.18 40.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.642 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 26' ' ' VAL . 61.5 mt -54.38 -36.95 35.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.788 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.66 -32.22 72.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -69.28 -47.46 64.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.208 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 23' ' ' ILE . 22.7 m -60.22 -39.28 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.969 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HE3' HG22 ' A' ' 23' ' ' ILE . 99.3 mttt -67.13 -38.75 86.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.84 -38.62 35.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.427 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.777 ' HD2' HD21 ' A' ' 15' ' ' LEU . 80.0 mttt -67.79 -41.07 83.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -55.14 -36.83 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.357 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' CD ' ' HD3' ' A' ' 38' ' ' PRO . 34.8 mt-30 -63.28 -45.0 93.49 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.94 -33.01 74.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.712 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.9 ' HD2' HD13 ' A' ' 15' ' ' LEU . 29.6 mtpp -71.71 -31.56 66.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.935 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -135.63 -60.18 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.11 57.06 0.19 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.083 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.872 HG21 HD21 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -145.07 131.43 9.78 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 120.819 0.342 . . . . 0.0 111.352 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 60.6 Cg_exo -40.89 139.46 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.29 2.66 . . . . 0.0 113.229 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HD3' ' CD ' ' A' ' 31' ' ' GLN . 18.0 Cg_endo -60.36 -36.2 88.18 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.922 2.414 . . . . 0.0 112.663 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.25 -37.19 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.473 ' HB3' ' H ' ' B' ' 48' ' ' LYS . 76.8 mt-30 -59.27 -45.41 91.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.672 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.34 124.37 15.74 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.73 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.687 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.9 ttm180 -91.46 123.18 34.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.555 HD21 HG21 ' A' ' 23' ' ' ILE . 9.3 mp -73.49 132.04 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.949 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 79.9 mt -143.61 134.65 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.669 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 8.3 m-85 -128.62 144.81 51.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.818 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.72 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.04 129.4 10.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.994 0.426 . . . . 0.0 111.439 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' B' ' 8' ' ' LEU . . . -56.75 138.39 47.04 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.897 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.718 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 28.1 tptp -71.1 74.54 0.66 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.028 0.442 . . . . 0.0 111.36 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 51' ' ' GLU . 73.5 mt-30 -66.34 99.8 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.82 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.7 mm? -44.91 80.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.754 0.658 . . . . 0.0 111.859 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.92 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.713 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 54.3 m -58.53 144.19 43.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.822 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.492 ' HE1' HD13 ' A' ' 43' ' ' LEU . 20.2 ptm -76.12 113.52 13.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.149 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.94 ' HB2' HG22 ' B' ' 14' ' ' THR . 21.3 pt20 -69.22 124.33 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.462 HG22 HD22 ' A' ' 43' ' ' LEU . 37.4 pt -88.33 145.83 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.831 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.76 135.51 33.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.153 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.717 ' HB ' HG13 ' B' ' 13' ' ' ILE . 57.6 t -148.47 138.31 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 111.132 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.9 125.55 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.437 HG22 ' H ' ' B' ' 9' ' ' THR . 90.4 m -67.03 151.32 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.484 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.798 HD22 ' H ' ' B' ' 8' ' ' LEU . 0.4 OUTLIER -47.26 -42.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.663 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.437 ' H ' HG22 ' B' ' 7' ' ' THR . 67.4 p -75.92 -45.36 35.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.86 -30.44 0.61 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.911 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -45.29 134.62 6.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 39.1 m -79.94 143.82 33.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.0 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.717 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.4 pt -142.78 135.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.142 0.496 . . . . 0.0 111.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.94 HG22 ' HB2' ' B' ' 2' ' ' GLN . 6.0 m -139.75 141.74 36.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.07 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.52 HD22 ' CD ' ' B' ' 33' ' ' LYS . 0.9 OUTLIER -150.69 130.8 13.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.022 0.439 . . . . 0.0 111.193 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.713 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 11.1 pt-20 -69.85 132.78 46.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.963 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.534 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 17.3 m -150.43 136.83 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.48 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 48.1 mt-10 -69.5 138.8 88.85 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.257 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.22 -36.05 65.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.061 2.507 . . . . 0.0 112.261 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 22' ' ' THR . 45.6 t -64.01 -32.69 74.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.05 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 55.3 m-20 -56.0 132.54 50.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.824 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 20' ' ' SER . 69.0 p -59.49 148.26 33.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.67 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.592 ' O ' HG22 ' B' ' 26' ' ' VAL . 61.3 mt -54.59 -36.89 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.38 -31.05 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.774 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -65.96 -52.04 53.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.061 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.592 HG22 ' O ' ' B' ' 23' ' ' ILE . 24.4 m -58.29 -39.7 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.262 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' B' ' 23' ' ' ILE . 98.8 mttt -66.88 -37.99 85.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.74 -40.74 55.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.314 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 78.7 mttt -68.23 -40.4 82.06 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' B' ' 27' ' ' LYS . 70.6 mt -54.34 -36.69 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.168 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 34.2 mt-30 -63.79 -44.54 93.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.394 0.616 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -67.46 -32.48 73.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.62 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.52 ' CD ' HD22 ' B' ' 15' ' ' LEU . 29.6 mtpp -70.61 -32.41 69.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.092 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.861 ' HB2' HD11 ' B' ' 36' ' ' ILE . 56.8 mm-40 -138.14 -55.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.678 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.77 54.89 0.23 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.62 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.861 HD11 ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -135.44 135.63 22.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.578 0.228 . . . . 0.0 111.057 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.566 ' HB2' ' HG3' ' B' ' 40' ' ' GLN . 75.7 Cg_exo -50.04 138.54 35.52 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.45 2.1 . . . . 0.0 112.028 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' B' ' 27' ' ' LYS . 18.5 Cg_endo -58.03 -35.55 98.67 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.817 2.345 . . . . 0.0 112.496 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.18 -36.12 79.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.259 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.718 ' HB3' ' H ' ' A' ' 48' ' ' LYS . 77.6 mt-30 -62.82 -44.2 96.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.57 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.669 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.79 126.42 22.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.785 0.326 . . . . 0.0 110.488 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.72 ' H ' ' H ' ' A' ' 46' ' ' ALA . 38.8 ttm180 -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.664 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.574 HD22 HG22 ' A' ' 3' ' ' ILE . 8.9 mp -74.49 132.5 41.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.949 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 76.7 mt -143.55 134.21 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.672 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 8.1 m-85 -128.4 144.32 51.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.687 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 132.39 13.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.954 0.407 . . . . 0.0 111.413 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.7 135.75 51.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.64 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 40' ' ' GLN . 28.1 tptp -71.19 74.7 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.98 0.419 . . . . 0.0 111.235 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' B' ' 51' ' ' GLU . 73.7 mt-30 -65.43 111.72 3.2 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.672 ' H ' HD22 ' B' ' 50' ' ' LEU . 2.8 mm? -53.12 80.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.366 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' B' ' 49' ' ' GLN . 9.8 mp0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.679 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 67.0 m -164.25 -126.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.509 0.195 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 17.0 ptm -160.19 117.38 2.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.986 0.422 . . . . 0.0 110.979 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.655 ' HB2' HG22 ' A' ' 14' ' ' THR . 19.8 pt20 -61.86 129.45 41.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.702 HD11 HD23 ' A' ' 15' ' ' LEU . 36.7 pt -97.49 135.04 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.76 125.5 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.838 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.2 t -147.79 134.44 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.692 0.282 . . . . 0.0 111.681 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -93.52 119.62 32.81 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -66.53 -159.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.484 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.906 HD11 HG21 ' A' ' 36' ' ' ILE . 2.3 mm? -81.59 -47.02 13.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -73.47 -45.44 54.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.394 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -35.7 0.55 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.806 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.2 133.01 15.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.967 0.413 . . . . 0.0 111.591 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 m -84.77 132.88 34.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.04 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.838 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -99.97 134.43 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.888 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.1 m -109.01 133.86 52.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.702 HD23 HD11 ' A' ' 3' ' ' ILE . 5.4 tp -159.84 114.85 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 112.099 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 16.9 pt-20 -79.01 137.13 37.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.219 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.27 135.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -57.88 140.99 81.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 12.2 Cg_endo -56.34 -40.03 87.38 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.818 2.345 . . . . 0.0 112.127 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -64.14 -28.81 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.064 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 8.3 t70 -53.53 132.33 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.8 p -62.94 144.37 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.875 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 26' ' ' VAL . 64.7 mt -55.4 -36.33 40.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.279 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -62.97 -35.67 80.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.4 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.544 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 50.6 m-20 -72.93 -48.03 40.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.621 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 23' ' ' ILE . 32.7 m -57.47 -44.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.138 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 99.3 mttt -65.06 -38.44 90.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 110.461 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . . . -55.26 -37.73 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.151 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HB2' HD21 ' A' ' 15' ' ' LEU . 29.8 mmtp -66.48 -39.67 88.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.996 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.465 HG23 HD12 ' A' ' 13' ' ' ILE . 62.2 mt -56.32 -35.94 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.886 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 28' ' ' ALA . 35.2 mt-30 -59.66 -44.6 93.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.07 -34.17 77.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.133 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 73.1 mmtt -66.27 -25.04 66.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.85 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -150.27 -79.59 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.943 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.43 57.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.236 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.906 HG21 HD11 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -140.97 129.28 12.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.465 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 59.7 Cg_exo -41.63 142.47 1.24 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.263 2.642 . . . . 0.0 113.179 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 25.7 Cg_endo -61.63 -37.26 70.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.958 2.438 . . . . 0.0 112.742 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.09 -36.22 72.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.474 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 81.6 mt-30 -60.5 -44.98 95.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.63 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.98 125.64 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.673 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.2 mtt180 -89.2 126.68 35.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.511 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -75.66 130.3 38.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.343 . . . . 0.0 110.857 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.935 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.4 mt -143.59 132.03 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.05 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.691 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 3.3 m-85 -127.34 145.39 50.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.577 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.728 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -149.98 125.47 10.25 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.872 0.368 . . . . 0.0 111.417 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.88 -139.13 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.106 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -70.8 74.88 0.61 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.984 0.421 . . . . 0.0 111.507 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.4 mm-40 -65.4 99.46 0.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.8 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.6 mm? -44.79 80.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.797 0.685 . . . . 0.0 111.718 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.587 ' N ' ' O ' ' A' ' 49' ' ' GLN . 16.3 tp10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.943 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.551 -0.22 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.892 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 68.6 m -164.4 -124.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.446 0.165 . . . . 0.0 110.646 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.8 ptm -163.32 117.16 1.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -61.7 130.35 45.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.648 HG12 ' HB3' ' B' ' 15' ' ' LEU . 35.3 pt -97.27 131.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.278 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.724 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -88.97 120.85 30.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.865 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.93 HG13 HG13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -150.91 130.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.063 0.459 . . . . 0.0 111.765 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -83.13 126.64 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.385 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -70.57 -157.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.309 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.699 HD21 HG12 ' B' ' 36' ' ' ILE . 2.0 mm? -83.0 -48.33 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p -71.77 -45.29 62.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.27 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 -34.22 0.62 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.763 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -49.43 130.91 20.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.863 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 37.2 m -80.92 147.27 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.901 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.93 HG13 HG13 ' B' ' 5' ' ' VAL . 18.6 pt -129.36 124.78 60.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 0.0 112.477 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -92.88 146.89 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.178 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.648 ' HB3' HG12 ' B' ' 3' ' ' ILE . 5.3 tt -164.2 114.62 1.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.829 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.892 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 11.3 pt-20 -78.02 138.05 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.622 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.584 HG13 ' CD2' ' B' ' 15' ' ' LEU . 1.0 OUTLIER -157.25 133.41 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.943 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -59.14 138.28 88.11 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.448 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 9.3 Cg_endo -52.51 -39.06 75.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.917 2.412 . . . . 0.0 112.106 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.5 t -63.93 -29.8 70.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.155 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.554 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.2 t70 -53.81 131.87 40.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 0.0 110.526 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -62.42 144.01 56.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.916 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 19' ' ' PRO . 65.2 mt -55.22 -35.72 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -63.15 -36.14 82.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.347 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.554 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 51.0 m-20 -72.7 -48.37 39.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.602 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 23' ' ' ILE . 31.0 m -57.23 -43.76 82.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.438 ' HE3' ' CG2' ' B' ' 23' ' ' ILE . 99.0 mttt -65.09 -38.34 90.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.413 ' HA ' ' OE1' ' B' ' 31' ' ' GLN . . . -55.18 -37.07 66.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.575 ' HB2' HD11 ' B' ' 15' ' ' LEU . 58.0 mmtt -64.56 -43.5 93.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' B' ' 33' ' ' LYS . 65.4 mt -53.5 -36.29 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.147 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 34.9 mt-30 -59.82 -45.57 91.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -67.57 -33.46 75.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.229 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.525 ' HG3' HD12 ' B' ' 15' ' ' LEU . 72.7 mmtt -65.44 -25.29 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.169 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' B' ' 36' ' ' ILE . 17.7 tp10 -152.61 -68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.299 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.85 55.7 0.04 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.72 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.739 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -133.89 133.33 22.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.51 0.195 . . . . 0.0 111.28 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.472 ' HD2' ' OE1' ' B' ' 40' ' ' GLN . 71.7 Cg_exo -51.04 139.59 41.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.451 2.101 . . . . 0.0 112.092 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.432 ' O ' ' HD3' ' B' ' 27' ' ' LYS . 19.8 Cg_endo -58.29 -35.75 98.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.831 2.354 . . . . 0.0 112.679 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.739 ' OE1' HG22 ' B' ' 36' ' ' ILE . 88.4 mt-30 -63.33 -41.96 98.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -56.25 126.36 25.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.834 0.349 . . . . 0.0 110.488 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.728 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.4 mtt180 -86.16 127.04 34.65 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.51 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.616 HD23 HG22 ' A' ' 3' ' ' ILE . 5.4 tp -78.3 127.6 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.656 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.935 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 70.5 mt -143.71 138.15 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-O 120.88 0.371 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.63 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 3.6 m-85 -131.24 148.67 52.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.673 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.9 124.26 8.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.94 -140.43 0.05 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.356 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -71.62 75.05 0.81 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 111.553 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' B' ' 51' ' ' GLU . 1.5 mm-40 -64.41 111.07 2.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.726 ' H ' HD22 ' B' ' 50' ' ' LEU . 2.7 mm? -52.76 80.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.559 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' B' ' 49' ' ' GLN . 38.3 tp10 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.007 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.522 ' C ' ' HB2' ' A' ' 16' ' ' GLU . 47.9 t -171.46 -50.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.726 0.298 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.3 ptm -100.12 112.75 25.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.233 0.539 . . . . 0.0 111.248 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.476 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 20.9 tt0 -62.95 120.79 12.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.3 pt -99.7 143.07 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 112.22 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.4 m-85 -89.86 135.31 33.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.124 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.799 ' HB ' HG13 ' A' ' 13' ' ' ILE . 67.4 t -148.79 132.76 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -92.46 129.22 38.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.698 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 11' ' ' LYS . 61.5 p -77.37 -157.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 110.908 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.865 HD21 HG21 ' A' ' 36' ' ' ILE . 51.7 mt -83.45 -53.49 5.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.57 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -73.16 -45.28 57.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.32 -27.15 0.25 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.325 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' HG23 ' A' ' 7' ' ' THR . 4.0 tppp? -43.24 130.36 4.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 111.952 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -89.21 138.84 31.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.981 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.799 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.2 pt -125.4 133.85 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.271 0.558 . . . . 0.0 111.907 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 4.7 p -117.72 144.27 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.623 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' O ' HG12 ' A' ' 3' ' ' ILE . 3.3 pp -168.0 124.73 1.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.292 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -77.15 143.01 39.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -179.344 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 15' ' ' LEU . 3.7 m -150.97 132.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.86 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 85.5 mt-10 -63.38 137.83 97.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.75 -36.19 61.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.13 2.553 . . . . 0.0 112.5 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.42 ' O ' HG22 ' B' ' 22' ' ' THR . 45.0 t -63.87 -33.23 75.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.094 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.637 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -56.47 133.23 53.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -60.27 148.47 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.826 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.723 HD11 HG21 ' B' ' 26' ' ' VAL . 69.0 mt -54.67 -45.33 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 12.1 pt-20 -59.82 -36.09 76.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -63.59 -48.25 78.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.752 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 23' ' ' ILE . 11.0 m -64.82 -41.01 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.171 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.42 -39.21 93.89 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.666 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -55.24 -37.45 67.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HE3' HG12 ' A' ' 17' ' ' VAL . 48.4 mttm -63.64 -41.95 98.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.643 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 13' ' ' ILE . 70.8 mt -55.09 -39.33 49.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.421 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 43.1 tt0 -61.17 -47.13 87.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.153 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -60.01 -37.38 79.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.051 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 4.5 mmmp? -66.18 -42.42 88.91 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.948 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -124.55 -70.21 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.083 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.0 -37.34 0.42 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.254 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.865 HG21 HD21 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -44.61 126.09 4.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.525 ' HD2' ' CD ' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -47.1 142.73 11.1 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.305 2.67 . . . . 0.0 112.761 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 46.8 Cg_exo -56.33 -37.34 97.1 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.766 2.311 . . . . 0.0 112.475 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.75 -38.32 81.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.624 ' OE1' HG22 ' A' ' 36' ' ' ILE . 89.6 mt-30 -60.51 -39.27 87.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.743 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.696 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.64 124.09 15.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 99.3 mtt180 -89.54 128.57 36.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.431 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HG22 ' B' ' 3' ' ' ILE . 23.7 mt -74.27 130.55 39.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.838 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 76.6 mt -143.88 133.04 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.2 m-85 -130.33 147.23 52.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.725 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.82 123.99 5.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 111.562 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.31 138.08 47.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 97.5 mttt -59.26 120.41 9.2 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.794 0.807 . . . . 0.0 111.317 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.598 ' O ' ' N ' ' A' ' 51' ' ' GLU . 18.8 pt20 -149.16 99.78 2.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.986 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' H ' ' CD2' ' A' ' 50' ' ' LEU . 3.5 mm? -44.96 80.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.692 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 49' ' ' GLN . 5.6 tp10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.423 ' N ' ' HB2' ' B' ' 16' ' ' GLU . 48.0 t -173.0 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.702 0.287 . . . . 0.0 111.156 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.6 ptm -109.63 117.53 34.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.465 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.41 ' HB3' ' CG2' ' B' ' 14' ' ' THR . 89.5 mt-30 -62.03 130.52 45.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.249 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.709 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.1 pt -104.09 139.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.592 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.0 m-85 -88.86 129.78 35.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.685 ' HB ' HG13 ' B' ' 13' ' ' ILE . 62.0 t -144.07 134.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 111.462 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -96.09 127.73 42.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 66.3 p -76.54 -157.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.961 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.586 HD11 HG23 ' B' ' 36' ' ' ILE . 7.7 mp -83.04 -52.63 6.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.519 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -74.27 -45.27 48.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.67 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.07 -28.45 0.27 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.559 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -42.96 130.68 4.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.768 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.685 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -106.22 129.5 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.115 0.483 . . . . 0.0 112.002 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' B' ' 2' ' ' GLN . 1.9 m -107.46 136.33 47.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.709 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -163.36 115.64 1.49 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.864 -178.085 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' B' ' 1' ' ' MET . 23.9 pt-20 -76.92 139.27 40.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.439 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -151.26 138.09 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.645 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 85.5 mt-10 -67.33 140.52 95.31 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.03 -37.62 86.56 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.082 2.521 . . . . 0.0 112.497 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.3 t -63.85 -32.97 74.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.188 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.645 ' OD1' ' HB2' ' B' ' 18' ' ' GLU . 1.0 OUTLIER -56.21 132.93 51.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 20' ' ' SER . 80.4 p -60.65 149.07 36.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.792 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.816 HD13 HD21 ' B' ' 43' ' ' LEU . 67.1 mt -55.2 -45.07 77.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.12 -41.62 88.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.834 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 12.9 t-20 -61.4 -44.14 97.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.515 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.723 HG21 HD11 ' A' ' 23' ' ' ILE . 16.8 t -61.47 -47.85 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.388 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 47.7 mtmt -65.08 -36.38 84.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.303 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.683 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -56.51 -32.65 65.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.152 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 50.4 mttm -69.26 -33.84 73.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.183 0.516 . . . . 0.0 109.735 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.625 HG23 HD12 ' B' ' 13' ' ' ILE . 60.9 mt -61.75 -42.18 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.597 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 22.3 pt20 -66.35 -45.33 80.57 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' B' ' 31' ' ' GLN . 63.7 t0 -58.77 -31.73 68.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' B' ' 30' ' ' ILE . 22.9 tptp -73.27 -32.23 64.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.556 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.403 ' HB3' HD11 ' B' ' 36' ' ' ILE . 36.9 tp10 -139.31 -64.76 0.49 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.004 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 159.07 -32.56 0.46 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.343 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.666 HG22 ' OE1' ' B' ' 40' ' ' GLN . 0.3 OUTLIER -49.74 128.95 20.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.478 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 50.4 Cg_exo -54.57 140.58 75.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.68 2.254 . . . . 0.0 111.668 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.605 ' HB3' ' HB2' ' B' ' 27' ' ' LYS . 53.6 Cg_exo -52.75 -37.26 75.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.563 2.175 . . . . 0.0 112.665 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -61.11 -37.4 82.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.564 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.666 ' OE1' HG22 ' B' ' 36' ' ' ILE . 78.6 mt-30 -62.87 -38.97 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.75 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.68 126.43 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.698 0.285 . . . . 0.0 110.588 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.725 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.4 mtt180 -92.35 127.48 37.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.992 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.816 HD21 HD13 ' B' ' 23' ' ' ILE . 7.7 mp -72.86 129.07 37.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.226 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 77.9 mt -143.89 131.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.696 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 5.3 m-85 -128.94 145.86 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.747 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.616 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -155.81 126.09 6.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 111.461 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.76 137.84 46.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.443 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' HE ' ' A' ' 42' ' ' ARG . 98.2 mttt -59.7 122.42 14.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.551 0.691 . . . . 0.0 111.375 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' B' ' 51' ' ' GLU . 19.1 pt20 -149.63 114.28 5.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.035 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.464 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.4 mm? -56.32 79.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' B' ' 49' ' ' GLN . 5.6 tp10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.711 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.417 ' HA3' ' CD ' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 81.0 p -61.79 -60.45 3.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 ptm 177.61 112.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.702 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 1.041 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.8 pt20 -69.05 130.12 41.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 15' ' ' LEU . 5.0 pt -99.75 147.05 7.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.79 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 4.6 m-85 -89.57 126.98 35.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.911 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.709 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.1 t -149.5 137.28 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.277 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -104.62 129.67 52.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.391 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -68.38 -157.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.117 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.529 ' H ' HD12 ' A' ' 8' ' ' LEU . 3.6 mp -86.57 -51.58 6.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.242 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.8 p -72.11 -45.48 60.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.729 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 -29.73 0.26 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -43.97 129.91 5.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.967 0.413 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -90.27 137.53 32.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.339 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.709 HG13 ' HB ' ' A' ' 5' ' ' VAL . 3.7 pt -122.87 134.63 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 111.344 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.041 HG22 ' HB2' ' A' ' 2' ' ' GLN . 3.8 m -127.0 105.1 8.37 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -123.68 127.91 48.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 1' ' ' MET . 12.5 pt-20 -72.39 139.27 47.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.83 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -150.26 135.17 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 80.4 mt-10 -64.22 137.9 97.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.235 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.34 -36.58 97.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.831 2.354 . . . . 0.0 112.031 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.583 ' O ' HG22 ' B' ' 22' ' ' THR . 43.4 t -64.19 -33.94 76.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.898 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.621 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 30.2 m-20 -57.99 133.33 55.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.576 HG22 ' O ' ' B' ' 20' ' ' SER . 76.1 p -58.49 149.51 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.453 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.623 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 63.2 mt -53.33 -38.23 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.846 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.426 ' HA ' ' HZ1' ' A' ' 27' ' ' LYS . 17.1 tp10 -59.27 -42.29 90.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.452 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.71 -44.9 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.774 HG21 HD11 ' B' ' 23' ' ' ILE . 24.3 t -57.34 -48.93 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.176 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.623 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 36.8 mtmm -66.04 -35.56 80.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . . . -55.27 -38.43 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.178 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HE2' ' NZ ' ' A' ' 33' ' ' LYS . 87.9 tttt -67.28 -38.86 85.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.04 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.601 HD12 ' HG2' ' A' ' 41' ' ' GLN . 58.4 mt -58.12 -34.29 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.891 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 27.8 mt-30 -64.08 -44.46 92.31 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 -32.58 71.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' NZ ' ' HE2' ' A' ' 29' ' ' LYS . 36.2 mmtm -71.67 -30.09 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.03 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -140.96 -66.49 0.43 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.204 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 150.86 -32.15 0.98 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.901 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.653 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -48.66 127.05 13.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD2' ' HG3' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -46.63 158.76 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.014 2.476 . . . . 0.0 112.43 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.506 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 17.1 Cg_endo -57.74 -37.37 96.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.598 2.198 . . . . 0.0 112.262 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.08 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.539 ' HG3' ' HD2' ' A' ' 37' ' ' PRO . 1.9 mm-40 -52.26 -55.94 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -56.79 128.24 35.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.783 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.2 mmt180 -96.83 125.65 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 23' ' ' ILE . 9.4 mp -68.81 122.52 18.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.539 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 62.4 mt -143.75 130.48 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.072 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.716 ' HB2' HG22 ' B' ' 5' ' ' VAL . 8.8 m-85 -130.03 145.12 51.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.794 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.766 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -146.42 127.45 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 111.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' HA2' ' C ' ' B' ' 40' ' ' GLN . . . -69.62 -141.85 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.304 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -71.92 75.18 0.9 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.917 0.389 . . . . 0.0 111.274 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 51' ' ' GLU . 85.6 mt-30 -65.32 102.02 0.63 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mp -44.83 80.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.714 0.634 . . . . 0.0 111.712 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 49' ' ' GLN . 5.0 mm-40 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' -1' ' ' GLY . . . . . 0.414 ' HA3' ' CD ' ' B' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 79.6 p -62.43 -59.75 4.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.295 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.3 ptm 177.69 110.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.964 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.996 ' HB2' HG22 ' B' ' 14' ' ' THR . 4.8 pt20 -68.97 127.02 31.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.504 HG12 ' O ' ' B' ' 15' ' ' LEU . 26.1 pt -99.86 150.04 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.479 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 3.5 m-85 -89.1 129.43 35.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.358 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.716 HG22 ' HB2' ' A' ' 45' ' ' PHE . 87.8 t -149.74 137.27 13.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -104.38 130.27 52.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.288 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 76.6 p -70.62 -157.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.406 . . . . 0.0 111.678 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.52 HD11 HG21 ' B' ' 36' ' ' ILE . 4.8 mp -82.44 -56.66 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.433 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -71.2 -45.44 63.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.881 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.29 -28.64 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.8 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -43.62 128.09 5.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.305 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -87.53 137.17 32.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.715 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.5 pt -123.59 128.44 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 111.441 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.996 HG22 ' HB2' ' B' ' 2' ' ' GLN . 7.5 m -124.01 110.51 14.87 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.67 HD13 ' HG3' ' B' ' 33' ' ' LYS . 1.5 pt? -136.19 131.17 34.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.406 0.622 . . . . 0.0 111.846 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.8 pt-20 -70.03 142.96 52.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.883 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.528 ' HB ' HG12 ' B' ' 26' ' ' VAL . 21.2 m -152.27 134.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.191 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 86.6 mt-10 -61.97 137.45 95.48 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.645 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.11 -39.19 81.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.831 2.354 . . . . 0.0 111.914 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.576 ' O ' HG22 ' A' ' 22' ' ' THR . 47.1 t -64.15 -30.64 71.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.467 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 46.5 m-20 -59.77 132.71 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 20' ' ' SER . 74.5 p -57.44 149.59 20.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.502 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.774 HD11 HG21 ' A' ' 26' ' ' VAL . 64.4 mt -54.27 -37.78 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 109.705 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' NZ ' ' B' ' 27' ' ' LYS . 4.6 tp10 -60.22 -37.4 80.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.453 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -66.58 -48.43 69.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.576 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.626 HG22 ' O ' ' B' ' 23' ' ' ILE . 9.4 m -60.65 -42.24 91.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.031 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.637 ' HZ2' HG22 ' B' ' 23' ' ' ILE . 36.8 mtmm -65.68 -38.1 88.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.922 0.391 . . . . 0.0 110.258 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.485 ' HA ' ' OE1' ' B' ' 31' ' ' GLN . . . -55.91 -36.44 67.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.489 ' HG2' HD12 ' B' ' 15' ' ' LEU . 88.3 tttt -68.51 -39.51 81.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.044 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.623 HD12 ' HG2' ' B' ' 41' ' ' GLN . 59.3 mt -57.67 -33.86 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.685 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 30.0 mt-30 -63.34 -47.18 83.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.16 -31.01 68.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.67 ' HG3' HD13 ' B' ' 15' ' ' LEU . 25.7 mmtp -75.18 -27.07 59.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -141.48 -66.74 0.41 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.158 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 149.31 -32.04 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.041 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.641 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 0.7 OUTLIER -50.41 129.53 25.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' B' ' 40' ' ' GLN . 91.0 Cg_exo -47.17 157.98 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.979 2.452 . . . . 0.0 112.323 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.508 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 13.9 Cg_endo -58.14 -36.06 98.2 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.451 2.101 . . . . 0.0 112.152 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -60.4 -33.45 72.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.523 ' HG3' ' HD2' ' B' ' 37' ' ' PRO . 1.9 mm-40 -52.2 -55.52 20.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.029 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -56.65 127.92 33.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.766 ' H ' ' H ' ' A' ' 46' ' ' ALA . 37.5 mmt180 -96.1 126.23 41.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.401 ' N ' HD12 ' B' ' 43' ' ' LEU . 8.9 mp -69.57 122.05 18.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.415 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 76.0 mt -143.79 130.1 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.693 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.7 m-85 -129.93 144.63 51.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.74 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.783 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -144.97 128.11 16.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.459 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . -70.03 -142.07 0.17 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.347 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -74.73 74.82 2.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.007 0.432 . . . . 0.0 111.572 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' B' ' 51' ' ' GLU . 82.6 mt-30 -64.84 112.01 3.07 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.624 ' H ' HD22 ' B' ' 50' ' ' LEU . 1.4 mm? -52.5 80.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.296 0.372 . . . . 0.0 111.428 -178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' B' ' 49' ' ' GLN . 5.0 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.788 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 53.6 m 56.05 -140.19 0.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.515 0.198 . . . . 0.0 111.05 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 1' ' ' MET . 15.7 tpt -82.23 48.81 1.31 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.028 0.442 . . . . 0.0 111.176 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.614 ' HB2' HG22 ' A' ' 14' ' ' THR . 18.9 pt20 -61.84 111.13 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' LEU . 34.9 pt -84.87 141.59 14.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -87.82 130.16 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.751 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.6 t -145.17 145.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.027 0.441 . . . . 0.0 111.553 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 67.3 mttm -108.33 129.81 55.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.323 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.29 -156.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.324 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.33 -52.06 66.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.5 t -76.63 -45.1 31.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.995 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 143.21 32.76 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.488 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 61.8 tttp -81.32 131.12 35.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -73.04 136.79 45.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.437 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.751 HG23 ' HB ' ' A' ' 5' ' ' VAL . 1.3 tt -139.49 124.08 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 111.749 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -86.54 144.12 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.984 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 15' ' ' LEU . 5.0 tt -158.32 113.31 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.805 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 25.7 pt-20 -88.18 132.64 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.588 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.684 HG21 HG13 ' A' ' 26' ' ' VAL . 2.9 m -159.92 146.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.73 139.24 76.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 33.5 Cg_endo -61.9 -40.06 46.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.358 . . . . 0.0 112.348 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 m -63.85 -20.55 65.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.795 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -57.51 134.21 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 26' ' ' VAL . 67.5 p -56.6 142.87 37.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.485 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.554 HG12 HG12 ' B' ' 23' ' ' ILE . 66.2 mt -57.75 -40.62 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.77 -44.57 90.65 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.138 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.61 -44.52 86.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG13 HG21 ' A' ' 17' ' ' VAL . 60.3 t -59.16 -49.28 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.33 -36.76 84.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.518 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.572 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -53.81 -36.12 62.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.875 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 86.7 tttt -69.54 -39.17 77.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.117 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.736 ' HB ' HE22 ' A' ' 41' ' ' GLN . 36.9 mm -54.87 -38.55 45.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.101 0.477 . . . . 0.0 109.775 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -60.37 -48.96 79.51 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.32 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.91 -30.52 71.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.449 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 30.7 mmmt -72.05 -32.1 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.23 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -138.91 -65.69 0.49 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.983 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.98 -40.39 0.52 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.571 HD11 HG22 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -45.06 126.78 5.49 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.66 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 87.2 Cg_exo -45.93 139.64 10.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.019 2.479 . . . . 0.0 112.399 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 45.6 Cg_exo -56.26 -40.6 83.72 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.37 2.046 . . . . 0.0 111.879 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.32 -36.04 81.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.66 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 51.3 tt0 -60.28 -37.15 79.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.092 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.845 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.6 mt-30 -56.33 132.05 49.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.692 ' H ' ' H ' ' B' ' 46' ' ' ALA . 56.3 ttp180 -91.82 125.61 36.59 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD21 ' HD3' ' A' ' 27' ' ' LYS . 14.5 mt -74.46 132.17 41.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.705 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 75.8 mt -143.73 133.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.808 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 15.4 m-85 -129.69 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.434 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.16 127.37 6.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.964 0.412 . . . . 0.0 111.722 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' B' ' 36' ' ' ILE . . . -73.65 138.88 25.58 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.541 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.714 ' H ' ' HG2' ' B' ' 40' ' ' GLN . 23.4 tptm -159.91 74.67 0.59 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.554 0.692 . . . . 0.0 111.089 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' GLU . 21.4 pt20 -71.27 105.14 3.35 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.839 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.2 mm? -48.81 80.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.462 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' GLN . 40.5 tt0 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.843 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -1' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' B' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 0' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 55.8 m 56.04 -140.61 0.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.541 0.21 . . . . 0.0 111.021 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' B' ' 1' ' ' MET . 15.7 tpt -82.14 48.84 1.3 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.895 0.378 . . . . 0.0 111.205 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 2' ' ' GLN . . . . . 0.514 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 18.4 pt20 -61.72 111.82 2.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.235 0.541 . . . . 0.0 110.841 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.803 HD11 HD23 ' B' ' 15' ' ' LEU . 30.5 pt -85.53 142.29 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -88.25 126.59 35.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.695 ' HB ' HG12 ' B' ' 13' ' ' ILE . 89.6 t -142.61 139.44 28.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.156 0.503 . . . . 0.0 111.519 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.6 ' HB3' ' HA2' ' B' ' 10' ' ' GLY . 67.1 mttm -102.96 131.52 49.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.547 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -67.8 -156.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.0 mt -62.01 -50.5 71.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 110.708 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -75.62 -45.17 38.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.047 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.6 ' HA2' ' HB3' ' B' ' 6' ' ' LYS . . . 142.89 34.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.652 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 60.5 tttp -82.4 128.4 34.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.776 0.322 . . . . 0.0 111.181 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -73.07 135.84 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.62 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.695 HG12 ' HB ' ' B' ' 5' ' ' VAL . 4.2 pt -137.44 134.94 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.097 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.25 144.28 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.803 HD23 HD11 ' B' ' 3' ' ' ILE . 6.0 tp -156.82 113.01 2.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 15.5 pt-20 -86.67 129.16 34.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.961 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.531 HG21 HG13 ' B' ' 26' ' ' VAL . 6.6 m -157.11 143.99 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.664 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.52 137.0 76.91 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.61 -39.63 72.84 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.824 2.349 . . . . 0.0 112.187 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 22' ' ' THR . 50.5 m -64.07 -24.6 67.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -54.01 134.06 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.432 ' O ' HG23 ' B' ' 26' ' ' VAL . 71.3 p -56.48 143.19 36.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.518 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.624 HG21 HD21 ' B' ' 43' ' ' LEU . 66.4 mt -58.09 -40.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.436 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -59.03 -44.87 91.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.051 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.35 -44.36 87.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.531 HG13 HG21 ' B' ' 17' ' ' VAL . 98.4 t -59.15 -48.81 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.255 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 49.4 mtmt -65.07 -35.82 82.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.678 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.657 ' HA ' ' HG3' ' B' ' 38' ' ' PRO . . . -54.31 -34.46 61.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.547 ' HD3' HD11 ' B' ' 15' ' ' LEU . 87.1 tttt -73.79 -32.27 63.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.384 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.756 ' HB ' HE22 ' B' ' 41' ' ' GLN . 40.8 mm -56.94 -44.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.426 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 11.3 pt20 -64.99 -39.15 93.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.64 -32.31 72.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' B' ' 29' ' ' LYS . 31.0 mmmt -74.97 -31.17 61.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.799 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.1 tp10 -139.13 -64.03 0.51 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 156.61 -32.71 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.11 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.845 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -47.95 124.03 10.3 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.702 ' HG2' ' HB2' ' B' ' 40' ' ' GLN . 2.3 Cg_endo -48.64 137.82 25.98 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.586 2.19 . . . . 0.0 111.412 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.657 ' HG3' ' HA ' ' B' ' 28' ' ' ALA . 50.2 Cg_exo -53.47 -39.91 80.47 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.472 2.115 . . . . 0.0 112.412 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.03 -35.93 79.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.635 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.845 ' NE2' HG22 ' B' ' 36' ' ' ILE . 7.0 tt0 -60.74 -36.69 79.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 111.145 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.756 HE22 ' HB ' ' B' ' 30' ' ' ILE . 70.8 mt-30 -57.23 132.13 52.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 56.4 ttp180 -91.64 127.55 37.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.657 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.624 HD21 HG21 ' B' ' 23' ' ' ILE . 8.3 mp -75.86 130.88 39.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -143.52 134.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.845 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 9.9 m-85 -129.94 141.78 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.294 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.692 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.54 123.18 6.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.093 0.473 . . . . 0.0 112.068 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 40' ' ' GLN . . . -70.8 137.54 27.16 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.436 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.622 ' H ' ' HG2' ' A' ' 40' ' ' GLN . 23.5 tptm -159.81 74.82 0.6 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.357 0.599 . . . . 0.0 110.883 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' B' ' 51' ' ' GLU . 22.0 pt20 -68.3 115.5 7.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.197 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.452 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.0 mm? -55.89 79.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.287 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.6 tt0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.5 tpt . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.23 0.538 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 17.4 pt20 -61.58 110.56 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.405 0.621 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.668 HG22 HD23 ' B' ' 43' ' ' LEU . 37.0 pt -72.49 146.21 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.098 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -87.84 130.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.881 ' HB ' HG23 ' A' ' 13' ' ' ILE . 64.8 t -144.55 151.05 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.96 117.95 29.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.325 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.465 HG21 ' NZ ' ' A' ' 11' ' ' LYS . 74.1 p -68.68 152.74 44.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.4 mt -50.29 -37.67 37.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.735 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -66.63 -44.99 80.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.02 -40.12 1.21 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.444 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG21 ' A' ' 7' ' ' THR . 21.8 pttp -52.13 139.66 22.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 111.668 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -73.34 148.1 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.62 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.881 HG23 ' HB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -134.83 133.33 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.274 0.559 . . . . 0.0 112.024 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 145.25 31.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.299 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.86 HD12 ' HG3' ' A' ' 33' ' ' LYS . 3.9 tt -155.31 113.76 3.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.339 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 25.4 pt-20 -80.43 136.69 36.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.422 . . . . 0.0 111.906 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.764 HG21 HG13 ' A' ' 26' ' ' VAL . 2.4 m -158.21 143.5 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.496 ' HB2' ' CG ' ' A' ' 21' ' ' ASP . 41.4 mt-10 -62.75 133.76 95.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.18 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 10.6 Cg_endo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.716 2.277 . . . . 0.0 111.851 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.5 t -64.72 -31.64 72.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.947 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.496 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 63.6 m-20 -52.44 135.33 33.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.4 p -56.71 143.79 35.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.769 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.727 HG12 HG12 ' B' ' 23' ' ' ILE . 60.7 mt -57.27 -44.45 83.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.98 -41.92 79.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.705 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -65.73 -43.01 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.648 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.764 HG13 HG21 ' A' ' 17' ' ' VAL . 59.9 t -59.55 -49.77 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.608 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 54.0 mttp -62.51 -39.79 94.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.827 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -35.72 67.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.328 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.76 ' HD2' HD21 ' A' ' 15' ' ' LEU . 24.4 ttmm -65.39 -36.48 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.031 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.719 HG22 HD11 ' A' ' 36' ' ' ILE . 51.1 mt -55.81 -31.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.589 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 68.9 mt-30 -61.09 -52.52 64.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.39 -34.67 72.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.25 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.86 ' HG3' HD12 ' A' ' 15' ' ' LEU . 43.9 mmtm -65.89 -33.43 75.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.298 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -141.66 -70.69 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.289 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.48 54.27 0.03 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.776 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.854 HG22 HE22 ' A' ' 40' ' ' GLN . 0.8 OUTLIER -138.35 128.12 14.88 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 111.728 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.711 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 78.0 Cg_exo -44.03 141.21 4.68 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.961 2.44 . . . . 0.0 112.703 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.589 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 11.9 Cg_endo -57.85 -35.01 99.01 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.765 2.31 . . . . 0.0 112.711 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.99 -37.87 80.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.854 HE22 HG22 ' A' ' 36' ' ' ILE . 19.9 mt-30 -60.7 -44.91 95.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.579 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.563 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.6 OUTLIER -54.33 125.48 19.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.343 . . . . 0.0 110.771 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.707 ' H ' ' H ' ' B' ' 46' ' ' ALA . 70.0 mtt-85 -85.84 122.02 29.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.664 HD23 HG22 ' B' ' 3' ' ' ILE . 13.8 tp -84.31 132.98 34.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.721 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.7 mt -143.16 145.53 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 111.672 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' B' ' 5' ' ' VAL . 17.2 m-85 -133.9 140.07 46.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.665 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.23 119.21 5.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.094 0.473 . . . . 0.0 111.648 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.72 179.722 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.531 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.4 tpt . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.317 0.58 . . . . 0.0 110.745 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.972 ' HB2' HG22 ' B' ' 14' ' ' THR . 16.9 pt20 -61.46 110.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.129 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.664 HG22 HD23 ' A' ' 43' ' ' LEU . 35.1 pt -72.96 147.48 9.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -87.87 130.15 34.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 45' ' ' PHE . 61.9 t -141.95 152.74 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -123.1 117.44 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.927 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.514 HG21 ' CE ' ' B' ' 11' ' ' LYS . 77.1 p -69.9 150.7 46.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.723 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -48.38 -37.81 17.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.979 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -66.81 -45.23 79.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.75 -41.92 1.1 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.517 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.514 ' CE ' HG21 ' B' ' 7' ' ' THR . 0.0 OUTLIER -54.07 140.1 32.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.126 0.489 . . . . 0.0 111.67 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 50.7 m -72.4 147.35 46.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.543 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.531 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -130.56 141.6 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.195 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.972 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.2 OUTLIER -119.21 143.97 46.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.019 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.699 HD11 ' HD2' ' B' ' 29' ' ' LYS . 3.5 tp -155.67 114.01 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 15.1 pt-20 -77.91 134.42 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.62 HG21 HG13 ' B' ' 26' ' ' VAL . 13.9 m -155.54 141.52 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.214 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.521 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 41.8 mt-10 -61.26 135.09 93.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.352 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.1 -39.55 90.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.777 2.318 . . . . 0.0 111.894 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 22' ' ' THR . 45.7 t -64.38 -30.55 71.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.912 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.521 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 63.0 m-20 -53.95 134.74 43.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.454 ' O ' HG23 ' B' ' 26' ' ' VAL . 74.1 p -55.91 142.95 33.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.695 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.749 HD11 HG21 ' A' ' 26' ' ' VAL . 60.1 mt -57.16 -43.61 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.032 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.33 -42.47 81.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.552 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -65.81 -42.01 91.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.615 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 23' ' ' ILE . 94.1 t -59.89 -48.78 86.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.624 ' NZ ' HD13 ' B' ' 43' ' ' LEU . 64.5 mttm -64.26 -40.09 95.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.923 0.392 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.86 65.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.398 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.699 ' HD2' HD11 ' B' ' 15' ' ' LEU . 24.6 ttmm -65.87 -35.32 80.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.527 HG22 ' CD1' ' B' ' 36' ' ' ILE . 50.2 mt -56.46 -30.69 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.705 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 66.6 mt-30 -61.12 -52.4 65.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -34.43 72.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.134 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.533 ' HE2' HD13 ' B' ' 15' ' ' LEU . 43.5 mmtm -65.79 -33.04 74.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.258 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -143.31 -68.43 0.34 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.746 0.307 . . . . 0.0 111.252 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.83 53.2 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.311 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.932 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -133.23 132.23 22.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.7 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 72.1 Cg_exo -50.87 142.39 33.3 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.729 2.286 . . . . 0.0 111.998 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.705 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 32.4 Cg_exo -56.66 -35.73 97.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.675 2.25 . . . . 0.0 112.482 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.36 -37.52 86.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.932 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.6 mt-30 -63.08 -42.52 99.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.692 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.414 ' OE1' ' N ' ' B' ' 41' ' ' GLN . 0.6 OUTLIER -56.52 127.28 30.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.745 0.307 . . . . 0.0 110.489 179.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.665 ' H ' ' H ' ' A' ' 46' ' ' ALA . 70.9 mtt-85 -86.84 123.44 31.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.433 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.668 HD23 HG22 ' A' ' 3' ' ' ILE . 14.3 tp -85.5 132.7 34.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.721 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 66.4 mt -143.22 145.64 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.894 0.378 . . . . 0.0 111.823 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.761 ' HB2' HG22 ' A' ' 5' ' ' VAL . 16.0 m-85 -134.53 139.98 45.82 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.993 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.707 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 117.34 5.03 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.084 0.469 . . . . 0.0 111.645 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.501 179.69 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 ptm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.018 0.437 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.934 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.3 pt20 -61.91 130.19 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.236 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.2 pt -103.72 140.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.39 124.77 34.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.789 ' HB ' HG12 ' A' ' 13' ' ' ILE . 35.2 t -141.89 143.7 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 111.43 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.681 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 67.5 mttm -111.45 128.3 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.291 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -63.81 -156.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.06 -53.6 55.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.849 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -72.99 -44.89 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 142.2 35.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 60.9 tttp -80.61 126.02 30.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.311 . . . . 0.0 110.861 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -72.88 134.49 44.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.611 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.789 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.6 pt -136.18 138.05 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.934 HG22 ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -95.81 144.01 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.729 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 29' ' ' LYS . 5.3 tt -161.55 114.34 1.85 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.5 pt-20 -87.99 136.28 33.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.553 HG13 ' CD2' ' A' ' 15' ' ' LEU . 3.3 m -156.92 151.9 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.766 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 50.9 mt-10 -72.71 136.9 80.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.43 -32.32 72.45 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.734 2.289 . . . . 0.0 111.959 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.51 ' O ' HG22 ' B' ' 22' ' ' THR . 69.1 m -63.97 -31.78 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.568 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -57.22 128.81 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.788 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.525 HG22 ' O ' ' B' ' 20' ' ' SER . 76.2 p -57.18 150.71 17.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.992 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.706 HG22 ' HE2' ' A' ' 27' ' ' LYS . 67.4 mt -57.28 -31.11 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.541 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -64.72 -36.89 85.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.877 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.3 m120 -73.71 -47.6 38.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.374 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 17' ' ' VAL . 33.2 m -57.82 -43.55 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.131 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.706 ' HE2' HG22 ' A' ' 23' ' ' ILE . 53.4 mtmt -72.02 -34.9 69.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.678 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.9 69.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HB2' HD11 ' A' ' 15' ' ' LEU . 41.2 mtpt -65.6 -38.48 89.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.656 ' HB ' HE22 ' A' ' 41' ' ' GLN . 48.3 mm -54.68 -31.96 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.628 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.687 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 64.9 mt-30 -61.13 -51.82 67.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.05 -34.62 75.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.254 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' HD12 ' A' ' 15' ' ' LEU . 73.6 mmtt -65.26 -32.1 73.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.399 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -145.46 -68.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.61 61.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.205 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.828 HG22 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -146.43 124.42 6.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.933 0.396 . . . . 0.0 112.003 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.631 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 39.7 Cg_exo -39.8 143.14 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.461 2.774 . . . . 0.0 112.979 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.687 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 38.3 Cg_exo -60.64 -37.79 76.85 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.805 2.336 . . . . 0.0 112.743 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.4 -35.54 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.008 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.828 HE22 HG22 ' A' ' 36' ' ' ILE . 19.7 mt-30 -62.03 -42.95 99.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.208 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.656 HE22 ' HB ' ' A' ' 30' ' ' ILE . 73.5 mt-30 -58.06 126.04 25.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.445 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 18.7 ttm105 -87.7 126.78 35.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.566 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.2 mm? -75.78 131.16 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.468 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.954 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 71.3 mt -143.24 136.03 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.781 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.5 m-85 -131.62 141.07 49.55 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.735 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -155.14 122.24 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.019 0.438 . . . . 0.0 111.951 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' B' ' 40' ' ' GLN . . . . . . . . 0 C--N 1.331 0.267 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.611 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.7 ptm . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.95 0.405 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.46 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 3.1 pt20 -62.39 128.92 38.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.807 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.772 HD11 HD23 ' B' ' 15' ' ' LEU . 32.7 pt -101.44 137.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.011 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.77 124.25 33.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 1.006 HG13 HG23 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.79 140.11 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 0.0 111.419 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.665 ' HB3' ' HA2' ' B' ' 10' ' ' GLY . 66.6 mttm -100.78 136.09 41.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.137 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.86 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.336 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 mt -59.26 -53.2 60.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.6 p -75.95 -45.45 34.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 110.812 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.665 ' HA2' ' HB3' ' B' ' 6' ' ' LYS . . . 144.32 32.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.418 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 61.4 tttp -79.63 127.25 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -73.51 136.52 44.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 1.006 HG23 HG13 ' B' ' 5' ' ' VAL . 0.9 OUTLIER -142.72 124.35 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -85.07 147.55 26.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.962 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.772 HD23 HD11 ' B' ' 3' ' ' ILE . 7.1 tp -160.66 113.22 1.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.6 pt-20 -80.14 140.27 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.682 HG21 HG12 ' B' ' 26' ' ' VAL . 2.8 p -169.13 133.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.7 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.467 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 52.9 mt-10 -56.35 139.17 74.19 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.612 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.11 -32.29 91.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.976 2.45 . . . . 0.0 112.226 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 22' ' ' THR . 33.8 t -63.37 -21.82 66.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.165 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 65.8 m-20 -66.18 133.02 49.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.734 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 20' ' ' SER . 66.9 p -59.12 148.5 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.607 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.725 HG22 ' HE2' ' B' ' 27' ' ' LYS . 65.5 mt -55.41 -30.86 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.433 0.635 . . . . 0.0 109.698 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.57 -37.83 88.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.91 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.493 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 3.2 m120 -72.94 -48.64 35.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.607 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.682 HG12 HG21 ' B' ' 17' ' ' VAL . 34.7 m -56.52 -44.59 80.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.223 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.725 ' HE2' HG22 ' B' ' 23' ' ' ILE . 53.6 mtmt -70.91 -34.26 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.1 -38.05 72.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.989 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.574 ' HB2' HD21 ' B' ' 15' ' ' LEU . 32.4 mtpt -64.66 -40.1 94.84 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.637 ' HB ' HE22 ' B' ' 41' ' ' GLN . 50.6 mm -54.47 -32.05 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.902 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.681 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 66.5 mt-30 -60.79 -53.32 58.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.53 -32.03 72.06 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.309 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 72.7 mmtt -66.41 -31.62 72.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.448 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.522 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.9 tp10 -147.48 -61.93 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.578 0.228 . . . . 0.0 111.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.77 58.11 0.06 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.79 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.878 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -137.99 129.87 16.14 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.633 0.254 . . . . 0.0 111.309 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.639 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -50.27 142.18 29.61 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.619 2.213 . . . . 0.0 112.128 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.681 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 35.6 Cg_exo -58.31 -38.87 88.8 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.744 2.296 . . . . 0.0 112.608 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.53 -35.45 76.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.878 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.2 mt-30 -64.96 -39.7 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.315 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 73.2 mt-30 -60.09 128.11 35.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.661 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.735 ' H ' ' H ' ' A' ' 46' ' ' ALA . 18.5 ttm105 -88.97 126.26 35.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.186 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.505 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.0 mm? -75.77 131.53 39.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.531 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.954 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.3 mt -144.04 138.3 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.57 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 13.5 m-85 -133.9 143.55 48.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.433 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.45 ' C ' ' HA ' ' A' ' 41' ' ' GLN . . . -156.25 120.27 4.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.649 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.2 ptt? . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.88 0.372 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.693 ' HB2' HG22 ' A' ' 14' ' ' THR . 16.7 pt20 -74.95 111.79 10.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.871 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 15' ' ' LEU . 33.5 pt -72.25 135.91 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.479 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.41 129.03 35.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.795 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.7 t -146.51 135.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.809 0.338 . . . . 0.0 111.593 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.45 123.05 36.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -70.41 -157.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.351 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.938 HD11 HG21 ' A' ' 36' ' ' ILE . 2.2 mm? -86.05 -48.97 8.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.125 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.8 t -71.08 -45.11 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 9' ' ' THR . . . 156.86 -36.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.787 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -49.22 131.16 19.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.897 0.38 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -84.76 132.3 34.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.795 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -96.65 130.04 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.696 179.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.693 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.4 m -107.5 129.13 54.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.727 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -159.56 114.56 2.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.106 0.479 . . . . 0.0 111.283 -178.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -76.39 144.32 40.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.389 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.417 HG22 HG23 ' A' ' 3' ' ' ILE . 30.9 m -149.7 145.99 17.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -68.55 143.52 95.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.154 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.78 -39.47 81.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.67 2.247 . . . . 0.0 112.189 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.578 ' O ' HG22 ' B' ' 22' ' ' THR . 47.0 t -64.42 -29.59 70.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.001 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -55.91 130.02 42.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 20' ' ' SER . 70.5 p -62.35 148.48 45.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.724 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.539 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 66.6 mt -54.91 -42.2 62.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -62.89 -29.59 70.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.25 -49.29 51.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.009 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 35.3 m -62.54 -42.04 94.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.15 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 57.8 mtpt -60.88 -37.18 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.404 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.66 79.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.488 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 1.009 ' HZ3' ' HA ' ' A' ' 26' ' ' VAL . 49.3 mttp -62.21 -41.5 98.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.603 HD13 HG11 ' A' ' 5' ' ' VAL . 60.3 mt -54.96 -31.79 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.893 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.438 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 60.9 mt-30 -63.09 -51.35 66.93 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.31 -32.96 70.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.794 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 31.3 mmmt -69.79 -31.88 70.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.916 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -140.52 -68.31 0.41 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.166 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.14 -32.57 1.05 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.452 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.938 HG21 HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -47.79 132.62 11.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.732 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 87.7 Cg_exo -49.88 155.72 3.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.418 2.746 . . . . 0.0 112.743 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 16.9 Cg_exo -66.79 -39.44 14.97 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.899 2.399 . . . . 0.0 112.944 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.1 -40.07 76.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.881 HE22 HG22 ' A' ' 36' ' ' ILE . 23.2 mt-30 -61.03 -42.22 98.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.411 . . . . 0.0 110.665 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' OE1' HD12 ' A' ' 30' ' ' ILE . 67.2 mt-30 -57.51 143.28 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.182 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.787 ' H ' ' H ' ' B' ' 46' ' ' ALA . 64.6 mtt85 -135.98 110.83 8.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.427 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.471 ' H ' ' CD2' ' A' ' 43' ' ' LEU . 1.4 pt? -77.46 138.71 39.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.716 ' H ' ' H ' ' B' ' 44' ' ' ILE . 62.9 mt -136.42 112.36 12.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.293 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.738 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 4.3 m-85 -84.65 146.69 27.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.735 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.85 126.42 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.401 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.039 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.2 ptt? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.861 0.362 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 16.4 pt20 -71.87 112.47 7.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 110.393 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.578 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.6 pt -72.64 133.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.825 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.48 125.07 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.114 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 1.011 HG13 HG13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -150.86 131.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.662 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.7 130.97 34.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -74.53 -157.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.767 HD21 HG12 ' B' ' 36' ' ' ILE . 2.0 mm? -86.05 -48.66 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.423 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.9 t -70.67 -45.23 65.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.575 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.423 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.94 -35.9 0.62 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -49.86 130.54 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 0.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -82.26 140.87 33.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.397 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 1.011 HG13 HG13 ' B' ' 5' ' ' VAL . 15.4 pt -116.98 130.17 72.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.291 0.567 . . . . 0.0 111.779 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -112.35 137.51 50.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.153 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.578 ' O ' HG12 ' B' ' 3' ' ' ILE . 2.6 pp -162.8 118.62 1.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -70.73 146.03 50.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.761 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.537 HG13 HD12 ' B' ' 15' ' ' LEU . 8.4 m -150.88 141.8 16.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.518 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 46.5 mm-40 -67.45 143.05 96.91 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -57.01 -36.72 99.44 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.752 2.302 . . . . 0.0 112.099 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.554 ' O ' HG22 ' A' ' 22' ' ' THR . 44.1 t -64.49 -31.49 72.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.159 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 47.2 m-20 -54.67 130.78 41.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 20' ' ' SER . 72.9 p -63.21 148.36 48.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.502 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 68.1 mt -54.27 -42.11 55.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -63.1 -29.83 71.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.22 -49.48 49.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.854 ' HA ' ' HZ2' ' B' ' 29' ' ' LYS . 35.5 m -62.52 -41.32 91.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 58.3 mtpt -61.52 -38.23 86.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.56 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.77 75.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.554 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.854 ' HZ2' ' HA ' ' B' ' 26' ' ' VAL . 50.1 mttp -62.57 -41.09 98.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.634 HD13 HG21 ' B' ' 5' ' ' VAL . 59.3 mt -54.78 -32.13 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.903 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.506 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 61.9 mt-30 -62.93 -51.27 67.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.9 -32.07 70.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.956 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 31.1 mmmt -69.75 -31.97 70.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.463 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.664 ' HB2' HD11 ' B' ' 36' ' ' ILE . 5.5 mm-40 -141.27 -61.32 0.48 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.714 0.292 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 126.79 40.93 0.32 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.453 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.804 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -110.46 135.94 20.63 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.558 0.218 . . . . 0.0 111.063 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.612 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 65.8 Cg_exo -51.55 143.71 35.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.451 2.1 . . . . 0.0 111.896 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.506 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -60.89 -37.61 76.06 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.727 2.285 . . . . 0.0 112.697 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -60.47 -39.11 86.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.155 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.804 ' NE2' HG22 ' B' ' 36' ' ' ILE . 26.8 mt-30 -63.56 -39.04 93.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.53 ' OE1' HD12 ' B' ' 30' ' ' ILE . 69.1 mt-30 -60.9 144.82 52.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.735 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.735 ' H ' ' H ' ' A' ' 46' ' ' ALA . 64.1 mtt85 -137.87 114.56 10.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.457 ' O ' HD12 ' B' ' 43' ' ' LEU . 0.4 OUTLIER -78.27 145.4 35.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.973 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.716 ' H ' ' H ' ' A' ' 44' ' ' ILE . 69.3 mt -142.46 108.51 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.01 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.0 m-85 -82.91 145.24 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.75 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.787 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -157.51 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.224 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.016 -179.754 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.118 0.485 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.589 ' HB2' HG22 ' A' ' 14' ' ' THR . 18.7 pt20 -68.99 135.53 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.958 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.528 HG22 HD22 ' B' ' 43' ' ' LEU . 35.5 pt -108.31 144.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -89.11 129.28 35.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.986 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.604 HG13 ' O ' ' B' ' 45' ' ' PHE . 87.1 t -149.13 129.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.46 126.69 34.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -73.13 -157.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.94 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 36' ' ' ILE . 54.2 mt -74.25 -50.39 19.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.998 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -73.35 -45.43 55.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.575 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.94 -31.81 0.55 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.807 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -46.35 129.98 10.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.908 0.385 . . . . 0.0 111.578 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -85.43 134.87 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.895 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.571 ' CD1' HG23 ' A' ' 30' ' ' ILE . 8.7 pt -101.3 128.23 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 112.014 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.9 m -93.05 116.91 29.49 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.672 ' O ' HD23 ' A' ' 15' ' ' LEU . 2.4 tt -143.67 115.21 8.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.263 0.554 . . . . 0.0 111.993 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 1' ' ' MET . 16.8 pt-20 -76.66 143.76 39.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.951 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 26' ' ' VAL . 10.8 p -168.45 138.15 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 38.7 mt-10 -51.72 140.17 28.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.007 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.91 -42.58 11.12 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.83 2.353 . . . . 0.0 111.954 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.585 ' O ' HG22 ' B' ' 22' ' ' THR . 50.6 m -63.67 -23.05 67.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.402 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.614 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 7.7 t70 -54.16 131.86 42.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.362 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.604 HG22 ' O ' ' B' ' 20' ' ' SER . 72.7 p -56.82 142.37 41.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.867 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.66 HG22 ' HE2' ' A' ' 27' ' ' LYS . 65.9 mt -54.63 -35.73 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.913 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.541 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 16.9 pt-20 -63.43 -37.05 85.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.386 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.614 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 3.5 m120 -74.54 -49.17 22.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.775 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 17' ' ' VAL . 30.4 m -54.06 -42.67 56.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.716 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 50.9 mtmt -70.43 -38.92 74.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -56.66 -35.13 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HG2' HD11 ' A' ' 15' ' ' LEU . 88.3 tttt -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.871 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.571 HG23 ' CD1' ' A' ' 13' ' ' ILE . 59.4 mt -58.32 -36.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 41.4 tt0 -60.76 -50.97 71.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.922 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.88 -33.09 71.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.901 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 30.6 mmmt -69.41 -35.73 76.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.267 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -135.08 -66.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.959 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.59 -39.53 0.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.347 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.846 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -45.04 121.45 4.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.72 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 82.8 Cg_exo -46.41 147.46 4.08 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.097 2.531 . . . . 0.0 112.251 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 18.0 Cg_endo -59.41 -36.51 93.72 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.475 2.117 . . . . 0.0 112.298 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.08 -36.79 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.413 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.846 ' NE2' HG22 ' A' ' 36' ' ' ILE . 27.8 mt-30 -61.58 -36.24 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.421 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.76 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 99.6 mm-40 -51.3 122.03 7.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.749 ' H ' ' H ' ' B' ' 46' ' ' ALA . 87.2 mtm180 -85.11 121.27 27.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.648 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.468 HD22 HG22 ' B' ' 3' ' ' ILE . 8.9 mp -69.13 122.6 19.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.404 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 61.4 mt -143.64 132.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.765 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 39.1 m-85 -136.63 148.76 47.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.706 ' HB3' ' HE ' ' B' ' 42' ' ' ARG . . . -153.06 131.34 12.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.984 0.421 . . . . 0.0 111.55 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.241 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.74 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.4 ptm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.016 0.436 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.84 130.97 44.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.605 HG12 ' HG ' ' B' ' 15' ' ' LEU . 39.5 pt -102.31 143.13 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.32 129.37 35.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 45' ' ' PHE . 97.4 t -148.92 127.7 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 111.34 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -83.23 126.45 32.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.554 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -73.29 -157.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 54.1 mt -74.34 -49.83 21.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -74.28 -45.35 48.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.95 -31.33 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.773 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -47.05 129.88 12.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.691 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 40.7 m -82.63 143.97 30.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.48 ' CD1' HG23 ' B' ' 30' ' ' ILE . 28.7 pt -119.24 129.31 75.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.14 0.495 . . . . 0.0 112.079 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.63 128.0 46.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.07 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.605 ' HG ' HG12 ' B' ' 3' ' ' ILE . 2.5 pp -152.9 120.16 5.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.2 pt-20 -73.06 138.18 45.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.029 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.412 HG13 ' O ' ' B' ' 16' ' ' GLU . 2.2 m -157.65 137.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.416 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' B' ' 21' ' ' ASP . 92.6 mt-10 -53.99 139.34 53.8 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.19 -41.73 26.29 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.621 2.214 . . . . 0.0 111.799 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.604 ' O ' HG22 ' A' ' 22' ' ' THR . 60.9 m -64.14 -21.87 66.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.494 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.596 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.0 t70 -55.06 132.34 47.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 20' ' ' SER . 77.1 p -57.98 142.43 46.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.807 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.658 HG22 ' HE2' ' B' ' 27' ' ' LYS . 65.7 mt -54.74 -36.09 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.88 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.463 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 11.4 pt-20 -63.43 -36.86 85.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.596 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 3.5 m120 -73.74 -50.05 22.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.426 HG13 ' OD1' ' B' ' 21' ' ' ASP . 19.6 m -53.75 -42.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.658 ' HE2' HG22 ' B' ' 23' ' ' ILE . 50.7 mtmt -70.58 -38.73 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.376 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.714 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -58.03 -28.67 64.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.496 ' HD3' HD13 ' B' ' 15' ' ' LEU . 87.4 tttt -74.66 -32.91 62.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 109.906 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.578 HG21 ' NE2' ' B' ' 41' ' ' GLN . 53.0 mt -61.9 -41.0 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.155 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.714 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.3 pt20 -63.91 -42.83 97.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -58.47 -34.29 70.71 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.4 mmmt -72.35 -33.09 67.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.924 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -136.96 -65.86 0.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 161.42 -34.77 0.38 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.37 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.802 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -48.78 122.75 11.26 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.674 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 84.2 Cg_exo -50.13 146.57 17.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.804 2.336 . . . . 0.0 111.897 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 18.4 Cg_endo -57.98 -38.28 92.67 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.529 2.153 . . . . 0.0 112.693 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.41 -37.26 86.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.468 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.802 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.3 mt-30 -61.38 -35.41 77.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.629 0.252 . . . . 0.0 111.482 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.765 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 6.1 mm-40 -54.6 124.55 16.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 110.876 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.706 ' HE ' ' HB3' ' A' ' 46' ' ' ALA . 87.0 mtm180 -85.93 123.24 31.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.832 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 3' ' ' ILE . 8.9 mp -70.57 123.14 21.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.199 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 61.5 mt -143.35 132.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 41.1 m-85 -136.9 148.38 47.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.591 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.749 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.15 134.75 15.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.024 0.44 . . . . 0.0 111.789 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.567 179.868 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 18.1 ptm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.017 0.437 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.407 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 18.7 pt20 -63.31 139.05 58.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 15' ' ' LEU . 32.0 pt -114.47 153.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -87.45 131.13 34.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.892 ' HB ' HG23 ' A' ' 13' ' ' ILE . 50.1 t -142.28 155.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 89.3 mttt -141.22 122.24 14.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 51.4 p -69.16 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.706 ' H ' HD12 ' A' ' 8' ' ' LEU . 4.1 mp -68.79 -46.51 68.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.785 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -83.44 26.8 0.63 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.107 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.88 37.1 83.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.594 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 22.0 ttmm -76.05 128.28 34.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.597 0.237 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -72.83 134.72 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.53 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.892 HG23 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -151.3 133.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.234 0.54 . . . . 0.0 112.233 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -97.64 149.63 22.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.509 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 3' ' ' ILE . 12.4 tp -155.83 113.19 3.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.0 pt-20 -81.53 130.22 34.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.268 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.574 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 5.6 m -156.72 131.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.495 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 25.4 pt-20 -55.55 141.59 63.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.84 -37.82 91.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.813 2.342 . . . . 0.0 112.313 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.411 ' O ' HG22 ' B' ' 22' ' ' THR . 62.8 m -63.67 -21.8 66.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' ' CG ' ' A' ' 18' ' ' GLU . 38.7 t70 -61.47 134.29 56.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.448 HG22 ' O ' ' B' ' 20' ' ' SER . 73.5 p -64.67 146.33 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.473 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.676 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 60.4 mt -55.43 -37.17 43.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.241 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 16.3 pt-20 -58.13 -35.62 71.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.209 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 m120 -75.12 -48.36 24.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.748 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG11 HD11 ' B' ' 23' ' ' ILE . 34.5 m -56.02 -42.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.561 0.219 . . . . 0.0 111.146 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 35.4 mtmm -69.8 -38.44 76.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.408 . . . . 0.0 110.569 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.21 77.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.638 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.574 ' NZ ' HG12 ' A' ' 17' ' ' VAL . 83.3 mttt -63.66 -38.29 90.55 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.509 HG22 HD11 ' A' ' 36' ' ' ILE . 72.8 mt -56.06 -34.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.731 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.421 ' OE1' ' HG3' ' A' ' 38' ' ' PRO . 20.7 mt-30 -61.52 -43.14 99.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -63.89 -39.82 95.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.26 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' HD11 ' A' ' 13' ' ' ILE . 67.4 mttm -78.08 3.4 15.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.124 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -169.05 -109.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.197 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.46 51.28 0.03 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.354 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.845 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -123.09 129.26 25.02 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.451 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.733 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 91.8 Cg_exo -45.84 150.09 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.997 2.465 . . . . 0.0 112.509 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 32.1 Cg_exo -57.15 -34.33 97.56 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.518 2.146 . . . . 0.0 112.07 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.96 -39.49 93.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.03 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.733 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 27.3 mt-30 -60.89 -36.64 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.257 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.693 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 4.1 mm-40 -53.07 122.73 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.807 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.685 ' H ' ' H ' ' B' ' 46' ' ' ALA . 79.5 mtp180 -91.38 121.31 33.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.488 HD12 HG22 ' B' ' 3' ' ' ILE . 8.0 mt -82.28 129.91 34.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.026 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 63.3 mt -143.14 140.77 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.948 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 42.0 m-85 -135.14 138.87 44.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.802 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.86 138.47 21.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 111.512 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.337 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.908 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.5 ptm . . . . . 0 C--O 1.23 0.038 0 CA-C-O 121.09 0.472 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.992 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.1 pt20 -62.28 142.75 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.665 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.4 pt -118.28 152.23 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.757 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -87.37 132.41 33.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' B' ' 13' ' ' ILE . 48.8 t -143.82 154.62 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.003 0.43 . . . . 0.0 111.349 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 57.9 mttp -139.04 123.22 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.186 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' B' ' 11' ' ' LYS . 56.2 p -72.72 -156.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.173 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.442 HD12 ' N ' ' B' ' 8' ' ' LEU . 6.5 mp -64.07 -50.91 66.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -82.8 28.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.335 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.02 36.66 68.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.485 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 21.6 ttmm -73.95 128.67 36.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 111.001 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -72.88 131.76 42.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.376 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.756 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -145.02 136.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.342 0.591 . . . . 0.0 111.85 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.992 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.3 OUTLIER -101.18 147.16 26.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.912 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.665 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.8 tt -157.62 114.13 2.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.153 0.502 . . . . 0.0 111.15 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.5 pt-20 -83.39 134.23 34.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.778 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.592 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 1.8 m -159.47 133.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' B' ' 21' ' ' ASP . 14.4 pt-20 -56.25 141.06 70.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.411 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.75 -37.86 95.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.921 2.414 . . . . 0.0 112.169 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 22' ' ' THR . 51.0 m -63.66 -24.45 67.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.715 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.561 ' HB2' ' HG3' ' B' ' 18' ' ' GLU . 63.2 t0 -58.95 133.46 56.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 20' ' ' SER . 76.8 p -64.12 146.86 53.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.637 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.681 HG22 ' NZ ' ' B' ' 27' ' ' LYS . 60.4 mt -56.07 -37.0 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.292 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.439 ' HG3' ' OD1' ' B' ' 25' ' ' ASN . 16.3 pt-20 -58.23 -36.54 73.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.363 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.504 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.1 m120 -74.88 -48.9 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.701 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 23' ' ' ILE . 34.4 m -55.12 -41.73 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.634 0.254 . . . . 0.0 111.017 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.681 ' NZ ' HG22 ' B' ' 23' ' ' ILE . 35.4 mtmm -70.21 -38.4 75.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.403 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.89 73.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.471 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.592 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 84.5 mttt -66.16 -37.22 85.12 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.807 HG22 HD11 ' B' ' 36' ' ' ILE . 67.8 mt -57.68 -32.12 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.643 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 21.8 mt-30 -61.58 -46.81 88.28 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.44 -33.89 77.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 71.9 mmtt -68.78 -18.08 64.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.435 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -157.72 -90.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.742 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.07 48.53 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.607 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.908 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -118.35 134.51 23.42 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.631 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 71.0 Cg_exo -51.57 147.64 22.82 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.771 2.314 . . . . 0.0 111.851 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.463 ' HG3' ' OE1' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -56.95 -34.44 97.37 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.448 2.098 . . . . 0.0 112.075 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.33 -35.03 78.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.561 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.908 ' NE2' HG22 ' B' ' 36' ' ' ILE . 26.5 mt-30 -66.96 -37.48 84.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.676 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.486 ' NE2' HD13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -52.26 126.93 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.788 0.327 . . . . 0.0 110.675 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.802 ' H ' ' H ' ' A' ' 46' ' ' ALA . 80.0 mtp180 -90.17 125.98 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.164 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 125.4 30.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 1.026 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 63.2 mt -143.25 138.82 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.408 . . . . 0.0 111.307 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 35.3 m-85 -136.93 140.26 42.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.685 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.02 136.4 17.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.605 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.216 179.747 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.646 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.6 ptt? . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.993 0.425 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.672 ' HB3' HG22 ' A' ' 14' ' ' THR . 15.2 mt-30 -66.49 111.23 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.69 HD11 HD23 ' A' ' 15' ' ' LEU . 44.7 pt -84.14 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.203 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -88.0 133.01 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.712 ' HB ' HG13 ' A' ' 13' ' ' ILE . 88.6 t -149.07 126.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -82.28 116.04 21.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.458 HG23 HG12 ' A' ' 13' ' ' ILE . 72.7 p -67.7 -159.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.432 . . . . 0.0 110.911 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 36' ' ' ILE . 1.3 mp -82.45 -44.63 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.72 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.9 t -73.15 -44.84 59.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.312 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 9' ' ' THR . . . 154.75 -39.96 0.64 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.998 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -51.86 135.12 30.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 111.565 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 p -81.18 138.65 35.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.6 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.712 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -96.4 129.33 46.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.672 HG22 ' HB3' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -96.76 137.0 36.51 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.69 HD23 HD11 ' A' ' 3' ' ' ILE . 2.0 tp -162.32 115.1 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 111.975 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 1' ' ' MET . 25.4 pt-20 -85.06 132.68 34.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.359 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 15' ' ' LEU . 6.9 m -157.27 139.76 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.747 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.64 144.03 89.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.431 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.94 -37.7 52.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.769 2.313 . . . . 0.0 112.159 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -63.13 -23.23 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.374 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -60.96 134.84 57.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 p -61.69 141.57 57.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.747 HG12 HG12 ' B' ' 23' ' ' ILE . 57.6 mt -53.83 -41.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.124 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 22.3 pt-20 -55.29 -39.99 70.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.334 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.5 m120 -66.34 -51.02 61.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.822 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 23' ' ' ILE . 11.5 m -60.08 -40.05 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.022 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.699 ' NZ ' ' HB2' ' A' ' 41' ' ' GLN . 29.5 mtpp -64.02 -43.7 94.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.768 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -58.37 -42.37 86.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.11 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HD2' HD11 ' A' ' 15' ' ' LEU . 39.5 ttmt -62.71 -36.5 83.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG23 HD12 ' A' ' 13' ' ' ILE . 62.8 mt -55.51 -37.05 43.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.768 HE21 ' HA ' ' A' ' 28' ' ' ALA . 68.1 mt-30 -58.83 -40.43 84.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.77 -39.83 95.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.649 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 33' ' ' LYS . 4.8 mmmp? -61.22 -40.0 92.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.71 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.35 -89.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.442 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 45.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.837 HG22 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -122.68 126.43 26.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.632 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 65.8 Cg_exo -43.13 141.7 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.089 2.526 . . . . 0.0 112.706 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 28.0 Cg_endo -62.14 -33.84 80.87 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.641 2.227 . . . . 0.0 112.125 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.837 HE22 HG22 ' A' ' 36' ' ' ILE . 15.6 mt-30 -63.33 -39.92 95.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.581 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.699 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 6.6 mm100 -53.06 132.26 37.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.816 ' H ' ' H ' ' B' ' 46' ' ' ALA . 22.1 tpp180 -107.53 119.67 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.34 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.88 126.79 30.19 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.158 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.83 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.9 mt -144.21 123.25 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.672 ' HB2' HG22 ' B' ' 5' ' ' VAL . 4.0 m-85 -121.84 148.6 44.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.425 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.749 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.64 130.28 14.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 0.0 111.916 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.394 179.313 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.1 ptt? . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.54 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 17.2 pt20 -65.4 110.72 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.302 0.572 . . . . 0.0 110.868 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' B' ' 15' ' ' LEU . 37.4 pt -76.99 141.04 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.08 131.29 34.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' B' ' 13' ' ' ILE . 98.4 t -149.04 124.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 111.353 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -82.49 120.53 25.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.253 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -69.96 -160.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.534 HD11 ' CG2' ' B' ' 36' ' ' ILE . 6.3 mp -82.14 -42.87 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.409 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -71.58 -44.79 63.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.409 ' N ' HG23 ' B' ' 9' ' ' THR . . . 152.91 -39.66 0.72 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.036 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -52.04 134.95 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 111.961 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -82.12 142.71 32.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.021 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.677 HG13 ' HB ' ' B' ' 5' ' ' VAL . 11.4 pt -114.15 122.86 69.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.308 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -87.51 148.67 24.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.67 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.596 ' C ' HD23 ' B' ' 15' ' ' LEU . 5.3 tt -162.94 112.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.429 . . . . 0.0 110.659 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' B' ' 1' ' ' MET . 14.5 pt-20 -82.78 132.16 35.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.821 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.588 HG21 HG22 ' B' ' 26' ' ' VAL . 2.4 m -159.44 139.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.617 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.86 142.75 88.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.452 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.466 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 26.3 Cg_endo -60.22 -37.24 84.49 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.878 2.385 . . . . 0.0 112.141 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.8 m -63.63 -26.48 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.659 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -56.64 135.26 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.343 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -61.87 142.27 57.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.747 HG12 HG12 ' A' ' 23' ' ' ILE . 58.8 mt -54.61 -40.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.542 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 12.0 pt-20 -55.16 -44.46 75.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.542 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.2 m120 -64.13 -47.95 77.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.588 HG22 HG21 ' B' ' 17' ' ' VAL . 24.6 t -56.34 -45.17 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.224 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.668 ' NZ ' ' HB2' ' B' ' 41' ' ' GLN . 28.2 mtpp -66.25 -41.16 90.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.203 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.744 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -58.28 -40.97 83.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.58 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.453 ' CG ' HD11 ' B' ' 15' ' ' LEU . 39.2 ttmt -63.41 -34.89 78.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.397 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.562 HG21 ' NE2' ' B' ' 41' ' ' GLN . 59.2 mt -58.19 -35.69 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.274 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.744 HE21 ' HA ' ' B' ' 28' ' ' ALA . 68.7 mt-30 -60.48 -47.74 84.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.66 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.687 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' B' ' 33' ' ' LYS . 22.8 tptp -65.65 -32.57 74.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.931 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.3 tp10 -144.89 -68.25 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.684 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.89 47.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.737 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.892 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -124.94 128.88 24.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.5 0.19 . . . . 0.0 111.394 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.65 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 54.2 Cg_exo -51.77 138.35 50.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.341 2.028 . . . . 0.0 111.554 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.573 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 19.0 Cg_endo -58.88 -34.0 98.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.577 2.185 . . . . 0.0 112.202 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.84 -39.15 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.643 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.892 ' NE2' HG22 ' B' ' 36' ' ' ILE . 22.9 mt-30 -65.79 -38.21 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.668 ' HB2' ' NZ ' ' B' ' 27' ' ' LYS . 7.0 mm100 -54.31 133.78 45.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.749 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.1 tpp180 -108.49 121.79 45.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 3' ' ' ILE . 10.8 mp -68.94 127.41 33.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.189 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.83 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -144.14 122.44 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.034 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.67 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.1 m-85 -120.97 146.03 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.816 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -148.25 128.9 14.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 111.696 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.302 179.526 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 1' ' ' MET . 15.1 tpt . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.209 0.528 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.429 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 3.2 pt20 -61.72 127.34 30.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.672 HD12 HD11 ' A' ' 30' ' ' ILE . 28.8 pt -95.47 132.44 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.576 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -88.83 128.77 35.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.756 HG21 HD13 ' A' ' 30' ' ' ILE . 63.4 t -148.49 138.49 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.151 0.501 . . . . 0.0 112.242 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -99.44 127.71 45.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.725 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.569 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 73.1 p -68.49 -156.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 111.302 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.729 ' H ' HD12 ' A' ' 8' ' ' LEU . 2.7 mp -64.36 -51.15 64.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -78.61 -45.73 20.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.866 0.365 . . . . 0.0 111.067 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 28.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.315 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 15.8 tppt? -77.37 122.65 25.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 m -75.38 138.71 41.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.557 HG13 ' HB ' ' A' ' 5' ' ' VAL . 12.4 pt -140.07 128.69 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.215 0.531 . . . . 0.0 112.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -97.37 145.99 25.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.67 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 3' ' ' ILE . 5.8 tt -163.94 114.05 1.27 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.04 0.448 . . . . 0.0 110.656 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' HG13 ' A' ' 17' ' ' VAL . 11.9 pt-20 -79.4 138.1 37.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -159.46 137.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.84 135.45 89.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -35.93 76.77 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 111.749 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' HG23 ' B' ' 22' ' ' THR . 45.0 t -63.77 -29.18 70.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.11 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.52 135.27 50.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.249 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.549 HG23 ' O ' ' B' ' 20' ' ' SER . 21.4 m -59.68 148.84 32.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 111.482 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 64.3 mt -60.34 -43.44 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.226 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.572 ' HG3' HD22 ' A' ' 25' ' ' ASN . 12.6 pt-20 -59.25 -30.46 68.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.572 HD22 ' HG3' ' A' ' 24' ' ' GLU . 2.0 m120 -71.26 -52.25 20.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 23' ' ' ILE . 34.4 m -59.97 -40.98 84.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.43 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 58.4 mtpt -62.39 -42.79 99.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -57.93 -34.8 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.349 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.3 mttm -66.6 -45.56 78.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.053 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.756 HD13 HG21 ' A' ' 5' ' ' VAL . 79.0 mt -55.15 -36.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 45.8 tt0 -61.92 -49.5 75.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.085 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -62.09 -32.27 72.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.058 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HG3' HD12 ' A' ' 15' ' ' LEU . 30.7 mmmt -68.49 -36.46 78.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.215 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.37 -67.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.789 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.33 -35.22 0.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.427 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.8 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.73 122.55 4.63 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.727 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 89.2 Cg_exo -47.22 147.07 5.95 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.161 2.574 . . . . 0.0 112.469 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.98 -35.62 98.27 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.463 2.109 . . . . 0.0 111.993 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -61.69 -38.34 87.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.8 ' NE2' HG22 ' A' ' 36' ' ' ILE . 26.2 mt-30 -65.72 -44.03 87.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.0 mt-30 -54.69 125.67 20.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.951 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.733 ' H ' ' H ' ' B' ' 46' ' ' ALA . 70.6 mtt-85 -97.36 127.99 43.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.524 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.57 HD23 HG22 ' B' ' 3' ' ' ILE . 10.8 tp -75.07 128.91 36.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.843 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 66.2 mt -143.5 139.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.935 0.397 . . . . 0.0 111.885 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 4.2 m-85 -128.19 147.72 50.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.697 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.4 124.66 5.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 111.596 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' HA2' ' C ' ' B' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.243 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.538 ' O ' ' HG3' ' B' ' 1' ' ' MET . 14.2 tpt . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.247 0.546 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.673 ' HB2' HG22 ' B' ' 14' ' ' THR . 3.3 pt20 -61.81 126.62 27.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.549 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.747 HD11 HD23 ' B' ' 15' ' ' LEU . 29.8 pt -95.62 133.39 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.92 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.36 129.63 35.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.728 HG21 HD13 ' B' ' 30' ' ' ILE . 61.0 t -147.8 143.97 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.053 0.454 . . . . 0.0 112.086 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -104.97 126.6 52.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.825 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -69.53 -156.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.868 0.366 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.444 HD12 ' N ' ' B' ' 8' ' ' LEU . 5.6 mp -59.96 -57.17 14.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -74.86 -45.49 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.64 30.59 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.003 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -82.43 130.99 35.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.408 . . . . 0.0 111.011 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -75.72 131.16 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.234 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.705 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -118.54 130.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.854 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.673 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -104.25 135.15 46.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.573 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.747 HD23 HD11 ' B' ' 3' ' ' ILE . 3.9 tp -161.35 113.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.169 0.509 . . . . 0.0 111.705 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.78 142.4 38.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.703 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.748 HG21 HG12 ' B' ' 26' ' ' VAL . 12.3 p -165.42 135.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -54.64 133.27 64.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.868 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.528 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 11.1 Cg_endo -55.94 -36.63 96.05 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.871 2.381 . . . . 0.0 111.843 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 22' ' ' THR . 46.1 t -63.74 -27.81 69.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -56.15 135.42 53.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.77 ' HB ' HD22 ' B' ' 25' ' ' ASN . 23.4 m -58.24 150.27 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.492 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.559 ' O ' HG22 ' B' ' 26' ' ' VAL . 64.2 mt -62.3 -43.92 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.546 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HG2' ' CG2' ' B' ' 22' ' ' THR . 12.5 pt-20 -57.4 -33.19 67.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.649 0.261 . . . . 0.0 111.195 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.77 HD22 ' HB ' ' B' ' 22' ' ' THR . 70.4 m-80 -73.05 -50.21 24.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.409 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.748 HG12 HG21 ' B' ' 17' ' ' VAL . 33.0 m -58.66 -38.06 69.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 59.0 mtpt -65.96 -43.64 87.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.044 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -59.31 -25.69 64.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.628 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 53.9 mttm -74.12 -39.79 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 109.918 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.728 HD13 HG21 ' B' ' 5' ' ' VAL . 69.4 mt -59.59 -41.74 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.283 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.9 pt20 -65.43 -40.18 92.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.33 -32.48 72.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.6 mmmt -73.92 -31.44 63.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.769 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -135.55 -67.19 0.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 151.85 -25.88 0.92 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.163 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.837 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -51.13 123.58 20.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.703 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -52.39 144.93 38.31 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.804 2.336 . . . . 0.0 111.85 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.48 -35.49 96.69 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.501 2.134 . . . . 0.0 112.246 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' B' ' 40' ' ' GLN . 2.5 p30 -62.15 -38.6 89.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.189 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.837 ' NE2' HG22 ' B' ' 36' ' ' ILE . 26.9 mt-30 -66.55 -41.63 88.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.437 ' OE1' HD12 ' B' ' 30' ' ' ILE . 71.3 mt-30 -56.77 130.93 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.697 ' H ' ' H ' ' A' ' 46' ' ' ALA . 71.6 mtt-85 -106.48 133.08 51.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.973 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.415 HD12 HG22 ' A' ' 3' ' ' ILE . 23.3 mt -76.61 131.83 39.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.896 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.843 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 65.4 mt -143.75 128.93 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.7 m-85 -121.45 142.41 50.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.733 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.44 125.66 9.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.048 0.452 . . . . 0.0 111.593 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.513 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.012 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.105 0.479 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.863 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.1 pt20 -66.58 110.59 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.295 0.569 . . . . 0.0 111.083 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 15' ' ' LEU . 18.8 pt -77.44 140.99 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.774 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -89.5 131.97 35.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.949 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 13' ' ' ILE . 2.3 p -149.86 135.04 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.804 0.335 . . . . 0.0 111.383 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -100.11 131.19 46.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.619 HG22 ' HG3' ' A' ' 34' ' ' GLU . 74.6 p -67.21 -158.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.735 0.302 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 36' ' ' ILE . 4.8 mp -89.28 -46.85 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 10' ' ' GLY . 6.0 t -72.05 -45.15 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 9' ' ' THR . . . 158.58 -31.37 0.47 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.927 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 12' ' ' THR . 7.0 tmtm? -45.48 126.95 7.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.905 0.384 . . . . 0.0 110.748 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.518 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 66.9 m -83.24 138.02 33.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.787 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.59 HG13 ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -118.8 139.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.863 HG22 ' HB2' ' A' ' 2' ' ' GLN . 6.8 m -127.37 137.99 52.9 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 3' ' ' ILE . 4.0 tt -159.82 121.97 3.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.048 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 22.8 pt-20 -72.13 143.42 48.98 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.75 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.584 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -158.36 140.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.414 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.34 143.24 90.44 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.086 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.85 -37.63 95.59 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.811 2.341 . . . . 0.0 112.14 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -64.17 -31.84 73.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.852 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -56.2 130.69 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.569 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -63.5 147.7 50.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.74 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.704 HG21 HD11 ' A' ' 43' ' ' LEU . 65.5 mt -54.58 -37.9 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.253 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.499 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 12.6 pt-20 -62.06 -31.7 72.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.95 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.499 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.4 m120 -74.62 -49.33 21.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.669 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG12 HG11 ' A' ' 17' ' ' VAL . 26.8 m -57.15 -42.63 80.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.162 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtmt -67.15 -37.71 84.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.464 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.497 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . . . -53.7 -36.86 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.262 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.584 ' NZ ' HG12 ' A' ' 17' ' ' VAL . 80.5 mttt -69.13 -42.55 75.86 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.648 HG22 HD11 ' A' ' 36' ' ' ILE . 61.4 mt -57.93 -30.35 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.571 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 15.6 mt-30 -60.83 -44.53 96.82 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.722 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HE3' HD12 ' A' ' 15' ' ' LEU . 72.5 mmtt -61.52 -29.17 69.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.621 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.619 ' HG3' HG22 ' A' ' 7' ' ' THR . 58.6 mm-40 -146.78 -84.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.88 43.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.079 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.832 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -113.28 124.04 32.22 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.79 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 56.8 Cg_exo -41.78 143.78 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.994 2.463 . . . . 0.0 112.334 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 11.8 Cg_endo -57.21 -35.53 98.91 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.494 2.129 . . . . 0.0 112.066 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -64.51 -39.65 94.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.683 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.832 ' NE2' HG22 ' A' ' 36' ' ' ILE . 27.8 mt-30 -60.22 -39.87 88.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.464 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.563 ' OE1' HD12 ' A' ' 30' ' ' ILE . 70.7 mt-30 -61.15 119.81 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.93 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 22.5 tpp180 -90.44 128.49 36.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.704 HD11 HG21 ' A' ' 23' ' ' ILE . 21.7 mt -80.82 136.24 36.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 111.01 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.97 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.1 mt -143.27 126.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.959 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.659 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 1.9 m-85 -116.48 142.08 47.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.7 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -145.13 123.23 12.12 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.992 0.425 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.311 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.819 179.748 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.54 ' O ' ' HG2' ' B' ' 1' ' ' MET . 28.2 ttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.13 0.49 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.942 ' HB2' HG22 ' B' ' 14' ' ' THR . 3.0 pt20 -62.27 110.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 43' ' ' LEU . 13.7 pt -80.09 140.74 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.105 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -89.12 130.13 35.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.012 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 1.076 HG13 HG13 ' B' ' 13' ' ' ILE . 1.6 p -150.07 131.52 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.335 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -93.38 131.58 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.599 HG22 ' HG3' ' B' ' 34' ' ' GLU . 74.1 p -68.44 -157.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 111.263 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.427 HD11 HG23 ' B' ' 36' ' ' ILE . 1.2 mt -85.96 -48.89 8.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.055 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.413 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.7 t -74.69 -45.2 46.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.827 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.413 ' N ' HG23 ' B' ' 9' ' ' THR . . . 159.49 -30.73 0.42 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.732 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' B' ' 12' ' ' THR . 7.3 tmtm? -45.65 127.87 8.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.97 0.414 . . . . 0.0 110.767 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . 0.505 ' N ' ' HD3' ' B' ' 11' ' ' LYS . 34.0 m -84.46 140.55 31.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.687 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 1.076 HG13 HG13 ' B' ' 5' ' ' VAL . 7.1 pt -134.67 140.62 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.022 0.439 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.942 HG22 ' HB2' ' B' ' 2' ' ' GLN . 4.1 m -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.727 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.491 ' C ' ' HA ' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -153.94 134.92 13.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 12.5 pt-20 -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.174 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.561 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 7.5 m -154.81 137.47 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.064 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 4.5 mm-40 -69.74 143.66 92.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.29 -35.82 98.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.778 2.319 . . . . 0.0 112.232 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.5 t -63.88 -31.5 72.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.986 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 49.7 m-20 -57.49 130.33 45.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.652 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -62.9 147.39 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.693 HG21 HD11 ' B' ' 43' ' ' LEU . 65.9 mt -53.28 -37.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.481 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 22.2 pt-20 -62.42 -32.61 73.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.4 m120 -73.39 -49.22 28.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.687 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 23' ' ' ILE . 28.2 m -57.86 -42.85 83.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.64 0.257 . . . . 0.0 111.158 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' B' ' 31' ' ' GLN . 51.8 mtmt -66.42 -37.25 84.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.508 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HA ' ' CD ' ' B' ' 31' ' ' GLN . . . -54.9 -37.48 66.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.561 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 78.9 mttt -67.63 -42.22 82.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.529 HG22 HD11 ' B' ' 36' ' ' ILE . 62.8 mt -58.45 -30.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.594 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.579 ' OE1' ' HD3' ' B' ' 38' ' ' PRO . 16.3 mt-30 -61.2 -45.57 94.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.61 -35.87 82.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.772 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 72.5 mmtt -61.01 -29.32 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.523 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.599 ' HG3' HG22 ' B' ' 7' ' ' THR . 57.4 mm-40 -147.41 -81.15 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.2 44.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.751 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.915 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -112.96 124.44 31.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.616 0.246 . . . . 0.0 111.479 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.793 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 97.1 Cg_exo -44.78 143.66 4.09 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.818 2.346 . . . . 0.0 112.043 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 11.6 Cg_endo -56.65 -35.74 97.62 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.194 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -64.99 -39.24 93.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.915 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.9 mt-30 -61.56 -39.76 92.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.468 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.519 ' OE1' HD12 ' B' ' 30' ' ' ILE . 70.5 mt-30 -59.72 124.41 20.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.532 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.4 tpp180 -95.43 123.47 38.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.73 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.693 HD11 HG21 ' B' ' 23' ' ' ILE . 27.1 mt -75.49 135.31 40.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.088 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.97 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 71.7 mt -143.39 124.99 11.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.578 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.2 m-85 -115.64 146.52 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.584 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.5 129.59 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.529 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.524 179.754 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.556 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.8 tpt . . . . . 0 CA--C 1.532 0.275 0 CA-C-O 121.062 0.458 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 pt20 -61.18 111.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.183 0.516 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 15' ' ' LEU . 24.6 pt -75.56 132.86 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.98 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -89.08 131.56 35.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.797 ' HB ' HG13 ' A' ' 13' ' ' ILE . 64.9 t -143.79 131.39 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 111.665 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.72 123.46 35.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.184 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -70.48 -157.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 36' ' ' ILE . 2.3 mm? -82.37 -48.13 11.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.778 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -73.18 -45.28 57.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.02 -31.64 0.5 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.881 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.66 130.08 11.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.985 0.421 . . . . 0.0 111.757 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 m -90.76 145.01 25.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.753 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.797 HG13 ' HB ' ' A' ' 5' ' ' VAL . 2.3 pt -119.44 126.64 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.68 132.04 43.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 3' ' ' ILE . 9.0 tp -153.59 113.18 3.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.157 0.503 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 39.3 tt0 -70.3 133.9 47.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.501 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 1' ' ' MET . 16.2 m -154.26 137.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.33 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 4.5 mm-40 -72.05 139.72 82.62 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.229 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.31 -38.0 61.37 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.817 2.345 . . . . 0.0 111.751 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 t -64.06 -33.68 76.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.017 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 36.3 m-20 -55.23 130.89 43.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.98 0.419 . . . . 0.0 110.627 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.4 p -59.49 146.79 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.905 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.615 HG21 HD11 ' A' ' 43' ' ' LEU . 63.3 mt -57.91 -29.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.022 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.02 -37.32 85.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.4 m120 -72.1 -46.83 55.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 23' ' ' ILE . 32.7 m -58.35 -41.69 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.961 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HZ2' ' HB2' ' A' ' 41' ' ' GLN . 68.1 mttm -66.7 -40.79 88.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 0.0 110.606 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.639 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -53.55 -40.29 65.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.406 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB2' HD21 ' A' ' 15' ' ' LEU . 50.0 mttm -64.74 -41.36 96.0 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.991 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.459 HG23 ' CD1' ' A' ' 13' ' ' ILE . 67.4 mt -57.46 -35.93 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 28' ' ' ALA . 70.1 mt-30 -61.45 -45.63 93.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.011 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -64.65 -31.69 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.725 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -144.89 -67.2 0.32 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 48.97 0.06 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.972 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.67 HG21 HD21 ' A' ' 8' ' ' LEU . 2.3 pt -125.05 129.03 24.68 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 95.2 Cg_exo -45.88 140.67 9.69 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.793 2.329 . . . . 0.0 112.242 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 17.3 Cg_endo -58.57 -32.62 96.99 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.429 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.37 -36.51 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.609 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 21.9 mt-30 -60.02 -45.64 92.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.549 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.742 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -58.8 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 111.144 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.731 ' H ' ' H ' ' B' ' 46' ' ' ALA . 72.2 mtt-85 -97.44 128.89 44.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 23' ' ' ILE . 27.1 mt -78.62 131.4 36.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 0.0 111.448 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 66.4 mt -143.97 127.5 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.626 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 0.5 OUTLIER -115.35 145.09 42.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.389 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -152.22 122.88 7.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.921 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.607 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.6 tpt . . . . . 0 CA--C 1.53 0.187 0 CA-C-O 121.25 0.547 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.605 ' HB2' HG22 ' B' ' 14' ' ' THR . 16.3 pt20 -61.32 110.44 1.42 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.637 HG12 ' O ' ' B' ' 15' ' ' LEU . 21.2 pt -76.74 131.43 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.069 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.26 132.91 34.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' B' ' 13' ' ' ILE . 66.3 t -145.08 131.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.757 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.26 123.5 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.196 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -71.05 -157.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.286 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.567 HD22 ' N ' ' B' ' 8' ' ' LEU . 2.6 mm? -81.15 -49.83 10.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -72.19 -45.35 60.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.575 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.61 -31.42 0.52 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.769 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.58 128.58 10.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.997 0.427 . . . . 0.0 111.627 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 42.9 m -89.46 139.3 30.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.615 HG13 ' HB ' ' B' ' 5' ' ' VAL . 13.4 pt -113.75 127.25 71.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 112.022 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.605 HG22 ' HB2' ' B' ' 2' ' ' GLN . 1.8 m -96.37 137.15 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.637 ' O ' HG12 ' B' ' 3' ' ' ILE . 5.0 tt -158.3 114.65 2.78 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.614 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 40.7 tt0 -71.91 138.6 48.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.609 HG13 ' CD2' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -158.92 134.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.181 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.69 137.64 95.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 10.2 Cg_endo -52.69 -37.9 75.98 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.847 2.365 . . . . 0.0 112.068 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.0 -30.97 72.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.306 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -55.4 134.16 50.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.855 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -61.19 146.34 47.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.664 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.495 ' O ' HG22 ' B' ' 26' ' ' VAL . 63.8 mt -57.86 -30.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.128 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -65.83 -36.65 84.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.905 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 3.5 m120 -72.29 -47.13 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.264 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 23' ' ' ILE . 32.9 m -58.02 -41.45 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.935 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.473 ' HZ2' ' HB2' ' B' ' 41' ' ' GLN . 68.1 mttm -66.6 -39.98 88.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.927 0.394 . . . . 0.0 110.619 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.656 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -53.44 -42.29 66.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.277 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.553 ' HB2' HD11 ' B' ' 15' ' ' LEU . 45.5 mttm -64.29 -42.8 96.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.042 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' B' ' 36' ' ' ILE . 67.3 mt -55.26 -35.86 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.849 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 68.9 mt-30 -62.26 -42.16 99.08 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.93 -35.27 79.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.405 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 17.1 mmtp -60.43 -37.83 82.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.564 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -141.52 -60.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.297 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.59 45.16 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.848 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.2 OUTLIER -112.13 130.63 23.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.56 0.219 . . . . 0.0 111.544 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.439 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 62.9 Cg_exo -51.97 139.6 50.83 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.434 2.09 . . . . 0.0 111.744 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.5 ' HD3' ' CD ' ' B' ' 31' ' ' GLN . 15.1 Cg_endo -57.22 -32.21 92.91 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.6 -35.93 82.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.848 ' NE2' HG22 ' B' ' 36' ' ' ILE . 25.9 mt-30 -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.703 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -60.07 124.48 20.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.319 . . . . 0.0 110.711 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.689 ' H ' ' H ' ' A' ' 46' ' ' ALA . 72.5 mtt-85 -91.69 126.65 36.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.053 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.572 HD23 ' CG2' ' A' ' 3' ' ' ILE . 10.5 tp -80.28 129.89 34.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.939 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 69.8 mt -143.64 136.98 24.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -121.37 146.71 46.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.471 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.731 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.5 123.91 6.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.357 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--N 1.331 0.262 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.899 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.951 0.405 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.04 125.0 25.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.506 HG12 ' HG ' ' A' ' 15' ' ' LEU . 32.3 pt -91.91 139.27 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.493 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.67 130.14 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.735 ' HB ' HG13 ' A' ' 13' ' ' ILE . 44.8 t -145.24 133.81 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -93.06 120.61 33.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.2 p -72.48 -157.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.738 0.304 . . . . 0.0 111.395 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.502 HD21 HG23 ' A' ' 36' ' ' ILE . 31.6 mt -80.6 -51.47 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.044 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.8 t -69.01 -45.17 71.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.593 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 9' ' ' THR . . . 153.89 -34.12 0.74 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.761 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -49.27 130.33 19.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.59 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -80.15 146.85 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.349 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.735 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.0 pt -126.05 129.53 72.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.775 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 p -107.85 142.65 37.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.422 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 15' ' ' LEU . 2.8 pp -165.41 122.32 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 1' ' ' MET . 11.4 pt-20 -75.71 140.97 42.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.427 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.418 HG13 ' CD1' ' A' ' 15' ' ' LEU . 3.4 m -153.21 133.53 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.162 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -59.74 138.83 90.07 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.074 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.25 -39.07 92.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.937 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 t -64.15 -30.57 71.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.122 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' HG23 ' A' ' 26' ' ' VAL . 38.0 t70 -54.6 136.28 45.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.618 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -64.96 144.46 57.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.557 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 67.3 mt -55.85 -38.69 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -56.18 -44.93 79.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.046 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.2 m120 -65.43 -46.35 80.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.492 HG21 HD11 ' B' ' 23' ' ' ILE . 6.5 t -53.61 -48.62 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.162 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.692 ' HE3' ' HB3' ' A' ' 38' ' ' PRO . 51.5 mtmt -68.62 -35.4 77.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.43 -40.29 71.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.458 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 25.5 mmmt -62.09 -43.75 98.16 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.334 0.588 . . . . 0.0 109.582 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.607 HD12 ' OE1' ' A' ' 41' ' ' GLN . 62.2 mt -57.16 -35.9 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.748 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.751 HE21 ' HA ' ' A' ' 28' ' ' ALA . 69.1 mt-30 -58.97 -43.97 91.46 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.25 -37.5 83.61 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.942 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 28.9 mtpp -76.8 3.45 11.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.815 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -169.22 -102.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.145 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.71 49.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.422 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.84 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -121.99 127.17 26.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.64 0.257 . . . . 0.0 111.437 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.605 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 79.0 Cg_exo -48.89 144.3 15.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.219 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.692 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -56.45 -37.74 96.64 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.569 2.18 . . . . 0.0 112.406 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.82 -38.88 92.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.309 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.84 ' NE2' HG22 ' A' ' 36' ' ' ILE . 26.2 mt-30 -63.54 -39.45 94.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.607 ' OE1' HD12 ' A' ' 30' ' ' ILE . 71.3 mt-30 -59.75 110.79 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -81.88 130.82 35.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.321 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.513 ' HB2' HG22 ' B' ' 3' ' ' ILE . 33.0 mt -80.05 135.7 36.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 81.0 mt -143.28 133.84 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.35 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.831 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 6.8 m-85 -127.53 140.98 51.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.813 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -151.63 126.05 9.42 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.093 0.473 . . . . 0.0 111.843 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.302 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.729 179.809 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.2 ptm . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.866 0.365 . . . . 0.0 111.519 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.731 ' HB2' HG22 ' B' ' 14' ' ' THR . 3.3 pt20 -67.3 127.91 34.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.226 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.622 HG12 ' O ' ' B' ' 15' ' ' LEU . 24.2 pt -97.35 136.69 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.975 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -89.97 126.82 35.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.122 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.936 HG13 HG13 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.45 132.55 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.999 0.428 . . . . 0.0 111.5 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -84.83 129.7 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.074 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.502 HG23 HG12 ' B' ' 13' ' ' ILE . 77.9 p -77.54 -157.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.163 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.402 ' H ' ' HB ' ' B' ' 7' ' ' THR . 53.6 mt -81.42 -50.76 9.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.197 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.425 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -71.33 -45.26 63.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.693 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.425 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.88 -35.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.841 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -48.61 130.47 17.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.342 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 62.1 m -82.48 134.17 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.141 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.936 HG13 HG13 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -100.76 131.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 111.624 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.731 HG22 ' HB2' ' B' ' 2' ' ' GLN . 1.3 m -105.27 134.23 48.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.622 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -162.53 115.04 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -178.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.5 pt-20 -78.39 140.26 38.73 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.196 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.03 136.2 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.242 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -59.91 140.07 90.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.077 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 12.9 Cg_endo -56.75 -40.01 87.34 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.799 2.333 . . . . 0.0 112.032 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.7 t -64.08 -29.78 70.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.118 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -56.15 136.02 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.61 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 71.1 p -65.07 145.81 55.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.697 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.591 ' O ' HG22 ' B' ' 26' ' ' VAL . 66.8 mt -55.84 -39.04 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.7 -40.0 74.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.17 -49.28 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 23' ' ' ILE . 15.7 m -57.24 -41.44 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.707 ' HE3' ' HB3' ' B' ' 38' ' ' PRO . 50.3 mtmt -69.82 -38.63 76.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 110.818 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.808 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -54.44 -41.52 69.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.737 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -68.26 -37.77 81.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.209 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.634 HG22 HD11 ' B' ' 36' ' ' ILE . 63.0 mt -57.62 -34.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.808 HE21 ' HA ' ' B' ' 28' ' ' ALA . 68.7 mt-30 -60.65 -41.41 94.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -67.23 -37.76 84.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.752 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -78.0 3.24 15.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.637 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -168.53 -106.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 50.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.812 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.824 HG22 HE22 ' B' ' 40' ' ' GLN . 0.7 OUTLIER -126.57 119.89 23.09 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.725 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 35.5 Cg_exo -38.89 146.3 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.296 2.664 . . . . 0.0 112.982 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.707 ' HB3' ' HE3' ' B' ' 27' ' ' LYS . 33.6 Cg_exo -58.83 -38.14 90.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.665 2.244 . . . . 0.0 112.646 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.56 -39.2 90.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.824 HE22 HG22 ' B' ' 36' ' ' ILE . 22.9 mt-30 -60.16 -44.99 94.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.391 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.831 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 71.4 mt-30 -54.37 115.75 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.982 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.813 ' H ' ' H ' ' A' ' 46' ' ' ALA . 56.2 ttp180 -87.49 124.3 33.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.818 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 3' ' ' ILE . 44.1 mt -72.87 133.34 44.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.968 0.414 . . . . 0.0 111.121 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 74.8 mt -143.51 131.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.466 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.582 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.7 m-85 -127.19 148.05 50.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.762 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.91 132.39 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.308 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.262 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.52 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.6 ptm . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.211 0.529 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.489 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 10.8 tt0 -72.63 134.63 45.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.492 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.658 HG12 ' O ' ' A' ' 15' ' ' LEU . 29.5 pt -117.6 145.3 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.027 0.442 . . . . 0.0 112.067 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.2 m-85 -89.3 133.91 34.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.761 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.745 ' HB ' HG12 ' A' ' 13' ' ' ILE . 92.3 t -144.91 136.64 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.136 0.493 . . . . 0.0 111.781 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 40.4 ttmt -91.47 134.41 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.499 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -71.43 -157.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.515 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.446 HD21 HG23 ' A' ' 36' ' ' ILE . 38.7 mt -65.37 -63.91 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.7 t -77.57 -45.18 26.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 9' ' ' THR . . . 155.49 108.05 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.329 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 24.2 ttmm -167.19 127.84 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.724 0.297 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -73.27 133.39 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.745 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.1 pt -135.44 135.54 51.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.489 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 3.3 p -90.43 144.43 25.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.069 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.658 ' O ' HG12 ' A' ' 3' ' ' ILE . 10.7 tp -160.58 114.05 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.216 0.532 . . . . 0.0 111.76 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.6 pt-20 -85.35 132.45 34.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.671 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -151.06 142.96 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.356 . . . . 0.0 111.141 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HB2' ' CG ' ' A' ' 21' ' ' ASP . 42.0 mt-10 -67.43 137.44 93.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.3 -36.14 88.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.807 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.475 ' O ' HG22 ' B' ' 22' ' ' THR . 79.8 p -64.44 -27.86 69.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.357 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 51.6 m-20 -58.96 133.1 55.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.686 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.418 HG22 ' O ' ' B' ' 20' ' ' SER . 59.3 p -63.06 145.95 54.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.695 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 56.1 mt -53.54 -38.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 16.1 pt-20 -60.44 -39.91 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.514 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.4 m120 -67.39 -48.81 66.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.646 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -61.34 -43.87 97.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.317 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.695 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 36.3 mtmm -62.6 -43.8 97.91 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.9 0.381 . . . . 0.0 110.044 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 31' ' ' GLN . . . -60.43 -29.25 68.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.451 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' NZ ' ' NZ ' ' A' ' 33' ' ' LYS . 26.2 tptp -64.85 -43.03 94.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.744 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.546 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 51.3 mt -57.28 -31.83 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.723 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' NE2' ' HA ' ' A' ' 37' ' ' PRO . 75.3 mt-30 -58.16 -48.01 81.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -61.32 -36.89 81.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.826 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 38.6 mmtm -67.49 -24.21 65.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.135 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -153.16 -90.0 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.092 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.78 61.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.888 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.906 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -139.54 118.27 8.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.559 0.218 . . . . 0.0 111.549 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.748 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 54.8 Cg_exo -40.27 146.03 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.152 2.568 . . . . 0.0 112.822 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.675 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 19.8 Cg_endo -60.04 -36.0 90.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.818 2.345 . . . . 0.0 112.61 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.44 -38.86 85.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.906 ' NE2' HG22 ' A' ' 36' ' ' ILE . 18.3 mt-30 -64.1 -40.49 96.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.244 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' NE2' HG21 ' A' ' 30' ' ' ILE . 8.4 mm100 -52.44 126.94 20.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.192 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.743 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.5 mtt180 -94.85 124.77 39.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.235 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.458 ' HB2' HG22 ' B' ' 3' ' ' ILE . 64.1 mt -78.35 132.03 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.384 . . . . 0.0 111.0 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.966 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 74.5 mt -143.57 131.96 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.539 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.662 ' O ' HG13 ' B' ' 5' ' ' VAL . 4.8 m-85 -126.36 147.12 49.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.6 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.7 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.39 128.04 7.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 111.703 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.26 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.972 179.972 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.1 ptm . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.983 ' HB3' HG22 ' B' ' 14' ' ' THR . 87.5 mt-30 -62.25 145.13 54.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.688 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.666 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.1 pt -121.77 143.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.1 m-85 -88.05 131.28 34.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.856 ' HB ' HG23 ' B' ' 13' ' ' ILE . 84.4 t -142.43 146.04 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.091 0.472 . . . . 0.0 111.563 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.425 ' CG ' ' HA2' ' B' ' 10' ' ' GLY . 40.3 ttmt -102.08 131.57 48.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.194 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 70.0 p -68.61 -157.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 111.457 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.46 HD21 HG23 ' B' ' 36' ' ' ILE . 75.1 mt -64.67 -65.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.221 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.4 t -76.79 -45.25 29.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.427 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.06 109.03 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.358 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -167.25 129.46 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.696 0.284 . . . . 0.0 110.903 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -73.37 134.34 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.756 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.856 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -137.85 122.49 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.266 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.983 HG22 ' HB3' ' B' ' 2' ' ' GLN . 0.1 OUTLIER -80.16 145.22 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.477 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.666 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.2 tt -162.72 112.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.21 0.529 . . . . 0.0 111.177 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.4 pt-20 -82.92 141.11 32.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.955 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.934 HG11 HG23 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -157.65 145.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.557 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.465 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 44.7 mt-10 -71.13 133.99 85.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.992 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.97 -37.69 97.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.796 2.33 . . . . 0.0 112.2 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.418 ' O ' HG22 ' A' ' 22' ' ' THR . 80.5 p -63.89 -25.92 68.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.465 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 53.0 m-20 -60.81 131.44 50.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 20' ' ' SER . 65.9 p -60.8 146.55 45.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.723 HG22 ' NZ ' ' B' ' 27' ' ' LYS . 54.8 mt -55.36 -37.79 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.099 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.546 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 15.9 pt-20 -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.3 m120 -67.7 -46.3 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.452 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.934 HG23 HG11 ' B' ' 17' ' ' VAL . 7.8 p -61.93 -41.21 90.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.723 ' NZ ' HG22 ' B' ' 23' ' ' ILE . 36.8 mtmm -66.61 -44.55 81.79 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.01 0.433 . . . . 0.0 110.203 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' B' ' 31' ' ' GLN . . . -57.87 -27.29 63.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.509 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -64.87 -43.89 91.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.817 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.66 HG22 HD11 ' B' ' 36' ' ' ILE . 51.5 mt -57.57 -30.95 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.824 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 74.2 mt-30 -58.05 -48.49 79.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.5 -37.34 83.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.767 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 38.5 mmtm -66.48 -25.1 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -152.03 -87.23 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.15 57.3 0.02 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.248 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.839 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.5 OUTLIER -134.9 125.56 17.32 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.71 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 70.5 Cg_exo -44.28 145.16 2.51 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.0 2.467 . . . . 0.0 112.386 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.663 ' HB2' ' HE2' ' B' ' 27' ' ' LYS . 20.2 Cg_endo -60.27 -35.13 92.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.497 2.131 . . . . 0.0 112.223 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.64 -38.15 89.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.839 ' NE2' HG22 ' B' ' 36' ' ' ILE . 26.3 mt-30 -64.19 -37.23 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.538 ' NE2' HD13 ' B' ' 36' ' ' ILE . 8.7 mm100 -54.54 129.26 35.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.3 mtt180 -97.52 124.67 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.251 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 3' ' ' ILE . 50.7 mt -79.46 132.71 36.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.399 . . . . 0.0 111.115 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.966 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.1 mt -143.54 131.27 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.367 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.8 m-85 -125.28 143.99 50.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.743 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -153.43 129.94 10.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.526 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.784 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.468 ' HE1' HD13 ' B' ' 43' ' ' LEU . 20.4 ptm . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.906 0.384 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.812 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.2 pt20 -71.47 122.73 20.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.574 HG22 HD22 ' B' ' 43' ' ' LEU . 38.0 pt -86.15 144.16 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.556 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -88.89 134.98 33.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.972 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.661 HG22 ' HB2' ' B' ' 45' ' ' PHE . 59.5 t -148.2 132.74 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.865 0.364 . . . . 0.0 111.145 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.83 126.43 43.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 9' ' ' THR . 91.1 m -67.62 150.55 48.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.872 HD21 HG21 ' A' ' 36' ' ' ILE . 4.2 mp -45.02 -45.2 10.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.438 ' H ' HG22 ' A' ' 7' ' ' THR . 72.0 p -75.46 -45.5 38.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.392 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.43 0.53 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.88 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -44.02 131.59 5.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -74.15 141.72 45.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 1.1 mt -128.62 139.12 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.028 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.812 HG22 ' HB2' ' A' ' 2' ' ' GLN . 7.2 m -133.52 142.86 48.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.9 HD13 ' HD2' ' A' ' 33' ' ' LYS . 5.8 tp -157.02 114.95 3.19 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 16.9 pt-20 -71.89 130.51 41.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.612 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 18.7 m -152.57 138.65 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 48.5 mt-10 -69.16 140.87 91.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.72 -36.37 81.59 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.969 2.446 . . . . 0.0 112.239 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.523 ' O ' HG22 ' B' ' 22' ' ' THR . 46.0 t -64.3 -32.04 73.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 54.5 m-20 -56.27 132.59 51.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.499 HG22 ' O ' ' B' ' 20' ' ' SER . 66.6 p -60.06 147.18 40.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.642 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 26' ' ' VAL . 61.5 mt -54.38 -36.95 35.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.788 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.66 -32.22 72.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -69.28 -47.46 64.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.208 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 23' ' ' ILE . 22.7 m -60.22 -39.28 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.969 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HE3' HG22 ' A' ' 23' ' ' ILE . 99.3 mttt -67.13 -38.75 86.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.555 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -49.84 -38.62 35.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.427 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.777 ' HD2' HD21 ' A' ' 15' ' ' LEU . 80.0 mttt -67.79 -41.07 83.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -55.14 -36.83 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.357 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.555 HE21 ' HA ' ' A' ' 28' ' ' ALA . 68.2 mt-30 -63.28 -45.0 93.49 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.94 -33.01 74.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.712 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.9 ' HD2' HD13 ' A' ' 15' ' ' LEU . 29.6 mtpp -71.71 -31.56 66.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.935 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -135.63 -60.18 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.11 57.06 0.19 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.083 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.872 HG21 HD21 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -145.07 131.43 9.78 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 120.819 0.342 . . . . 0.0 111.352 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.563 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 60.6 Cg_exo -40.89 139.46 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.29 2.66 . . . . 0.0 113.229 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 18.0 Cg_endo -60.36 -36.2 88.18 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.922 2.414 . . . . 0.0 112.663 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.25 -37.19 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.698 HE22 HG22 ' A' ' 36' ' ' ILE . 16.0 mt-30 -59.27 -45.41 91.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.672 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.34 124.37 15.74 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.73 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.687 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.9 ttm180 -91.46 123.18 34.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.555 HD21 HG21 ' A' ' 23' ' ' ILE . 9.3 mp -73.49 132.04 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.949 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 79.9 mt -143.61 134.65 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.669 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 8.3 m-85 -128.62 144.81 51.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.818 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.72 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.04 129.4 10.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.994 0.426 . . . . 0.0 111.439 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' B' ' 8' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.254 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.897 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.492 ' HE1' HD13 ' A' ' 43' ' ' LEU . 20.2 ptm . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.888 0.375 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.94 ' HB2' HG22 ' B' ' 14' ' ' THR . 3.1 pt20 -69.22 124.33 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.462 HG22 HD22 ' A' ' 43' ' ' LEU . 37.4 pt -88.33 145.83 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.831 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.76 135.51 33.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.153 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.717 ' HB ' HG13 ' B' ' 13' ' ' ILE . 57.6 t -148.47 138.31 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 111.132 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.9 125.55 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.437 HG22 ' H ' ' B' ' 9' ' ' THR . 90.4 m -67.03 151.32 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.484 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.798 HD22 ' H ' ' B' ' 8' ' ' LEU . 0.4 OUTLIER -47.26 -42.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.663 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.437 ' H ' HG22 ' B' ' 7' ' ' THR . 67.4 p -75.92 -45.36 35.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.86 -30.44 0.61 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.911 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -45.29 134.62 6.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 39.1 m -79.94 143.82 33.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.0 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.717 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.4 pt -142.78 135.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.142 0.496 . . . . 0.0 111.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.94 HG22 ' HB2' ' B' ' 2' ' ' GLN . 6.0 m -139.75 141.74 36.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.07 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.52 HD22 ' CD ' ' B' ' 33' ' ' LYS . 0.9 OUTLIER -150.69 130.8 13.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.022 0.439 . . . . 0.0 111.193 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 11.1 pt-20 -69.85 132.78 46.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.963 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.534 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 17.3 m -150.43 136.83 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.48 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 48.1 mt-10 -69.5 138.8 88.85 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.257 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.22 -36.05 65.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.061 2.507 . . . . 0.0 112.261 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 22' ' ' THR . 45.6 t -64.01 -32.69 74.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.05 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 55.3 m-20 -56.0 132.54 50.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.824 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 20' ' ' SER . 69.0 p -59.49 148.26 33.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.67 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.592 ' O ' HG22 ' B' ' 26' ' ' VAL . 61.3 mt -54.59 -36.89 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.38 -31.05 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.774 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -65.96 -52.04 53.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.061 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.592 HG22 ' O ' ' B' ' 23' ' ' ILE . 24.4 m -58.29 -39.7 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.262 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' B' ' 23' ' ' ILE . 98.8 mttt -66.88 -37.99 85.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.547 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -50.74 -40.74 55.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.314 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 78.7 mttt -68.23 -40.4 82.06 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' B' ' 27' ' ' LYS . 70.6 mt -54.34 -36.69 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.168 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 67.6 mt-30 -63.79 -44.54 93.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.394 0.616 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -67.46 -32.48 73.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.62 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.52 ' CD ' HD22 ' B' ' 15' ' ' LEU . 29.6 mtpp -70.61 -32.41 69.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.092 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.861 ' HB2' HD11 ' B' ' 36' ' ' ILE . 56.8 mm-40 -138.14 -55.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.678 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.77 54.89 0.23 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.62 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.861 HD11 ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -135.44 135.63 22.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.578 0.228 . . . . 0.0 111.057 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.566 ' HB2' ' HG3' ' B' ' 40' ' ' GLN . 75.7 Cg_exo -50.04 138.54 35.52 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.45 2.1 . . . . 0.0 112.028 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' B' ' 27' ' ' LYS . 18.5 Cg_endo -58.03 -35.55 98.67 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.817 2.345 . . . . 0.0 112.496 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.18 -36.12 79.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.259 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.716 ' NE2' HG22 ' B' ' 36' ' ' ILE . 23.3 mt-30 -62.82 -44.2 96.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.57 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.669 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.79 126.42 22.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.785 0.326 . . . . 0.0 110.488 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.72 ' H ' ' H ' ' A' ' 46' ' ' ALA . 38.8 ttm180 -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.664 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.574 HD22 HG22 ' A' ' 3' ' ' ILE . 8.9 mp -74.49 132.5 41.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.949 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 76.7 mt -143.55 134.21 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.672 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 8.1 m-85 -128.4 144.32 51.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.687 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 132.39 13.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.954 0.407 . . . . 0.0 111.413 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.64 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 17.0 ptm . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.986 0.422 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.655 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.3 pt20 -61.86 129.45 41.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.702 HD11 HD23 ' A' ' 15' ' ' LEU . 36.7 pt -97.49 135.04 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.76 125.5 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.838 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.2 t -147.79 134.44 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.692 0.282 . . . . 0.0 111.681 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -93.52 119.62 32.81 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -66.53 -159.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.484 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.906 HD11 HG21 ' A' ' 36' ' ' ILE . 2.3 mm? -81.59 -47.02 13.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -73.47 -45.44 54.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.394 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -35.7 0.55 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.806 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.2 133.01 15.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.967 0.413 . . . . 0.0 111.591 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 m -84.77 132.88 34.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.04 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.838 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -99.97 134.43 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.888 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.1 m -109.01 133.86 52.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.702 HD23 HD11 ' A' ' 3' ' ' ILE . 5.4 tp -159.84 114.85 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 112.099 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 1' ' ' MET . 16.9 pt-20 -79.01 137.13 37.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.219 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.27 135.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -57.88 140.99 81.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 12.2 Cg_endo -56.34 -40.03 87.38 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.818 2.345 . . . . 0.0 112.127 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -64.14 -28.81 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.064 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 8.3 t70 -53.53 132.33 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.8 p -62.94 144.37 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.875 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 26' ' ' VAL . 64.7 mt -55.4 -36.33 40.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.279 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.503 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 23.8 pt-20 -62.97 -35.67 80.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.4 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.544 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 m120 -72.93 -48.03 40.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.621 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 23' ' ' ILE . 32.7 m -57.47 -44.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.138 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 99.3 mttt -65.06 -38.44 90.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 110.461 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.26 -37.73 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.151 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HB2' HD21 ' A' ' 15' ' ' LEU . 29.8 mmtp -66.48 -39.67 88.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.996 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.465 HG23 HD12 ' A' ' 13' ' ' ILE . 62.2 mt -56.32 -35.94 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.886 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.751 HE21 ' HA ' ' A' ' 28' ' ' ALA . 71.4 mt-30 -59.66 -44.6 93.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.07 -34.17 77.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.133 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 73.1 mmtt -66.27 -25.04 66.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.85 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -150.27 -79.59 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.943 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.43 57.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.236 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.906 HG21 HD11 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -140.97 129.28 12.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.465 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.624 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 59.7 Cg_exo -41.63 142.47 1.24 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.263 2.642 . . . . 0.0 113.179 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 25.7 Cg_endo -61.63 -37.26 70.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.958 2.438 . . . . 0.0 112.742 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.09 -36.22 72.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.761 HE22 HG22 ' A' ' 36' ' ' ILE . 18.1 mt-30 -60.5 -44.98 95.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.63 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.98 125.64 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.673 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.2 mtt180 -89.2 126.68 35.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.511 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -75.66 130.3 38.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.343 . . . . 0.0 110.857 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.935 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.4 mt -143.59 132.03 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.05 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.691 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 3.3 m-85 -127.34 145.39 50.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.577 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.728 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -149.98 125.47 10.25 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.872 0.368 . . . . 0.0 111.417 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.22 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.106 -179.699 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.8 ptm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.97 0.414 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.7 130.35 45.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.648 HG12 ' HB3' ' B' ' 15' ' ' LEU . 35.3 pt -97.27 131.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.278 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.724 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -88.97 120.85 30.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.865 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.93 HG13 HG13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -150.91 130.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.063 0.459 . . . . 0.0 111.765 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -83.13 126.64 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.385 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -70.57 -157.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.309 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.699 HD21 HG12 ' B' ' 36' ' ' ILE . 2.0 mm? -83.0 -48.33 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p -71.77 -45.29 62.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.27 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 -34.22 0.62 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.763 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -49.43 130.91 20.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.863 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 37.2 m -80.92 147.27 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.901 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.93 HG13 HG13 ' B' ' 5' ' ' VAL . 18.6 pt -129.36 124.78 60.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 0.0 112.477 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -92.88 146.89 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.178 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.648 ' HB3' HG12 ' B' ' 3' ' ' ILE . 5.3 tt -164.2 114.62 1.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.829 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.3 pt-20 -78.02 138.05 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.622 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.584 HG13 ' CD2' ' B' ' 15' ' ' LEU . 1.0 OUTLIER -157.25 133.41 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.943 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -59.14 138.28 88.11 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.448 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 9.3 Cg_endo -52.51 -39.06 75.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.917 2.412 . . . . 0.0 112.106 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.5 t -63.93 -29.8 70.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.155 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.554 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.2 t70 -53.81 131.87 40.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 0.0 110.526 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -62.42 144.01 56.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.916 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 19' ' ' PRO . 65.2 mt -55.22 -35.72 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.519 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 24.4 pt-20 -63.15 -36.14 82.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.347 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.554 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 3.5 m120 -72.7 -48.37 39.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.602 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 23' ' ' ILE . 31.0 m -57.23 -43.76 82.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.438 ' HE3' ' CG2' ' B' ' 23' ' ' ILE . 99.0 mttt -65.09 -38.34 90.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.718 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -55.18 -37.07 66.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.575 ' HB2' HD11 ' B' ' 15' ' ' LEU . 58.0 mmtt -64.56 -43.5 93.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' B' ' 33' ' ' LYS . 65.4 mt -53.5 -36.29 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.147 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.718 HE21 ' HA ' ' B' ' 28' ' ' ALA . 71.8 mt-30 -59.82 -45.57 91.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -67.57 -33.46 75.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.229 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.525 ' HG3' HD12 ' B' ' 15' ' ' LEU . 72.7 mmtt -65.44 -25.29 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.169 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' B' ' 36' ' ' ILE . 17.7 tp10 -152.61 -68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.299 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.85 55.7 0.04 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.72 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.889 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -133.89 133.33 22.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.51 0.195 . . . . 0.0 111.28 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.625 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 71.7 Cg_exo -51.04 139.59 41.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.451 2.101 . . . . 0.0 112.092 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.561 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 19.8 Cg_endo -58.29 -35.75 98.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.831 2.354 . . . . 0.0 112.679 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.889 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.1 mt-30 -63.33 -41.96 98.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -56.25 126.36 25.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.834 0.349 . . . . 0.0 110.488 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.728 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.4 mtt180 -86.16 127.04 34.65 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.51 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.616 HD23 HG22 ' A' ' 3' ' ' ILE . 5.4 tp -78.3 127.6 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.656 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.935 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 70.5 mt -143.71 138.15 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-O 120.88 0.371 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.63 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 3.6 m-85 -131.24 148.67 52.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.673 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.9 124.26 8.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.292 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.356 -179.632 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.3 ptm . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 121.233 0.539 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.476 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 36.5 tt0 -62.95 120.79 12.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.3 pt -99.7 143.07 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 112.22 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.4 m-85 -89.86 135.31 33.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.124 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.799 ' HB ' HG13 ' A' ' 13' ' ' ILE . 67.4 t -148.79 132.76 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -92.46 129.22 38.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.698 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 11' ' ' LYS . 61.5 p -77.37 -157.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 110.908 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.865 HD21 HG21 ' A' ' 36' ' ' ILE . 51.7 mt -83.45 -53.49 5.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.57 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -73.16 -45.28 57.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.32 -27.15 0.25 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.325 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' HG23 ' A' ' 7' ' ' THR . 4.0 tppp? -43.24 130.36 4.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 111.952 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -89.21 138.84 31.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.981 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.799 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.2 pt -125.4 133.85 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.271 0.558 . . . . 0.0 111.907 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 4.7 p -117.72 144.27 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.623 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' O ' HG12 ' A' ' 3' ' ' ILE . 3.3 pp -168.0 124.73 1.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.292 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -77.15 143.01 39.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -179.344 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 15' ' ' LEU . 3.7 m -150.97 132.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.86 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 85.5 mt-10 -63.38 137.83 97.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.75 -36.19 61.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.13 2.553 . . . . 0.0 112.5 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.42 ' O ' HG22 ' B' ' 22' ' ' THR . 45.0 t -63.87 -33.23 75.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.094 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.637 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -56.47 133.23 53.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -60.27 148.47 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.826 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.723 HD11 HG21 ' B' ' 26' ' ' VAL . 69.0 mt -54.67 -45.33 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 12.1 pt-20 -59.82 -36.09 76.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.552 HD22 ' HB3' ' A' ' 21' ' ' ASP . 42.7 t30 -63.59 -48.25 78.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 23' ' ' ILE . 11.0 m -64.82 -41.01 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.171 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.42 -39.21 93.89 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.666 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -55.24 -37.45 67.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HE3' HG12 ' A' ' 17' ' ' VAL . 48.4 mttm -63.64 -41.95 98.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.643 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 13' ' ' ILE . 70.8 mt -55.09 -39.33 49.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.421 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 43.1 tt0 -61.17 -47.13 87.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.153 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -60.01 -37.38 79.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.051 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 4.5 mmmp? -66.18 -42.42 88.91 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.948 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -124.55 -70.21 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.083 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.0 -37.34 0.42 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.254 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.983 HG22 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.61 126.09 4.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.679 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -47.1 142.73 11.1 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.305 2.67 . . . . 0.0 112.761 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 46.8 Cg_exo -56.33 -37.34 97.1 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.766 2.311 . . . . 0.0 112.475 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.75 -38.32 81.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.983 HE22 HG22 ' A' ' 36' ' ' ILE . 26.0 mt-30 -60.51 -39.27 87.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.743 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.696 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.64 124.09 15.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 99.3 mtt180 -89.54 128.57 36.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.431 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HG22 ' B' ' 3' ' ' ILE . 23.7 mt -74.27 130.55 39.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.838 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 76.6 mt -143.88 133.04 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.2 m-85 -130.33 147.23 52.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.725 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.82 123.99 5.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 111.562 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.6 ptm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.779 0.323 . . . . 0.0 111.465 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.435 ' NE2' HG21 ' B' ' 14' ' ' THR . 27.6 mt-30 -62.03 130.52 45.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.249 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.709 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.1 pt -104.09 139.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.592 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.0 m-85 -88.86 129.78 35.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.685 ' HB ' HG13 ' B' ' 13' ' ' ILE . 62.0 t -144.07 134.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 111.462 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -96.09 127.73 42.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 66.3 p -76.54 -157.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.961 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.586 HD11 HG23 ' B' ' 36' ' ' ILE . 7.7 mp -83.04 -52.63 6.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.519 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -74.27 -45.27 48.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.67 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.07 -28.45 0.27 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.559 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -42.96 130.68 4.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.768 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.685 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -106.22 129.5 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.115 0.483 . . . . 0.0 112.002 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.435 HG21 ' NE2' ' B' ' 2' ' ' GLN . 1.9 m -107.46 136.33 47.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.709 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -163.36 115.64 1.49 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.864 -178.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' B' ' 1' ' ' MET . 23.9 pt-20 -76.92 139.27 40.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.439 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -151.26 138.09 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.645 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 85.5 mt-10 -67.33 140.52 95.31 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.03 -37.62 86.56 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.082 2.521 . . . . 0.0 112.497 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.3 t -63.85 -32.97 74.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.188 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.645 ' OD1' ' HB2' ' B' ' 18' ' ' GLU . 1.0 OUTLIER -56.21 132.93 51.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 20' ' ' SER . 80.4 p -60.65 149.07 36.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.792 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.816 HD13 HD21 ' B' ' 43' ' ' LEU . 67.1 mt -55.2 -45.07 77.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.12 -41.62 88.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.834 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . 0.457 HD22 ' HB3' ' B' ' 21' ' ' ASP . 37.5 t30 -61.4 -44.14 97.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.515 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.723 HG21 HD11 ' A' ' 23' ' ' ILE . 16.8 t -61.47 -47.85 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.388 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 47.7 mtmt -65.08 -36.38 84.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.303 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.683 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -56.51 -32.65 65.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.152 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 50.4 mttm -69.26 -33.84 73.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.183 0.516 . . . . 0.0 109.735 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.625 HG23 HD12 ' B' ' 13' ' ' ILE . 60.9 mt -61.75 -42.18 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.597 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.7 pt20 -66.35 -45.33 80.57 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' B' ' 31' ' ' GLN . 63.7 t0 -58.77 -31.73 68.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' B' ' 30' ' ' ILE . 22.9 tptp -73.27 -32.23 64.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.556 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.403 ' HB3' HD11 ' B' ' 36' ' ' ILE . 36.9 tp10 -139.31 -64.76 0.49 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.004 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 159.07 -32.56 0.46 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.343 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.811 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.3 OUTLIER -49.74 128.95 20.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.478 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 50.4 Cg_exo -54.57 140.58 75.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.68 2.254 . . . . 0.0 111.668 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.605 ' HB3' ' HB2' ' B' ' 27' ' ' LYS . 53.6 Cg_exo -52.75 -37.26 75.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.563 2.175 . . . . 0.0 112.665 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -61.11 -37.4 82.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.564 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.811 ' NE2' HG22 ' B' ' 36' ' ' ILE . 24.5 mt-30 -62.87 -38.97 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.75 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.68 126.43 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.698 0.285 . . . . 0.0 110.588 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.725 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.4 mtt180 -92.35 127.48 37.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.992 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.816 HD21 HD13 ' B' ' 23' ' ' ILE . 7.7 mp -72.86 129.07 37.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.226 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 77.9 mt -143.89 131.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.696 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 5.3 m-85 -128.94 145.86 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.747 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.616 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -155.81 126.09 6.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 111.461 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.443 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 ptm . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.865 0.364 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 1.041 ' HB2' HG22 ' A' ' 14' ' ' THR . 19.3 pt20 -69.05 130.12 41.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 15' ' ' LEU . 5.0 pt -99.75 147.05 7.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.79 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 4.6 m-85 -89.57 126.98 35.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.911 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.709 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.1 t -149.5 137.28 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.277 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -104.62 129.67 52.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.391 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -68.38 -157.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.117 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.529 ' H ' HD12 ' A' ' 8' ' ' LEU . 3.6 mp -86.57 -51.58 6.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.242 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.8 p -72.11 -45.48 60.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.729 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 -29.73 0.26 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -43.97 129.91 5.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.967 0.413 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -90.27 137.53 32.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.339 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.709 HG13 ' HB ' ' A' ' 5' ' ' VAL . 3.7 pt -122.87 134.63 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 111.344 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.041 HG22 ' HB2' ' A' ' 2' ' ' GLN . 3.8 m -127.0 105.1 8.37 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -123.68 127.91 48.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 1' ' ' MET . 12.5 pt-20 -72.39 139.27 47.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.83 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -150.26 135.17 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 80.4 mt-10 -64.22 137.9 97.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.235 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.34 -36.58 97.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.831 2.354 . . . . 0.0 112.031 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.583 ' O ' HG22 ' B' ' 22' ' ' THR . 43.4 t -64.19 -33.94 76.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.898 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.621 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 30.2 m-20 -57.99 133.33 55.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.576 HG22 ' O ' ' B' ' 20' ' ' SER . 76.1 p -58.49 149.51 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.453 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.623 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 63.2 mt -53.33 -38.23 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.846 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.426 ' HA ' ' HZ1' ' A' ' 27' ' ' LYS . 17.1 tp10 -59.27 -42.29 90.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.452 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.71 -44.9 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.774 HG21 HD11 ' B' ' 23' ' ' ILE . 24.3 t -57.34 -48.93 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.176 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.623 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 36.8 mtmm -66.04 -35.56 80.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.845 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.27 -38.43 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.178 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HE2' ' NZ ' ' A' ' 33' ' ' LYS . 87.9 tttt -67.28 -38.86 85.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.04 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.601 HD12 ' HG2' ' A' ' 41' ' ' GLN . 58.4 mt -58.12 -34.29 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.891 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.845 HE21 ' HA ' ' A' ' 28' ' ' ALA . 54.7 mt-30 -64.08 -44.46 92.31 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 -32.58 71.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' NZ ' ' HE2' ' A' ' 29' ' ' LYS . 36.2 mmtm -71.67 -30.09 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.03 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -140.96 -66.49 0.43 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.204 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 150.86 -32.15 0.98 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.901 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.852 HG22 HE21 ' A' ' 40' ' ' GLN . 0.6 OUTLIER -48.66 127.05 13.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD2' ' HG3' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -46.63 158.76 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.014 2.476 . . . . 0.0 112.43 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 17.1 Cg_endo -57.74 -37.37 96.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.598 2.198 . . . . 0.0 112.262 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.08 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.852 HE21 HG22 ' A' ' 36' ' ' ILE . 15.3 mm100 -52.26 -55.94 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -56.79 128.24 35.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.783 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.2 mmt180 -96.83 125.65 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 23' ' ' ILE . 9.4 mp -68.81 122.52 18.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.539 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 62.4 mt -143.75 130.48 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.072 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.716 ' HB2' HG22 ' B' ' 5' ' ' VAL . 8.8 m-85 -130.03 145.12 51.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.794 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.766 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -146.42 127.45 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 111.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' HA2' ' C ' ' B' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.304 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.3 ptm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.9 0.381 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.996 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.2 pt20 -68.97 127.02 31.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.504 HG12 ' O ' ' B' ' 15' ' ' LEU . 26.1 pt -99.86 150.04 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.479 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 3.5 m-85 -89.1 129.43 35.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.358 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.716 HG22 ' HB2' ' A' ' 45' ' ' PHE . 87.8 t -149.74 137.27 13.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -104.38 130.27 52.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.288 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 76.6 p -70.62 -157.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.406 . . . . 0.0 111.678 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.52 HD11 HG21 ' B' ' 36' ' ' ILE . 4.8 mp -82.44 -56.66 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.433 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -71.2 -45.44 63.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.881 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.29 -28.64 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.8 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -43.62 128.09 5.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.305 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -87.53 137.17 32.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.715 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.5 pt -123.59 128.44 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 111.441 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.996 HG22 ' HB2' ' B' ' 2' ' ' GLN . 7.5 m -124.01 110.51 14.87 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.67 HD13 ' HG3' ' B' ' 33' ' ' LYS . 1.5 pt? -136.19 131.17 34.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.406 0.622 . . . . 0.0 111.846 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.8 pt-20 -70.03 142.96 52.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.883 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.528 ' HB ' HG12 ' B' ' 26' ' ' VAL . 21.2 m -152.27 134.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.191 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 86.6 mt-10 -61.97 137.45 95.48 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.645 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.11 -39.19 81.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.831 2.354 . . . . 0.0 111.914 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.576 ' O ' HG22 ' A' ' 22' ' ' THR . 47.1 t -64.15 -30.64 71.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.467 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 46.5 m-20 -59.77 132.71 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 20' ' ' SER . 74.5 p -57.44 149.59 20.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.502 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.774 HD11 HG21 ' A' ' 26' ' ' VAL . 64.4 mt -54.27 -37.78 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 109.705 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' NZ ' ' B' ' 27' ' ' LYS . 4.6 tp10 -60.22 -37.4 80.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.453 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -66.58 -48.43 69.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.576 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.626 HG22 ' O ' ' B' ' 23' ' ' ILE . 9.4 m -60.65 -42.24 91.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.031 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.637 ' HZ2' HG22 ' B' ' 23' ' ' ILE . 36.8 mtmm -65.68 -38.1 88.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.922 0.391 . . . . 0.0 110.258 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.838 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -55.91 -36.44 67.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.489 ' HG2' HD12 ' B' ' 15' ' ' LEU . 88.3 tttt -68.51 -39.51 81.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.044 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.623 HD12 ' HG2' ' B' ' 41' ' ' GLN . 59.3 mt -57.67 -33.86 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.685 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.838 HE21 ' HA ' ' B' ' 28' ' ' ALA . 59.6 mt-30 -63.34 -47.18 83.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.16 -31.01 68.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.67 ' HG3' HD13 ' B' ' 15' ' ' LEU . 25.7 mmtp -75.18 -27.07 59.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -141.48 -66.74 0.41 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.158 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 149.31 -32.04 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.041 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.858 HG22 HE21 ' B' ' 40' ' ' GLN . 0.7 OUTLIER -50.41 129.53 25.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' B' ' 40' ' ' GLN . 91.0 Cg_exo -47.17 157.98 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.979 2.452 . . . . 0.0 112.323 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.663 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 13.9 Cg_endo -58.14 -36.06 98.2 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.451 2.101 . . . . 0.0 112.152 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -60.4 -33.45 72.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.858 HE21 HG22 ' B' ' 36' ' ' ILE . 15.4 mm100 -52.2 -55.52 20.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.029 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -56.65 127.92 33.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.766 ' H ' ' H ' ' A' ' 46' ' ' ALA . 37.5 mmt180 -96.1 126.23 41.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.401 ' N ' HD12 ' B' ' 43' ' ' LEU . 8.9 mp -69.57 122.05 18.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.415 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 76.0 mt -143.79 130.1 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.693 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.7 m-85 -129.93 144.63 51.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.74 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.783 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -144.97 128.11 16.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.459 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.347 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 1' ' ' MET . 15.7 tpt . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.028 0.442 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.614 ' HB2' HG22 ' A' ' 14' ' ' THR . 18.9 pt20 -61.84 111.13 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' LEU . 34.9 pt -84.87 141.59 14.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -87.82 130.16 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.751 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.6 t -145.17 145.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.027 0.441 . . . . 0.0 111.553 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 67.3 mttm -108.33 129.81 55.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.323 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.29 -156.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.324 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.33 -52.06 66.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.5 t -76.63 -45.1 31.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.995 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 143.21 32.76 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.488 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 61.8 tttp -81.32 131.12 35.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -73.04 136.79 45.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.437 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.751 HG23 ' HB ' ' A' ' 5' ' ' VAL . 1.3 tt -139.49 124.08 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 111.749 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -86.54 144.12 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.984 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 15' ' ' LEU . 5.0 tt -158.32 113.31 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.805 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 17' ' ' VAL . 25.7 pt-20 -88.18 132.64 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.588 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.684 HG21 HG13 ' A' ' 26' ' ' VAL . 2.9 m -159.92 146.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.73 139.24 76.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.492 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 33.5 Cg_endo -61.9 -40.06 46.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.358 . . . . 0.0 112.348 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 m -63.85 -20.55 65.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.795 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -57.51 134.21 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 26' ' ' VAL . 67.5 p -56.6 142.87 37.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.485 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.554 HG12 HG12 ' B' ' 23' ' ' ILE . 66.2 mt -57.75 -40.62 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.77 -44.57 90.65 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.138 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.61 -44.52 86.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG13 HG21 ' A' ' 17' ' ' VAL . 60.3 t -59.16 -49.28 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.33 -36.76 84.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.518 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.572 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -53.81 -36.12 62.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.875 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 86.7 tttt -69.54 -39.17 77.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.117 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.736 ' HB ' HE22 ' A' ' 41' ' ' GLN . 36.9 mm -54.87 -38.55 45.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.101 0.477 . . . . 0.0 109.775 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -60.37 -48.96 79.51 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.32 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.91 -30.52 71.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.449 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 30.7 mmmt -72.05 -32.1 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.23 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -138.91 -65.69 0.49 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.983 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.98 -40.39 0.52 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.812 HG22 HE22 ' A' ' 40' ' ' GLN . 0.9 OUTLIER -45.06 126.78 5.49 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.806 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 87.2 Cg_exo -45.93 139.64 10.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.019 2.479 . . . . 0.0 112.399 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 45.6 Cg_exo -56.26 -40.6 83.72 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.37 2.046 . . . . 0.0 111.879 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.32 -36.04 81.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.812 HE22 HG22 ' A' ' 36' ' ' ILE . 6.5 tt0 -60.28 -37.15 79.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.092 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.845 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.6 mt-30 -56.33 132.05 49.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.692 ' H ' ' H ' ' B' ' 46' ' ' ALA . 56.3 ttp180 -91.82 125.61 36.59 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD21 ' HD3' ' A' ' 27' ' ' LYS . 14.5 mt -74.46 132.17 41.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.705 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 75.8 mt -143.73 133.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.808 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 15.4 m-85 -129.69 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.434 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.16 127.37 6.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.964 0.412 . . . . 0.0 111.722 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' B' ' 36' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.541 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' B' ' 1' ' ' MET . 15.7 tpt . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.895 0.378 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' GLN . . . . . 0.514 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 18.4 pt20 -61.72 111.82 2.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.235 0.541 . . . . 0.0 110.841 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ILE . . . . . 0.803 HD11 HD23 ' B' ' 15' ' ' LEU . 30.5 pt -85.53 142.29 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -88.25 126.59 35.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.695 ' HB ' HG12 ' B' ' 13' ' ' ILE . 89.6 t -142.61 139.44 28.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.156 0.503 . . . . 0.0 111.519 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' LYS . . . . . 0.6 ' HB3' ' HA2' ' B' ' 10' ' ' GLY . 67.1 mttm -102.96 131.52 49.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.547 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -67.8 -156.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.0 mt -62.01 -50.5 71.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 110.708 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -75.62 -45.17 38.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.047 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.6 ' HA2' ' HB3' ' B' ' 6' ' ' LYS . . . 142.89 34.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.652 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 60.5 tttp -82.4 128.4 34.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.776 0.322 . . . . 0.0 111.181 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -73.07 135.84 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.62 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.695 HG12 ' HB ' ' B' ' 5' ' ' VAL . 4.2 pt -137.44 134.94 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.097 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.25 144.28 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.803 HD23 HD11 ' B' ' 3' ' ' ILE . 6.0 tp -156.82 113.01 2.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLU . . . . . 0.409 ' O ' HG13 ' B' ' 17' ' ' VAL . 15.5 pt-20 -86.67 129.16 34.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.961 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.531 HG21 HG13 ' B' ' 26' ' ' VAL . 6.6 m -157.11 143.99 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.664 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.52 137.0 76.91 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.61 -39.63 72.84 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.824 2.349 . . . . 0.0 112.187 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 22' ' ' THR . 50.5 m -64.07 -24.6 67.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -54.01 134.06 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.432 ' O ' HG23 ' B' ' 26' ' ' VAL . 71.3 p -56.48 143.19 36.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.518 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.624 HG21 HD21 ' B' ' 43' ' ' LEU . 66.4 mt -58.09 -40.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.436 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -59.03 -44.87 91.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.051 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.35 -44.36 87.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.531 HG13 HG21 ' B' ' 17' ' ' VAL . 98.4 t -59.15 -48.81 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.255 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 49.4 mtmt -65.07 -35.82 82.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.678 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.657 ' HA ' ' HG3' ' B' ' 38' ' ' PRO . . . -54.31 -34.46 61.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.547 ' HD3' HD11 ' B' ' 15' ' ' LEU . 87.1 tttt -73.79 -32.27 63.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.384 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.756 ' HB ' HE22 ' B' ' 41' ' ' GLN . 40.8 mm -56.94 -44.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.426 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 23.9 pt20 -64.99 -39.15 93.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.64 -32.31 72.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' B' ' 29' ' ' LYS . 31.0 mmmt -74.97 -31.17 61.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.799 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.1 tp10 -139.13 -64.03 0.51 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 156.61 -32.71 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.11 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.845 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -47.95 124.03 10.3 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.702 ' HG2' ' HB2' ' B' ' 40' ' ' GLN . 2.3 Cg_endo -48.64 137.82 25.98 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.586 2.19 . . . . 0.0 111.412 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.657 ' HG3' ' HA ' ' B' ' 28' ' ' ALA . 50.2 Cg_exo -53.47 -39.91 80.47 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.472 2.115 . . . . 0.0 112.412 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.03 -35.93 79.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.635 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLN . . . . . 0.845 ' NE2' HG22 ' B' ' 36' ' ' ILE . 7.0 tt0 -60.74 -36.69 79.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 111.145 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' GLN . . . . . 0.756 HE22 ' HB ' ' B' ' 30' ' ' ILE . 70.8 mt-30 -57.23 132.13 52.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 56.4 ttp180 -91.64 127.55 37.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.657 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.624 HD21 HG21 ' B' ' 23' ' ' ILE . 8.3 mp -75.86 130.88 39.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -143.52 134.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.845 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 9.9 m-85 -129.94 141.78 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.294 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . 0.692 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.54 123.18 6.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.093 0.473 . . . . 0.0 112.068 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.436 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 52.6 m -61.33 -44.82 96.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.5 tpt -167.02 52.89 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.23 0.538 . . . . 0.0 110.739 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 17.4 pt20 -61.58 110.56 1.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.405 0.621 . . . . 0.0 111.002 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.668 HG22 HD23 ' B' ' 43' ' ' LEU . 37.0 pt -72.49 146.21 11.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.098 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.55 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -87.84 130.39 34.9 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.881 ' HB ' HG23 ' A' ' 13' ' ' ILE . 64.8 t -144.55 151.05 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -119.96 117.95 29.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.325 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 HG21 ' NZ ' ' A' ' 11' ' ' LYS . 74.1 p -68.68 152.74 44.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.4 mt -50.29 -37.67 37.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.735 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -66.63 -44.99 80.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.02 -40.12 1.21 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.444 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' NZ ' HG21 ' A' ' 7' ' ' THR . 21.8 pttp -52.13 139.66 22.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 111.668 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -73.34 148.1 43.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.62 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.881 HG23 ' HB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -134.83 133.33 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.274 0.559 . . . . 0.0 112.024 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 145.25 31.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.299 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.86 HD12 ' HG3' ' A' ' 33' ' ' LYS . 3.9 tt -155.31 113.76 3.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.339 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 25.4 pt-20 -80.43 136.69 36.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.422 . . . . 0.0 111.906 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.764 HG21 HG13 ' A' ' 26' ' ' VAL . 2.4 m -158.21 143.5 7.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.402 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.496 ' HB2' ' CG ' ' A' ' 21' ' ' ASP . 41.4 mt-10 -62.75 133.76 95.17 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.18 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 10.6 Cg_endo -55.24 -38.79 93.44 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.716 2.277 . . . . 0.0 111.851 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.5 t -64.72 -31.64 72.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.947 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.496 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 63.6 m-20 -52.44 135.33 33.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.4 p -56.71 143.79 35.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.769 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.727 HG12 HG12 ' B' ' 23' ' ' ILE . 60.7 mt -57.27 -44.45 83.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -56.98 -41.92 79.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.705 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -65.73 -43.01 90.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.648 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.764 HG13 HG21 ' A' ' 17' ' ' VAL . 59.9 t -59.55 -49.77 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.608 ' NZ ' HD13 ' A' ' 43' ' ' LEU . 54.0 mttp -62.51 -39.79 94.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.827 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.19 -35.72 67.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.328 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.76 ' HD2' HD21 ' A' ' 15' ' ' LEU . 24.4 ttmm -65.39 -36.48 84.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.031 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.719 HG22 HD11 ' A' ' 36' ' ' ILE . 51.1 mt -55.81 -31.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.589 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 68.9 mt-30 -61.09 -52.52 64.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -59.39 -34.67 72.72 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.25 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.86 ' HG3' HD12 ' A' ' 15' ' ' LEU . 43.9 mmtm -65.89 -33.43 75.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.298 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -141.66 -70.69 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.289 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.48 54.27 0.03 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.776 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.854 HG22 HE22 ' A' ' 40' ' ' GLN . 0.8 OUTLIER -138.35 128.12 14.88 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 111.728 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.711 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 78.0 Cg_exo -44.03 141.21 4.68 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.961 2.44 . . . . 0.0 112.703 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.589 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 11.9 Cg_endo -57.85 -35.01 99.01 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.765 2.31 . . . . 0.0 112.711 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -59.99 -37.87 80.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 111.078 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.854 HE22 HG22 ' A' ' 36' ' ' ILE . 19.9 mt-30 -60.7 -44.91 95.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.579 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.563 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.6 OUTLIER -54.33 125.48 19.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.343 . . . . 0.0 110.771 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.746 ' HE ' ' HG3' ' B' ' 48' ' ' LYS . 70.0 mtt-85 -85.84 122.02 29.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.664 HD23 HG22 ' B' ' 3' ' ' ILE . 13.8 tp -84.31 132.98 34.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.721 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.7 mt -143.16 145.53 22.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 111.672 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' B' ' 5' ' ' VAL . 17.2 m-85 -133.9 140.07 46.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.665 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.23 119.21 5.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.094 0.473 . . . . 0.0 111.648 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.78 138.78 23.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.72 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.683 ' HG3' ' HE ' ' B' ' 42' ' ' ARG . 75.2 mmtt -149.26 74.55 1.25 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.434 0.635 . . . . 0.0 110.988 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.1 pt20 -67.33 103.64 1.32 Allowed 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.834 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.506 ' H ' ' CD2' ' A' ' 50' ' ' LEU . 3.4 mm? -45.09 80.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.713 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 49' ' ' GLN . 40.4 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 53.0 m -61.42 -43.46 98.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.759 0.314 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.531 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.4 tpt -168.29 51.76 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.317 0.58 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.972 ' HB2' HG22 ' B' ' 14' ' ' THR . 16.9 pt20 -61.46 110.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.129 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.664 HG22 HD23 ' A' ' 43' ' ' LEU . 35.1 pt -72.96 147.48 9.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -87.87 130.15 34.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 45' ' ' PHE . 61.9 t -141.95 152.74 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -123.1 117.44 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.927 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.514 HG21 ' CE ' ' B' ' 11' ' ' LYS . 77.1 p -69.9 150.7 46.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.723 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -48.38 -37.81 17.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.979 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.9 p -66.81 -45.23 79.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.75 -41.92 1.1 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.517 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.514 ' CE ' HG21 ' B' ' 7' ' ' THR . 0.0 OUTLIER -54.07 140.1 32.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.126 0.489 . . . . 0.0 111.67 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 50.7 m -72.4 147.35 46.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.543 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.531 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -130.56 141.6 45.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.195 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.972 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.2 OUTLIER -119.21 143.97 46.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.019 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.699 HD11 ' HD2' ' B' ' 29' ' ' LYS . 3.5 tp -155.67 114.01 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 15.1 pt-20 -77.91 134.42 37.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.561 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.62 HG21 HG13 ' B' ' 26' ' ' VAL . 13.9 m -155.54 141.52 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.214 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.521 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 41.8 mt-10 -61.26 135.09 93.46 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.352 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.1 -39.55 90.07 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.777 2.318 . . . . 0.0 111.894 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 22' ' ' THR . 45.7 t -64.38 -30.55 71.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.912 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.521 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 63.0 m-20 -53.95 134.74 43.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.698 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.454 ' O ' HG23 ' B' ' 26' ' ' VAL . 74.1 p -55.91 142.95 33.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.695 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.749 HD11 HG21 ' A' ' 26' ' ' VAL . 60.1 mt -57.16 -43.61 81.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.032 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.33 -42.47 81.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.552 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -65.81 -42.01 91.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.615 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 23' ' ' ILE . 94.1 t -59.89 -48.78 86.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.624 ' NZ ' HD13 ' B' ' 43' ' ' LEU . 64.5 mttm -64.26 -40.09 95.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.923 0.392 . . . . 0.0 110.57 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.35 -35.86 65.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.398 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.699 ' HD2' HD11 ' B' ' 15' ' ' LEU . 24.6 ttmm -65.87 -35.32 80.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.527 HG22 ' CD1' ' B' ' 36' ' ' ILE . 50.2 mt -56.46 -30.69 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.705 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 66.6 mt-30 -61.12 -52.4 65.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -59.65 -34.43 72.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.134 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.533 ' HE2' HD13 ' B' ' 15' ' ' LEU . 43.5 mmtm -65.79 -33.04 74.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.258 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -143.31 -68.43 0.34 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.746 0.307 . . . . 0.0 111.252 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.83 53.2 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.311 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.932 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -133.23 132.23 22.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.7 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 72.1 Cg_exo -50.87 142.39 33.3 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.729 2.286 . . . . 0.0 111.998 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.705 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 32.4 Cg_exo -56.66 -35.73 97.67 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.675 2.25 . . . . 0.0 112.482 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -62.36 -37.52 86.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.932 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.6 mt-30 -63.08 -42.52 99.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.692 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.414 ' OE1' ' N ' ' B' ' 41' ' ' GLN . 0.6 OUTLIER -56.52 127.28 30.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.745 0.307 . . . . 0.0 110.489 179.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.683 ' HE ' ' HG3' ' A' ' 48' ' ' LYS . 70.9 mtt-85 -86.84 123.44 31.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.433 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.668 HD23 HG22 ' A' ' 3' ' ' ILE . 14.3 tp -85.5 132.7 34.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.721 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 66.4 mt -143.22 145.64 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.894 0.378 . . . . 0.0 111.823 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.761 ' HB2' HG22 ' A' ' 5' ' ' VAL . 16.0 m-85 -134.53 139.98 45.82 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.993 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.707 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 117.34 5.03 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.084 0.469 . . . . 0.0 111.645 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.48 137.49 23.67 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.501 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.746 ' HG3' ' HE ' ' A' ' 42' ' ' ARG . 75.1 mmtt -149.68 74.79 1.24 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.219 0.533 . . . . 0.0 111.08 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.2 pt20 -66.02 115.92 6.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.031 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.448 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.6 mm? -54.33 79.92 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.341 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.4 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.888 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 53.3 m -67.97 -125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.604 0.24 . . . . 0.0 110.656 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 ptm -158.58 116.8 2.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.018 0.437 . . . . 0.0 110.975 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.934 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.3 pt20 -61.91 130.19 44.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.236 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.2 pt -103.72 140.09 22.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.506 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.39 124.77 34.27 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.789 ' HB ' HG12 ' A' ' 13' ' ' ILE . 35.2 t -141.89 143.7 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.005 0.431 . . . . 0.0 111.43 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.681 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 67.5 mttm -111.45 128.3 55.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.291 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -63.81 -156.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -61.06 -53.6 55.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.897 0.379 . . . . 0.0 110.849 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -72.99 -44.89 60.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 142.2 35.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 60.9 tttp -80.61 126.02 30.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.311 . . . . 0.0 110.861 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -72.88 134.49 44.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.611 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.789 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.6 pt -136.18 138.05 47.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.934 HG22 ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -95.81 144.01 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.729 179.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 29' ' ' LYS . 5.3 tt -161.55 114.34 1.85 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 24.5 pt-20 -87.99 136.28 33.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.755 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.553 HG13 ' CD2' ' A' ' 15' ' ' LEU . 3.3 m -156.92 151.9 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.766 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.568 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 50.9 mt-10 -72.71 136.9 80.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.992 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.43 -32.32 72.45 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.734 2.289 . . . . 0.0 111.959 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.51 ' O ' HG22 ' B' ' 22' ' ' THR . 69.1 m -63.97 -31.78 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.299 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.568 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -57.22 128.81 38.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.788 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.525 HG22 ' O ' ' B' ' 20' ' ' SER . 76.2 p -57.18 150.71 17.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.992 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.706 HG22 ' HE2' ' A' ' 27' ' ' LYS . 67.4 mt -57.28 -31.11 37.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.541 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -64.72 -36.89 85.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.877 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.3 m120 -73.71 -47.6 38.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.374 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 17' ' ' VAL . 33.2 m -57.82 -43.55 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.131 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.706 ' HE2' HG22 ' A' ' 23' ' ' ILE . 53.4 mtmt -72.02 -34.9 69.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.678 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.9 69.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.092 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HB2' HD11 ' A' ' 15' ' ' LEU . 41.2 mtpt -65.6 -38.48 89.61 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.656 ' HB ' HE22 ' A' ' 41' ' ' GLN . 48.3 mm -54.68 -31.96 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.628 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.687 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 64.9 mt-30 -61.13 -51.82 67.49 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.05 -34.62 75.17 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.254 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' HG3' HD12 ' A' ' 15' ' ' LEU . 73.6 mmtt -65.26 -32.1 73.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.399 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -145.46 -68.7 0.29 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.417 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.61 61.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.205 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.828 HG22 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -146.43 124.42 6.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.933 0.396 . . . . 0.0 112.003 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.631 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 39.7 Cg_exo -39.8 143.14 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.461 2.774 . . . . 0.0 112.979 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.687 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 38.3 Cg_exo -60.64 -37.79 76.85 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.805 2.336 . . . . 0.0 112.743 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.4 -35.54 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.008 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.828 HE22 HG22 ' A' ' 36' ' ' ILE . 19.7 mt-30 -62.03 -42.95 99.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.208 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.656 HE22 ' HB ' ' A' ' 30' ' ' ILE . 73.5 mt-30 -58.06 126.04 25.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.445 ' HB2' ' NH1' ' A' ' 42' ' ' ARG . 18.7 ttm105 -87.7 126.78 35.17 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.566 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.2 mm? -75.78 131.16 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.468 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.954 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 71.3 mt -143.24 136.03 24.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.058 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.781 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.5 m-85 -131.62 141.07 49.55 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.735 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -155.14 122.24 5.5 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.019 0.438 . . . . 0.0 111.951 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' B' ' 40' ' ' GLN . . . -76.76 -134.84 0.61 Allowed Glycine 0 C--N 1.331 0.267 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.611 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -68.52 74.72 0.26 Allowed 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.258 0.551 . . . . 0.0 110.977 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.618 ' O ' ' N ' ' A' ' 51' ' ' GLU . 17.0 pt20 -65.41 96.29 0.24 Allowed 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -44.27 80.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.702 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.618 ' N ' ' O ' ' A' ' 49' ' ' GLN . 86.9 tt0 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.979 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.724 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 53.3 m -68.07 -125.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.619 0.247 . . . . 0.0 110.831 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.7 ptm -159.93 116.41 2.49 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.95 0.405 . . . . 0.0 111.393 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.46 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 3.1 pt20 -62.39 128.92 38.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.807 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.772 HD11 HD23 ' B' ' 15' ' ' LEU . 32.7 pt -101.44 137.87 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.011 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.77 124.25 33.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 1.006 HG13 HG23 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.79 140.11 15.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 0.0 111.419 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.665 ' HB3' ' HA2' ' B' ' 10' ' ' GLY . 66.6 mttm -100.78 136.09 41.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.137 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.86 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.336 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 mt -59.26 -53.2 60.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 70.6 p -75.95 -45.45 34.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 110.812 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.665 ' HA2' ' HB3' ' B' ' 6' ' ' LYS . . . 144.32 32.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.418 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 61.4 tttp -79.63 127.25 31.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.1 m -73.51 136.52 44.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.651 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 1.006 HG23 HG13 ' B' ' 5' ' ' VAL . 0.9 OUTLIER -142.72 124.35 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.046 0.451 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -85.07 147.55 26.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.962 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.772 HD23 HD11 ' B' ' 3' ' ' ILE . 7.1 tp -160.66 113.22 1.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.849 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 24.6 pt-20 -80.14 140.27 36.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.682 HG21 HG12 ' B' ' 26' ' ' VAL . 2.8 p -169.13 133.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.7 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.467 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 52.9 mt-10 -56.35 139.17 74.19 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.612 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.11 -32.29 91.3 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.976 2.45 . . . . 0.0 112.226 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 22' ' ' THR . 33.8 t -63.37 -21.82 66.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.165 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 65.8 m-20 -66.18 133.02 49.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.734 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 20' ' ' SER . 66.9 p -59.12 148.5 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.607 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.725 HG22 ' HE2' ' B' ' 27' ' ' LYS . 65.5 mt -55.41 -30.86 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.433 0.635 . . . . 0.0 109.698 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.57 -37.83 88.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.91 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.493 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 3.2 m120 -72.94 -48.64 35.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.607 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.682 HG12 HG21 ' B' ' 17' ' ' VAL . 34.7 m -56.52 -44.59 80.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.223 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.725 ' HE2' HG22 ' B' ' 23' ' ' ILE . 53.6 mtmt -70.91 -34.26 71.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.1 -38.05 72.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.989 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.574 ' HB2' HD21 ' B' ' 15' ' ' LEU . 32.4 mtpt -64.66 -40.1 94.84 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.637 ' HB ' HE22 ' B' ' 41' ' ' GLN . 50.6 mm -54.47 -32.05 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.902 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.681 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 66.5 mt-30 -60.79 -53.32 58.75 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.53 -32.03 72.06 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.309 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 72.7 mmtt -66.41 -31.62 72.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.448 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.522 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.9 tp10 -147.48 -61.93 0.27 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.578 0.228 . . . . 0.0 111.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.77 58.11 0.06 OUTLIER Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.79 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.878 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -137.99 129.87 16.14 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.633 0.254 . . . . 0.0 111.309 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.639 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -50.27 142.18 29.61 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.619 2.213 . . . . 0.0 112.128 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.681 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 35.6 Cg_exo -58.31 -38.87 88.8 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.744 2.296 . . . . 0.0 112.608 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.53 -35.45 76.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.878 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.2 mt-30 -64.96 -39.7 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.315 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.781 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 73.2 mt-30 -60.09 128.11 35.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.73 0.3 . . . . 0.0 110.661 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.735 ' H ' ' H ' ' A' ' 46' ' ' ALA . 18.5 ttm105 -88.97 126.26 35.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.186 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.505 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.0 mm? -75.77 131.53 39.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.531 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.954 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.3 mt -144.04 138.3 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.57 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 13.5 m-85 -133.9 143.55 48.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.433 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.45 ' C ' ' HA ' ' A' ' 41' ' ' GLN . . . -156.25 120.27 4.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 111.436 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.11 -135.31 0.18 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.649 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.7 75.58 1.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.247 0.546 . . . . 0.0 111.27 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' B' ' 51' ' ' GLU . 18.9 pt20 -64.4 107.03 1.24 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.319 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.54 79.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.7 tt0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.893 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.469 ' HA2' ' HG3' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.572 -0.211 . . . . 0.0 112.572 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.496 ' OG ' ' HD3' ' A' ' 19' ' ' PRO . 48.4 t -168.71 -47.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.662 0.268 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.2 ptt? -172.67 121.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.693 ' HB2' HG22 ' A' ' 14' ' ' THR . 16.7 pt20 -74.95 111.79 10.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.871 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 15' ' ' LEU . 33.5 pt -72.25 135.91 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.479 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -89.41 129.03 35.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.795 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.7 t -146.51 135.38 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.809 0.338 . . . . 0.0 111.593 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.45 123.05 36.48 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.4 p -70.41 -157.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.852 0.358 . . . . 0.0 111.351 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.938 HD11 HG21 ' A' ' 36' ' ' ILE . 2.2 mm? -86.05 -48.97 8.15 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.125 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.8 t -71.08 -45.11 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 9' ' ' THR . . . 156.86 -36.43 0.57 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.787 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -49.22 131.16 19.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.897 0.38 . . . . 0.0 111.322 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -84.76 132.3 34.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.795 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -96.65 130.04 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.696 179.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.693 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.4 m -107.5 129.13 54.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.727 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -159.56 114.56 2.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.106 0.479 . . . . 0.0 111.283 -178.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -76.39 144.32 40.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.389 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.417 HG22 HG23 ' A' ' 3' ' ' ILE . 30.9 m -149.7 145.99 17.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.455 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -68.55 143.52 95.33 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.154 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HD3' ' OG ' ' A' ' 0' ' ' SER . 18.2 Cg_endo -58.78 -39.47 81.5 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.67 2.247 . . . . 0.0 112.189 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.578 ' O ' HG22 ' B' ' 22' ' ' THR . 47.0 t -64.42 -29.59 70.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.001 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -55.91 130.02 42.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 20' ' ' SER . 70.5 p -62.35 148.48 45.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.724 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.539 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 66.6 mt -54.91 -42.2 62.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -62.89 -29.59 70.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -70.25 -49.29 51.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.084 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.009 ' HA ' ' HZ3' ' A' ' 29' ' ' LYS . 35.3 m -62.54 -42.04 94.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.15 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 57.8 mtpt -60.88 -37.18 81.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.404 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.66 79.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.488 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 1.009 ' HZ3' ' HA ' ' A' ' 26' ' ' VAL . 49.3 mttp -62.21 -41.5 98.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.603 HD13 HG11 ' A' ' 5' ' ' VAL . 60.3 mt -54.96 -31.79 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.893 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.438 ' NE2' ' HD3' ' A' ' 38' ' ' PRO . 60.9 mt-30 -63.09 -51.35 66.93 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -59.31 -32.96 70.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.794 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 31.3 mmmt -69.79 -31.88 70.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.916 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -140.52 -68.31 0.41 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.166 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.14 -32.57 1.05 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.452 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.938 HG21 HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -47.79 132.62 11.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.732 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 87.7 Cg_exo -49.88 155.72 3.92 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.418 2.746 . . . . 0.0 112.743 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 16.9 Cg_exo -66.79 -39.44 14.97 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.899 2.399 . . . . 0.0 112.944 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -57.1 -40.07 76.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.602 0.239 . . . . 0.0 111.118 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.881 HE22 HG22 ' A' ' 36' ' ' ILE . 23.2 mt-30 -61.03 -42.22 98.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.411 . . . . 0.0 110.665 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' OE1' HD12 ' A' ' 30' ' ' ILE . 67.2 mt-30 -57.51 143.28 41.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.182 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.787 ' H ' ' H ' ' B' ' 46' ' ' ALA . 64.6 mtt85 -135.98 110.83 8.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.427 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.471 ' H ' ' CD2' ' A' ' 43' ' ' LEU . 1.4 pt? -77.46 138.71 39.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.571 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.716 ' H ' ' H ' ' B' ' 44' ' ' ILE . 62.9 mt -136.42 112.36 12.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.293 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.738 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 4.3 m-85 -84.65 146.69 27.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.735 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.85 126.42 5.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.939 0.4 . . . . 0.0 111.401 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.2 -133.58 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.039 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' O ' HD22 ' A' ' 50' ' ' LEU . 4.1 tppp? -67.31 75.91 0.15 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.92 0.39 . . . . 0.0 111.646 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 51' ' ' GLU . 72.7 mt-30 -64.01 101.56 0.4 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.519 HD22 ' O ' ' A' ' 48' ' ' LYS . 3.5 mm? -44.71 84.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.619 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 49' ' ' GLN . 47.6 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . 0.602 ' HA2' ' HG3' ' B' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.497 ' HB2' ' OE1' ' B' ' 18' ' ' GLU . 47.5 t -171.41 -48.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.564 0.221 . . . . 0.0 110.971 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.2 ptt? -174.28 120.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.242 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' B' ' 16' ' ' GLU . 16.4 pt20 -71.87 112.47 7.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 110.393 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.578 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.6 pt -72.64 133.26 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.825 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.48 125.07 35.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.114 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 1.011 HG13 HG13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -150.86 131.11 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.067 0.461 . . . . 0.0 111.662 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.7 130.97 34.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -74.53 -157.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.08 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.767 HD21 HG12 ' B' ' 36' ' ' ILE . 2.0 mm? -86.05 -48.66 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.969 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.423 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.9 t -70.67 -45.23 65.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.575 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.423 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.94 -35.9 0.62 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -49.86 130.54 21.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.401 . . . . 0.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -82.26 140.87 33.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.397 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 1.011 HG13 HG13 ' B' ' 5' ' ' VAL . 15.4 pt -116.98 130.17 72.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.291 0.567 . . . . 0.0 111.779 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -112.35 137.51 50.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.153 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.578 ' O ' HG12 ' B' ' 3' ' ' ILE . 2.6 pp -162.8 118.62 1.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 110.016 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.602 ' HG3' ' HA2' ' B' ' -1' ' ' GLY . 0.0 OUTLIER -70.73 146.03 50.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.761 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.537 HG13 HD12 ' B' ' 15' ' ' LEU . 8.4 m -150.88 141.8 16.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.172 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.518 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 46.5 mm-40 -67.45 143.05 96.91 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.763 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.452 ' HD3' ' OG ' ' B' ' 0' ' ' SER . 12.9 Cg_endo -57.01 -36.72 99.44 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.752 2.302 . . . . 0.0 112.099 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.554 ' O ' HG22 ' A' ' 22' ' ' THR . 44.1 t -64.49 -31.49 72.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.159 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 47.2 m-20 -54.67 130.78 41.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.988 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.578 HG22 ' O ' ' A' ' 20' ' ' SER . 72.9 p -63.21 148.36 48.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.502 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' B' ' 27' ' ' LYS . 68.1 mt -54.27 -42.11 55.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -63.1 -29.83 71.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -70.22 -49.48 49.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.854 ' HA ' ' HZ2' ' B' ' 29' ' ' LYS . 35.5 m -62.52 -41.32 91.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 58.3 mtpt -61.52 -38.23 86.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.56 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.77 75.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.554 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.854 ' HZ2' ' HA ' ' B' ' 26' ' ' VAL . 50.1 mttp -62.57 -41.09 98.7 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.634 HD13 HG21 ' B' ' 5' ' ' VAL . 59.3 mt -54.78 -32.13 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.903 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.506 ' NE2' ' HD3' ' B' ' 38' ' ' PRO . 61.9 mt-30 -62.93 -51.27 67.57 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.9 -32.07 70.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.956 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 31.1 mmmt -69.75 -31.97 70.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.463 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.664 ' HB2' HD11 ' B' ' 36' ' ' ILE . 5.5 mm-40 -141.27 -61.32 0.48 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.714 0.292 . . . . 0.0 111.22 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 126.79 40.93 0.32 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.453 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.804 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -110.46 135.94 20.63 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.558 0.218 . . . . 0.0 111.063 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.612 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 65.8 Cg_exo -51.55 143.71 35.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.451 2.1 . . . . 0.0 111.896 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.506 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -60.89 -37.61 76.06 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.727 2.285 . . . . 0.0 112.697 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -60.47 -39.11 86.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.155 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.804 ' NE2' HG22 ' B' ' 36' ' ' ILE . 26.8 mt-30 -63.56 -39.04 93.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.53 ' OE1' HD12 ' B' ' 30' ' ' ILE . 69.1 mt-30 -60.9 144.82 52.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.735 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.735 ' H ' ' H ' ' A' ' 46' ' ' ALA . 64.1 mtt85 -137.87 114.56 10.53 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.457 ' O ' HD12 ' B' ' 43' ' ' LEU . 0.4 OUTLIER -78.27 145.4 35.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.973 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.716 ' H ' ' H ' ' A' ' 44' ' ' ILE . 69.3 mt -142.46 108.51 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.01 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.0 m-85 -82.91 145.24 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.75 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.787 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -157.51 125.97 5.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.927 0.394 . . . . 0.0 111.224 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.63 -134.42 0.1 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.016 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -67.27 75.94 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.944 0.402 . . . . 0.0 111.528 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' B' ' 51' ' ' GLU . 71.6 mt-30 -64.01 110.87 2.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.453 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.5 mm? -52.22 79.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.347 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' B' ' 49' ' ' GLN . 21.4 pt-20 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.998 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.539 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 32.6 t 56.03 -128.36 2.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.484 0.183 . . . . 0.0 110.622 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm -165.54 117.13 1.1 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.118 0.485 . . . . 0.0 111.23 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.589 ' HB2' HG22 ' A' ' 14' ' ' THR . 18.7 pt20 -68.99 135.53 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.958 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.528 HG22 HD22 ' B' ' 43' ' ' LEU . 35.5 pt -108.31 144.08 17.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.069 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -89.11 129.28 35.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.986 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.604 HG13 ' O ' ' B' ' 45' ' ' PHE . 87.1 t -149.13 129.15 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.46 126.69 34.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.8 p -73.13 -157.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.94 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 36' ' ' ILE . 54.2 mt -74.25 -50.39 19.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.998 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -73.35 -45.43 55.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.575 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.94 -31.81 0.55 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.807 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -46.35 129.98 10.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.908 0.385 . . . . 0.0 111.578 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -85.43 134.87 34.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.895 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.571 ' CD1' HG23 ' A' ' 30' ' ' ILE . 8.7 pt -101.3 128.23 53.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 0.0 112.014 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.9 m -93.05 116.91 29.49 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.672 ' O ' HD23 ' A' ' 15' ' ' LEU . 2.4 tt -143.67 115.21 8.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.263 0.554 . . . . 0.0 111.993 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 0' ' ' SER . 16.8 pt-20 -76.66 143.76 39.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.951 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 26' ' ' VAL . 10.8 p -168.45 138.15 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 38.7 mt-10 -51.72 140.17 28.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.007 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.91 -42.58 11.12 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.83 2.353 . . . . 0.0 111.954 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.585 ' O ' HG22 ' B' ' 22' ' ' THR . 50.6 m -63.67 -23.05 67.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.402 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.614 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 7.7 t70 -54.16 131.86 42.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.362 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.604 HG22 ' O ' ' B' ' 20' ' ' SER . 72.7 p -56.82 142.37 41.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.867 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.66 HG22 ' HE2' ' A' ' 27' ' ' LYS . 65.9 mt -54.63 -35.73 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.913 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.541 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 16.9 pt-20 -63.43 -37.05 85.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.386 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.614 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 3.5 m120 -74.54 -49.17 22.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.775 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG12 HG21 ' A' ' 17' ' ' VAL . 30.4 m -54.06 -42.67 56.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.716 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 50.9 mtmt -70.43 -38.92 74.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -56.66 -35.13 68.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.971 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HG2' HD11 ' A' ' 15' ' ' LEU . 88.3 tttt -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.871 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.571 HG23 ' CD1' ' A' ' 13' ' ' ILE . 59.4 mt -58.32 -36.27 57.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 41.4 tt0 -60.76 -50.97 71.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.922 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.88 -33.09 71.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.901 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 30.6 mmmt -69.41 -35.73 76.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.267 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -135.08 -66.13 0.59 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.959 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.59 -39.53 0.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.347 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.846 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -45.04 121.45 4.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.72 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 82.8 Cg_exo -46.41 147.46 4.08 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.097 2.531 . . . . 0.0 112.251 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 18.0 Cg_endo -59.41 -36.51 93.72 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.475 2.117 . . . . 0.0 112.298 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -63.08 -36.79 84.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.413 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.846 ' NE2' HG22 ' A' ' 36' ' ' ILE . 27.8 mt-30 -61.58 -36.24 80.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.421 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.76 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 99.6 mm-40 -51.3 122.03 7.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.749 ' H ' ' H ' ' B' ' 46' ' ' ALA . 87.2 mtm180 -85.11 121.27 27.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.648 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.468 HD22 HG22 ' B' ' 3' ' ' ILE . 8.9 mp -69.13 122.6 19.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 110.404 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 61.4 mt -143.64 132.77 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.831 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.765 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 39.1 m-85 -136.63 148.76 47.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.793 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.706 ' HB3' ' HE ' ' B' ' 42' ' ' ARG . . . -153.06 131.34 12.02 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.984 0.421 . . . . 0.0 111.55 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.62 143.65 48.69 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.74 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.696 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 14.5 mmmm -67.19 74.93 0.13 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 111.281 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.566 ' O ' ' N ' ' A' ' 51' ' ' GLU . 55.7 tp60 -66.73 97.93 0.49 Allowed 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.804 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.4 mm? -44.88 80.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.654 0.596 . . . . 0.0 112.141 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 49' ' ' GLN . 12.7 pt-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.837 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.86 ' HB3' ' HB2' ' B' ' 16' ' ' GLU . 33.2 t 56.88 -127.82 1.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.603 -0.147 . . . . 0.0 110.603 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.4 ptm -166.64 115.74 0.89 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.016 0.436 . . . . 0.0 111.464 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -67.84 130.97 44.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.891 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.605 HG12 ' HG ' ' B' ' 15' ' ' LEU . 39.5 pt -102.31 143.13 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.621 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.32 129.37 35.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 45' ' ' PHE . 97.4 t -148.92 127.7 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 0.0 111.34 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -83.23 126.45 32.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.554 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 70.8 p -73.29 -157.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.243 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 54.1 mt -74.34 -49.83 21.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.182 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 69.7 p -74.28 -45.35 48.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.49 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.95 -31.33 0.55 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.773 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -47.05 129.88 12.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 111.691 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 40.7 m -82.63 143.97 30.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.474 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.48 ' CD1' HG23 ' B' ' 30' ' ' ILE . 28.7 pt -119.24 129.31 75.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.14 0.495 . . . . 0.0 112.079 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.63 128.0 46.83 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.07 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.605 ' HG ' HG12 ' B' ' 3' ' ' ILE . 2.5 pp -152.9 120.16 5.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.86 ' HB2' ' HB3' ' B' ' 0' ' ' SER . 11.2 pt-20 -73.06 138.18 45.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.029 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.412 HG13 ' O ' ' B' ' 16' ' ' GLU . 2.2 m -157.65 137.82 4.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.416 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' B' ' 21' ' ' ASP . 92.6 mt-10 -53.99 139.34 53.8 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.19 -41.73 26.29 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.621 2.214 . . . . 0.0 111.799 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.604 ' O ' HG22 ' A' ' 22' ' ' THR . 60.9 m -64.14 -21.87 66.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.494 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.596 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.0 t70 -55.06 132.34 47.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 20' ' ' SER . 77.1 p -57.98 142.43 46.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.807 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.658 HG22 ' HE2' ' B' ' 27' ' ' LYS . 65.7 mt -54.74 -36.09 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.88 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.463 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 11.4 pt-20 -63.43 -36.86 85.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.443 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.596 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 3.5 m120 -73.74 -50.05 22.57 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.426 HG13 ' OD1' ' B' ' 21' ' ' ASP . 19.6 m -53.75 -42.55 52.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.658 ' HE2' HG22 ' B' ' 23' ' ' ILE . 50.7 mtmt -70.58 -38.73 74.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.376 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.714 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -58.03 -28.67 64.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.038 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.496 ' HD3' HD13 ' B' ' 15' ' ' LEU . 87.4 tttt -74.66 -32.91 62.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 109.906 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.578 HG21 ' NE2' ' B' ' 41' ' ' GLN . 53.0 mt -61.9 -41.0 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.155 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.714 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.3 pt20 -63.91 -42.83 97.32 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -58.47 -34.29 70.71 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.4 mmmt -72.35 -33.09 67.02 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.924 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -136.96 -65.86 0.54 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.119 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 161.42 -34.77 0.38 Allowed Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.37 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.802 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -48.78 122.75 11.26 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.674 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 84.2 Cg_exo -50.13 146.57 17.34 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.804 2.336 . . . . 0.0 111.897 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' B' ' 27' ' ' LYS . 18.4 Cg_endo -57.98 -38.28 92.67 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.529 2.153 . . . . 0.0 112.693 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -63.41 -37.26 86.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.468 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.802 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.3 mt-30 -61.38 -35.41 77.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.629 0.252 . . . . 0.0 111.482 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.765 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 6.1 mm-40 -54.6 124.55 16.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.873 0.368 . . . . 0.0 110.876 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.706 ' HE ' ' HB3' ' A' ' 46' ' ' ALA . 87.0 mtm180 -85.93 123.24 31.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.832 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 3' ' ' ILE . 8.9 mp -70.57 123.14 21.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.199 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 61.5 mt -143.35 132.74 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 41.1 m-85 -136.9 148.38 47.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.591 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.749 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.15 134.75 15.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.024 0.44 . . . . 0.0 111.789 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.52 141.74 47.95 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.567 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.628 ' H ' ' HB3' ' A' ' 40' ' ' GLN . 14.4 mmmm -70.35 74.94 0.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.679 0.276 . . . . 0.0 111.657 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.2 mm100 -64.25 115.85 5.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.498 HD22 ' N ' ' B' ' 50' ' ' LEU . 2.9 mm? -56.9 79.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.939 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' B' ' 49' ' ' GLN . 22.4 pt-20 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.89 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 16' ' ' GLU . 68.3 p -65.85 -120.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.46 0.171 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 18.1 ptm -155.24 120.32 4.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.017 0.437 . . . . 0.0 111.654 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 18.7 pt20 -63.31 139.05 58.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.79 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.724 HD11 HD23 ' A' ' 15' ' ' LEU . 32.0 pt -114.47 153.37 15.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.768 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -87.45 131.13 34.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.892 ' HB ' HG23 ' A' ' 13' ' ' ILE . 50.1 t -142.28 155.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 89.3 mttt -141.22 122.24 14.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.536 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 51.4 p -69.16 -156.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.706 ' H ' HD12 ' A' ' 8' ' ' LEU . 4.1 mp -68.79 -46.51 68.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.785 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -83.44 26.8 0.63 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 111.107 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.88 37.1 83.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.594 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.687 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 22.0 ttmm -76.05 128.28 34.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.597 0.237 . . . . 0.0 111.081 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.6 m -72.83 134.72 45.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.53 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.892 HG23 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -151.3 133.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.234 0.54 . . . . 0.0 112.233 -179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -97.64 149.63 22.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.509 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.724 HD23 HD11 ' A' ' 3' ' ' ILE . 12.4 tp -155.83 113.19 3.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.066 0.46 . . . . 0.0 111.289 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 1' ' ' MET . 24.0 pt-20 -81.53 130.22 34.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.268 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.574 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 5.6 m -156.72 131.41 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.495 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' CG ' ' HB2' ' A' ' 21' ' ' ASP . 25.4 pt-20 -55.55 141.59 63.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.84 -37.82 91.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.813 2.342 . . . . 0.0 112.313 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.411 ' O ' HG22 ' B' ' 22' ' ' THR . 62.8 m -63.67 -21.8 66.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.623 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' ' CG ' ' A' ' 18' ' ' GLU . 38.7 t70 -61.47 134.29 56.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.591 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 HG22 ' O ' ' B' ' 20' ' ' SER . 73.5 p -64.67 146.33 54.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.473 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.676 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 60.4 mt -55.43 -37.17 43.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.241 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HG3' ' OD1' ' A' ' 25' ' ' ASN . 16.3 pt-20 -58.13 -35.62 71.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.209 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 m120 -75.12 -48.36 24.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.748 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG11 HD11 ' B' ' 23' ' ' ILE . 34.5 m -56.02 -42.21 71.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.561 0.219 . . . . 0.0 111.146 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 35.4 mtmm -69.8 -38.44 76.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.408 . . . . 0.0 110.569 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.21 77.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.638 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.574 ' NZ ' HG12 ' A' ' 17' ' ' VAL . 83.3 mttt -63.66 -38.29 90.55 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.509 HG22 HD11 ' A' ' 36' ' ' ILE . 72.8 mt -56.06 -34.07 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.731 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.421 ' OE1' ' HG3' ' A' ' 38' ' ' PRO . 20.7 mt-30 -61.52 -43.14 99.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -63.89 -39.82 95.09 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.26 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HD3' HD11 ' A' ' 13' ' ' ILE . 67.4 mttm -78.08 3.4 15.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.124 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -169.05 -109.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.197 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 169.46 51.28 0.03 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.354 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.845 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -123.09 129.26 25.02 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.451 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.733 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 91.8 Cg_exo -45.84 150.09 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.997 2.465 . . . . 0.0 112.509 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 32.1 Cg_exo -57.15 -34.33 97.56 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.518 2.146 . . . . 0.0 112.07 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.96 -39.49 93.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.03 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.733 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 27.3 mt-30 -60.89 -36.64 79.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.257 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.693 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 4.1 mm-40 -53.07 122.73 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.807 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.685 ' H ' ' H ' ' B' ' 46' ' ' ALA . 79.5 mtp180 -91.38 121.31 33.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.399 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.488 HD12 HG22 ' B' ' 3' ' ' ILE . 8.0 mt -82.28 129.91 34.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.026 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 63.3 mt -143.14 140.77 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.948 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 42.0 m-85 -135.14 138.87 44.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.802 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.86 138.47 21.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.847 0.356 . . . . 0.0 111.512 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.66 -133.62 0.02 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.908 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -159.74 82.29 0.73 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.354 0.597 . . . . 0.0 111.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.3 tp-100 -65.82 98.07 0.38 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.851 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.3 mm? -44.14 81.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.973 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 49' ' ' GLN . 94.7 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.868 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.449 ' HB2' ' C ' ' B' ' 17' ' ' VAL . 70.7 p -65.69 -121.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.527 0.203 . . . . 0.0 110.875 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 18.5 ptm -153.97 120.67 5.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.09 0.472 . . . . 0.0 111.513 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.992 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.1 pt20 -62.28 142.75 57.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.04 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.665 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.4 pt -118.28 152.23 20.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.757 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -87.37 132.41 33.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' B' ' 13' ' ' ILE . 48.8 t -143.82 154.62 15.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.003 0.43 . . . . 0.0 111.349 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' B' ' 11' ' ' LYS . 57.9 mttp -139.04 123.22 18.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.186 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' B' ' 11' ' ' LYS . 56.2 p -72.72 -156.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.173 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.442 HD12 ' N ' ' B' ' 8' ' ' LEU . 6.5 mp -64.07 -50.91 66.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -82.8 28.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.335 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.02 36.66 68.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.485 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 21.6 ttmm -73.95 128.67 36.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 111.001 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 91.4 m -72.88 131.76 42.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.376 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.756 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -145.02 136.44 20.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.342 0.591 . . . . 0.0 111.85 -179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.992 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.3 OUTLIER -101.18 147.16 26.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.912 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.665 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.8 tt -157.62 114.13 2.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.153 0.502 . . . . 0.0 111.15 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' B' ' 1' ' ' MET . 24.5 pt-20 -83.39 134.23 34.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.778 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.592 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 1.8 m -159.47 133.26 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' B' ' 21' ' ' ASP . 14.4 pt-20 -56.25 141.06 70.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.411 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.75 -37.86 95.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.921 2.414 . . . . 0.0 112.169 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 22' ' ' THR . 51.0 m -63.66 -24.45 67.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.715 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.561 ' HB2' ' HG3' ' B' ' 18' ' ' GLU . 63.2 t0 -58.95 133.46 56.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 20' ' ' SER . 76.8 p -64.12 146.86 53.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.637 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.681 HG22 ' NZ ' ' B' ' 27' ' ' LYS . 60.4 mt -56.07 -37.0 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.292 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.439 ' HG3' ' OD1' ' B' ' 25' ' ' ASN . 16.3 pt-20 -58.23 -36.54 73.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.363 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.504 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 4.1 m120 -74.88 -48.9 22.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.701 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 23' ' ' ILE . 34.4 m -55.12 -41.73 61.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.634 0.254 . . . . 0.0 111.017 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.681 ' NZ ' HG22 ' B' ' 23' ' ' ILE . 35.4 mtmm -70.21 -38.4 75.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.403 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.89 73.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.471 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.592 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 84.5 mttt -66.16 -37.22 85.12 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.807 HG22 HD11 ' B' ' 36' ' ' ILE . 67.8 mt -57.68 -32.12 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.643 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 21.8 mt-30 -61.58 -46.81 88.28 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.44 -33.89 77.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 71.9 mmtt -68.78 -18.08 64.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.435 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -157.72 -90.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.742 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.07 48.53 0.01 OUTLIER Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.607 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.908 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -118.35 134.51 23.42 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.631 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 71.0 Cg_exo -51.57 147.64 22.82 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.771 2.314 . . . . 0.0 111.851 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.463 ' HG3' ' OE1' ' B' ' 31' ' ' GLN . 31.8 Cg_exo -56.95 -34.44 97.37 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.448 2.098 . . . . 0.0 112.075 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.33 -35.03 78.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.561 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.908 ' NE2' HG22 ' B' ' 36' ' ' ILE . 26.5 mt-30 -66.96 -37.48 84.35 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.676 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.486 ' NE2' HD13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -52.26 126.93 20.44 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.788 0.327 . . . . 0.0 110.675 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.802 ' H ' ' H ' ' A' ' 46' ' ' ALA . 80.0 mtp180 -90.17 125.98 35.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.164 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.87 125.4 30.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 1.026 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 63.2 mt -143.25 138.82 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.408 . . . . 0.0 111.307 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 35.3 m-85 -136.93 140.26 42.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.26 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.685 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.02 136.4 17.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.605 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.87 -134.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.216 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -160.24 111.4 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.257 0.551 . . . . 0.0 111.777 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.633 HE21 ' HB3' ' A' ' 8' ' ' LEU . 48.0 mm-40 -85.18 115.82 23.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.746 177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.635 ' H ' HD22 ' B' ' 50' ' ' LEU . 2.7 mm? -59.62 79.4 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.015 0.436 . . . . 0.0 110.588 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' B' ' 49' ' ' GLN . 93.2 mt-10 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.917 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.808 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 56.7 m -67.46 -125.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.504 0.192 . . . . 0.0 110.756 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.646 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 25.6 ptt? -160.35 124.76 3.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.993 0.425 . . . . 0.0 111.05 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.672 ' HB3' HG22 ' A' ' 14' ' ' THR . 15.2 mt-30 -66.49 111.23 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.69 HD11 HD23 ' A' ' 15' ' ' LEU . 44.7 pt -84.14 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.203 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.69 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.7 m-85 -88.0 133.01 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.712 ' HB ' HG13 ' A' ' 13' ' ' ILE . 88.6 t -149.07 126.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -82.28 116.04 21.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.458 HG23 HG12 ' A' ' 13' ' ' ILE . 72.7 p -67.7 -159.55 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.006 0.432 . . . . 0.0 110.911 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 36' ' ' ILE . 1.3 mp -82.45 -44.63 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.72 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.9 t -73.15 -44.84 59.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.312 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 9' ' ' THR . . . 154.75 -39.96 0.64 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.998 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -51.86 135.12 30.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.399 . . . . 0.0 111.565 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 p -81.18 138.65 35.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.6 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.712 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -96.4 129.33 46.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 178.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.672 HG22 ' HB3' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -96.76 137.0 36.51 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.69 HD23 HD11 ' A' ' 3' ' ' ILE . 2.0 tp -162.32 115.1 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.117 0.484 . . . . 0.0 111.975 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.808 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 25.4 pt-20 -85.06 132.68 34.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.359 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 15' ' ' LEU . 6.9 m -157.27 139.76 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.747 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.64 144.03 89.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.431 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.94 -37.7 52.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.769 2.313 . . . . 0.0 112.159 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.4 m -63.13 -23.23 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.374 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -60.96 134.84 57.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.2 p -61.69 141.57 57.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.747 HG12 HG12 ' B' ' 23' ' ' ILE . 57.6 mt -53.83 -41.11 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.124 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 22.3 pt-20 -55.29 -39.99 70.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.334 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.5 m120 -66.34 -51.02 61.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.822 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 23' ' ' ILE . 11.5 m -60.08 -40.05 82.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.022 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.699 ' NZ ' ' HB2' ' A' ' 41' ' ' GLN . 29.5 mtpp -64.02 -43.7 94.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.768 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -58.37 -42.37 86.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.11 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HD2' HD11 ' A' ' 15' ' ' LEU . 39.5 ttmt -62.71 -36.5 83.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG23 HD12 ' A' ' 13' ' ' ILE . 62.8 mt -55.51 -37.05 43.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.768 HE21 ' HA ' ' A' ' 28' ' ' ALA . 68.1 mt-30 -58.83 -40.43 84.15 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -63.77 -39.83 95.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.649 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 33' ' ' LYS . 4.8 mmmp? -61.22 -40.0 92.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.71 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -131.35 -89.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.442 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.24 45.27 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.067 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.837 HG22 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -122.68 126.43 26.11 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.632 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 65.8 Cg_exo -43.13 141.7 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.089 2.526 . . . . 0.0 112.706 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 28.0 Cg_endo -62.14 -33.84 80.87 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.641 2.227 . . . . 0.0 112.125 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.96 -38.75 73.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.837 HE22 HG22 ' A' ' 36' ' ' ILE . 15.6 mt-30 -63.33 -39.92 95.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.581 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.699 ' HB2' ' NZ ' ' A' ' 27' ' ' LYS . 6.6 mm100 -53.06 132.26 37.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.995 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.816 ' H ' ' H ' ' B' ' 46' ' ' ALA . 22.1 tpp180 -107.53 119.67 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.34 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.88 126.79 30.19 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 120.884 0.373 . . . . 0.0 111.158 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.83 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.9 mt -144.21 123.25 7.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.07 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.672 ' HB2' HG22 ' B' ' 5' ' ' VAL . 4.0 m-85 -121.84 148.6 44.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.425 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.749 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -148.64 130.28 14.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.934 0.397 . . . . 0.0 111.916 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.86 137.51 13.7 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.394 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.575 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -161.49 73.8 0.45 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 121.426 0.631 . . . . 0.0 111.281 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.597 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.6 tp-100 -68.53 105.43 2.22 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' H ' ' CD2' ' A' ' 50' ' ' LEU . 3.4 mm? -45.38 80.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.662 0.601 . . . . 0.0 111.774 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.597 ' N ' ' O ' ' A' ' 49' ' ' GLN . 56.2 mt-10 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.887 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.844 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 52.0 m -67.75 -125.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.549 0.214 . . . . 0.0 110.731 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 25.1 ptt? -163.54 115.3 1.43 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.54 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 17.2 pt20 -65.4 110.72 2.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.302 0.572 . . . . 0.0 110.868 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' B' ' 15' ' ' LEU . 37.4 pt -76.99 141.04 16.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.8 m-85 -88.08 131.29 34.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.677 ' HB ' HG13 ' B' ' 13' ' ' ILE . 98.4 t -149.04 124.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.66 0.267 . . . . 0.0 111.353 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -82.49 120.53 25.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.253 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -69.96 -160.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.534 HD11 ' CG2' ' B' ' 36' ' ' ILE . 6.3 mp -82.14 -42.87 18.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.48 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.409 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -71.58 -44.79 63.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.409 ' N ' HG23 ' B' ' 9' ' ' THR . . . 152.91 -39.66 0.72 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.036 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -52.04 134.95 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 111.961 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 18.1 p -82.12 142.71 32.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.021 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.677 HG13 ' HB ' ' B' ' 5' ' ' VAL . 11.4 pt -114.15 122.86 69.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.308 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.439 ' HB ' ' HB2' ' B' ' 2' ' ' GLN . 0.9 OUTLIER -87.51 148.67 24.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.67 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.596 ' C ' HD23 ' B' ' 15' ' ' LEU . 5.3 tt -162.94 112.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.0 0.429 . . . . 0.0 110.659 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.844 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 14.5 pt-20 -82.78 132.16 35.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.821 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.588 HG21 HG22 ' B' ' 26' ' ' VAL . 2.4 m -159.44 139.8 3.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.617 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -59.86 142.75 88.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.452 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.466 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 26.3 Cg_endo -60.22 -37.24 84.49 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.878 2.385 . . . . 0.0 112.141 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.8 m -63.63 -26.48 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.659 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -56.64 135.26 54.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.343 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -61.87 142.27 57.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.747 HG12 HG12 ' A' ' 23' ' ' ILE . 58.8 mt -54.61 -40.57 51.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.542 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 12.0 pt-20 -55.16 -44.46 75.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.271 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.542 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.2 m120 -64.13 -47.95 77.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.588 HG22 HG21 ' B' ' 17' ' ' VAL . 24.6 t -56.34 -45.17 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.224 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.668 ' NZ ' ' HB2' ' B' ' 41' ' ' GLN . 28.2 mtpp -66.25 -41.16 90.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.203 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.744 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -58.28 -40.97 83.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.58 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.453 ' CG ' HD11 ' B' ' 15' ' ' LEU . 39.2 ttmt -63.41 -34.89 78.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.397 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.562 HG21 ' NE2' ' B' ' 41' ' ' GLN . 59.2 mt -58.19 -35.69 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.274 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.744 HE21 ' HA ' ' B' ' 28' ' ' ALA . 68.7 mt-30 -60.48 -47.74 84.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.66 -31.44 72.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.687 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' B' ' 33' ' ' LYS . 22.8 tptp -65.65 -32.57 74.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.931 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.3 tp10 -144.89 -68.25 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.684 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 141.89 47.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.737 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.892 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -124.94 128.88 24.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.5 0.19 . . . . 0.0 111.394 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.65 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 54.2 Cg_exo -51.77 138.35 50.58 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.341 2.028 . . . . 0.0 111.554 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.573 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 19.0 Cg_endo -58.88 -34.0 98.86 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.577 2.185 . . . . 0.0 112.202 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.84 -39.15 77.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.643 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.892 ' NE2' HG22 ' B' ' 36' ' ' ILE . 22.9 mt-30 -65.79 -38.21 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.668 ' HB2' ' NZ ' ' B' ' 27' ' ' LYS . 7.0 mm100 -54.31 133.78 45.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.835 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.749 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.1 tpp180 -108.49 121.79 45.7 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.449 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 3' ' ' ILE . 10.8 mp -68.94 127.41 33.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.189 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.83 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -144.14 122.44 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.034 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.67 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.1 m-85 -120.97 146.03 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.816 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -148.25 128.9 14.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 111.696 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.76 137.7 13.61 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.302 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.608 ' HD2' ' N ' ' B' ' 48' ' ' LYS . 0.0 OUTLIER -160.27 73.97 0.54 Allowed 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.509 0.671 . . . . 0.0 111.463 179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.559 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.9 tp-100 -66.61 110.87 3.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.743 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.541 ' H ' HD22 ' B' ' 50' ' ' LEU . 3.3 mm? -50.47 80.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.497 0.498 . . . . 0.0 111.545 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' B' ' 49' ' ' GLN . 56.1 mt-10 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.828 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 52.7 m -60.45 -40.04 89.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.745 0.307 . . . . 0.0 110.963 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 1' ' ' MET . 15.1 tpt -163.83 57.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.209 0.528 . . . . 0.0 110.958 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.429 ' HA ' ' C ' ' A' ' 15' ' ' LEU . 3.2 pt20 -61.72 127.34 30.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.445 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.672 HD12 HD11 ' A' ' 30' ' ' ILE . 28.8 pt -95.47 132.44 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.576 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -88.83 128.77 35.66 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.756 HG21 HD13 ' A' ' 30' ' ' ILE . 63.4 t -148.49 138.49 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.151 0.501 . . . . 0.0 112.242 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -99.44 127.71 45.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.725 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.569 ' OG1' ' HB3' ' A' ' 11' ' ' LYS . 73.1 p -68.49 -156.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 111.302 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.729 ' H ' HD12 ' A' ' 8' ' ' LEU . 2.7 mp -64.36 -51.15 64.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.065 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.0 p -78.61 -45.73 20.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.866 0.365 . . . . 0.0 111.067 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 28.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.315 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 15.8 tppt? -77.37 122.65 25.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.798 0.332 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 m -75.38 138.71 41.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.557 HG13 ' HB ' ' A' ' 5' ' ' VAL . 12.4 pt -140.07 128.69 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.215 0.531 . . . . 0.0 112.08 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -97.37 145.99 25.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.67 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 3' ' ' ILE . 5.8 tt -163.94 114.05 1.27 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.04 0.448 . . . . 0.0 110.656 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' O ' HG13 ' A' ' 17' ' ' VAL . 11.9 pt-20 -79.4 138.1 37.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.775 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -159.46 137.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.84 135.45 89.95 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.944 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.34 -35.93 76.77 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.765 2.31 . . . . 0.0 111.749 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' HG23 ' B' ' 22' ' ' THR . 45.0 t -63.77 -29.18 70.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.11 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -55.52 135.27 50.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.249 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.549 HG23 ' O ' ' B' ' 20' ' ' SER . 21.4 m -59.68 148.84 32.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 111.482 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 64.3 mt -60.34 -43.44 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.226 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.572 ' HG3' HD22 ' A' ' 25' ' ' ASN . 12.6 pt-20 -59.25 -30.46 68.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.73 0.3 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.572 HD22 ' HG3' ' A' ' 24' ' ' GLU . 2.0 m120 -71.26 -52.25 20.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 23' ' ' ILE . 34.4 m -59.97 -40.98 84.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.43 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 58.4 mtpt -62.39 -42.79 99.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.892 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -57.93 -34.8 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.349 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.3 mttm -66.6 -45.56 78.8 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.053 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.756 HD13 HG21 ' A' ' 5' ' ' VAL . 79.0 mt -55.15 -36.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.627 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 45.8 tt0 -61.92 -49.5 75.93 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.085 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -62.09 -32.27 72.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.058 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HG3' HD12 ' A' ' 15' ' ' LEU . 30.7 mmmt -68.49 -36.46 78.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.215 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -132.37 -67.33 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.789 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.33 -35.22 0.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.304 -0.95 . . . . 0.0 113.427 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.8 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.73 122.55 4.63 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.727 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 89.2 Cg_exo -47.22 147.07 5.95 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.161 2.574 . . . . 0.0 112.469 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.98 -35.62 98.27 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.463 2.109 . . . . 0.0 111.993 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -61.69 -38.34 87.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.953 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.8 ' NE2' HG22 ' A' ' 36' ' ' ILE . 26.2 mt-30 -65.72 -44.03 87.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.885 0.374 . . . . 0.0 110.826 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.0 mt-30 -54.69 125.67 20.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.951 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.733 ' H ' ' H ' ' B' ' 46' ' ' ALA . 70.6 mtt-85 -97.36 127.99 43.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.524 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.57 HD23 HG22 ' B' ' 3' ' ' ILE . 10.8 tp -75.07 128.91 36.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.438 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.843 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 66.2 mt -143.5 139.12 26.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.935 0.397 . . . . 0.0 111.885 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 4.2 m-85 -128.19 147.72 50.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.16 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.697 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.4 124.66 5.72 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.952 0.406 . . . . 0.0 111.596 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' HA2' ' C ' ' B' ' 40' ' ' GLN . . . -71.6 -135.5 0.15 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.243 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.498 ' O ' HD22 ' A' ' 50' ' ' LEU . 28.0 tptp -69.5 75.28 0.4 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.744 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 51' ' ' GLU . 85.2 mt-30 -64.41 102.33 0.53 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 50' ' ' LEU . 3.4 mm? -44.99 80.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.766 0.666 . . . . 0.0 111.741 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 49' ' ' GLN . 88.0 tt0 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.836 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 53.0 m -60.99 -45.85 93.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.538 ' O ' ' HG3' ' B' ' 1' ' ' MET . 14.2 tpt -156.37 57.6 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.247 0.546 . . . . 0.0 110.945 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.673 ' HB2' HG22 ' B' ' 14' ' ' THR . 3.3 pt20 -61.81 126.62 27.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.549 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.747 HD11 HD23 ' B' ' 15' ' ' LEU . 29.8 pt -95.62 133.39 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.92 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.36 129.63 35.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.728 HG21 HD13 ' B' ' 30' ' ' ILE . 61.0 t -147.8 143.97 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.053 0.454 . . . . 0.0 112.086 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -104.97 126.6 52.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.825 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -69.53 -156.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.868 0.366 . . . . 0.0 111.711 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.444 HD12 ' N ' ' B' ' 8' ' ' LEU . 5.6 mp -59.96 -57.17 14.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.993 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -74.86 -45.49 42.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.64 30.59 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.003 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -82.43 130.99 35.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.958 0.408 . . . . 0.0 111.011 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 89.9 m -75.72 131.16 39.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.234 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.705 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -118.54 130.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.854 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.673 HG22 ' HB2' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -104.25 135.15 46.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.573 179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.747 HD23 HD11 ' B' ' 3' ' ' ILE . 3.9 tp -161.35 113.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.169 0.509 . . . . 0.0 111.705 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.78 142.4 38.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.703 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.748 HG21 HG12 ' B' ' 26' ' ' VAL . 12.3 p -165.42 135.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -54.64 133.27 64.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.868 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.528 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 11.1 Cg_endo -55.94 -36.63 96.05 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.871 2.381 . . . . 0.0 111.843 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 22' ' ' THR . 46.1 t -63.74 -27.81 69.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.003 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -56.15 135.42 53.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.77 ' HB ' HD22 ' B' ' 25' ' ' ASN . 23.4 m -58.24 150.27 22.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.492 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.559 ' O ' HG22 ' B' ' 26' ' ' VAL . 64.2 mt -62.3 -43.92 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.546 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HG2' ' CG2' ' B' ' 22' ' ' THR . 12.5 pt-20 -57.4 -33.19 67.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.649 0.261 . . . . 0.0 111.195 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.77 HD22 ' HB ' ' B' ' 22' ' ' THR . 70.4 m-80 -73.05 -50.21 24.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.409 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.748 HG12 HG21 ' B' ' 17' ' ' VAL . 33.0 m -58.66 -38.06 69.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 59.0 mtpt -65.96 -43.64 87.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.044 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -59.31 -25.69 64.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.628 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 53.9 mttm -74.12 -39.79 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 109.918 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.728 HD13 HG21 ' B' ' 5' ' ' VAL . 69.4 mt -59.59 -41.74 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.283 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.9 pt20 -65.43 -40.18 92.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.33 -32.48 72.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 30.6 mmmt -73.92 -31.44 63.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.769 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -135.55 -67.19 0.54 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 151.85 -25.88 0.92 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.163 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.837 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -51.13 123.58 20.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.703 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 74.6 Cg_exo -52.39 144.93 38.31 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.804 2.336 . . . . 0.0 111.85 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.48 -35.49 96.69 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.501 2.134 . . . . 0.0 112.246 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' B' ' 40' ' ' GLN . 2.5 p30 -62.15 -38.6 89.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.189 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.837 ' NE2' HG22 ' B' ' 36' ' ' ILE . 26.9 mt-30 -66.55 -41.63 88.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.38 . . . . 0.0 110.875 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.437 ' OE1' HD12 ' B' ' 30' ' ' ILE . 71.3 mt-30 -56.77 130.93 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.973 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.697 ' H ' ' H ' ' A' ' 46' ' ' ALA . 71.6 mtt-85 -106.48 133.08 51.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.973 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.415 HD12 HG22 ' A' ' 3' ' ' ILE . 23.3 mt -76.61 131.83 39.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.896 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.843 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 65.4 mt -143.75 128.93 15.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.666 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 2.7 m-85 -121.45 142.41 50.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.733 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.44 125.66 9.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.048 0.452 . . . . 0.0 111.593 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.513 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . -70.74 -136.77 0.13 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.012 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -69.6 75.89 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 111.592 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' B' ' 51' ' ' GLU . 85.9 mt-30 -64.01 108.71 1.58 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.473 ' H ' HD22 ' B' ' 50' ' ' LEU . 3.3 mm? -49.62 80.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.581 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.1 tt0 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 51.7 m -68.77 -135.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.649 0.261 . . . . 0.0 110.981 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt -78.02 57.32 1.75 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.105 0.479 . . . . 0.0 110.988 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.863 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.1 pt20 -66.58 110.59 3.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.295 0.569 . . . . 0.0 111.083 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 15' ' ' LEU . 18.8 pt -77.44 140.99 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.774 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -89.5 131.97 35.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.949 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 13' ' ' ILE . 2.3 p -149.86 135.04 10.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.804 0.335 . . . . 0.0 111.383 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -100.11 131.19 46.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.619 HG22 ' HG3' ' A' ' 34' ' ' GLU . 74.6 p -67.21 -158.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.735 0.302 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 36' ' ' ILE . 4.8 mp -89.28 -46.85 8.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.407 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 10' ' ' GLY . 6.0 t -72.05 -45.15 61.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 9' ' ' THR . . . 158.58 -31.37 0.47 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.927 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HD3' ' N ' ' A' ' 12' ' ' THR . 7.0 tmtm? -45.48 126.95 7.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.905 0.384 . . . . 0.0 110.748 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.518 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 66.9 m -83.24 138.02 33.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.787 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.59 HG13 ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -118.8 139.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.982 0.42 . . . . 0.0 111.473 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.863 HG22 ' HB2' ' A' ' 2' ' ' GLN . 6.8 m -127.37 137.99 52.9 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.645 ' O ' HG12 ' A' ' 3' ' ' ILE . 4.0 tt -159.82 121.97 3.35 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.048 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 22.8 pt-20 -72.13 143.42 48.98 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.75 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.584 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -158.36 140.28 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.414 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.34 143.24 90.44 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.086 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.85 -37.63 95.59 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.811 2.341 . . . . 0.0 112.14 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.4 t -64.17 -31.84 73.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.852 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -56.2 130.69 45.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.569 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -63.5 147.7 50.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.74 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.704 HG21 HD11 ' A' ' 43' ' ' LEU . 65.5 mt -54.58 -37.9 40.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.253 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.499 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 12.6 pt-20 -62.06 -31.7 72.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.95 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.499 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.4 m120 -74.62 -49.33 21.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.669 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG12 HG11 ' A' ' 17' ' ' VAL . 26.8 m -57.15 -42.63 80.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.162 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 51.1 mtmt -67.15 -37.71 84.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.464 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.497 ' HA ' ' CD ' ' A' ' 31' ' ' GLN . . . -53.7 -36.86 62.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.262 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.584 ' NZ ' HG12 ' A' ' 17' ' ' VAL . 80.5 mttt -69.13 -42.55 75.86 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.648 HG22 HD11 ' A' ' 36' ' ' ILE . 61.4 mt -57.93 -30.35 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.571 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 15.6 mt-30 -60.83 -44.53 96.82 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.722 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HE3' HD12 ' A' ' 15' ' ' LEU . 72.5 mmtt -61.52 -29.17 69.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.621 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.619 ' HG3' HG22 ' A' ' 7' ' ' THR . 58.6 mm-40 -146.78 -84.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.553 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 154.88 43.1 0.02 OUTLIER Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.079 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.832 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -113.28 124.04 32.22 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 111.706 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.79 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 56.8 Cg_exo -41.78 143.78 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.994 2.463 . . . . 0.0 112.334 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 11.8 Cg_endo -57.21 -35.53 98.91 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.494 2.129 . . . . 0.0 112.066 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -64.51 -39.65 94.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.683 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.832 ' NE2' HG22 ' A' ' 36' ' ' ILE . 27.8 mt-30 -60.22 -39.87 88.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.464 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.563 ' OE1' HD12 ' A' ' 30' ' ' ILE . 70.7 mt-30 -61.15 119.81 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 0.0 110.93 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 22.5 tpp180 -90.44 128.49 36.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.704 HD11 HG21 ' A' ' 23' ' ' ILE . 21.7 mt -80.82 136.24 36.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 111.01 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.97 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 72.1 mt -143.27 126.74 13.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.959 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.659 ' HA ' ' O ' ' B' ' 42' ' ' ARG . 1.9 m-85 -116.48 142.08 47.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.936 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.7 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -145.13 123.23 12.12 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 120.992 0.425 . . . . 0.0 111.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 139.79 44.3 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.819 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.487 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 54.8 tptt -77.1 74.1 3.68 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.125 0.488 . . . . 0.0 110.883 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 51' ' ' GLU . 38.6 tt0 -67.48 90.57 0.25 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.496 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -45.93 79.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.983 0.802 . . . . 0.0 111.584 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 49' ' ' GLN . 39.5 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.067 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.768 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 52.2 m -68.47 -133.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.58 0.229 . . . . 0.0 110.932 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.54 ' O ' ' HG2' ' B' ' 1' ' ' MET . 28.2 ttt -80.26 53.39 1.76 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.13 0.49 . . . . 0.0 110.824 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.942 ' HB2' HG22 ' B' ' 14' ' ' THR . 3.0 pt20 -62.27 110.88 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.311 0.577 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.555 HG22 ' HB2' ' A' ' 43' ' ' LEU . 13.7 pt -80.09 140.74 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.105 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -89.12 130.13 35.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.012 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 1.076 HG13 HG13 ' B' ' 13' ' ' ILE . 1.6 p -150.07 131.52 5.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.94 0.4 . . . . 0.0 111.335 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -93.38 131.58 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.423 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.599 HG22 ' HG3' ' B' ' 34' ' ' GLU . 74.1 p -68.44 -157.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 111.263 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.427 HD11 HG23 ' B' ' 36' ' ' ILE . 1.2 mt -85.96 -48.89 8.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.055 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.413 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.7 t -74.69 -45.2 46.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.827 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.413 ' N ' HG23 ' B' ' 9' ' ' THR . . . 159.49 -30.73 0.42 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.732 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' B' ' 12' ' ' THR . 7.3 tmtm? -45.65 127.87 8.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.97 0.414 . . . . 0.0 110.767 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . 0.505 ' N ' ' HD3' ' B' ' 11' ' ' LYS . 34.0 m -84.46 140.55 31.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.687 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 1.076 HG13 HG13 ' B' ' 5' ' ' VAL . 7.1 pt -134.67 140.62 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.022 0.439 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.942 HG22 ' HB2' ' B' ' 2' ' ' GLN . 4.1 m -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.727 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.491 ' C ' ' HA ' ' B' ' 2' ' ' GLN . 0.6 OUTLIER -153.94 134.92 13.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.768 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 12.5 pt-20 -70.21 140.35 52.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.174 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.561 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 7.5 m -154.81 137.47 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.064 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 4.5 mm-40 -69.74 143.66 92.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.104 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.29 -35.82 98.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.778 2.319 . . . . 0.0 112.232 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.5 t -63.88 -31.5 72.71 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.986 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 49.7 m-20 -57.49 130.33 45.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.652 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -62.9 147.39 50.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.46 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.693 HG21 HD11 ' B' ' 43' ' ' LEU . 65.9 mt -53.28 -37.41 28.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.481 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 22.2 pt-20 -62.42 -32.61 73.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.4 m120 -73.39 -49.22 28.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.687 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 23' ' ' ILE . 28.2 m -57.86 -42.85 83.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.64 0.257 . . . . 0.0 111.158 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' B' ' 31' ' ' GLN . 51.8 mtmt -66.42 -37.25 84.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.849 0.357 . . . . 0.0 110.508 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HA ' ' CD ' ' B' ' 31' ' ' GLN . . . -54.9 -37.48 66.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.15 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.561 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 78.9 mttt -67.63 -42.22 82.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.529 HG22 HD11 ' B' ' 36' ' ' ILE . 62.8 mt -58.45 -30.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.594 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.579 ' OE1' ' HD3' ' B' ' 38' ' ' PRO . 16.3 mt-30 -61.2 -45.57 94.05 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.61 -35.87 82.06 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.772 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 72.5 mmtt -61.01 -29.32 69.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.523 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.599 ' HG3' HG22 ' B' ' 7' ' ' THR . 57.4 mm-40 -147.41 -81.15 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.543 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.2 44.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.751 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.915 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.4 OUTLIER -112.96 124.44 31.64 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.616 0.246 . . . . 0.0 111.479 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.793 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 97.1 Cg_exo -44.78 143.66 4.09 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.818 2.346 . . . . 0.0 112.043 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' OE1' ' B' ' 31' ' ' GLN . 11.6 Cg_endo -56.65 -35.74 97.62 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.194 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -64.99 -39.24 93.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.915 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.9 mt-30 -61.56 -39.76 92.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.468 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.519 ' OE1' HD12 ' B' ' 30' ' ' ILE . 70.5 mt-30 -59.72 124.41 20.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.532 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' ALA . 22.4 tpp180 -95.43 123.47 38.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.73 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.693 HD11 HG21 ' B' ' 23' ' ' ILE . 27.1 mt -75.49 135.31 40.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.088 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.97 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 71.7 mt -143.39 124.99 11.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.343 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.578 ' O ' HG23 ' A' ' 5' ' ' VAL . 2.2 m-85 -115.64 146.52 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.584 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.5 129.59 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 111.529 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.97 132.61 34.02 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.524 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.63 ' H ' ' HB3' ' A' ' 40' ' ' GLN . 57.3 tptt -82.92 74.11 9.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.679 0.276 . . . . 0.0 111.172 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' B' ' 51' ' ' GLU . 18.7 pt20 -73.51 116.33 13.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.61 79.98 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.399 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' B' ' 49' ' ' GLN . 39.3 tt0 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.836 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.4 m -60.9 -40.42 93.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.813 0.34 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 15.8 tpt -163.42 49.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.088 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 20.7 pt20 -61.18 111.06 1.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.183 0.516 . . . . 0.0 110.464 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 15' ' ' LEU . 24.6 pt -75.56 132.86 32.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.98 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.6 m-85 -89.08 131.56 35.18 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.797 ' HB ' HG13 ' A' ' 13' ' ' ILE . 64.9 t -143.79 131.39 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 0.0 111.665 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.72 123.46 35.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.184 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -70.48 -157.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.743 0.306 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 36' ' ' ILE . 2.3 mm? -82.37 -48.13 11.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.778 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -73.18 -45.28 57.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.518 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.02 -31.64 0.5 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.881 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.66 130.08 11.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.985 0.421 . . . . 0.0 111.757 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 m -90.76 145.01 25.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.753 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.797 HG13 ' HB ' ' A' ' 5' ' ' VAL . 2.3 pt -119.44 126.64 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.68 132.04 43.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.614 ' O ' HG12 ' A' ' 3' ' ' ILE . 9.0 tp -153.59 113.18 3.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.157 0.503 . . . . 0.0 111.577 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 39.3 tt0 -70.3 133.9 47.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.501 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.556 ' O ' ' HB3' ' A' ' 1' ' ' MET . 16.2 m -154.26 137.75 8.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.33 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 4.5 mm-40 -72.05 139.72 82.62 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.229 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.31 -38.0 61.37 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.817 2.345 . . . . 0.0 111.751 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 t -64.06 -33.68 76.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.017 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 36.3 m-20 -55.23 130.89 43.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.98 0.419 . . . . 0.0 110.627 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.4 p -59.49 146.79 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.905 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.615 HG21 HD11 ' A' ' 43' ' ' LEU . 63.3 mt -57.91 -29.67 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.022 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -66.02 -37.32 85.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.4 m120 -72.1 -46.83 55.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.268 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 23' ' ' ILE . 32.7 m -58.35 -41.69 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.961 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.601 ' HZ2' ' HB2' ' A' ' 41' ' ' GLN . 68.1 mttm -66.7 -40.79 88.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 0.0 110.606 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.639 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -53.55 -40.29 65.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.406 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HB2' HD21 ' A' ' 15' ' ' LEU . 50.0 mttm -64.74 -41.36 96.0 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.991 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.459 HG23 ' CD1' ' A' ' 13' ' ' ILE . 67.4 mt -57.46 -35.93 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.022 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 28' ' ' ALA . 70.1 mt-30 -61.45 -45.63 93.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -65.95 -32.62 74.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.011 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -64.65 -31.69 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.725 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -144.89 -67.2 0.32 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.252 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.3 48.97 0.06 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.972 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.67 HG21 HD21 ' A' ' 8' ' ' LEU . 2.3 pt -125.05 129.03 24.68 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 120.69 0.281 . . . . 0.0 111.714 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 95.2 Cg_exo -45.88 140.67 9.69 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.793 2.329 . . . . 0.0 112.242 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 17.3 Cg_endo -58.57 -32.62 96.99 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.691 2.261 . . . . 0.0 112.429 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -61.37 -36.51 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.179 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.609 ' NE2' ' HD2' ' A' ' 37' ' ' PRO . 21.9 mt-30 -60.02 -45.64 92.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.549 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.742 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -58.8 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.866 0.365 . . . . 0.0 111.144 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.731 ' H ' ' H ' ' B' ' 46' ' ' ALA . 72.2 mtt-85 -97.44 128.89 44.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.17 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 23' ' ' ILE . 27.1 mt -78.62 131.4 36.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.984 0.421 . . . . 0.0 111.448 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 66.4 mt -143.97 127.5 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.626 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 0.5 OUTLIER -115.35 145.09 42.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.389 -179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -152.22 122.88 7.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.05 -136.62 0.11 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.921 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.66 ' O ' HD22 ' A' ' 50' ' ' LEU . 97.9 mttt -66.8 121.56 15.73 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.107 0.479 . . . . 0.0 111.744 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 51' ' ' GLU . 71.1 mt-30 -72.61 96.57 2.0 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 48' ' ' LYS . 3.1 mm? -47.33 80.03 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.41 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 49' ' ' GLN . 88.5 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.873 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 53.2 p -60.63 -44.61 96.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.578 0.227 . . . . 0.0 111.043 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.607 ' HB3' ' O ' ' B' ' 17' ' ' VAL . 15.6 tpt -155.87 51.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.25 0.547 . . . . 0.0 110.919 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.605 ' HB2' HG22 ' B' ' 14' ' ' THR . 16.3 pt20 -61.32 110.44 1.42 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.637 HG12 ' O ' ' B' ' 15' ' ' LEU . 21.2 pt -76.74 131.43 34.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.069 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -89.26 132.91 34.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' B' ' 13' ' ' ILE . 66.3 t -145.08 131.06 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.757 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -91.26 123.5 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.196 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.5 p -71.05 -157.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.37 . . . . 0.0 111.286 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.567 HD22 ' N ' ' B' ' 8' ' ' LEU . 2.6 mm? -81.15 -49.83 10.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.009 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 76.0 p -72.19 -45.35 60.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.575 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.61 -31.42 0.52 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.769 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -46.58 128.58 10.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.997 0.427 . . . . 0.0 111.627 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 42.9 m -89.46 139.3 30.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.558 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.615 HG13 ' HB ' ' B' ' 5' ' ' VAL . 13.4 pt -113.75 127.25 71.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 112.022 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.605 HG22 ' HB2' ' B' ' 2' ' ' GLN . 1.8 m -96.37 137.15 35.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.637 ' O ' HG12 ' B' ' 3' ' ' ILE . 5.0 tt -158.3 114.65 2.78 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.614 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' B' ' 2' ' ' GLN . 40.7 tt0 -71.91 138.6 48.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.609 HG13 ' CD2' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -158.92 134.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.181 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -66.69 137.64 95.11 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.917 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 10.2 Cg_endo -52.69 -37.9 75.98 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.847 2.365 . . . . 0.0 112.068 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.0 -30.97 72.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.306 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -55.4 134.16 50.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.855 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 82.6 p -61.19 146.34 47.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.664 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.495 ' O ' HG22 ' B' ' 26' ' ' VAL . 63.8 mt -57.86 -30.42 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.128 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -65.83 -36.65 84.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.905 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' B' ' 29' ' ' LYS . 3.5 m120 -72.29 -47.13 52.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.264 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 23' ' ' ILE . 32.9 m -58.02 -41.45 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.935 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.473 ' HZ2' ' HB2' ' B' ' 41' ' ' GLN . 68.1 mttm -66.6 -39.98 88.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.927 0.394 . . . . 0.0 110.619 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.656 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -53.44 -42.29 66.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.277 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.553 ' HB2' HD11 ' B' ' 15' ' ' LEU . 45.5 mttm -64.29 -42.8 96.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.042 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.547 HG22 ' CD1' ' B' ' 36' ' ' ILE . 67.3 mt -55.26 -35.86 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.849 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 68.9 mt-30 -62.26 -42.16 99.08 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -62.93 -35.27 79.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.405 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 30' ' ' ILE . 17.1 mmtp -60.43 -37.83 82.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.564 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -141.52 -60.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.297 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.59 45.16 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.31 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.848 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.2 OUTLIER -112.13 130.63 23.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.56 0.219 . . . . 0.0 111.544 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.439 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 62.9 Cg_exo -51.97 139.6 50.83 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.434 2.09 . . . . 0.0 111.744 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.5 ' HD3' ' CD ' ' B' ' 31' ' ' GLN . 15.1 Cg_endo -57.22 -32.21 92.91 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.741 2.294 . . . . 0.0 112.336 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.6 -35.93 82.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.848 ' NE2' HG22 ' B' ' 36' ' ' ILE . 25.9 mt-30 -63.89 -42.36 97.49 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.703 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.722 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -60.07 124.48 20.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.771 0.319 . . . . 0.0 110.711 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.689 ' H ' ' H ' ' A' ' 46' ' ' ALA . 72.5 mtt-85 -91.69 126.65 36.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.053 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.572 HD23 ' CG2' ' A' ' 3' ' ' ILE . 10.5 tp -80.28 129.89 34.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.939 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 69.8 mt -143.64 136.98 24.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.391 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -121.37 146.71 46.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.471 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.731 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.5 123.91 6.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.357 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . -72.29 -138.79 0.27 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.899 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.42 ' O ' HD22 ' B' ' 50' ' ' LEU . 97.3 mttt -65.36 123.6 20.02 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.121 0.486 . . . . 0.0 111.356 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' B' ' 51' ' ' GLU . 71.1 mt-30 -74.35 104.8 5.23 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.461 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.4 mm? -52.74 80.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.394 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' B' ' 49' ' ' GLN . 37.3 tt0 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.874 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.401 ' HA2' ' OE1' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 18' ' ' GLU . 47.3 t -61.6 -57.88 10.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.604 0.24 . . . . 0.0 111.051 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.4 ptm 178.54 106.95 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.419 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.04 125.0 25.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.506 HG12 ' HG ' ' A' ' 15' ' ' LEU . 32.3 pt -91.91 139.27 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.493 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.67 130.14 35.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.735 ' HB ' HG13 ' A' ' 13' ' ' ILE . 44.8 t -145.24 133.81 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -93.06 120.61 33.54 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.2 p -72.48 -157.62 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.738 0.304 . . . . 0.0 111.395 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.502 HD21 HG23 ' A' ' 36' ' ' ILE . 31.6 mt -80.6 -51.47 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.044 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.8 t -69.01 -45.17 71.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.593 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 9' ' ' THR . . . 153.89 -34.12 0.74 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.761 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -49.27 130.33 19.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.992 0.425 . . . . 0.0 111.59 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -80.15 146.85 31.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.349 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.735 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.0 pt -126.05 129.53 72.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.775 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 p -107.85 142.65 37.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.422 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 15' ' ' LEU . 2.8 pp -165.41 122.32 1.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.262 0.553 . . . . 0.0 110.385 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 1' ' ' MET . 11.4 pt-20 -75.71 140.97 42.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.427 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.418 HG13 ' CD1' ' A' ' 15' ' ' LEU . 3.4 m -153.21 133.53 4.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.162 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 87.0 mt-10 -59.74 138.83 90.07 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.074 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.25 -39.07 92.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.801 2.334 . . . . 0.0 111.937 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 t -64.15 -30.57 71.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.122 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD2' HG23 ' A' ' 26' ' ' VAL . 38.0 t70 -54.6 136.28 45.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.618 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.0 p -64.96 144.46 57.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.557 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 19' ' ' PRO . 67.3 mt -55.85 -38.69 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.254 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -56.18 -44.93 79.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.046 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.2 m120 -65.43 -46.35 80.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.791 0.329 . . . . 0.0 110.736 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.492 HG21 HD11 ' B' ' 23' ' ' ILE . 6.5 t -53.61 -48.62 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.162 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.692 ' HE3' ' HB3' ' A' ' 38' ' ' PRO . 51.5 mtmt -68.62 -35.4 77.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.003 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.43 -40.29 71.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.458 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 25.5 mmmt -62.09 -43.75 98.16 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.334 0.588 . . . . 0.0 109.582 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.607 HD12 ' OE1' ' A' ' 41' ' ' GLN . 62.2 mt -57.16 -35.9 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.748 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.751 HE21 ' HA ' ' A' ' 28' ' ' ALA . 69.1 mt-30 -58.97 -43.97 91.46 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.25 -37.5 83.61 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.942 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 28.9 mtpp -76.8 3.45 11.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.815 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -169.22 -102.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.145 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.71 49.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.422 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.84 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -121.99 127.17 26.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.64 0.257 . . . . 0.0 111.437 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.605 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 79.0 Cg_exo -48.89 144.3 15.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.719 2.279 . . . . 0.0 112.219 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.692 ' HB3' ' HE3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -56.45 -37.74 96.64 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.569 2.18 . . . . 0.0 112.406 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.82 -38.88 92.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.309 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.84 ' NE2' HG22 ' A' ' 36' ' ' ILE . 26.2 mt-30 -63.54 -39.45 94.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.607 ' OE1' HD12 ' A' ' 30' ' ' ILE . 71.3 mt-30 -59.75 110.79 1.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -81.88 130.82 35.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.321 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.513 ' HB2' HG22 ' B' ' 3' ' ' ILE . 33.0 mt -80.05 135.7 36.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.965 0.412 . . . . 0.0 110.791 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 81.0 mt -143.28 133.84 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.35 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.831 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 6.8 m-85 -127.53 140.98 51.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.882 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.813 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -151.63 126.05 9.42 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.093 0.473 . . . . 0.0 111.843 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.09 141.2 48.1 Favored Glycine 0 C--N 1.331 0.302 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.729 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' O ' HD22 ' A' ' 50' ' ' LEU . 31.8 mmmt -69.2 74.59 0.33 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.014 0.435 . . . . 0.0 111.639 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.3 mm100 -69.32 103.01 1.86 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 50' ' ' LEU . 3.4 mm? -45.05 80.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.795 0.684 . . . . 0.0 111.69 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 49' ' ' GLN . 56.1 mt-10 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.057 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' B' ' 18' ' ' GLU . 47.5 t -60.94 -58.31 8.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.678 0.275 . . . . 0.0 110.978 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.2 ptm 179.67 106.61 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.519 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.731 ' HB2' HG22 ' B' ' 14' ' ' THR . 3.3 pt20 -67.3 127.91 34.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.226 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.622 HG12 ' O ' ' B' ' 15' ' ' LEU . 24.2 pt -97.35 136.69 27.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.975 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -89.97 126.82 35.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.122 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.936 HG13 HG13 ' B' ' 13' ' ' ILE . 0.9 OUTLIER -150.45 132.55 5.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.999 0.428 . . . . 0.0 111.5 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -84.83 129.7 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.074 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.502 HG23 HG12 ' B' ' 13' ' ' ILE . 77.9 p -77.54 -157.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 111.163 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.402 ' H ' ' HB ' ' B' ' 7' ' ' THR . 53.6 mt -81.42 -50.76 9.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.197 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.425 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -71.33 -45.26 63.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.693 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.425 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.88 -35.7 0.62 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.841 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -48.61 130.47 17.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.945 0.402 . . . . 0.0 111.342 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 62.1 m -82.48 134.17 35.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.141 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.936 HG13 HG13 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -100.76 131.43 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.055 0.455 . . . . 0.0 111.624 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.731 HG22 ' HB2' ' B' ' 2' ' ' GLN . 1.3 m -105.27 134.23 48.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.622 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.2 OUTLIER -162.53 115.04 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.354 0.597 . . . . 0.0 111.998 -178.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.5 pt-20 -78.39 140.26 38.73 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.196 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -153.03 136.2 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.242 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.463 ' HA ' ' OG ' ' B' ' 0' ' ' SER . 87.4 mt-10 -59.91 140.07 90.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.077 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 12.9 Cg_endo -56.75 -40.01 87.34 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.799 2.333 . . . . 0.0 112.032 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.7 t -64.08 -29.78 70.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.118 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -56.15 136.02 52.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.61 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 71.1 p -65.07 145.81 55.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.697 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.591 ' O ' HG22 ' B' ' 26' ' ' VAL . 66.8 mt -55.84 -39.04 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -56.7 -40.0 74.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.17 -49.28 61.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 23' ' ' ILE . 15.7 m -57.24 -41.44 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.047 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.707 ' HE3' ' HB3' ' B' ' 38' ' ' PRO . 50.3 mtmt -69.82 -38.63 76.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 110.818 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.808 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -54.44 -41.52 69.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.737 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -68.26 -37.77 81.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.209 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.634 HG22 HD11 ' B' ' 36' ' ' ILE . 63.0 mt -57.62 -34.63 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.808 HE21 ' HA ' ' B' ' 28' ' ' ALA . 68.7 mt-30 -60.65 -41.41 94.92 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -67.23 -37.76 84.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.752 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -78.0 3.24 15.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.637 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -168.53 -106.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.55 50.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.812 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.824 HG22 HE22 ' B' ' 40' ' ' GLN . 0.7 OUTLIER -126.57 119.89 23.09 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.725 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 35.5 Cg_exo -38.89 146.3 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.296 2.664 . . . . 0.0 112.982 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.707 ' HB3' ' HE3' ' B' ' 27' ' ' LYS . 33.6 Cg_exo -58.83 -38.14 90.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.665 2.244 . . . . 0.0 112.646 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.56 -39.2 90.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.824 HE22 HG22 ' B' ' 36' ' ' ILE . 22.9 mt-30 -60.16 -44.99 94.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.391 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.831 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 71.4 mt-30 -54.37 115.75 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.982 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.813 ' H ' ' H ' ' A' ' 46' ' ' ALA . 56.2 ttp180 -87.49 124.3 33.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.818 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 3' ' ' ILE . 44.1 mt -72.87 133.34 44.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.968 0.414 . . . . 0.0 111.121 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 1.013 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 74.8 mt -143.51 131.39 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.466 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.582 ' HB2' HG22 ' A' ' 5' ' ' VAL . 4.7 m-85 -127.19 148.05 50.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.762 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.91 132.39 8.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 111.308 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.05 141.8 43.91 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.52 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 40' ' ' GLN . 32.2 mmmt -69.19 74.89 0.34 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 120.899 0.38 . . . . 0.0 111.803 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.3 mm100 -68.16 111.8 4.72 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.47 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.4 mm? -52.85 80.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.452 0.47 . . . . 0.0 111.368 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' B' ' 49' ' ' GLN . 55.4 mt-10 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.961 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.579 ' OG ' ' HA ' ' A' ' 18' ' ' GLU . 47.8 t -65.46 -56.72 10.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.688 0.28 . . . . 0.0 111.069 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.6 ptm -175.54 115.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.211 0.529 . . . . 0.0 111.303 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.489 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 10.8 tt0 -72.63 134.63 45.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.492 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.658 HG12 ' O ' ' A' ' 15' ' ' LEU . 29.5 pt -117.6 145.3 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-O 121.027 0.442 . . . . 0.0 112.067 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.2 m-85 -89.3 133.91 34.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.761 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.745 ' HB ' HG12 ' A' ' 13' ' ' ILE . 92.3 t -144.91 136.64 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.136 0.493 . . . . 0.0 111.781 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 40.4 ttmt -91.47 134.41 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.499 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -71.43 -157.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.0 111.515 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.446 HD21 HG23 ' A' ' 36' ' ' ILE . 38.7 mt -65.37 -63.91 0.99 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.7 t -77.57 -45.18 26.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 9' ' ' THR . . . 155.49 108.05 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.329 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 24.2 ttmm -167.19 127.84 1.52 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.724 0.297 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -73.27 133.39 43.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.569 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.745 HG12 ' HB ' ' A' ' 5' ' ' VAL . 2.1 pt -135.44 135.54 51.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.489 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 3.3 p -90.43 144.43 25.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.069 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.658 ' O ' HG12 ' A' ' 3' ' ' ILE . 10.7 tp -160.58 114.05 2.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.216 0.532 . . . . 0.0 111.76 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 1' ' ' MET . 23.6 pt-20 -85.35 132.45 34.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.671 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -151.06 142.96 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.356 . . . . 0.0 111.141 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.579 ' HA ' ' OG ' ' A' ' 0' ' ' SER . 42.0 mt-10 -67.43 137.44 93.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.3 -36.14 88.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.751 2.301 . . . . 0.0 111.807 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.475 ' O ' HG22 ' B' ' 22' ' ' THR . 79.8 p -64.44 -27.86 69.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.357 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' CG ' ' HB2' ' A' ' 18' ' ' GLU . 51.6 m-20 -58.96 133.1 55.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.686 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.418 HG22 ' O ' ' B' ' 20' ' ' SER . 59.3 p -63.06 145.95 54.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.695 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 56.1 mt -53.54 -38.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.514 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 16.1 pt-20 -60.44 -39.91 89.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.514 ' ND2' ' HG3' ' A' ' 24' ' ' GLU . 3.4 m120 -67.39 -48.81 66.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.646 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -61.34 -43.87 97.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.317 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.695 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 36.3 mtmm -62.6 -43.8 97.91 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.9 0.381 . . . . 0.0 110.044 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 31' ' ' GLN . . . -60.43 -29.25 68.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.451 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' NZ ' ' NZ ' ' A' ' 33' ' ' LYS . 26.2 tptp -64.85 -43.03 94.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.744 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.546 ' HA ' ' HB2' ' A' ' 33' ' ' LYS . 51.3 mt -57.28 -31.83 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.723 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' NE2' ' HA ' ' A' ' 37' ' ' PRO . 75.3 mt-30 -58.16 -48.01 81.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -61.32 -36.89 81.38 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.826 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 38.6 mmtm -67.49 -24.21 65.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.135 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -153.16 -90.0 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.092 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.78 61.04 0.02 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.888 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.906 HG22 ' NE2' ' A' ' 40' ' ' GLN . 0.4 OUTLIER -139.54 118.27 8.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.559 0.218 . . . . 0.0 111.549 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.748 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 54.8 Cg_exo -40.27 146.03 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.152 2.568 . . . . 0.0 112.822 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.675 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 19.8 Cg_endo -60.04 -36.0 90.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.818 2.345 . . . . 0.0 112.61 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -60.44 -38.86 85.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.906 ' NE2' HG22 ' A' ' 36' ' ' ILE . 18.3 mt-30 -64.1 -40.49 96.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.244 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' NE2' HG21 ' A' ' 30' ' ' ILE . 8.4 mm100 -52.44 126.94 20.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.192 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.743 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.5 mtt180 -94.85 124.77 39.08 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.235 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.458 ' HB2' HG22 ' B' ' 3' ' ' ILE . 64.1 mt -78.35 132.03 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.384 . . . . 0.0 111.0 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.966 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 74.5 mt -143.57 131.96 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.539 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.662 ' O ' HG13 ' B' ' 5' ' ' VAL . 4.8 m-85 -126.36 147.12 49.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.6 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.7 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.39 128.04 7.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.93 0.395 . . . . 0.0 111.703 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.568 ' N ' HE22 ' A' ' 49' ' ' GLN . . . -68.18 -138.04 0.07 OUTLIER Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.972 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 50' ' ' LEU . 23.4 tptm -96.75 74.82 2.72 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.084 0.469 . . . . 0.0 111.701 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 51' ' ' GLU . 14.3 mp0 -69.06 103.59 1.91 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.476 ' H ' ' CD2' ' A' ' 50' ' ' LEU . 3.5 mm? -44.9 80.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.745 0.653 . . . . 0.0 111.772 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 49' ' ' GLN . 24.2 pt-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.96 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.553 ' OG ' ' HA ' ' B' ' 18' ' ' GLU . 46.8 t -65.06 -56.41 13.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.462 0.172 . . . . 0.0 111.013 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.1 ptm 179.56 108.45 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 112.044 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.983 ' HB3' HG22 ' B' ' 14' ' ' THR . 87.5 mt-30 -62.25 145.13 54.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.688 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.666 HG12 ' O ' ' B' ' 15' ' ' LEU . 33.1 pt -121.77 143.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.054 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.1 m-85 -88.05 131.28 34.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.856 ' HB ' HG23 ' B' ' 13' ' ' ILE . 84.4 t -142.43 146.04 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.091 0.472 . . . . 0.0 111.563 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.425 ' CG ' ' HA2' ' B' ' 10' ' ' GLY . 40.3 ttmt -102.08 131.57 48.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.194 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 70.0 p -68.61 -157.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 111.457 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.46 HD21 HG23 ' B' ' 36' ' ' ILE . 75.1 mt -64.67 -65.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.221 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.4 t -76.79 -45.25 29.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.427 ' N ' HG23 ' B' ' 9' ' ' THR . . . 155.06 109.03 0.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.358 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -167.25 129.46 1.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.696 0.284 . . . . 0.0 110.903 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 90.0 m -73.37 134.34 44.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.756 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.856 HG23 ' HB ' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -137.85 122.49 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.266 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.983 HG22 ' HB3' ' B' ' 2' ' ' GLN . 0.1 OUTLIER -80.16 145.22 32.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.477 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.666 ' O ' HG12 ' B' ' 3' ' ' ILE . 4.2 tt -162.72 112.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.21 0.529 . . . . 0.0 111.177 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' B' ' 1' ' ' MET . 12.4 pt-20 -82.92 141.11 32.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.955 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.934 HG11 HG23 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -157.65 145.65 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.557 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.553 ' HA ' ' OG ' ' B' ' 0' ' ' SER . 44.7 mt-10 -71.13 133.99 85.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.992 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.97 -37.69 97.8 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.796 2.33 . . . . 0.0 112.2 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.418 ' O ' HG22 ' A' ' 22' ' ' THR . 80.5 p -63.89 -25.92 68.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.518 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.465 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 53.0 m-20 -60.81 131.44 50.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.812 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 20' ' ' SER . 65.9 p -60.8 146.55 45.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.554 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.723 HG22 ' NZ ' ' B' ' 27' ' ' LYS . 54.8 mt -55.36 -37.79 45.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.099 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.546 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 15.9 pt-20 -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.546 ' ND2' ' HG3' ' B' ' 24' ' ' GLU . 3.3 m120 -67.7 -46.3 72.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.452 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.934 HG23 HG11 ' B' ' 17' ' ' VAL . 7.8 p -61.93 -41.21 90.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.226 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.723 ' NZ ' HG22 ' B' ' 23' ' ' ILE . 36.8 mtmm -66.61 -44.55 81.79 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.01 0.433 . . . . 0.0 110.203 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' B' ' 31' ' ' GLN . . . -57.87 -27.29 63.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.509 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -64.87 -43.89 91.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.817 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.66 HG22 HD11 ' B' ' 36' ' ' ILE . 51.5 mt -57.57 -30.95 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.824 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 74.2 mt-30 -58.05 -48.49 79.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 177.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.5 -37.34 83.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.767 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' B' ' 30' ' ' ILE . 38.5 mmtm -66.48 -25.1 66.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.029 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -152.03 -87.23 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 162.15 57.3 0.02 OUTLIER Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.248 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.839 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.5 OUTLIER -134.9 125.56 17.32 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.71 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 70.5 Cg_exo -44.28 145.16 2.51 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.0 2.467 . . . . 0.0 112.386 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.663 ' HB2' ' HE2' ' B' ' 27' ' ' LYS . 20.2 Cg_endo -60.27 -35.13 92.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.497 2.131 . . . . 0.0 112.223 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -62.64 -38.15 89.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.989 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.839 ' NE2' HG22 ' B' ' 36' ' ' ILE . 26.3 mt-30 -64.19 -37.23 86.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.094 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.538 ' NE2' HD13 ' B' ' 36' ' ' ILE . 8.7 mm100 -54.54 129.26 35.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.084 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.7 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.3 mtt180 -97.52 124.67 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.251 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.467 HD12 ' CG2' ' A' ' 3' ' ' ILE . 50.7 mt -79.46 132.71 36.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.399 . . . . 0.0 111.115 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.966 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 75.1 mt -143.54 131.27 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.367 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 42' ' ' ARG . 4.8 m-85 -125.28 143.99 50.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.743 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -153.43 129.94 10.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 111.526 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.597 ' N ' HE22 ' B' ' 49' ' ' GLN . . . -68.91 -138.22 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.784 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -98.23 74.9 2.25 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.052 0.454 . . . . 0.0 111.693 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.597 HE22 ' N ' ' B' ' 47' ' ' GLY . 14.3 mp0 -68.09 112.58 5.14 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.466 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.4 mm? -51.45 80.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.551 0.532 . . . . 0.0 111.467 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' B' ' 49' ' ' GLN . 24.1 pt-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 52.3 m -58.39 141.14 52.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.849 0.357 . . . . 0.0 110.834 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HE1' HD13 ' B' ' 43' ' ' LEU . 20.4 ptm -72.27 116.53 12.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.812 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.2 pt20 -71.47 122.73 20.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.211 0.529 . . . . 0.0 110.98 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.574 HG22 HD22 ' B' ' 43' ' ' LEU . 38.0 pt -86.15 144.16 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.556 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.9 m-85 -88.89 134.98 33.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.972 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.661 HG22 ' HB2' ' B' ' 45' ' ' PHE . 59.5 t -148.2 132.74 9.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.865 0.364 . . . . 0.0 111.145 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.83 126.43 43.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 9' ' ' THR . 91.1 m -67.62 150.55 48.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.731 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.872 HD21 HG21 ' A' ' 36' ' ' ILE . 4.2 mp -45.02 -45.2 10.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.75 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.438 ' H ' HG22 ' A' ' 7' ' ' THR . 72.0 p -75.46 -45.5 38.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.392 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.23 -30.43 0.53 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.88 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -44.02 131.59 5.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.971 0.415 . . . . 0.0 111.584 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.7 m -74.15 141.72 45.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.978 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 1.1 mt -128.62 139.12 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.971 0.415 . . . . 0.0 111.028 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.812 HG22 ' HB2' ' A' ' 2' ' ' GLN . 7.2 m -133.52 142.86 48.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.9 HD13 ' HD2' ' A' ' 33' ' ' LYS . 5.8 tp -157.02 114.95 3.19 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 16.9 pt-20 -71.89 130.51 41.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.743 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.612 HG12 ' NZ ' ' A' ' 29' ' ' LYS . 18.7 m -152.57 138.65 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 48.5 mt-10 -69.16 140.87 91.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.139 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.72 -36.37 81.59 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.969 2.446 . . . . 0.0 112.239 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.523 ' O ' HG22 ' B' ' 22' ' ' THR . 46.0 t -64.3 -32.04 73.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.133 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 54.5 m-20 -56.27 132.59 51.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.499 HG22 ' O ' ' B' ' 20' ' ' SER . 66.6 p -60.06 147.18 40.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.642 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 26' ' ' VAL . 61.5 mt -54.38 -36.95 35.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.788 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -67.66 -32.22 72.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -69.28 -47.46 64.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.208 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 23' ' ' ILE . 22.7 m -60.22 -39.28 80.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.969 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HE3' HG22 ' A' ' 23' ' ' ILE . 99.3 mttt -67.13 -38.75 86.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.555 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -49.84 -38.62 35.8 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.427 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.777 ' HD2' HD21 ' A' ' 15' ' ' LEU . 80.0 mttt -67.79 -41.07 83.75 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.6 mt -55.14 -36.83 40.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.357 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.555 HE21 ' HA ' ' A' ' 28' ' ' ALA . 68.2 mt-30 -63.28 -45.0 93.49 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -66.94 -33.01 74.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.712 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.9 ' HD2' HD13 ' A' ' 15' ' ' LEU . 29.6 mtpp -71.71 -31.56 66.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.935 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -135.63 -60.18 0.75 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.593 0.219 . . . . 0.0 111.593 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.11 57.06 0.19 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.313 -0.946 . . . . 0.0 113.083 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.872 HG21 HD21 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -145.07 131.43 9.78 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 120.819 0.342 . . . . 0.0 111.352 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.563 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 60.6 Cg_exo -40.89 139.46 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.29 2.66 . . . . 0.0 113.229 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 18.0 Cg_endo -60.36 -36.2 88.18 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.922 2.414 . . . . 0.0 112.663 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -58.25 -37.19 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.698 HE22 HG22 ' A' ' 36' ' ' ILE . 16.0 mt-30 -59.27 -45.41 91.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.593 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.672 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.34 124.37 15.74 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.73 -179.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.687 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.9 ttm180 -91.46 123.18 34.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.436 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.555 HD21 HG21 ' A' ' 23' ' ' ILE . 9.3 mp -73.49 132.04 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.949 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 79.9 mt -143.61 134.65 22.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.935 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.669 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 8.3 m-85 -128.62 144.81 51.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.818 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.72 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -153.04 129.4 10.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.994 0.426 . . . . 0.0 111.439 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' CD1' ' B' ' 8' ' ' LEU . . . -56.75 138.39 47.04 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.897 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.718 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 28.1 tptp -71.1 74.54 0.66 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.028 0.442 . . . . 0.0 111.36 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.589 ' O ' ' N ' ' A' ' 51' ' ' GLU . 73.5 mt-30 -66.34 99.8 0.58 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.82 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.7 mm? -44.91 80.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.754 0.658 . . . . 0.0 111.859 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.92 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.713 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 54.3 m -58.53 144.19 43.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.822 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.492 ' HE1' HD13 ' A' ' 43' ' ' LEU . 20.2 ptm -76.12 113.52 13.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.149 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.94 ' HB2' HG22 ' B' ' 14' ' ' THR . 3.1 pt20 -69.22 124.33 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.688 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.462 HG22 HD22 ' A' ' 43' ' ' LEU . 37.4 pt -88.33 145.83 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.831 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.7 m-85 -88.76 135.51 33.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.153 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.717 ' HB ' HG13 ' B' ' 13' ' ' ILE . 57.6 t -148.47 138.31 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.894 0.378 . . . . 0.0 111.132 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.9 125.55 50.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.437 HG22 ' H ' ' B' ' 9' ' ' THR . 90.4 m -67.03 151.32 47.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.484 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.798 HD22 ' H ' ' B' ' 8' ' ' LEU . 0.4 OUTLIER -47.26 -42.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.663 -179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.437 ' H ' HG22 ' B' ' 7' ' ' THR . 67.4 p -75.92 -45.36 35.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.425 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.86 -30.44 0.61 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.911 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -45.29 134.62 6.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 111.736 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 39.1 m -79.94 143.82 33.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.0 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.717 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.4 pt -142.78 135.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.142 0.496 . . . . 0.0 111.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.94 HG22 ' HB2' ' B' ' 2' ' ' GLN . 6.0 m -139.75 141.74 36.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.07 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.52 HD22 ' CD ' ' B' ' 33' ' ' LYS . 0.9 OUTLIER -150.69 130.8 13.5 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.022 0.439 . . . . 0.0 111.193 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.713 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 11.1 pt-20 -69.85 132.78 46.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.963 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.534 HG12 ' NZ ' ' B' ' 29' ' ' LYS . 17.3 m -150.43 136.83 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.48 ' HB2' ' OD2' ' B' ' 21' ' ' ASP . 48.1 mt-10 -69.5 138.8 88.85 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.257 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.22 -36.05 65.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.061 2.507 . . . . 0.0 112.261 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 22' ' ' THR . 45.6 t -64.01 -32.69 74.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.05 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' B' ' 18' ' ' GLU . 55.3 m-20 -56.0 132.54 50.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.824 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 20' ' ' SER . 69.0 p -59.49 148.26 33.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.67 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.592 ' O ' HG22 ' B' ' 26' ' ' VAL . 61.3 mt -54.59 -36.89 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.705 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -67.38 -31.05 71.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.774 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -65.96 -52.04 53.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.061 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.592 HG22 ' O ' ' B' ' 23' ' ' ILE . 24.4 m -58.29 -39.7 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.262 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' B' ' 23' ' ' ILE . 98.8 mttt -66.88 -37.99 85.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.039 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.547 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -50.74 -40.74 55.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.314 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' NZ ' HG12 ' B' ' 17' ' ' VAL . 78.7 mttt -68.23 -40.4 82.06 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' B' ' 27' ' ' LYS . 70.6 mt -54.34 -36.69 34.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.168 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' B' ' 36' ' ' ILE . 67.6 mt-30 -63.79 -44.54 93.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.394 0.616 . . . . 0.0 109.338 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -67.46 -32.48 73.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.62 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.52 ' CD ' HD22 ' B' ' 15' ' ' LEU . 29.6 mtpp -70.61 -32.41 69.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.092 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.861 ' HB2' HD11 ' B' ' 36' ' ' ILE . 56.8 mm-40 -138.14 -55.11 0.65 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.678 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.77 54.89 0.23 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.62 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.861 HD11 ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -135.44 135.63 22.69 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.578 0.228 . . . . 0.0 111.057 -179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.566 ' HB2' ' HG3' ' B' ' 40' ' ' GLN . 75.7 Cg_exo -50.04 138.54 35.52 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.45 2.1 . . . . 0.0 112.028 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' B' ' 27' ' ' LYS . 18.5 Cg_endo -58.03 -35.55 98.67 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.817 2.345 . . . . 0.0 112.496 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -61.18 -36.12 79.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.259 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.718 ' HB3' ' H ' ' A' ' 48' ' ' LYS . 23.3 mt-30 -62.82 -44.2 96.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.57 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.669 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.79 126.42 22.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.785 0.326 . . . . 0.0 110.488 179.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.72 ' H ' ' H ' ' A' ' 46' ' ' ALA . 38.8 ttm180 -93.37 123.71 36.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.664 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.574 HD22 HG22 ' A' ' 3' ' ' ILE . 8.9 mp -74.49 132.5 41.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.046 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.949 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 76.7 mt -143.55 134.21 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.672 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 8.1 m-85 -128.4 144.32 51.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.687 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -152.7 132.39 13.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.954 0.407 . . . . 0.0 111.413 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.7 135.75 51.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.64 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 40' ' ' GLN . 28.1 tptp -71.19 74.7 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.98 0.419 . . . . 0.0 111.235 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' B' ' 51' ' ' GLU . 73.7 mt-30 -65.43 111.72 3.2 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.672 ' H ' HD22 ' B' ' 50' ' ' LEU . 2.8 mm? -53.12 80.26 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.366 -178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' B' ' 49' ' ' GLN . 9.8 mp0 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.917 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.679 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 67.0 m -164.25 -126.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.509 0.195 . . . . 0.0 110.502 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.577 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 17.0 ptm -160.19 117.38 2.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.986 0.422 . . . . 0.0 110.979 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.655 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.3 pt20 -61.86 129.45 41.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.016 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.702 HD11 HD23 ' A' ' 15' ' ' LEU . 36.7 pt -97.49 135.04 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -88.76 125.5 34.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.838 ' HB ' HG13 ' A' ' 13' ' ' ILE . 41.2 t -147.79 134.44 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.692 0.282 . . . . 0.0 111.681 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.815 ' HD2' HE22 ' B' ' 49' ' ' GLN . 24.8 ttmm -93.52 119.62 32.81 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -66.53 -159.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.484 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.906 HD11 HG21 ' A' ' 36' ' ' ILE . 2.3 mm? -81.59 -47.02 13.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -73.47 -45.44 54.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.394 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -35.7 0.55 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.806 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -48.2 133.01 15.83 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.967 0.413 . . . . 0.0 111.591 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 m -84.77 132.88 34.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.04 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.838 HG13 ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -99.97 134.43 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.888 179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.655 HG22 ' HB2' ' A' ' 2' ' ' GLN . 1.1 m -109.01 133.86 52.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.702 HD23 HD11 ' A' ' 3' ' ' ILE . 5.4 tp -159.84 114.85 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.292 0.568 . . . . 0.0 112.099 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 16.9 pt-20 -79.01 137.13 37.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.219 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.27 135.21 4.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.961 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -57.88 140.99 81.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 12.2 Cg_endo -56.34 -40.03 87.38 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.818 2.345 . . . . 0.0 112.127 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 t -64.14 -28.81 70.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.064 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 25' ' ' ASN . 8.3 t70 -53.53 132.33 39.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.631 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.8 p -62.94 144.37 56.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.875 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 26' ' ' VAL . 64.7 mt -55.4 -36.33 40.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.279 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.503 ' HG3' ' ND2' ' A' ' 25' ' ' ASN . 23.8 pt-20 -62.97 -35.67 80.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.4 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.544 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 3.4 m120 -72.93 -48.03 40.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.621 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 23' ' ' ILE . 32.7 m -57.47 -44.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.138 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HE3' ' CG2' ' A' ' 23' ' ' ILE . 99.3 mttt -65.06 -38.44 90.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.904 0.383 . . . . 0.0 110.461 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.26 -37.73 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.151 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HB2' HD21 ' A' ' 15' ' ' LEU . 29.8 mmtp -66.48 -39.67 88.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.996 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.465 HG23 HD12 ' A' ' 13' ' ' ILE . 62.2 mt -56.32 -35.94 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.886 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.751 HE21 ' HA ' ' A' ' 28' ' ' ALA . 71.4 mt-30 -59.66 -44.6 93.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.07 -34.17 77.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.133 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 30' ' ' ILE . 73.1 mmtt -66.27 -25.04 66.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.85 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -150.27 -79.59 0.12 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.943 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.43 57.18 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.235 -0.984 . . . . 0.0 113.236 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.906 HG21 HD11 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -140.97 129.28 12.44 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.465 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.624 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 59.7 Cg_exo -41.63 142.47 1.24 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.263 2.642 . . . . 0.0 113.179 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 25.7 Cg_endo -61.63 -37.26 70.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.958 2.438 . . . . 0.0 112.742 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -58.09 -36.22 72.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.816 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.761 HE22 HG22 ' A' ' 36' ' ' ILE . 18.1 mt-30 -60.5 -44.98 95.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.443 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.63 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.98 125.64 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.861 0.362 . . . . 0.0 110.81 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.673 ' H ' ' H ' ' B' ' 46' ' ' ALA . 99.2 mtt180 -89.2 126.68 35.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.511 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -75.66 130.3 38.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.343 . . . . 0.0 110.857 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.935 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 68.4 mt -143.59 132.03 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.05 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.691 ' HB2' ' HB ' ' B' ' 5' ' ' VAL . 3.3 m-85 -127.34 145.39 50.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.577 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.728 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -149.98 125.47 10.25 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.872 0.368 . . . . 0.0 111.417 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.88 -139.13 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.106 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -70.8 74.88 0.61 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.984 0.421 . . . . 0.0 111.507 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.661 HE22 ' HD2' ' B' ' 6' ' ' LYS . 11.4 mm100 -65.4 99.46 0.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.8 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.6 mm? -44.79 80.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.797 0.685 . . . . 0.0 111.718 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.587 ' N ' ' O ' ' A' ' 49' ' ' GLN . 16.3 tp10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.943 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.551 -0.22 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.892 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 68.6 m -164.4 -124.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.446 0.165 . . . . 0.0 110.646 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 14.8 ptm -163.32 117.16 1.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.029 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.7 130.35 45.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.648 HG12 ' HB3' ' B' ' 15' ' ' LEU . 35.3 pt -97.27 131.88 43.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.278 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.724 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.5 m-85 -88.97 120.85 30.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.865 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.93 HG13 HG13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -150.91 130.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.063 0.459 . . . . 0.0 111.765 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.661 ' HD2' HE22 ' A' ' 49' ' ' GLN . 24.6 ttmm -83.13 126.64 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.385 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -70.57 -157.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 111.309 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.699 HD21 HG12 ' B' ' 36' ' ' ILE . 2.0 mm? -83.0 -48.33 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 73.0 p -71.77 -45.29 62.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.27 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.9 -34.22 0.62 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.763 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -49.43 130.91 20.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.025 0.44 . . . . 0.0 111.863 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 37.2 m -80.92 147.27 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.901 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.93 HG13 HG13 ' B' ' 5' ' ' VAL . 18.6 pt -129.36 124.78 60.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 0.0 112.477 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -92.88 146.89 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.178 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.648 ' HB3' HG12 ' B' ' 3' ' ' ILE . 5.3 tt -164.2 114.62 1.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 0.0 110.829 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.892 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 11.3 pt-20 -78.02 138.05 38.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.622 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.584 HG13 ' CD2' ' B' ' 15' ' ' LEU . 1.0 OUTLIER -157.25 133.41 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.943 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -59.14 138.28 88.11 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.154 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.448 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 9.3 Cg_endo -52.51 -39.06 75.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.917 2.412 . . . . 0.0 112.106 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.5 t -63.93 -29.8 70.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.155 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.554 ' OD1' ' HB2' ' B' ' 25' ' ' ASN . 8.2 t70 -53.81 131.87 40.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 0.0 110.526 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -62.42 144.01 56.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.916 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 19' ' ' PRO . 65.2 mt -55.22 -35.72 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.519 ' HG3' ' ND2' ' B' ' 25' ' ' ASN . 24.4 pt-20 -63.15 -36.14 82.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.347 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.554 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 3.5 m120 -72.7 -48.37 39.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.602 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.433 HG22 ' O ' ' B' ' 23' ' ' ILE . 31.0 m -57.23 -43.76 82.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.652 0.263 . . . . 0.0 111.053 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.438 ' HE3' ' CG2' ' B' ' 23' ' ' ILE . 99.0 mttt -65.09 -38.34 90.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.932 0.396 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.718 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -55.18 -37.07 66.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.575 ' HB2' HD11 ' B' ' 15' ' ' LEU . 58.0 mmtt -64.56 -43.5 93.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' B' ' 33' ' ' LYS . 65.4 mt -53.5 -36.29 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.147 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.718 HE21 ' HA ' ' B' ' 28' ' ' ALA . 71.8 mt-30 -59.82 -45.57 91.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -67.57 -33.46 75.08 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.229 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.525 ' HG3' HD12 ' B' ' 15' ' ' LEU . 72.7 mmtt -65.44 -25.29 67.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.169 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' B' ' 36' ' ' ILE . 17.7 tp10 -152.61 -68.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.299 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.85 55.7 0.04 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.72 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.889 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -133.89 133.33 22.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.51 0.195 . . . . 0.0 111.28 -179.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.625 ' HD2' ' NE2' ' B' ' 40' ' ' GLN . 71.7 Cg_exo -51.04 139.59 41.85 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.451 2.101 . . . . 0.0 112.092 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.561 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 19.8 Cg_endo -58.29 -35.75 98.39 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.831 2.354 . . . . 0.0 112.679 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.889 ' NE2' HG22 ' B' ' 36' ' ' ILE . 27.1 mt-30 -63.33 -41.96 98.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -56.25 126.36 25.88 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.834 0.349 . . . . 0.0 110.488 179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.728 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.4 mtt180 -86.16 127.04 34.65 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.51 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.616 HD23 HG22 ' A' ' 3' ' ' ILE . 5.4 tp -78.3 127.6 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.656 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.935 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 70.5 mt -143.71 138.15 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-O 120.88 0.371 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.63 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 3.6 m-85 -131.24 148.67 52.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.477 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.673 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -151.9 124.26 8.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.936 0.398 . . . . 0.0 111.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.94 -140.43 0.05 OUTLIER Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.356 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -71.62 75.05 0.81 Allowed 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.905 0.383 . . . . 0.0 111.553 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.815 HE22 ' HD2' ' A' ' 6' ' ' LYS . 11.3 mm100 -64.41 111.07 2.49 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.726 ' H ' HD22 ' B' ' 50' ' ' LEU . 2.7 mm? -52.76 80.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.559 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' B' ' 49' ' ' GLN . 38.3 tp10 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.007 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.522 ' C ' ' HB2' ' A' ' 16' ' ' GLU . 47.9 t -171.46 -50.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.726 0.298 . . . . 0.0 111.077 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 20.3 ptm -100.12 112.75 25.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.233 0.539 . . . . 0.0 111.248 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.476 ' CG ' ' HB ' ' A' ' 14' ' ' THR . 36.5 tt0 -62.95 120.79 12.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.819 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 15' ' ' LEU . 36.3 pt -99.7 143.07 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 112.22 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.4 m-85 -89.86 135.31 33.71 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.124 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.799 ' HB ' HG13 ' A' ' 13' ' ' ILE . 67.4 t -148.79 132.76 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.927 0.394 . . . . 0.0 111.425 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -92.46 129.22 38.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.698 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 11' ' ' LYS . 61.5 p -77.37 -157.12 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.29 . . . . 0.0 110.908 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.865 HD21 HG21 ' A' ' 36' ' ' ILE . 51.7 mt -83.45 -53.49 5.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.57 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.4 p -73.16 -45.28 57.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.592 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.32 -27.15 0.25 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.325 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' HG23 ' A' ' 7' ' ' THR . 4.0 tppp? -43.24 130.36 4.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.127 0.489 . . . . 0.0 111.952 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -89.21 138.84 31.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.981 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.799 HG13 ' HB ' ' A' ' 5' ' ' VAL . 14.2 pt -125.4 133.85 68.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.271 0.558 . . . . 0.0 111.907 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' CG ' ' A' ' 2' ' ' GLN . 4.7 p -117.72 144.27 45.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.623 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' O ' HG12 ' A' ' 3' ' ' ILE . 3.3 pp -168.0 124.73 1.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.292 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -77.15 143.01 39.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -179.344 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 15' ' ' LEU . 3.7 m -150.97 132.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.86 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 85.5 mt-10 -63.38 137.83 97.19 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.235 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.75 -36.19 61.24 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.13 2.553 . . . . 0.0 112.5 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.42 ' O ' HG22 ' B' ' 22' ' ' THR . 45.0 t -63.87 -33.23 75.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.094 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.637 ' OD1' ' HB2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -56.47 133.23 53.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.7 p -60.27 148.47 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.826 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.723 HD11 HG21 ' B' ' 26' ' ' VAL . 69.0 mt -54.67 -45.33 72.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.864 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 12.1 pt-20 -59.82 -36.09 76.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.751 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.552 HD22 ' HB3' ' A' ' 21' ' ' ASP . 42.7 t30 -63.59 -48.25 78.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.752 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 23' ' ' ILE . 11.0 m -64.82 -41.01 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.171 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.42 -39.21 93.89 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.666 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -55.24 -37.45 67.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HE3' HG12 ' A' ' 17' ' ' VAL . 48.4 mttm -63.64 -41.95 98.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.643 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 13' ' ' ILE . 70.8 mt -55.09 -39.33 49.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.421 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.563 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 43.1 tt0 -61.17 -47.13 87.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.153 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -60.01 -37.38 79.54 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.051 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 4.5 mmmp? -66.18 -42.42 88.91 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.948 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -124.55 -70.21 0.77 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.083 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 31' ' ' GLN . . . 161.0 -37.34 0.42 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.254 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.983 HG22 HE22 ' A' ' 40' ' ' GLN . 0.7 OUTLIER -44.61 126.09 4.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.679 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -47.1 142.73 11.1 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 123.305 2.67 . . . . 0.0 112.761 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 46.8 Cg_exo -56.33 -37.34 97.1 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.766 2.311 . . . . 0.0 112.475 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.75 -38.32 81.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.327 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.983 HE22 HG22 ' A' ' 36' ' ' ILE . 26.0 mt-30 -60.51 -39.27 87.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.743 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.696 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -54.64 124.09 15.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.823 0.344 . . . . 0.0 110.756 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' B' ' 45' ' ' PHE . 99.3 mtt180 -89.54 128.57 36.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.431 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HG22 ' B' ' 3' ' ' ILE . 23.7 mt -74.27 130.55 39.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.838 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 76.6 mt -143.88 133.04 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.66 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.75 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 11.2 m-85 -130.33 147.23 52.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.725 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -156.82 123.99 5.25 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 111.562 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.31 138.08 47.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.661 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' H ' ' HB3' ' B' ' 40' ' ' GLN . 97.5 mttt -59.26 120.41 9.2 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.794 0.807 . . . . 0.0 111.317 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.598 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.9 pt20 -149.16 99.78 2.98 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.986 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' H ' ' CD2' ' A' ' 50' ' ' LEU . 3.5 mm? -44.96 80.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.692 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 49' ' ' GLN . 5.6 tp10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.423 ' N ' ' HB2' ' B' ' 16' ' ' GLU . 48.0 t -173.0 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.702 0.287 . . . . 0.0 111.156 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 20.6 ptm -109.63 117.53 34.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.465 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.435 ' NE2' HG21 ' B' ' 14' ' ' THR . 27.6 mt-30 -62.03 130.52 45.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.249 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.709 HG12 ' O ' ' B' ' 15' ' ' LEU . 31.1 pt -104.09 139.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.592 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.559 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.0 m-85 -88.86 129.78 35.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.685 ' HB ' HG13 ' B' ' 13' ' ' ILE . 62.0 t -144.07 134.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 111.462 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -96.09 127.73 42.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.567 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 66.3 p -76.54 -157.17 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.961 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.586 HD11 HG23 ' B' ' 36' ' ' ILE . 7.7 mp -83.04 -52.63 6.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.519 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -74.27 -45.27 48.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.67 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.07 -28.45 0.27 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.559 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -42.96 130.68 4.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.053 0.454 . . . . 0.0 111.755 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 78.6 m -90.36 130.46 36.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.768 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.685 HG13 ' HB ' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -106.22 129.5 59.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.115 0.483 . . . . 0.0 112.002 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.435 HG21 ' NE2' ' B' ' 2' ' ' GLN . 1.9 m -107.46 136.33 47.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.709 ' O ' HG12 ' B' ' 3' ' ' ILE . 0.1 OUTLIER -163.36 115.64 1.49 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.347 0.594 . . . . 0.0 111.864 -178.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' B' ' 1' ' ' MET . 23.9 pt-20 -76.92 139.27 40.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.439 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -151.26 138.09 12.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.645 ' HB2' ' OD1' ' B' ' 21' ' ' ASP . 85.5 mt-10 -67.33 140.52 95.31 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.03 -37.62 86.56 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.082 2.521 . . . . 0.0 112.497 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.3 t -63.85 -32.97 74.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.188 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.645 ' OD1' ' HB2' ' B' ' 18' ' ' GLU . 1.0 OUTLIER -56.21 132.93 51.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 20' ' ' SER . 80.4 p -60.65 149.07 36.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.792 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.816 HD13 HD21 ' B' ' 43' ' ' LEU . 67.1 mt -55.2 -45.07 77.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -59.12 -41.62 88.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.834 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . 0.457 HD22 ' HB3' ' B' ' 21' ' ' ASP . 37.5 t30 -61.4 -44.14 97.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.515 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.723 HG21 HD11 ' A' ' 23' ' ' ILE . 16.8 t -61.47 -47.85 91.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.388 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 47.7 mtmt -65.08 -36.38 84.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.303 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.683 ' O ' ' HG2' ' B' ' 31' ' ' GLN . . . -56.51 -32.65 65.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 111.152 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' B' ' 25' ' ' ASN . 50.4 mttm -69.26 -33.84 73.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.183 0.516 . . . . 0.0 109.735 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.625 HG23 HD12 ' B' ' 13' ' ' ILE . 60.9 mt -61.75 -42.18 93.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.597 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 2.7 pt20 -66.35 -45.33 80.57 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' B' ' 31' ' ' GLN . 63.7 t0 -58.77 -31.73 68.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' B' ' 30' ' ' ILE . 22.9 tptp -73.27 -32.23 64.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.556 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.403 ' HB3' HD11 ' B' ' 36' ' ' ILE . 36.9 tp10 -139.31 -64.76 0.49 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.004 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 159.07 -32.56 0.46 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.343 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.811 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.3 OUTLIER -49.74 128.95 20.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.478 ' HD2' ' CD ' ' B' ' 40' ' ' GLN . 50.4 Cg_exo -54.57 140.58 75.37 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.68 2.254 . . . . 0.0 111.668 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.605 ' HB3' ' HB2' ' B' ' 27' ' ' LYS . 53.6 Cg_exo -52.75 -37.26 75.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.563 2.175 . . . . 0.0 112.665 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -61.11 -37.4 82.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.564 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.811 ' NE2' HG22 ' B' ' 36' ' ' ILE . 24.5 mt-30 -62.87 -38.97 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.75 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -53.68 126.43 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.698 0.285 . . . . 0.0 110.588 179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.725 ' H ' ' H ' ' A' ' 46' ' ' ALA . 99.4 mtt180 -92.35 127.48 37.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.992 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.816 HD21 HD13 ' B' ' 23' ' ' ILE . 7.7 mp -72.86 129.07 37.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.226 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.952 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 77.9 mt -143.89 131.64 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.696 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 5.3 m-85 -128.94 145.86 51.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.747 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.616 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -155.81 126.09 6.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 111.461 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.76 137.84 46.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.443 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' HE ' ' A' ' 42' ' ' ARG . 98.2 mttt -59.7 122.42 14.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.551 0.691 . . . . 0.0 111.375 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.506 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.0 pt20 -149.63 114.28 5.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.035 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.464 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.4 mm? -56.32 79.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.183 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' B' ' 49' ' ' GLN . 5.6 tp10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.711 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.417 ' HA3' ' CD ' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 81.0 p -61.79 -60.45 3.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 ptm 177.61 112.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.702 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 1.041 ' HB2' HG22 ' A' ' 14' ' ' THR . 19.3 pt20 -69.05 130.12 41.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.082 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 15' ' ' LEU . 5.0 pt -99.75 147.05 7.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.79 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 4.6 m-85 -89.57 126.98 35.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.911 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.709 ' HB ' HG13 ' A' ' 13' ' ' ILE . 85.1 t -149.5 137.28 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 0.0 111.277 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -104.62 129.67 52.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.391 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -68.38 -157.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.117 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.529 ' H ' HD12 ' A' ' 8' ' ' LEU . 3.6 mp -86.57 -51.58 6.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.242 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.8 p -72.11 -45.48 60.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.729 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.06 -29.73 0.26 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.836 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -43.97 129.91 5.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.967 0.413 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -90.27 137.53 32.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.339 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.709 HG13 ' HB ' ' A' ' 5' ' ' VAL . 3.7 pt -122.87 134.63 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 111.344 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.041 HG22 ' HB2' ' A' ' 2' ' ' GLN . 3.8 m -127.0 105.1 8.37 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.66 ' O ' HG12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -123.68 127.91 48.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 1' ' ' MET . 12.5 pt-20 -72.39 139.27 47.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.83 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -150.26 135.17 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HB2' ' OD2' ' A' ' 21' ' ' ASP . 80.4 mt-10 -64.22 137.9 97.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.235 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.34 -36.58 97.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.831 2.354 . . . . 0.0 112.031 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.583 ' O ' HG22 ' B' ' 22' ' ' THR . 43.4 t -64.19 -33.94 76.95 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.898 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.621 ' OD2' ' HB2' ' A' ' 18' ' ' GLU . 30.2 m-20 -57.99 133.33 55.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.576 HG22 ' O ' ' B' ' 20' ' ' SER . 76.1 p -58.49 149.51 25.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.453 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.623 HG22 ' NZ ' ' A' ' 27' ' ' LYS . 63.2 mt -53.33 -38.23 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.846 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.426 ' HA ' ' HZ1' ' A' ' 27' ' ' LYS . 17.1 tp10 -59.27 -42.29 90.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.452 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.71 -44.9 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.774 HG21 HD11 ' B' ' 23' ' ' ILE . 24.3 t -57.34 -48.93 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.176 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.623 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 36.8 mtmm -66.04 -35.56 80.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.829 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.845 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -55.27 -38.43 68.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.178 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HE2' ' NZ ' ' A' ' 33' ' ' LYS . 87.9 tttt -67.28 -38.86 85.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.04 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.601 HD12 ' HG2' ' A' ' 41' ' ' GLN . 58.4 mt -58.12 -34.29 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.891 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.845 HE21 ' HA ' ' A' ' 28' ' ' ALA . 54.7 mt-30 -64.08 -44.46 92.31 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.37 -32.58 71.43 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' NZ ' ' HE2' ' A' ' 29' ' ' LYS . 36.2 mmtm -71.67 -30.09 65.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.03 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -140.96 -66.49 0.43 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.204 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . 150.86 -32.15 0.98 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.901 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.852 HG22 HE21 ' A' ' 40' ' ' GLN . 0.6 OUTLIER -48.66 127.05 13.53 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD2' ' HG3' ' A' ' 40' ' ' GLN . 94.4 Cg_exo -46.63 158.76 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.014 2.476 . . . . 0.0 112.43 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HD3' ' NE2' ' A' ' 31' ' ' GLN . 17.1 Cg_endo -57.74 -37.37 96.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.598 2.198 . . . . 0.0 112.262 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -60.08 -33.62 72.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.852 HE21 HG22 ' A' ' 36' ' ' ILE . 15.3 mm100 -52.26 -55.94 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.091 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 0.5 OUTLIER -56.79 128.24 35.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.296 -179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.783 ' H ' ' H ' ' B' ' 46' ' ' ALA . 38.2 mmt180 -96.83 125.65 41.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.467 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 23' ' ' ILE . 9.4 mp -68.81 122.52 18.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.539 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' B' ' 4' ' ' PHE . 62.4 mt -143.75 130.48 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.072 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.716 ' HB2' HG22 ' B' ' 5' ' ' VAL . 8.8 m-85 -130.03 145.12 51.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.794 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.766 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -146.42 127.45 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 111.16 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' HA2' ' C ' ' B' ' 40' ' ' GLN . . . -69.62 -141.85 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.304 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -71.92 75.18 0.9 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.917 0.389 . . . . 0.0 111.274 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 51' ' ' GLU . 85.6 mt-30 -65.32 102.02 0.63 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mp -44.83 80.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.714 0.634 . . . . 0.0 111.712 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 49' ' ' GLN . 5.0 mm-40 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . 0.414 ' HA3' ' CD ' ' B' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . . . . . . . . . 79.6 p -62.43 -59.75 4.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.718 0.295 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' B' ' 16' ' ' GLU . 21.3 ptm 177.69 110.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.964 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.996 ' HB2' HG22 ' B' ' 14' ' ' THR . 19.2 pt20 -68.97 127.02 31.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.747 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.504 HG12 ' O ' ' B' ' 15' ' ' LEU . 26.1 pt -99.86 150.04 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.479 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 3.5 m-85 -89.1 129.43 35.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.358 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.716 HG22 ' HB2' ' A' ' 45' ' ' PHE . 87.8 t -149.74 137.27 13.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -104.38 130.27 52.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.288 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' B' ' 8' ' ' LEU . 76.6 p -70.62 -157.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.954 0.406 . . . . 0.0 111.678 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.52 HD11 HG21 ' B' ' 36' ' ' ILE . 4.8 mp -82.44 -56.66 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.433 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 77.3 p -71.2 -45.44 63.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.881 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.29 -28.64 0.24 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.8 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -43.62 128.09 5.09 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.928 0.394 . . . . 0.0 111.305 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -87.53 137.17 32.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.198 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.715 HG13 ' HB ' ' B' ' 5' ' ' VAL . 4.5 pt -123.59 128.44 74.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 111.441 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.996 HG22 ' HB2' ' B' ' 2' ' ' GLN . 7.5 m -124.01 110.51 14.87 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.67 HD13 ' HG3' ' B' ' 33' ' ' LYS . 1.5 pt? -136.19 131.17 34.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.406 0.622 . . . . 0.0 111.846 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' B' ' 1' ' ' MET . 11.8 pt-20 -70.03 142.96 52.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.883 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.528 ' HB ' HG12 ' B' ' 26' ' ' VAL . 21.2 m -152.27 134.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.191 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.467 ' HB2' ' CG ' ' B' ' 21' ' ' ASP . 86.6 mt-10 -61.97 137.45 95.48 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.645 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.11 -39.19 81.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.831 2.354 . . . . 0.0 111.914 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.576 ' O ' HG22 ' A' ' 22' ' ' THR . 47.1 t -64.15 -30.64 71.69 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.651 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.467 ' CG ' ' HB2' ' B' ' 18' ' ' GLU . 46.5 m-20 -59.77 132.71 54.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 20' ' ' SER . 74.5 p -57.44 149.59 20.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.502 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.774 HD11 HG21 ' A' ' 26' ' ' VAL . 64.4 mt -54.27 -37.78 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 109.705 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.416 ' HA ' ' NZ ' ' B' ' 27' ' ' LYS . 4.6 tp10 -60.22 -37.4 80.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.453 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -66.58 -48.43 69.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.576 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.626 HG22 ' O ' ' B' ' 23' ' ' ILE . 9.4 m -60.65 -42.24 91.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.031 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.637 ' HZ2' HG22 ' B' ' 23' ' ' ILE . 36.8 mtmm -65.68 -38.1 88.34 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.922 0.391 . . . . 0.0 110.258 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.838 ' HA ' HE21 ' B' ' 31' ' ' GLN . . . -55.91 -36.44 67.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.854 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.489 ' HG2' HD12 ' B' ' 15' ' ' LEU . 88.3 tttt -68.51 -39.51 81.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.044 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.623 HD12 ' HG2' ' B' ' 41' ' ' GLN . 59.3 mt -57.67 -33.86 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.685 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.838 HE21 ' HA ' ' B' ' 28' ' ' ALA . 59.6 mt-30 -63.34 -47.18 83.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.16 -31.01 68.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.67 ' HG3' HD13 ' B' ' 15' ' ' LEU . 25.7 mmtp -75.18 -27.07 59.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.139 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -141.48 -66.74 0.41 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.158 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 149.31 -32.04 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.041 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.858 HG22 HE21 ' B' ' 40' ' ' GLN . 0.7 OUTLIER -50.41 129.53 25.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' B' ' 40' ' ' GLN . 91.0 Cg_exo -47.17 157.98 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.979 2.452 . . . . 0.0 112.323 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.663 ' HD3' ' NE2' ' B' ' 31' ' ' GLN . 13.9 Cg_endo -58.14 -36.06 98.2 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.451 2.101 . . . . 0.0 112.152 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -60.4 -33.45 72.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.858 HE21 HG22 ' B' ' 36' ' ' ILE . 15.4 mm100 -52.2 -55.52 20.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.029 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -56.65 127.92 33.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.766 ' H ' ' H ' ' A' ' 46' ' ' ALA . 37.5 mmt180 -96.1 126.23 41.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.554 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.401 ' N ' HD12 ' B' ' 43' ' ' LEU . 8.9 mp -69.57 122.05 18.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.415 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 76.0 mt -143.79 130.1 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.044 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.693 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.7 m-85 -129.93 144.63 51.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.74 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.783 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -144.97 128.11 16.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 111.175 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.459 ' HA2' ' C ' ' A' ' 40' ' ' GLN . . . -70.03 -142.07 0.17 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.347 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -74.73 74.82 2.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.007 0.432 . . . . 0.0 111.572 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' B' ' 51' ' ' GLU . 82.6 mt-30 -64.84 112.01 3.07 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.624 ' H ' HD22 ' B' ' 50' ' ' LEU . 1.4 mm? -52.5 80.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.296 0.372 . . . . 0.0 111.428 -178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' B' ' 49' ' ' GLN . 5.0 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.788 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 16' ' ' GLU . 53.6 m 56.05 -140.19 0.9 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.515 0.198 . . . . 0.0 111.05 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 1' ' ' MET . 15.7 tpt -82.23 48.81 1.31 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.028 0.442 . . . . 0.0 111.176 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.614 ' HB2' HG22 ' A' ' 14' ' ' THR . 18.9 pt20 -61.84 111.13 1.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.229 0.538 . . . . 0.0 110.607 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' LEU . 34.9 pt -84.87 141.59 14.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.581 ' O ' ' HA ' ' B' ' 44' ' ' ILE . 1.8 m-85 -87.82 130.16 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.751 ' HB ' HG23 ' A' ' 13' ' ' ILE . 86.6 t -145.17 145.27 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.027 0.441 . . . . 0.0 111.553 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.535 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 67.3 mttm -108.33 129.81 55.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.323 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -68.29 -156.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.324 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.33 -52.06 66.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.5 t -76.63 -45.1 31.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.995 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 6' ' ' LYS . . . 143.21 32.76 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.488 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 61.8 tttp -81.32 131.12 35.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 111.084 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -73.04 136.79 45.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.437 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.751 HG23 ' HB ' ' A' ' 5' ' ' VAL . 1.3 tt -139.49 124.08 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 111.749 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.614 HG22 ' HB2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -86.54 144.12 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.984 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.622 HD23 ' C ' ' A' ' 15' ' ' LEU . 5.0 tt -158.32 113.31 2.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.805 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 0' ' ' SER . 25.7 pt-20 -88.18 132.64 34.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.588 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.684 HG21 HG13 ' A' ' 26' ' ' VAL . 2.9 m -159.92 146.36 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -56.73 139.24 76.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' O ' ' HB ' ' B' ' 23' ' ' ILE . 33.5 Cg_endo -61.9 -40.06 46.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.838 2.358 . . . . 0.0 112.348 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.7 m -63.85 -20.55 65.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.795 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -57.51 134.21 55.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 26' ' ' VAL . 67.5 p -56.6 142.87 37.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.485 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.554 HG12 HG12 ' B' ' 23' ' ' ILE . 66.2 mt -57.75 -40.62 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.5 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -58.77 -44.57 90.65 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.138 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.61 -44.52 86.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG13 HG21 ' A' ' 17' ' ' VAL . 60.3 t -59.16 -49.28 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.179 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 49.6 mtmt -63.33 -36.76 84.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.518 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.572 ' HA ' ' HG3' ' A' ' 38' ' ' PRO . . . -53.81 -36.12 62.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.875 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 86.7 tttt -69.54 -39.17 77.64 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.117 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.736 ' HB ' HE22 ' A' ' 41' ' ' GLN . 36.9 mm -54.87 -38.55 45.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-O 121.101 0.477 . . . . 0.0 109.775 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -60.37 -48.96 79.51 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.32 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -63.91 -30.52 71.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.449 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 30.7 mmmt -72.05 -32.1 66.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.23 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -138.91 -65.69 0.49 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.983 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.98 -40.39 0.52 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.444 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.812 HG22 HE22 ' A' ' 40' ' ' GLN . 0.9 OUTLIER -45.06 126.78 5.49 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.806 ' HD2' ' NE2' ' A' ' 40' ' ' GLN . 87.2 Cg_exo -45.93 139.64 10.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.019 2.479 . . . . 0.0 112.399 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 45.6 Cg_exo -56.26 -40.6 83.72 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.37 2.046 . . . . 0.0 111.879 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.32 -36.04 81.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.275 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.812 HE22 HG22 ' A' ' 36' ' ' ILE . 6.5 tt0 -60.28 -37.15 79.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.092 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.845 ' HB3' ' HB3' ' B' ' 45' ' ' PHE . 71.6 mt-30 -56.33 132.05 49.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.692 ' H ' ' H ' ' B' ' 46' ' ' ALA . 56.3 ttp180 -91.82 125.61 36.59 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD21 ' HD3' ' A' ' 27' ' ' LYS . 14.5 mt -74.46 132.17 41.68 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.705 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' B' ' 44' ' ' ILE . 75.8 mt -143.73 133.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.808 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' B' ' 41' ' ' GLN . 15.4 m-85 -129.69 143.73 50.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.434 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' B' ' 42' ' ' ARG . . . -157.16 127.37 6.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.964 0.412 . . . . 0.0 111.722 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' B' ' 36' ' ' ILE . . . -73.65 138.88 25.58 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.541 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.714 ' H ' ' HG2' ' B' ' 40' ' ' GLN . 23.4 tptm -159.91 74.67 0.59 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.554 0.692 . . . . 0.0 111.089 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' GLU . 3.1 pt20 -71.27 105.14 3.35 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.839 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.775 HD22 ' H ' ' A' ' 50' ' ' LEU . 2.2 mm? -48.81 80.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.462 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' GLN . 40.5 tt0 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.843 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -1' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' B' ' 16' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 0' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' B' ' 16' ' ' GLU . 55.8 m 56.04 -140.61 0.88 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.541 0.21 . . . . 0.0 111.021 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' B' ' 1' ' ' MET . 15.7 tpt -82.14 48.84 1.3 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.895 0.378 . . . . 0.0 111.205 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . 0.514 ' HA ' ' C ' ' B' ' 15' ' ' LEU . 18.4 pt20 -61.72 111.82 2.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.235 0.541 . . . . 0.0 110.841 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.803 HD11 HD23 ' B' ' 15' ' ' LEU . 30.5 pt -85.53 142.29 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 1.6 m-85 -88.25 126.59 35.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.695 ' HB ' HG12 ' B' ' 13' ' ' ILE . 89.6 t -142.61 139.44 28.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.156 0.503 . . . . 0.0 111.519 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.6 ' HB3' ' HA2' ' B' ' 10' ' ' GLY . 67.1 mttm -102.96 131.52 49.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.547 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -67.8 -156.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 27.0 mt -62.01 -50.5 71.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 110.708 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.427 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.8 t -75.62 -45.17 38.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.047 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.6 ' HA2' ' HB3' ' B' ' 6' ' ' LYS . . . 142.89 34.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.652 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' B' ' 6' ' ' LYS . 60.5 tttp -82.4 128.4 34.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.776 0.322 . . . . 0.0 111.181 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -73.07 135.84 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.62 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.695 HG12 ' HB ' ' B' ' 5' ' ' VAL . 4.2 pt -137.44 134.94 46.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.018 0.437 . . . . 0.0 111.097 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 1.1 p -94.25 144.28 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.121 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.803 HD23 HD11 ' B' ' 3' ' ' ILE . 6.0 tp -156.82 113.01 2.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.961 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' B' ' 0' ' ' SER . 15.5 pt-20 -86.67 129.16 34.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.961 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.531 HG21 HG13 ' B' ' 26' ' ' VAL . 6.6 m -157.11 143.99 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.664 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -56.52 137.0 76.91 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.61 -39.63 72.84 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.824 2.349 . . . . 0.0 112.187 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 22' ' ' THR . 50.5 m -64.07 -24.6 67.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.887 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -54.01 134.06 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.633 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.432 ' O ' HG23 ' B' ' 26' ' ' VAL . 71.3 p -56.48 143.19 36.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.518 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.624 HG21 HD21 ' B' ' 43' ' ' LEU . 66.4 mt -58.09 -40.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.436 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -59.03 -44.87 91.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.051 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.35 -44.36 87.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.531 HG13 HG21 ' B' ' 17' ' ' VAL . 98.4 t -59.15 -48.81 85.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.255 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' B' ' 23' ' ' ILE . 49.4 mtmt -65.07 -35.82 82.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.678 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.657 ' HA ' ' HG3' ' B' ' 38' ' ' PRO . . . -54.31 -34.46 61.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.547 ' HD3' HD11 ' B' ' 15' ' ' LEU . 87.1 tttt -73.79 -32.27 63.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.384 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.756 ' HB ' HE22 ' B' ' 41' ' ' GLN . 40.8 mm -56.94 -44.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.426 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' B' ' 28' ' ' ALA . 23.9 pt20 -64.99 -39.15 93.03 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.64 -32.31 72.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' B' ' 29' ' ' LYS . 31.0 mmmt -74.97 -31.17 61.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.799 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' B' ' 36' ' ' ILE . 5.1 tp10 -139.13 -64.03 0.51 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.17 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' B' ' 31' ' ' GLN . . . 156.61 -32.71 0.58 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.11 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.845 HG22 ' NE2' ' B' ' 40' ' ' GLN . 0.1 OUTLIER -47.95 124.03 10.3 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.702 ' HG2' ' HB2' ' B' ' 40' ' ' GLN . 2.3 Cg_endo -48.64 137.82 25.98 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.586 2.19 . . . . 0.0 111.412 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.657 ' HG3' ' HA ' ' B' ' 28' ' ' ALA . 50.2 Cg_exo -53.47 -39.91 80.47 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.472 2.115 . . . . 0.0 112.412 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -68.03 -35.93 79.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.635 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.845 ' NE2' HG22 ' B' ' 36' ' ' ILE . 7.0 tt0 -60.74 -36.69 79.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 111.145 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.756 HE22 ' HB ' ' B' ' 30' ' ' ILE . 70.8 mt-30 -57.23 132.13 52.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.295 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 56.4 ttp180 -91.64 127.55 37.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.657 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.624 HD21 HG21 ' B' ' 23' ' ' ILE . 8.3 mp -75.86 130.88 39.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.939 ' HB ' ' HB ' ' A' ' 44' ' ' ILE . 72.9 mt -143.52 134.23 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.845 ' HB3' ' HB3' ' A' ' 41' ' ' GLN . 9.9 m-85 -129.94 141.78 50.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.294 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.692 ' H ' ' H ' ' A' ' 42' ' ' ARG . . . -154.54 123.18 6.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.093 0.473 . . . . 0.0 112.068 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 40' ' ' GLN . . . -70.8 137.54 27.16 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.436 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.622 ' H ' ' HG2' ' A' ' 40' ' ' GLN . 23.5 tptm -159.81 74.82 0.6 Allowed 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.357 0.599 . . . . 0.0 110.883 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' B' ' 51' ' ' GLU . 3.1 pt20 -68.3 115.5 7.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.197 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.452 HD22 ' N ' ' B' ' 50' ' ' LEU . 3.0 mm? -55.89 79.72 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.287 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 49' ' ' GLN . 43.6 tt0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.891 179.977 . . . . . . . . 1 1 . 1 stop_ save_